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Zusammenfassung 
Prenylierte Rab-GTPasen regulieren den intrazellulären Transport in 
eukaryotischen Zellen durch Assoziation mit spezifischen Membranen sowie durch 
Rekrutierung einer Reihe von Rab-spezifischen Effektorproteinen. Die Katalyse der 
Prenylierung der mehr als 60 Mitglieder der Rab-GTPase-Familie erfolgt durch die 
Rab-Geranylgeranyltransferase (RabGGTase), wobei die Rab-Proteine mit dem Rab 
Escort Protein (REP) komplexiert sind. Das Recycling der Rab-GTPasen wird durch 
ein dem REP verwandten Protein, dem GDP dissociation inhibitor (GDI), reguliert. 
Diese zwei Regulatoren besitzen beide die Fähigkeit, einen Komplex mit prenylierten 
Rab-Proteinen zu bilden und dadurch als molekulare Chaperone zu fungieren, um 
unspezifische Aggregation zu verhindern, sowie prenylierte Rabs zu ihren 
Zielmembranen zu transportieren. Erst kürzlich wurde die gezielte Beeinflussung der 
Prenylierung von Rab-GTPasen als hoffnungsvolle Krebs- und Osteoporosetherapie 
beschrieben.  
Mechanistische Studien der Rab-Prenylierung und die Identifizierung von 
RabGGTase-Inhibitoren setzen einen sensitiven und zweckmäßigen Rab-
Prenylierungsassay voraus. Zudem kann die Untersuchung der Interaktion 
prenylierter Rabs mit REP/GDI dem Verständnis des molekularen Mechanismus des 
Rab-Recyclings durch REP/GDI und der funktionalen Segregation beider 
Regulatoren dienen. Die biophysikalische Analyse der Interaktion wird jedoch 
aufgrund der geringen Löslichkeit prenylierter Proteine in wässriger Lösung 
kompliziert. 
In der vorliegenden Doktorarbeit wurden Methoden des Proteinengineerings, der 
organischen Synthese sowie der Expressed Protein Ligation (EPL) angewandt, um 
ein Ensemble semisynthetischer, fluoreszenter Rab7-Konjugate herzustellen. Hierzu 
wurde eine Vielzahl an Fluorophoren unterschiedlicher Anregungswellenlängen an 
Cystein- oder Lysin-Aminosäurereste in der Nähe des Prenylierungsmotives 
gekoppelt. Zwei Konstrukte, Rab7CCK(NBD) und Rab7SCCC-dans, zeigten einen 
200%igen bzw. 50%igen Anstieg der Fluoreszenz in Folge von Prenylierung. Des 
Weiteren wiesen Rab7-Konstrukte mit einem dans-, NBD-, I-BA- oder I-SO-Label 
eine 2-10-fache Fluoreszenzänderung nach Bindung an REP oder RabGGTase auf.  
Diese fluoreszenzsensitiven Sensoren wurden zur Untersuchung der Bildung des 
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binären Rab:REP-Komplexes sowie des ternären Rab:REP:RabGGTase-Komplexes 
herangezogen.  
Außerdem zeigte ein synthetisches fluoreszentes Analog des 
Phosphoisoprenoids, NBD-Farnesylpyrophosphat (NBD-FPP), einen 23-fachen 
Fluoreszenzanstieg nach Einbau in das Rab-Protein. Kinetische und 
thermodynamische Analysen wiesen auf, dass dieser Prozess verschieden von der 
Prenylierung mit dem physiologischen Substrat Geranylgeranyl-pyrophosphat 
(GGPP) erfolgt. NBD-FPP wurde dazu genutzt, die Rab-Prenylierung in vitro zu 
verfolgen und einen fluorometrischen Assay im Hochdurchsatzformat für die 
Prenylierung durch RabGGTase zu entwickeln, welches die Identifizierung von 
RabGGTase-Inhibitoren ermöglichte.  
Mittels dieses Assay wurde eine Peptidbibliothek von etwa 400 chemischen 
Verbindungen gescreent. Dies führte zur Identifizierung mehrerer potenter (niedrige 
mikromolare IC50-Werte), spezifischer sowie zellulär aktiver RabGGTase-Inhibitoren 
mit aromatischen Aminosäureresten (Phe, His, Tyr) im zentralen Kern des Peptides 
(R2-R4), einer langen Lipidkette oder einem Arylring am N-Terminus (R5) und einer 
potentiell Zink-bindenden Gruppe wie dem N-Methyl-2-Ethylpyridin am C-Terminus 
(R1). Die Untersuchung der Spezifität gegenüber den zwei anderen 
Prenyltransferasen FTase und GGTase-I sowie die kinetische Analyse des 
Inhibitionsmechanismus ergaben, dass Verbindung 5 und 10, die sich nur in einem 
Aminosäurenrest unterscheiden (R3), nicht-kompetitive bzw. kompetitive Inhibitoren 
zu NBD-FPP sind. Diese Beobachtungen legen nahe, dass der zentrale Kern des 
Peptids (R2-R4) die Bindungskonfiguration der Peptidverbindungen bestimmt. 
Structure activity relationship- (SAR) und Spezifitätsstudien zeigten, dass der C-
terminale (R1) Rest die Aktivität des Peptids in hohem Maße beeinflusst, wohingegen 
die chemische Gruppe am N-Terminus (R5) kritisch für die Selektivität zwischen den 
drei Prenyltransferasen zu sein scheint. Die strukturelle Analyse weist ebenfalls 
darauf hin, dass die mutmaßliche Bindungsstelle des Isoprenoids des mono-
prenylierten Rabs in der RabGGTase ein vielversprechendes Target für die 
zukünftige Identifizierung spezifischer RabGGTase-Inhibitoren darstellt.  
Des Weiteren ermöglichte der sensitive fluorometrische Assay für die Rab-
Prenylierung die Untersuchung der Prenylierung von C-terminalen Rab- Mutanten. 
Sequenzanalysen zeigten, dass das mutmaßliche C-terminale Rab- Interaktionsmotiv 
(CIM), in dem zwei nicht-polare Aminosäurereste einen polaren Aminosäurerest 
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umschließen, in der gesamten Rab-Familie vorhanden (IKL in Rab7) und für die Rab-
Prenylierung essentiell ist. Mutationen in diesem Motiv führen zur partiellen oder 
sogar totalen Inhibition der Prenylierung. Im Gegensatz dazu gab es keine 
bestimmenden Faktoren für die Rab-Prenylierung innerhalb des Peptidlinkers, der 
das CIM- und das Prenylierungsmotiv verbindet. Das CIM fungiert somit als Anker 
zur Konzentrierung des C-terminalen Rab-Peptids in der aktiven Stelle der 
RabGGTase. Thermodynamische Analysen zur Bildung des binären Rab:REP-
Komplexes sowie des ternären Rab:REP:RabGGTase-Komplexes wurden unter 
Anwendung der fluoreszenten Sensoren durchgeführt. Mutationen oder 
Verkürzungen des CIM führten zu einer Reduktion der Affinität des Rab:REP-
Komplexes um zwei Größenordnungen, welches nahe legt, dass das CIM-Motiv 
signifikant zur hochaffinen Rab:REP-Bindung beiträgt, jedoch  in geringerem 
Ausmaß als die GTPase-Domäne des Rab-Proteins selbst. Die Bildung des ternären 
Komplexes scheint durch sequentielle Formation der Rab-GTPase-Domäne-REP 
RBP (Rab binding platform) Interaktion, der Rab CIM-REP CBR (Rab C-terminal 
binding region) Interaktion sowie der REP-RabbGGTase-Bindungsoberfläche zu 
erfolgen. Somit assoziiert das C-terminale Rab-Peptid mit der RabGGTase in einer 
nicht-spezifischen Weise und positioniert die C-terminalen Cysteine an das reaktive 
Zn2+-Zentrum zur Prenylierung. Dies liefert ein Erklärung dafür, warum die Rab-
Prenylierungsmaschinerie sämtliche Rab-Proteine trotz ihrer hypervariablen C-
terminalen Region als Substrat erkennen kann.  
In weiterführenden Arbeiten wurde ein fluoreszentes Analog eines prenylierten 
Rab-Proteins, Rab7-NBD-farnesyl (Rab-NF), durch Expressed Protein Ligation 
hergestellt. Trotz einer hohen Löslichkeit in Abwesenheit von Detergenzien zeigte es 
ein ähnliches Verhalten wie die durch RabGGTase-Katalyse  prenylierte Rab7-
GTPase. Um Informationen über die Interaktion von nativ mono- und di-
geranylgeranylierten Rab7-GTPasen mit REP und GDI zu erhalten, wurden die 
prenylierten GTPasen in Lösung durch Verwendung der β-Untereinheit der 
RabGGTase stabilisiert, welche als unspezifisches Chaperon von prenylierten 
Proteinen identifiziert wurde. Unter Anwendung kompetitiver Titrationen nativ-
prenylierter und fluoreszenter Rab-Proteine konnte gezeigt werden, dass mono-
geranylgeranyliertes Rab7 mit einem Kd-Wert von etwa 70 pM an REP bindet. Die 
Affinität des doppelt-prenylierten Rab7 ist etwa 20-fach schwächer. Im Gegensatz 
dazu bindet GDI beide prenylierten Formen mit vergleichbaren Affinitäten (Kd = 1-5 
X 
nM), jedoch nur sehr schwach an unprenylierte Rab-Proteine. Die erhaltenen Daten 
erlauben nun die Aufstellung eines thermodynamischen Modells für die Interaktion 
von RabGTPasen mit ihren Regulatoren und Membranen, welches die Notwendigkeit 
der Existenz von sowohl REP als auch GDI für die korrekte physiologische Funktion 
von Rab-Proteinen erklärt.  
 
1. Abstract 
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1. Abstract 
Prenylated Rab GTPases regulate intracellular vesicular transport in eukaryotic 
cells by association with specific membranes and recruiting a multitude of Rab-
specific effector proteins. Prenylation of more than 60 members of the Rab GTPase 
family in the human genome is catalyzed by Rab geranylgeranyl transferase 
(RabGGTase) while Rabs are complexed to Rab escort protein (REP). Recycling of 
Rab GTPases is regulated by a REP-related protein, GDP dissociation inhibitor (GDI). 
These two regulators share the ability to form a complex with prenylated Rab 
proteins, thereby functioning as molecular chaperones to prevent their aggregation, 
and the capability of delivery of prenylated Rabs to the target membrane. Recently, 
interference with prenylation of Rab GTPases has emerged as a very promising 
approach in cancer and osteoporosis therapy.  
Mechanistic studies of Rab prenylation and identification of RabGGTase 
inhibitors require a sensitive and convenient assay for Rab prenylation. Moreover, 
investigation of the interaction of prenylated Rab with REP/GDI can facilitate 
understanding the molecular mechanism of Rab recycling by REP/GDI and the 
functional segregation of these two regulators. However, biophysical analysis of the 
interaction of prenylated proteins is complicated by their low solubility in aqueous 
solutions.  
In this work, a combination of protein engineering, organic synthesis and 
expressed protein ligation was used to construct a family of semi-synthetic Rab7 
fluorescent conjugates. A variety of fluorophores (excitation from UV to far red light) 
were coupled to a Cys or Lys amino acid residue at different places in the vicinity of 
the prenylation site. Two constructs, Rab7CCK(NBD) and Rab7SCCC-dans, 
displayed 200% and 50% fluorescence increase upon prenylation. Moreover, dans, 
NBD, I-BA and I-SO labeled Rab7 conjugates exhibited 2-10 fold fluorescence 
change upon binding to REP or RabGGTase. These fluorescently sensitive sensors 
were used to investigate the assembly of Rab:REP binary complex and 
Rab:REP:RabGGTase ternary complex.  
In addition, a synthetic fluorescent analogue of phosphoisoprenoid, NBD-
farnesyl pyrophosphate (NBD-FPP), displayed 23-fold fluorescence enhancement 
upon incorporation into Rab. The kinetic and thermodynamic analysis of the 
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prenylation using NBD-FPP showed that it is quite different from the native 
prenylation using geranylgeranyl pyrophosphate (GGPP). NBD-FPP was used to 
report Rab prenylation in vitro and develop a high-throughput fluorometric assay for 
RabGGTase, which facilitated the rapid identification of RabGGTase inhibitors. 
A peptide library containing ca. 400 compounds was screened using this assay. 
Several potent (low micromolar IC50 values), specific and cellularly active 
RabGGTase inhibitors were identified, with the features of aromatic amino acid 
residues (Phe, His, Tyr) at the peptide central core (R2-R4), a long lipid chain or an 
aryl ring at the N-terminus (R5) and a potential zinc binding group, such as N-methyl 
2-ethyl pyridine, at the C-terminus (R1). The specificity over the other two protein 
prenyltransferases, FTase and GGTase-I, and the inhibition mechanism of these 
inhibitors were characterized. Compound 5 and 10, which differ in only one amino 
acid residue (R3), are non-competitive and competitive to NBD-FPP, respectively. 
This finding suggests that the peptide central core (R2-R4) determines the binding 
configuration of the peptide compounds. Structure activity relationship (SAR) and 
specificity studies revealed that the C-terminal (R1) residue strongly influences the 
activity of the peptide, while the chemical moiety at the N-terminus (R5) appears to be 
critical for the selectivity among the three prenyltransferases. Structural analysis also 
suggests that targeting the putative binding site for the isoprenoid of mono-
prenylated Rab in RabGGTase would be a very promising approach for future 
identification of specific RabGGTase inhibitors.  
The sensitive fluorometric assay for Rab prenylation also allowed the 
investigation of prenylation of Rab C-terminal mutants. Sequence analysis revealed 
that the putative Rab C-terminal interacting motif (CIM), which has the property of 
two non-polar amino acid residue flanking a polar amino acid residue, is present 
throughout the Rab family (IKL in Rab7). The CIM motif is essential for Rab 
prenylation. Mutations of the CIM motif resulted in reducing the prenylation efficiency 
of Rab prenylation. In contrast, there are no determinants for Rab prenylation within 
the linker peptide connecting the CIM and the prenylation motif. However, the length 
of the linker peptide is critical for proper Rab prenylation. Therefore, the CIM 
functions as an anchor to concentrate the Rab C-terminal peptide in the active site of 
RabGGTase for prenylation. Thermodynamic analysis of the assembly of the 
Rab:REP binary complex and the Rab:REP:RabGGTase ternary complex was 
performed using the fluorescent sensors described above. Mutations or truncations 
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of CIM led to reduction of the affinity of the Rab:REP complex by 2 order of 
magnitude, suggesting that the CIM motif significantly contributes to Rab:REP 
binding. However, the CIM is not such a critical determinant for the ternary complex 
association as the GTPase domain. The ternary complex appears to assemble by the 
sequential formation of the Rab GTPase domain-REP RBP (Rab binding platform) 
interaction, the Rab CIM-REP CBR (Rab C-terminal binding region) interaction and 
the REP-RabGGTase interface. These three anchors ensure the assembly of the 
ternary catalytic complex. Thus, the Rab C-terminal peptide non-specifically 
associates with RabGGTase and positions the C-terminal cysteines to the reactive 
center Zn2+ for prenylation. This provides an explanation for how Rab prenylation 
machinery can process the whole Rab family despite the hypervariable C-terminal 
region.  
In further work, a fluorescent analogue of prenylated Rab, Rab7-NBD-farnesyl 
(Rab-NF) was constructed by expressed protein ligation. This molecule was 
demonstrated to be soluble in the absence of detergent but otherwise similar in its 
behavior to naturally prenylated Rab7 GTPase. In order to obtain information on the 
interaction of natively mono- and di-geranylgeranylated Rab7 GTPases with REP 
and GDI molecules, the former molecules were stabilized in solution by using the β-
subunit of RabGGTase, which was demonstrated to function as an unspecific 
chaperone of prenylated proteins. Using competitive titrations of mixtures of natively 
prenylated and fluorescent Rab, mono-geranylgeranylated Rab7 was shown to bind 
to the REP protein with a Kd value of ca. 70pM. The affinity of doubly prenylated 
Rab7 is ca. 20 fold weaker. In contrast, GDI binds both prenylated forms of Rab7 
with comparable affinities (Kd = 1 to 5 nM), but has extremely low affinity to 
unprenylated Rab molecules. The obtained data allows the formulation of a 
thermodynamic model for the interaction of RabGTPases with their regulators and 
membranes and leads to an explanation for the requirement for both REP and GDI in 
Rab function. 
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2. Introduction 
2.1 Protein prenylation and prenyltransferases 
 
Posttranslational modifications of proteins are vital to the regulation of their 
physiological function. Whereas some important posttranslational modifications like 
phosphorylation and glycosylation have been well studied, lipid modification is an 
emerging field that has attracted more and more attention (Resh, 2006; Gelb, 1997). 
In particular, prenylation, a type of lipid modification with 15-carbon farnesyl and 20-
carbon geranylgeranyl isoprenoids, is of increasing interest since many prenylated 
proteins are involved in signal transduction pathways controlling cell growth and 
differentiation, cytoskeletal rearrangement, and vesicular transport (Zhang and 
Casey, 1996). Covalent attachment of either of the isoprenyl moieties via thioether 
linkages to the C-terminal cysteine residues is critical for proper function of the 
modified proteins. The conjugated prenyl group is not only a mediator of membrane 
association but also functions as a molecular handle for specific protein-protein 
interactions, such as GDI interaction that allows cycling the prenylated proteins 
between different membranes (Zhang and Casey, 1996). Although a search of the 
human proteome revealed about 300 proteins which are potentially prenylated, only a 
fraction of these have been reported (Sebti, 2005). The majority of identified 
prenylated proteins belong to signal transducing Ras superfamily of small GTPases.  
2.1.1 Discovery of protein prenylation 
 
The first reports of prenylated peptides described secreted yeast sex hormones, 
which contain a farnesylated cysteine residue at the C-terminus (Tsuchiya et al., 
1978; Sakagami et al., 1978). In the 1980s, the elucidation of the cholesterol 
biosynthesis pathway with respect to the cell cycle in human cells formed the basis 
for the discovery of prenylated proteins. A crucial early step in cholesterol formation 
is the synthesis of mevalonic acid by HMG CoA reductase (Goldstein and Brown, 
1990). A specific inhibitor of HMG CoA reductase, compactin, made it possible to 
manipulate the metabolism of mevalonic acid in cells (Endo, 1992; Brown et al., 
1978). In a set of studies, an intermediate of mevalonate metabolism other than 
cholesterol was found to be essential for DNA synthesis in the cell (Endo, 1992; 
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Fairbanks et al., 1984; Brown et al., 1978). The search for the required metabolite of 
mevalonate, which involved following the destiny of exogenously supplemented (Van 
Voorhis et al., 1991) mevalonate to compactin-treated cells, revealed that 
metabolites of mevalonic acid are incorporated into proteins (Maltese and Sheridan, 
1987; Schmidt et al., 1984). Extensive structure elucidation studies revealed that 
these proteins contain cysteine-linked farnesyl and geranylgeranyl groups 
(Farnsworth et al., 1990; Farnsworth et al., 1989) (for a review see (Glomset et al., 
1990)). These two isoprenoids are donated from soluble farnesyl pyrophosphate 
(FPP) and geranylgeranyl pyrophosphate (GGPP), metabolites in the mevalonate 
pathway (Swanson and Hohl, 2006; Goldstein and Brown, 1990) (Scheme 2-1 and 2-
2). FPP and GGPP consist of 3 and 4 basic five-carbon building blocks, termed 
isoprene units, respectively (Scheme 2-2). Formation of FPP and GGPP is the result 
of chain elongation catalyzed by isoprenyl pyrophosphate synthases (IPPSs). In this 
biosynthesis pathway, condensation between 5-carbon isopentenyl pyrophosphates 
(IPP) and an isomer of IPP, dimethylallyl pyrophosphate, results in 10-carbon geranyl 
pyrophosphate, which is subsequently coupled consecutively with IPP to form FPP 
and GGPP (Scheme 2-1, a review see (Liang et al., 2002)).  
Scheme 2-1. The biosynthesis of isoprenoids in animals 
 
Scheme 2-2. Protein prenylation and post-prenylation modifications 
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2.1.2 Protein prenyltransferases and their substrates 
 
So far three protein prenyltransferases responsible for isoprenoid addition to 
proteins have been identified (for reviews see (Maurer-Stroh et al., 2003; Casey and 
Seabra, 1996)). They can be classified into two categories according to their 
functions. One is the CAAX prenyltransferases: protein farnesyltransferase (FTase) 
(Reiss et al., 1990) and protein geranylgeranyltransferase type I (GGTase-I) (Seabra 
et al., 1991) share the same motif CAAX box (C is cysteine, A is usually but not 
necessarily an aliphatic amino acid, and X can be one of a variety of amino acids) in 
their substrates. The other is the non-CAAX prenytransferase: Rab 
geranylgeranyltransferase (RabGGTase), also called protein 
geranylgeranyltransferase type II (GGTase-II) (Seabra et al., 1992b), processes 
different substrates, Rab GTPases.   
FTase and GGTase-I are heterodimers that share an α subunit and have 30% 
amino acid identity in their β subunits. They are designated CAAX prenyltransferases 
because both of them recognize a C-terminal CAAX motif and transfer either farnesyl 
(FTase) or geranylgeranyl (GGTase-I) to the invariant cysteine residue located at the 
fourth from the C-terminus of the protein (Scheme 2-2). Substrates for FTase include 
Ras GTPases, which regulate signal transduction involved in cellular growth; nuclear 
lamins A and B, which form structural lamina on the inner nuclear membrane; the 
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γ subunit of heterotrimeric G-protein transducin, which functions in visual signal 
transduction in the retina; the large-antigen component of the hepatitis δ virus; and 
yeast mating factors (Clarke, 1992). Known targets of GGTase-I include most 
γ subunits of heterotrimeric G-proteins (Marrari et al., 2007) and many small 
GTPases such as the Rho/Rac family (Glomset and Farnsworth, 1994).  
The rules for specificity in recognition of CAAX motifs by FTase and GGTase-I 
are not fully understood. These two enzymes possess distinct but overlapping protein 
substrate specificity that is determined primarily by the sequence identity of the 
CAAX motif. The X residue of CAAX is the most decisive element for differential 
recognition by FTase versus GGTase-I (Hartman et al., 2005; Roskoski, Jr. and 
Ritchie, 1998; Yokoyama et al., 1991; Casey et al., 1991)] (see Table 2-1). The AA 
part of the CA1A2X motif is also important for specificity of FTase and GGTase-I, with 
a relaxed requirement at the A1 residue and more restricted in the A2 residue (Reid et 
al., 2004; Reiss et al., 1991). It has also been shown that the presence of an 
upstream polybasic region enhances the dual specificity of these substrates (Hicks et 
al., 2005). In contrast to the variety in the peptide substrate specificity, FTase only 
efficiently transfers the lipid substrate FPP, while GGTase-I prefers transferring 
GGPP with FPP as a moderately effective substrate. Therefore, FTase and GGTase-
I show mixed specificity under certain conditions (Yokoyama et al., 1995; Armstrong 
et al., 1995b; Trueblood et al., 1993; Adamson et al., 1992; Yokoyama et al., 1991). 
However, FTase binds FPP 15-fold tighter than GGPP and GGTase-I binds GGPP 
330-fold tighter than FPP (Yokoyama et al., 1997), indicating that in vivo GGTase-I 
and FTase will likely predominantly bind to GGPP and FPP, respectively. A 
“molecular ruler” mechanism (Liang et al., 2002) was proposed for lipid substrate 
specificity base on the crystal structures of FPP bound FTase (Strickland et al., 1998; 
Long et al., 1998) and GGPP bound GGTase-I (Taylor et al., 2003), where the 
appropriate prenyl pyrophosphate is recognized by the depth of the active site. 
Although the properties of the C-terminal residue of the protein substrate affect 
reactivity with FTase and GGTase-I, it is not yet clear whether the nature of the 
prenyl group causes differential behavior in vivo, such as targeting to a specific 
membrane. However, the overlapping protein substrate specificity between the 
FTase and GGTase-I allows the modified substrates having a range of features, 
suggesting that in some cases the farnesyl versus geranylgeranyl distinction might 
not be very important (see section 2.3). 
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Table 2-1. Properties of protein prenyltransferases 
CAAX prenyltransferases Type 
FTase GGTase-I 
RabGGTase  
(GGTase-II) 
Subunit composition 
(mammalian) 
44 kDa (α) 
48 kDa (β) 
44 kDa (α) 
43 kDa (β) 
65 kDa (α) 
37 kDa (β) 
Metal requirements Zn2+, Mg2+ Zn2+ Zn2+, Mg2+ 
Isoprenoid substrate FPP GGPP GGPP 
Protein substrates Ras, nuclear lamins, trimeric G-protein transductin γ subunit 
Rho, Rac, most trimeric G-
protein γ subunits Rab (requires REP) 
C-terminal motif of 
protein substrate  
-CA1A2X 
X=S, M, A, Q, F 
a1: no restriction, a2: preference 
for I, V 
-CA1A2X 
X=L, F 
a1: no restriction, a2:  
preference for I, L 
Usually double Cys motifs 
-CC, -CXC, CCX, -CCXX, -
CCXXX, in a few cases single 
Cys motif -CXXX 
 
RabGGTase is also a heterodimer, with its α subunit having 27% identity with 
the α subunit of FTase and GGTase-I, and the β subunit showing 29% identity to the 
β subunit of FTase (Sebti, 2005). However, RabGGTase stands quite apart from the 
other two protein prenyltransferases both functionally and structurally. RabGGTase 
has a very strict substrate preference and acts only on members of Rab GTPase 
family, which play a central role in membrane trafficking in eukaryotic cells (Stenmark 
and Olkkonen, 2001). Unlike FTase and GGTase-I, RabGGTase does not recognize 
a short C-terminal sequence but requires an additional factor termed Rab escort 
protein (REP) to recruit Rab protein (Andres et al., 1993). REP interacts with the 
unprenylated Rab protein preferentially in its GDP-bound form (Alexandrov et al., 
1998; Seabra, 1996b; Sanford et al., 1993) and mediates its recognition by 
RabGGTase (Pylypenko et al., 2003; Alexandrov et al., 1999; Anant et al., 1998). 
Upon catalytic quaternary complex (Rab:REP:RabGGTase:GGPP) formation, 
consecutive double prenylation without dissociation of the mono-prenylated 
intermediate from enzyme (Thoma et al., 2001c). To ensure complete di-prenylation 
of Rab, the mono-prenylated Rab still tightly associate with REP so that they cannot 
be disrupted by liposome or detergent (Shen and Seabra, 1996). Following double 
prenylation, binding of another GGPP molecule triggers the release of the 
prernylated Rab:REP complex (Thoma et al., 2001b), which is then ready for 
membrane delivery of prenylated Rabs (Alexandrov et al., 1994). After that, REP is 
released and supports another round of Rab prenylation. 
Intriguingly, some Rab proteins have only one prenylatable C-terminal cysteine, 
ending in CXXX. Most, but not all, of them contain sequences that do not conform to 
the classic CAAX motif. Conversely, Rab8 contains a CVLL motif, which may be 
geranylgeranylated by both RabGGTase and GGTase-I in vitro. Nevertheless, the 
majority of Rab8 appears to be geranylgeranylated in vivo by RabGGTase (Wilson et 
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al., 1998). Recently, FPP was found to be incorporated into Rab by RabGGTase 
resulting in formation of a di-farnesylated product. On the other hand, RabGGTase 
binds to GGPP with 100-fold preference over FPP, which may represent a 
thermodynamic proofreading of lipid substrate for RabGGTase in vivo. Evidence for 
farnesylated Rab in cells has not been forthcoming (Wu, et al. unpublished data).  
2.1.3 Mechanism of protein prenylation 
 
All three protein prenyltransferases are Zn2+-dependent metalloenzymes, and 
each contains a single zinc atom necessary for reactivity (Chen et al., 1993; 
Moomaw and Casey, 1992; Reiss et al., 1992; Seabra et al., 1992b). The Zn2+ 
functions as a reactive center that coordinates the cysteine sulfur so as to reduce the 
pKa of the thiol resulting in formation of a bound thiolate at physiological pH 
(Hightower et al., 1998; Strickland et al., 1998; Huang et al., 1997). Zinc-catalyzed 
sulfur alkylation has been proposed as the general mechanism for the greater family 
of zinc metalloproteins that facilitate the transfer of an alkyl group to sulfur and 
selenium residues (Hightower and Fierke, 1999). In FTase mediated farnesylation, 
the activated thiolate of Cys acts as a nucleophile to attack the polarized C1 of the 
farnesyl chain by Mg2+ coordination of the pyrophosphate leaving group (Saderholm 
et al., 2000). Stereochemical (Clausen et al., 2001; Edelstein et al., 1998; Mu et al., 
1996), kinetic (Huang et al., 2000; Dolence and Poulter, 1995) and kinetic isotope 
effect (KIE) analyses (Lenevich et al., 2007; Pais and Fierke, 2007; Pais et al., 2006; 
Weller and Distefano, 1998) reveal that the condensation between cysteine thiol and 
prenyl pyrophosphate is mainly through an associative (SN2) mechanism with an 
“exploded” transition state (Figure 2-1). 
 
Figure 2-1. Transition state model for FTase catalysted farnesylation (Pais et al., 2006). 
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Over the past decade, high-resolution crystal structures of FTase and GGTase-I 
complexed with various substrates, products, and inhibitors have provided insights 
into the mechanism of these enzymes. Structures representing each of the major 
steps along the reaction pathway of CAAX prenyltransferases have been solved 
(Figure 2-2) (Taylor et al., 2003; Long et al., 2002). Steady-state kinetic studies 
reveal an random order sequential mechanism in FTase and GGTase-I (Zhang et al., 
1994; Pompliano et al., 1992b). Nevertheless, a preferred catalytic pathway is 
through initial binding of isoprenoid to the enzyme followed by association of the 
CAAX substrate (Yokoyama et al., 1995; Pompliano et al., 1993). Reaction of the 
CAAX substrate with the FPP bound enzyme is functionally irreversible, 
accompanied by a rapid chemical step to form the enzyme-bound farnesylated 
peptide product (Huang et al., 2000; Yokoyama et al., 1997; Furfine et al., 1995). 
Product release is the rate-limiting step of the reaction and occurs only in the 
presence of excess of either substrate, particularly isoprenoid diphosphate (Tschantz 
et al., 1997; Furfine et al., 1995). This reaction cycle effectively maintains FTase in a 
substrate- or product-bound complex at all times. On account of this, one interesting 
possibility is that CAAX prenyltransferase itself could serve as a chaperone for the 
nascent prenylated Ras and Rho proteins and may deliver them to the endoplasmic 
reticulum (ER). 
 
Figure 2-2. Structures along the FTase reaction pathway (Lane and Beese, 2006). In each of these 
complexes, the enzyme acts as a rigid scaffold, therefore, for clarity, only the substrates and products 
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are shown as they bind in the active site. The path begins with the unliganded (apo) enzyme (0) (PDB 
ID 1FT1), with the α subunit shown in red and the β subunit in blue. The FPP molecule binds to form a 
binary substrate complex (1) (PDB ID 1FT2), followed by binding of the CAAX substrate to form a 
ternary substrate complex (2) (PDB ID 1D8D). The resulting farnesylated product remains bound in 
the active site (3) (1KZP). Excess substrate, particularly FPP, facilitates product displacement, 
demonstrated by a complex in which binding of a new FPP molecule expelled the farnenylated product 
to the “exit groove”, ready for dissociation from enzyme (4) (1KZO). The double dagger symbol 
indicates a modeled transition state along the reaction coordinate between 2 and 3 (see Figure 2-1 for 
a more detailed view of the transition state). Throughout this figure, the isoprenoid is shown in blue, 
the CAAX in yellow, and the catalytic zinc ion in magenta. Also shown are the kinetic parameters 
determined for this reaction. 
 
2.1.4 Post-prenylation modification 
 
Prenylation of proteins enables them to associate with the endoplasmic 
reticulum, where they are further modified in subsequent post-prenylation reactions. 
The three C-terminal amino acid residues (AAX) of CAAX protein are removed by the 
endoprotease Rce1 (Ras converting enzyme 1) (Trueblood et al., 2000; Boyartchuk 
et al., 1997) and the α-carboxyl group of the newly exposed isoprenylcysteine is 
methylated by Icmt (isoprenylcysteine carboxymethyltransferase) (Clarke, 1992; 
Clarke et al., 1988). Embryonic lethality of either Rce1–/– or Icmt–/– knockout mouse 
argues for the physiological significance of post-prenylation CAAX processing (Bergo 
et al., 2004; Bergo et al., 2001). It was proposed that 15-carbon farnesyl modification 
is below the threshold for promoting membrane association and requires AAX 
proteolysis and carboxyl methylation (Wright and Philips, 2006). This hypothesis is 
correlated with the finding that carboxy-methylation of farnesylated peptide increases 
the affinity for vesicles by more than 40-fold (Silvius and l'Heureux, 1994). Although 
carboxy-methylation of prenylated proteins has been suggested to be reversible 
(Chelsky et al., 1985), and therefore could represent a regulatory event, no in vivo 
evidence has been observed until now.  
At the Golgi apparatus, some GTPases, such as N-Ras, H-Ras and K-Ras4A, 
then undergo another lipid modification – palmitoylation, a conjugation of a 16-carbon 
fatty-acid chain to the thiol group of an upstream cysteine via a thioester bond 
(Hancock et al., 1989) (for a recent review see (Mitchell et al., 2006)). A Golgi-
associated protein, GCP16 complexed with one of the DHHC family proteins (protein 
containing an Asp-His-His-Cys domain), DHHC9, has shown palmitoyl 
acyltransferase (PAT) activity towards H-Ras and N-Ras (Swarthout et al., 2005). 
Scheme 2-2 shows the structures of the C-termini of example prenylated proteins 
after prenylation and post-prenylation modifications. Palmitoylation for H-Ras, N-Ras 
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and K-Ras4A, and a polybasic, lysine-rich sequence for K-Ras4B (Hancock et al., 
1991) provide a second signal for targeting of these proteins to the plasma 
membrane via vesicular transport. Depalmitoylation of H-/N-Ras at the plasma 
membrane triggers the back transport of the farnesylated proteins to the Golgi via a 
nonvesicular pathway (Goodwin et al., 2005; Rocks et al., 2005). The eukaryotic acyl 
protein thioesterase 1 (APT1) has been found to function in removal of palmitate from 
proteins on the cytosolic face of plasma membranes (Duncan and Gilman, 1998). 
The reversible palmitoylation is essential for regulation of partitioning of Ras isoforms 
between plasma membrane and Golgi. In contrast, the association of K-Ras4B with 
plasma membrane is controlled by an electrostatic switch regulated by protein kinase 
C, which phosphorylates K-Ras4B on serine 181 within the polybasic region and 
thereby partially neutralizes the charge of the polylysine sequence (Bivona et al., 
2006). This modification may reduce the affinity of K-Ras4B with negatively charged 
phosphatidylinositol 4,5-bisphosphate (Heo et al., 2006) and phosphatidylinositol 
3,4,5-trisphosphate (Heo et al., 2006) clusters on the plasma membrane, resulting in 
dissociation from PM (Heo et al., 2006). 
Similar post-prenylation modifications (proteolysis and methylation) seem to 
apply to Rho GTPases except that they bind to the cytosolic protein RhoGDI (Rho-
guanine nucleotide dissociation inhibitor) (Wright and Philips, 2006), which keeps 
them soluble in the cytosol and regulate the membrane binding of Rho GTPases 
(Michaelson et al., 2001; Hoffman et al., 2000). 
After (usually) doubly geranylgeranylation, Rab GTPases ending in CXC 
undergo carboxymethylation by Icmt at ER membrane, whereas those having CC 
and CCXX sequences in their C-termini are not carboxyl-methylated (Gelb et al., 
1995; Smeland et al., 1994; Li and Stahl, 1993a). Recently, some Rab GTPases 
containing an analogous CAAX motif, like Rab8a(CVLL), Rab13(CSLG), 
Rab18(CSVL) and Rab23(CSVP), were also found to undergo the same AAX 
proteolysis and carboxy-methylation at the endoplasmic reticulum as other CAAX 
proteins (Leung et al., 2007). However, the regulatory function of carboxymethylation 
of Rab proteins is still unclear. One example showed that carboxy-methylation of 
Rab3D is developmentally regulated and coincides with the acquisition of stimulus–
secretion coupling in rat pancreas and the rat pancreatic acinar tumor cell line AR42J 
(Qiu et al., 2001; Valentijn and Jamieson, 1998). Carboxy-methylation of Rab 
proteins may increase their affinity to membranes. It has been shown that carboxy-
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methylation of a di-geranylgeranylated peptide decreases the rate of interbilayer 
transfer by more than 10-fold (Silvius and l'Heureux, 1994). This correlates with the 
observation that more carboxylmethylated Rabs partition into membranes when they 
are subjected to RabGDI extraction (Leung et al., 2007; Li and Stahl, 1993b). 
Carboxy-methylation may also result in an indirect pathway for Rab membrane 
targeting. In the indirect pathway, prenylated Rabs that require methylation may first 
contact with the ER and the fully processed Rabs are then redirected to their target 
membrane, in a step probably mediated through a soluble complex with their 
chaperone, RabGDI (Leung et al., 2007). 
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Figure 2-3. Overview of protein prenylation, post-prenylation modification and function of prenylated 
proteins. CAAX protein prenyltransferases (FTase and GGTase-I) attach a farnesyl or geranylgeranyl 
group to the C-terminal CAAX motif of certain cytosolic proteins (shown examples are Ras in orange, 
and Rho in dark red). The prenylated proteins undergo C-terminal AAX proteolysis by Rce1 (light red), 
and afterward carboxylmethylated by Icmt (light green) at the ER. Some Ras proteins, such as N-Ras, 
H-Ras and K-Ras4A are subsequently palmitoylated at the one or two upstream C-terminal cysteines 
after transfer to the Golgi membranes. This reaction is catalyzed by DHHC9-GCP16 in mammals 
using palmitoyl coenzyme A (CoA) as the fatty-acid donor (palmitoyl group is shown in black and 
farnesyl group is in red). The palmitoylation controls plasma membrane localization of Ras proteins. 
After its insertion into the membrane via its lipid tail, Ras proteins transduce signals from plasma 
membrane to nucleus, upon activation into GTP-bound form. A simplified depiction of the Ras 
signaling pathway is also illustrated (shown in pink arrows) (Vojtek and Der, 1998). Rho family 
proteins exert their function on the membrane, and are involved in regulation of cytoskeletal 
rearrangement and gene expression. Rab proteins are geranylgeranylated by RabGGTase with the 
aid of REP. REP presents prenylated Rab proteins to the target membrane. Once associate with 
membranes, Rab proteins regulate vesicular transport including endo- and exocytosis. Abbreviation: 
Icmt, isoprenylcysteine carboxylmethyltransferase; Rce1, Ras converting enzyme 1; PPO, 
pyrophosphate; SAM, S-adenosylmethionine; MEK, mitogen-activated protein (MAP) or extracellular 
signal-regulated kinase (ERK) kinase. 
 
Modification of Rab GTPases by two long (20-carbon) hydrophobic moieties 
allows them to stably associate with membranes (Shahinian and Silvius, 1995), and 
serves as a molecular handle for specific interaction with RabGDI that extracts 
prenylated Rab from membranes (Pylypenko et al., 2006; Rak et al., 2003; Alory and 
Balch, 2001). The reversibility of this association is of particular importance, since it 
allows recycling of Rab proteins between different membranes upon completion of 
their functional cycle. Points concerning Rab recycling will be discussed in section 
2.2.4. 
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2.2 Function of small GTPases 
2.2.1 GTPase cycle 
 
GTP-binding proteins (also called GTPases or G proteins) are responsible for 
regulation of a host of functions ranging from transduction of signals from plasma 
membrane receptors to regulation of the cytoskeleton, membrane traffic, nuclear 
transport, and protein synthesis in eukaryotic cells (Figure 2-3). The main families of 
G proteins include the monomeric small G proteins, the heterotrimeric G proteins, 
elongation factors and dynamin-related G proteins. Most identified prenylated 
proteins belong to small G proteins (also referred to as small GTPases). Of the small 
G proteins, the Ras superfamily of GTPases is the most studied and consists of over 
150 human members with a typical size of 20–25 kDa (Wennerberg et al., 2005). 
This superfamily is classified into five major subfamilies: Ras, Rho/Rac, Rab, 
Sar1/Arf and Ran (Takai et al., 2001). These proteins function as regulators of a 
variety of important biological processes: the Ras family regulates gene expression, 
the Rho family regulates cytoskeletal reorganization and gene expression, the Rab 
and Sar1/Arf families regulate vesicle trafficking, and the Ran family regulates 
nucleocytoplasmic transport and microtubule organization (for recent reviews see 
(Konstantinopoulos et al., 2007; Rocks et al., 2006; Souza-Schorey and Chavrier, 
2006; Pfeffer and Aivazian, 2004; Quimby and Dasso, 2003; Etienne-Manneville and 
Hall, 2002)). Among these proteins, Arfs are myristoylated, but Ran GTPases are not 
modified and are soluble in the cytosol and the nucleosol, while Ras, some Rho and 
all Rab GTPases are prenylated as described in section 2.1. 
All G proteins share a conserved GTPase domain that binds a guanine 
nucleotide and use a common enzymatic cycle between GTP-bound and GDP-bound 
state to switch the protein “on” and “off”, (the GTPase cycle; Figure 2-4) (Sprang, 
1997). The GTP-bound conformation is active, since it interacts with effector proteins, 
which stimulate downstream signaling events. The GDP-bound conformation is 
inactive for it does not bind effectors. Hydrolysis of GTP to GDP switches G proteins 
from the active state to the inactive state. Thus, within G proteins are found clocks 
(hetertotrimeric G protein α subunits), molecular switches (Ras superfamily), and 
sensors (translation elongation factors, EF-Tu and EF-G). 
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Figuer 2-4. GTPase cycle. The size of the arrows indicates the relative rate of the reactions. GAP: 
GTPase-activating protein; GDI: guanine nucleotide dissociation inhibitor; GEF: guanine nucleotide 
exchange factor.  
 
The GTPase cycle is highly regulated by guanine nucleotide exchange factors 
(GEFs) that induce the release of the bound GDP to be replaced by the more 
abundant GTP and by GTPase-activating proteins (GAPs) that accelerate the 
intrinsic GTP hydrolysis of GTPases (for reviews see (Bos et al., 2007; Cherfils and 
Chardin, 1999; Scheffzek et al., 1998)). For a subset of small G proteins (Rho and 
Rab proteins) guanine nucleotide dissociation inhibitors (GDIs) provide an additional 
level of control. These proteins remove membrane-anchored small G proteins from 
membranes by sequestration of their lipid tails, and inhibit the release of GDP, The 
prenylated proteins are unloaded from GDI by GDI displacement factors (GDFs) on 
membranes. 
GDP release is the rate limiting step in the GTPase cycle with a half-life on the 
order of one or more hours. GEFs accelerate the exchange reaction by several 
orders of magnitude (Vetter and Wittinghofer, 2001), and thus activation of G proteins 
in biological processes occurs within minutes or less. Since the binding of a GEF 
reduces the affinity for the nucleotide, and visa versa, the nucleotide weakens the 
affinity for the GEF, the nucleotide-free G protein binds with either the GEF or the 
nucleotide in high-affinity binary complexes. In the exchange reaction the GEF 
displaces the bound nucleotide, and in the reverse reaction rebinding of GDP or GTP 
results in the dissociation of the GEF. Binding of GTP is fast and is favored over GDP 
since the cytoplasmic concentration of GTP (about 1 mM) is ten times higher than 
that of GDP, resulting in preferential binding of GTP. 
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The intrinsic GTP hydrolysis of GTPase is very slow, occurring with half-lives in 
tens of seconds to hours, depending on the GTPase. Efficient hydrolysis requires the 
association with a GAP, which accelerates the cleavage of the γ-phosphate group by 
several orders of magnitude. The first major insight into GAP-assisted GTP 
hydrolysis was obtained from the structure of the Ras-RasGAP complex (Scheffzek 
et al., 1997). The RasGAP stabilizes the interaction of the conserved rasGln61 with 
the attacking water, and in addition, inserts an “arginine finger” into the phosphate-
binding site, thus stabilizing the transition state by neutralizing negative charge at the 
γ-phosphate. The interactions are conserved between the Ras, Rho, and trimetric G-
protein families. In contrast, RabGAP supplies two catalytic fingers, an analogous 
arginine finger and a glutamine finger that substitutes for the glutamine in the 
conserved DxxGQ motif of the GTPase (Pan et al., 2006). Subsequent dissociation 
of inorganic phosphate is fast and reverses the conformational change of switch I 
and II. This inactivates GTPases by dismantling the binding site for effector proteins. 
The net rate of GTP hydrolysis serves as a timing mechanism to limit the duration of 
interaction with effectors. 
2.2.2 The structural basis of Rab GTPases function 
 
All GTPases share a core GTP-binding domain with a minimum size of about 
160-170 residues. The basic architecture of this domain has been maintained during 
the evolutionary divergence of the various GTPases. The common GTP-binding 
domain (also referred to as the G protein fold) consists of a 6-stranded β sheet 
sandwiched between 5 α helices (Sprang, 1997) (Figure 2-6). In this domain the 
elements responsible for the guanine nucleotide and Mg2+ binding and GTP 
hydrolysis are located in five loops (designated G1 to G5), which are the most highly 
conserved and define the G protein superfamily (Valencia et al., 1991; Bourne et al., 
1991).  
The G1 motif (also called the P-loop) with the consensus sequence 
GxxxxGK(S/T) connects the β1 strand to the α1 helix and contacts the α- and β-
phosphates of the guanine nucleotide. The G2 motif (T) located between the α1 helix 
and the β2 strand, and the G3 motif [DxxG(Q/H/T)] at the N-terminus of the α2 helix 
associate with Mg2+ and the γ-phosphate of GTP. The guanine is recognized, in part, 
by the conserved NKxD sequence (G4) that links the β5 strand and α4 helix and the 
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G5 box that connects β6 and α5 with the consensus sequence, (C/S)A(K/L/T) 
(Wennerberg et al., 2005) (Figure 2-5).  
 
 
Figure 2-5. Consensus sequence alignment of profile hidden Markov models (HMM) of Ras, Rab, Rho 
and Arf family (Pereira-Leal and Seabra, 2000). The uppercase/lowercase coding represents the 
probabilities (p) of the profile HMM, in which uppercase characters were found at p>0.5. Blue 
characters denote the conserved nucleotide binding motifs (G motif) with conserved residues indicated 
in boldface type. RabF residues are highlighted in yellow, and the corresponding residues conserved 
in other families are also highlighted in yellow. RabSF regions are highlighted in red. Putative CBR 
interacting motif (CIM) is highlighted in gray. Prenylation motif is highlighted in turquoise.  
 
The availability of high resolution structures of both the GDP- and GTP-bound 
form of GTPases enables definition of the requirements of the molecular switch 
(Figure 2-6). The extent of the conformational change between GDP- and GTP-
bound forms are usually subtle but may turn out to be quite large in some cases, and 
involves extra elements for some proteins. The regions of major conformational 
changes are confined primarily to two segments, called switch I and switch II, first 
observed in Ras (Schlichting et al., 1990; Milburn et al., 1990). The trigger for the 
conformational change is most probably universal. In the GTP-bound form, switch I 
and II are bound to the γ-phosphate via the main chain NH groups of the invariant Thr 
(G2 motif) and Gly (part of the G3 motif, DxxG) residues, respectively. Release of the 
γ-phosphate after GTP hydrolysis allows the two switch regions to relax into the 
GDP-bound conformation, which is characterized as a loaded-spring mechanism 
(Vetter and Wittinghofer, 2001). 
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It is mainly through the conformational changes in these two switches that 
regulatory proteins and effectors sense the nucleotide bound state of the GTPases 
(Figure 2-6). This implies that regulator and effector binding involves the switch 
regions of GTPases, and this is indeed supported by the structural and functional 
studies (Vetter and Wittinghofer, 2001).  
 
Figure 2-6. Structures of Rab4a in GDP (PDB code: 2BMD) and GppNHp (non-hydrolysable analogue 
of GTP) (PDB code: 2BME) bound form. Rab4a is displayed in ribbon representation, nucleotides in 
stick representation and Mg2+ in cyan sphere. Switch I is orange and switch II is light blue. The dashed 
ribbon in Rab4a-GDP represents the invisible part in the crystal structure.  
 
Despite conservation of critical residues involved in nucleotide binding and 
hydrolysis, Rab GTPases are only distantly related to other small GTPases in 
sequence (< 30% identity) (Dumas et al., 1999). Conformational changes in switch I 
and II during GDP/GTP cycling were also observed in Rab GTPases (Huber and 
Scheidig, 2005; Pasqualato et al., 2004; Constantinescu et al., 2002; Stroupe and 
Brunger, 2000) (Figure 2-6). As for other small GTPases, these two segments are 
crucial for the interaction of Rab GTPases with regulators and effectors. For example, 
the crystal structure of Rab3a complexed with the effector domain of Rabphilin-3A 
shows that the binding specificity for active/inactive conformations is determined by 
the switch regions of Rab3a (Ostermeier and Brunger, 1999).  
Analysis of sequence conservation in the mammalian Rab family revealed the 
existence of five Rab-specific regions that cluster in and around switch regions, 
termed Rab family (RabF) motifs (Pereira-Leal and Seabra, 2000). These RabF 
motifs were proposed to provide criteria for the Rab family classification. Furthermore, 
four Rab subfamily (RabSF) motifs have been identified to define the ten Rab 
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subfamilies (Pereira-Leal and Seabra, 2000; Moore et al., 1995) (Figure 2-5). RabSF 
regions are located on two subfamily-specific surfaces of Rab proteins. They were 
suggested to determine specific binding of effectors and regulators, since the 
conserved switch regions among all Rabs might not be sufficient to define the binding 
to specific effectors and regulators, given that these proteins must discriminate 
between GDP/GTP-bound states of Rab GTPases (Pereira-Leal and Seabra, 2000).  
This model is not universal in the Rab family. But it is indeed supported by some 
crystal structures of Rab-effector complexes (Figure 2-7). The Rab3a-Rabphilin 
complex revealed that the interaction involves both switch regions and RabSF1, 3 
and 4 (Ostermeier and Brunger, 1999). The structure of Rab7-RILP complex showed 
that RabSF1 and RabSF4 regions of Rab7 are important for interaction with RILP 
(Wu et al., 2005). 
However, in some cases different subsets of residues within the switch regions 
determine specificity (Figure 2-7). Rabex-5 VPS9 domain, a RabGEF, selects for the 
Rab5 subfamily primarily through a strict requirement for a small nonacidic residue 
preceding the invariant phenylanaline in the switch I T(I/V)GA(A/S)F motif, while the 
selectivity for Rab21 also involves Gln53 in the TLQASF motif (Delprato and 
Lambright, 2007; Delprato et al., 2004). Sec2p, the specific GEF for Sec4p GTPase, 
discriminates its substrates via the switch regions (Dong et al., 2007). In contrast, 
MSS4, which is a less specific RabGEF and activates a range of Rabs, interacts with 
switch I, interswitch regions, and the N-terminus, but not with switch II (Itzen et al., 
2006). Different elements contribute to the interacting specificity between Rab and its 
effectors. In the Rab11–FIP3-RBD complex the unique Rab11 switch II structure is 
essential for its specific interaction with FIP3-RBD independent of the RabSF regions 
(Shiba et al., 2006). Rabaptin5 specifically binds to Rab5 probably through some 
distinct residues in switch and interswitch regions (Zhu et al., 2004). Furthermore, 
other nonconserved residues in Rab that alter the conformation of those conserved 
residues in direct effector contacts may also contribute to the binding specificity 
(Merithew et al., 2001). A family-wide analysis of RabGTPases interaction with 
effector rabenosyn-5 revealed that the specificity is determined by a combination of 
structural diversity in the active conformation, which governs the plasticity of critical 
conserved recognition, and sequence determinants in the switch and interswitch 
regions (Eathiraj et al., 2006).  
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Figure 2-7. Structures of the complexes of Rabs with GEFs, GAP, and effectors. Rabs are shown in 
gray, while effectors and regulators are shown in yellow. The Switch I region of Rab is highlighted in 
orange, and Switch II in light blue. GEFs are in complex with nucleotide free Rabs, and GAP is in 
complex with GDP·AlF3-bound Rab, while effectors are in complex with GTP-bound Rabs. In Rab3A-
Rabphilin3A and Rab7-RILP complexes, the RabSF regions involved in interaction are highlighted in 
red. 
 
According to this model, it was proposed that the binding of general Rab-specific 
regulators such as REP and GDI involves RabF regions. This hypothesis is 
confirmed by the crystal structures of the Rab-GDI complex (Rak et al., 2003) and 
the Rab-REP complex (Rak et al., 2004). Moreover, an additional important binding 
motif (CBR interacting motif, CIM) was identified in these interactions. In this motif, 
two key hydrophobic residues make critical contacts with REP and GDI and mount 
the Rab C-terminal hypervariable domain (see below) onto REP/GDI. This interaction 
may facilitate the insertion of geranylgeranyl moieties into the lipid binding site of 
REP/GDI (Pylypenko et al., 2006). 
Apart from the GTP-binding domain, the so called C-terminal hypervariable 
domain, which is consist of ca. 30-40 amino acid residues, is another important 
structural element of Rab GTPases. Rab hypervariable domains represent the most 
divergent parts of Rab sequences and are primarily unstructured (Pfeffer, 2005) 
(Figure 2-5). This domain is presumed to contain a targeting signal for Rab proteins 
(Stenmark et al., 1994b; Brennwald and Novick, 1993; Chavrier et al., 1991). The 
targeting signal can be some special residues, for instance, the polybasic cluster in 
Rab35 C-termini that is responsible for targeting to the plasma membrane via 
interaction with negatively charged phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) 
and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) lipids (Heo et al., 2006). 
The hypervariable domain of Rab9 is involved in membrane localization by 
interacting with the effector protein TIP47 (tail-interacting protein of 47 kDa) (Aivazian 
et al., 2006). Subsequent studies show that Rab localization is likely to be more 
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complex and involve additional determinants (Aivazian et al., 2006; Ali et al., 2004; 
Beranger et al., 1994; Stenmark et al., 1994b).  
At or near the C-terminus, the conserved cysteine(s) in the Rab prenylation motif 
(CC, CXC, CCX, CCXX, CCXXX, CXXX) are post-translationally modified by 
geranylgeranyl group(s) (as described in section 2.1). This hydrophobic modification 
of Rab GTPases enables reversible association with membranes, which is essential 
for proper Rab functioning (see section 2.2.3, 4). 
2.2.3 Rabs function in vesicular transport 
 
 
Figure 2-8. The essential steps of vesicular transport (endocytosis from the plasma membrane as an 
example). (1) Budding. A specific transport intermediate (vesicle or tubule) carrying the selected cargo 
is formed during assembly of the coat. Dynamin mediates scission and release of the vesicle from the 
donor organelle. (2) Transport. The vesicle is subsequently transported to its destination using motor 
proteins (kenesins/dyneins and myosins) to drive the movement of vesicles along microtubules and 
actin filaments, respectively. (3) Tethering and docking. ATP hydrolysis drives the disassembly of cis-
SNARE complexes by NSF and α-SNAP. GTP-Rabs mediate the recruitment of tethering factors and 
SNAREs into a microdomain. Vesicle and target membrane are then brought into close proximity by 
formation of tethering complexes (coiled-coiled tethers or multimeric tethering complexes). This 
process facilitates the trans-SNARE pairing between the cognate v-SNAREs on vesicles and t-
SNAREs on the target compartment, which is referred to as “docking”. (4) Fusion. The assembly of 
tans-SNARE complexes drives membrane fusion. Transported cargo is incorporated into the 
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membrane of the target compartment of released into its lumen. The tethers dissociated from the 
membrane or remain stably associated with the target membrane. 
 
Eukaryotic cells, due to the spatial differentiation of intracellular organelles, 
require a sophisticated system of vesiculo-tubular transport that ensures the 
communication between different compartments. In the exocytic pathway, newly 
synthesized proteins and lipids are sorted from the endoplasmic reticulum, via the 
Golgi apparatus to their destination at the lysosome, the plasma membrane and the 
extra cellular space. On the other hand, the endocytic pathway is required for the 
uptake of nutrients and signaling molecules, and the internalization of receptors. The 
newly internalized cargos are transported to the early endosome, and subsequently 
proteins destined for recycling are sorted to recycling endosomes and then to the 
plasma membrane, while proteins destined for degradation are transported to late 
endosomes and then to the lysosome (Zerial and McBride, 2001) (Figure 2-13). 
Vesicular transport takes place in four essential steps (Figure 2-8) that comprise 
vesicle budding, transport, tethering/docking, and fusion. Rab GTPases have been 
implicated in regulation of each of these steps (Grosshans et al., 2006) (Figure 2-8, 
2-14).  
Vesicle budding is a process of cargo selection combined with formation of a 
vesicle or tubular intermediate. Packaging of cargo into transport container involves 
the coat protein complexes (CPCs) machinery (Figure 2-9), including the clathrin 
(Fotin et al., 2004a; Fotin et al., 2004b), coat protein complex-I(COPI) (Presley et al., 
2002) and coat protein complex-II (COPII) (Fath et al., 2007; Stagg et al., 2006). The 
clathrin CPC functions at the Golgi and the plasma membrane (Edeling et al., 2006), 
the COPII coat machinery mediates the exocytic pathway at the ER (Gurkan et al., 
2006), whereas the COPI coat machinery is involved in recycling of proteins between 
the compartments of the Golgi and from the Golgi apparatus to the ER (Lippincott-
Schwartz and Liu, 2006). The small GTPases Arf and Sar1 regulate the assembly of 
the COPI and COPII vesicular coats, respectively (Memon, 2004). The coat 
assembly and disassembly are dictated by the GTP- and GDP-bound Arf/Sar1, which 
are controlled by GEFs and GAPs (see section 2.2.1). CPCs include adaptor proteins 
(APs) that recognize sorting motifs present in cargo proteins, which provide the “first 
line” of cargo-sequestration specificity on budding machinery (Sato and Nakano, 
2007; McNiven and Thompson, 2006). Clathrin coated vesicle (CCV) fission and 
release are proposed to be driven by a mechanochemical molecule, dynamin. CCV 
assembly results in the formation of a deeply invaginated coated pit. The GTPase 
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dynamin is targeted to coated pits and, upon binding GTP, self-assembles into a 
helical collar at the necks of deeply invaginated coated pits (Figure 2-8). Dynamin 
oligomerization stimulates GTPase activity, and GTP hydrolysis may drive membrane 
tubulation, fission and vesicle release (Praefcke and McMahon, 2004; Hinshaw, 
2000). Whereas in the case of COPII coated vesicles, membrane curvature and 
vesicle fission are promoted by the Sar1 N-terminal amphipathic α helix that is 
regulated by GTP-binding and hydrolysis (Lee et al., 2005; Bielli et al., 2005). Upon 
GTP binding by Sar1, membrane insertion of the N-terminal amphipathic α helix 
initiates membrane tubulation. Therefore, the initiation of COPII vesicle budding by 
Sar1 GTPase couples the formation of membrane curvature with coat protein 
assembly and cargo selection. 
  
Figure 2-9. Molecular model of COPII-cage (left) (Fath et al., 2007) and a 7.9 Å (cryo-EM) 
reconstruction of clathrin-cage (right) (Fotin et al., 2004b). In the left, the COPII-cage is built by fitting 
Sec13/31 crystal structures into a Cryo-EM map. The molecular model of the cage comprises 24 
copies of the assembly unit with octahedral or 432 symmetry. The full-length Sec13 proteins are 
shown in red and orange and the central α-solenoid domains of Sec31 are shown in light and dark 
green. In the right, there are 36 clathrin triskelions in the structure, which has D6 symmetry. Thus, 
there are three symmetry-independent triskelions (or nine symmetry-independent legs). The coloured 
triskelions show one choice of the three independent clathrin triskelions. 
 
Rabs have been implicated in cargo selection and vesicle formation (Pagano et 
al., 2004; McLauchlan et al., 1998; Jedd et al., 1997; de Hoop et al., 1994). For 
example, GTP bound Rab9 increases the affinity of its effector TIP47 for mannose 6-
phosphate receptors (MPRs), resulting in the enrichment of MPRs within vesicles 
that recycle MPRs from late endosomes back to the Golgi for additional rounds of 
transport (Carroll et al., 2001; Diaz and Pfeffer, 1998).  
The vesicles are delivered to their target compartment, often using motor 
proteins (kinesins/dyneins and myosins) to drive the movement of vesicles along 
microtubules and actin filaments, respectively. In animal cells, microtubules provide 
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high-speed, long-range transport, whereas the actin network usually facilitates slower 
and short-range local transport events (Jordens et al., 2005). The first indications that 
Rab proteins might be involved in cytoskeleton-mediated vesicle delivery come from 
the observations that actin-mediated movement of vesicles was largely dependent on 
Rab8 activity (Peranen et al., 1996). Subsequently, the identification of specific 
interaction of GTP-Rab6 with Rabkinesin-6(RB6K) provided the first view of a Rab 
protein linked to a motor protein (Echard et al., 1998). From then on, an emerging 
number of findings have revealed that Rabs control recruitment of motor proteins 
through direct interactions and/or via effectors (Figure 2-10).  
 
 
Figure 2-10. Rab-mediated connection of microtubule- and actin filament-based motor proteins for 
delivery of vesicles. Red and green indicate, respectively, minus-end- and plus-end-directed motors. 
In dynein/dynactin motors, dyneins are shown in gray, dynactins in red. Rab effectors are shown in 
yellow. Rab7 effector RILP is shown in light blue (see text for details). 
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There are many examples of Rab proteins associating with the actin-based 
myosin motors (for recent reviews see ref (Desnos et al., 2007; Seabra and Coudrier, 
2004)). An interaction between the class V myosin Myo2p and a yeast Rab GTPase, 
Sec4p, is required for secretory vesicle transport to the sites of vesicle delivery 
during budding and mating (Pruyne et al., 2004; Wagner et al., 2002). Rab11 binds to 
the mammalian class V myosin homologue, myosin Vb, directly or via family of 
Rab11-interacting proteins (FIPs) (Hales et al., 2002) (Figure 2-7, structure of Rab11-
FIP2 complex). They function in the delivery of recycling endosomes to the cleavage 
furrow of plasma membrane, which is essential for plasma membrane expansion of 
the associated furrow ingression and/or during the abscission and separation of 
daughter cells (Wilson et al., 2005; Fielding et al., 2005).  
A fast-growing field about myosin-dependent vesicle transport is the trafficking of 
melanosome, the pigment-containing organelle of melanocytes, due to its connection 
to Griscelli syndrome (for review see (Desnos et al., 2007)). Melanosomes are 
delivered rapidly to the melanocyte cell periphery via kinesin motor traveling along 
microtubles (Wu et al., 1998b). At the melanocyte periphery, melanosomes are 
captured to actin filaments through melanosome-residing Rab27a, which attaches 
the melanosome to the actin motor myosin-Va (MyoVa) via its effector 
melanophilin/Slac2a (synaptotagmin-like protein homologue lacking C2 domain A) 
(Fukuda and Kuroda, 2002; Fukuda et al., 2002; Strom et al., 2002; Nagashima et al., 
2002; Wu et al., 2002a; Wu et al., 2002b). The slow and local transport along actin 
filaments lead to the retention of melanosomes at the cell periphery for their final 
transfer to the neighboring keratinocytes (Wu et al., 1998b). Therefore, mutations in 
MY05A, RAB27A and MLPH, the genes encoding MyoVa, Rab27a and melanophilin, 
correspondingly, lead to albinism (a pigmentary dilution of skin and hair) and Griscelli 
syndrome. Griscelli syndrome type I (GS1) is a recessive disease characterized by 
partial albinism and primary neurological disorders. The primary defect in GS1 was 
localized to MyoVa that functions in synaptic vesicle transport in neurons. Moreover, 
since Rab27a and its effector are also necessary for various secretory events, 
patients with mutations in Rab27a (Griscelli syndrome type II) display a combination 
of albinism and immunodeficiency, which is due to the loss of cytotoxic killing activity 
in T-lymphocytes (Menasche et al., 2003; Menasche et al., 2000).  
An interesting example of the recruitment of microtubule-based dynein/dynactin 
motors to the target compartment is the Rab7 GTPase-mediated stepwise assembly 
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of the complex transport machinery (Johansson et al., 2007). Rab7 controls late 
endocytic transport by recruiting the dynein/dynactin motor through a series of mutual 
interactions mediated by its effectors, Rab7-interacting lysosomal protein (RILP) and 
oxysterol-binding protein-related protein 1L (ORP1L). GTP-Rab7 binds to RILP and 
ORP1L to form a heterotrimeric complex (Figure 2-7 shows the structure of a dimer 
of Rab7-RILP complex). The N-terminal domain of RILP binds to the C-terminal 
region of the dynactin projecting arm p150Glued, resulting in the recruitment of the 2.4-
MD dynein/dynactin motor to late endosomes (LEs). In addition, ORP1L is required 
to direct the entire complex to αIβIII spectrin. The interaction is mediated by Arp1 
binding to βIII spectrin, which is the general dynein receptor on LEs, Golgi and other 
organelles (Johansson et al., 2007; Cantalupo et al., 2001; Jordens et al., 2001). 
After the delivery of a vesicle to the target membrane, the tethering factors serve 
in the initial recognition between a vesicle and its target and bring them in close 
proximity. Two types of tethering factors have been described: long coiled-coiled 
tethers and large multisubunit complexes (for review see (Sztul and Lupashin, 2006)).  
Coiled-coiled tethers are characterized by long, extended rod-like structures 
appearing to function as long fibrous connections that have been observed between 
vesicles and Golgi membranes. Rab proteins have been shown to be involved in 
assembly of tethering complexes. For example, GTP-Rab1 is required to recruit the 
tethering factor p115 to COPII vesicles derived from the ER (Allan et al., 2000). The 
cis-Golgi coiled-coiled tethering protein GM130 complexed with GRASP65 functions 
as a Rab1 effector complex that directly interacts with GTP-Rab1 (Moyer et al., 2001). 
The interaction of p115 with the GM130-GRASP65 complex is thought to tether ER-
derived COPII vesicles to the Golgi membrane, which is required for vesicle 
targeting/fusion with the Golgi (Sztul and Lupashin, 2006) (Figure 2-11 A). In addition 
to the tethering of COPII vesicles, p115-GM130 together with giantin have been 
proposed to mediate the tethering of recycling COPI vesicles. The COPI vesicle-
residing coiled-coiled tether giantin also binds to GTP-Rab1. Giantin and GM130 
associate with the C-terminal, acidic domain of p115, thus releasing the 
autoinhibitory intramolecular interaction of p115 so as to facilitate p115 binding to 
Rab1 (Beard et al., 2005). This study suggests that the tethering factors GM130 and 
giantin regulate recruitment of p115 for further downstream events rather than merely 
forming a bridge. 
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Figure 2-11.  Two types of tethering complexes and the roles of Rab GTPases in membrane tethering. 
(A) GTP-Rab1 is required for the recruitment of its effector, coiled-coiled protein p115 into ER-derived 
COPII vesicles. At the cis-Golgi membrane, GTP-Rab1 binds a coiled-coiled protein GM130 
complexed with GRASP65, directly via GM130. This interaction might then facilitate the formation of 
the tripartite p115-GM130-GRASP65 protein complex, which seems to be essential for the tethering of 
COPII vesicles to the cis-Golgi. (B) Potential COG complex-mediated bridge formation between COPI 
vesicles and the Golgi in a Rab-dependent manner. The mammalian COG architecture is show in 
detail (Ungar et al., 2005). Numbers represent COG subunits, with the N- and C-terminal regions of 
Gog1 indicated. Two herterotrimeric subcomplexes (Gog2-4 and Gog5-7) are linked by a 
heterodimeric unit containing Cog1 and Cog8. 
 
The second type of tethering factor, multisubunit complexes, represent examples 
of in vivo function of proteins as parts of large macromolecular machines. Large 
multisubunit complexes, including COG (8 subunits), GARP (4 subunits), Dsl1 (3 
subunits), TRAPP I (7 subunits), TRAPP II (10 subunits) and Exocyst (8 subunits), 
have been shown to regulate distinct steps of membrane traffic (Sztul and Lupashin, 
2006). One example is the conserved oligomeric Golgi (COG) complex, an eight-
subunit complex essential for normal Golgi structure and function (for review see 
(Ungar et al., 2006)). COG complex was initially suggested to be involved in 
membrane trafficking in yeast. The COG complex has been shown to interact with 
SNARE proteins that mediate membrane fusion, Ypt/Rab GTPases, and the COPI 
coat (Figure 2-11 B). These findings led to the hypothesis that the COG complex 
functions as a tether connecting COPI vesicles with cis-Golgi membranes during 
retrograde trafficking (Suvorova et al., 2002). Very recently, the TRAPP I complex 
was found to link to a component of COPII cargo adaptor complex, Sec23, via Bet3 
subunit. These findings reveal an additional role for vesicle coats and indicate that 
ER-derived COPII vesicles tether to their target membrane before uncoating (Cai et 
al., 2007). 
Once a vesicle is brought to the proximity of its target membrane by tethering, 
the vesicle undergoes membrane fusion with the target membrane. Soluble N-
ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) mediate 
membrane fusion in all of the trafficking steps of the secretory pathway (for review 
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see (Jahn and Scheller, 2006; Hong, 2005)). SNAREs contain a transmembrane 
domain at their C-terminal ends, a conserved SNARE motif that are arranged in 
heptad repeats, and N-terminal domains.  
 
Figure 2-12.  Structure of SNARE complex (PDB file: 1SFC). (A) The 4-helix bundle of trans-SNARE 
pair in a structural view. Synaptobrevin (VAMP-2) is a v/R-SNARE shown in blue, syntaxin is a t/Q-
SNARE shown in red, and SANP-25 is a t/Q-SNARE shown in green. (B) The central ionic layer of the 
SNARE complex (looking down the coiled-coil from the C-terminus) illustrates the critical arginine of 
synaptobrevin (R-SNARE) forming hydrogen-bonding with glutamines of syntaxin (Q-SNARE) and 
SNAP-25 (Q-SNARE). 
 
Vesicle-associated SNAREs (v-SNAREs) and SNAREs at the target membrane 
(t-SNAREs) recognize each other and form four-helix bundles, with the associated 
release of free energy being used to drive membrane fusion (see Figure 2-8, 2-12). 
This has been referred to as a “zippering” hypothesis (Nichols et al., 1997; Hanson et 
al., 1997; Lin and Scheller, 1997). Structural analysis shows that the four-helix 
bundle of SNAREs depends on interactions of an arginine from one helix with 
glutamines from three other helices, which results in a structure-based classification 
of SNAREs into R- and Q-SNAREs, based on the presence of these critical arginine 
(R) and glutamine (Q) residues (Ossig et al., 2000; Sutton et al., 1998; Fasshauer et 
al., 1998) (Figure 2-12 B). The cis-SNARE complexes, i.e. complexes formed 
between SNAREs located on the same membrane, are disassembled by the ATPase 
NSF (N-ethylmaleimide-sensitive factor) together with its cochaperone α-SNAP 
(soluble NSF attachment protein), driven by ATP hydrolysis (Mayer et al., 1996; 
Sollner et al., 1993). This process is called initial priming. Upon tethering and priming, 
the activated SNAREs associated with the vesicle and the target compartment, 
respectively, participate in the docking through a process termed trans-SNARE 
paring. Trans-SNARE complexes proceed from a loose state to a tight state 
(zippering), which may exert a mechanical force on the membranes through the stiff 
linkers between the transmembrane domains and the helical bundle of SNARE motifs, 
resulting in opening the fusion pore (McNew et al., 2000; McNew et al., 1999). 
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Although SNAREs reconstituted into liposomes are enough to mediate a fusion 
reaction on the order of minutes (Weber et al., 1998), intracellular fusion reactions, 
which often happen in the microsecond range, also requires Rab GTPases and Rab 
effectors, SM (Sec1/Munc18-related) proteins, and some other regulatory factors 
(like calmodulin, synaptotagmin). 
A large amount of evidence indicates that Rab GTPases indirectly regulate 
SNARE function. They bind the SNARE machinery (SNAREs and NSF) via effectors 
(such as tethering factors) (reviewed in (Lupashin and Sztul, 2005; Zerial and 
McBride, 2001)). For example, Rab5 effectors Rabaptin-5/Rabex-5 (Figure 2-7, 
structure of Rab5-Rabaptin complex and Rab21-Rabex-5 VPS9 domain complex) 
and coiled-coiled tethering factor EEA1 recruit the t-SNARE, syntaxin-13, via EEA1 in 
an NSF-dependent manner. This interaction is required to drive homotypic early 
endosome fusion (McBride et al., 1999). A proposal for Rab GTPase regulation of a 
membrane fusion is that Rab and its effectors create a so called “Rab domain” on 
specific membrane, and selective incorporation of cis-SNARE complexes into a Rab 
domain leads to trans-SNARE paring between cognate SNAREs upon tethering 
(Zerial and McBride, 2001). One good example to support this model comes from a 
recent report by William Wickner and coworkers (Starai et al., 2007). They showed 
that Rab-independent liposome fusion needs high levels of SNAREs, but Ypt7 
enhanced the rate constant of 4SNARE/HOPS complex formation by many 
thousand-fold. Therefore, Rabs function in membrane fusion by concentrating 
SNAREs, SM proteins and key lipids in a microdomain. Rab GTP hydrolysis seems 
to define the timeframe for Rab effector assembly and therefore influences the 
tethering, docking and fusion steps (Rybin V et al., 1996; Stenmark et al., 1994a). 
Some evidence also showed that disassembly  of SNAREs is required for tethering of 
COPII vesicle, suggesting that on the contrary SNAREs determine the recruitment of 
the tether as well (Bentley et al., 2006). This may represent a “dead end” tethering 
elimination mechanism, since tethering would only happen at focal sites containing 
appropriated poised SNAREs.  
Although the list of Rab GTPases, Rab effectors, tethers, other regulatory 
proteins is still growing, the exact functions of these trafficking machineries are still 
somewhat elusive (Pfeffer, 2007). 
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2.2.4 Regulation of Rab membrane localization and 
recycling 
 
Rab GTPases compromise the largest subgroup of the Ras superfamily, with 
more than 60 members in humans and 11 members in yeast (Pereira-Leal and 
Seabra, 2001). It seems that the increased complexity throughout evolution results 
from a higher level of cell organization and intracellular transport in the differentiated 
cells of multicellular organisms. Rab GTPases localize to distinct intracellular 
compartments and direct vesicular transport through specific interaction with 
effectors (as discussed in section 2.2.3). Evolutionarily conserved Rab proteins tend 
to be expressed in all cell and tissue types and regulate fundamental transports, 
whereas certain family members function in specialized transport events observed in 
different cell types (Figure2-13). 
As discussed in section 2.2.1, the regulatory principle of Rab GTPases lies in 
their ability to cycle between active GTP- and inactive GDP-bound conformations, 
therefore functioning as molecular switches to exert temporal and spatial control of 
vesicular transport (Figure 2-14). Malfunction of these regulations may lead to 
defects in eukaryotic cells. For example, hijacking Rab1GAP, TBC1D20 of host cells 
by hepatitis C viruses (HCV) is involved in HCV infection. Rab1 GTPase has been 
implicated in the regulation of anterograde traffic between the ER and the Golgi 
(Figure 2-13). Interaction of HCV protein NS5A with TBC1D20 was proposed to 
locally inactivate Rab1 at the sites of nascent viral protein synthesis, thus, promote 
redirection from a Golgi-bound pathway to viral-induced membrane structures 
supporting HCV RNA replication (Sklan et al., 2007).  
Interestingly, Rab activation and deactivation seem often to be concentrated to 
the site (membrane) of its function, namely the Rab machinery. Two factors may 
contribute to this restriction. First, in the cytosol Rab proteins normally bind to 
REP/GDI, which serves as a chaperone for prenylated Rab soluble in cytosol 
(Sanford JC et al., 1995). REP and GDI also act as GDP dissociation inhibitors, 
which helps prevent Rab proteins from inadvertent activation (Alexandrov et al., 1994; 
Sasaki et al., 1990) (Figure 2-14). Second, a number of GEFs are actually members 
of large protein complexes (like the TRAPP tethering complex) that function as Rab 
effectors as well (Liang et al., 2007; Jones et al., 2000; Wurmser et al., 2000). Yeast 
homologues of Rab, Ypt31/32 have been shown to recruit Sec2p, a GEF for Sec4p 
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GTPase (Figure 2-7 shows the structure of Sec4-Sec2), leading to the activation of 
Sec4p on secretory vesicles (Ortiz et al., 2002). Recent studies showed that the Rab 
machinery is peripherally associated with the membrane in a dynamic equilibrium 
that depends on the balance between GEFs and GAPs. Interaction of GTP-Rab5 
with the class C VPS/HOPS complex, which contains Vps39p (the GEF for Rab7), is 
required to recruit Rab7 so as to exchange Rab5 for Rab7 at the interface between 
early and late endosomes (Rink et al., 2005).   
 
 
Figure 2-13. Intracellular localization of Rab proteins and Rab-regulated vesicular transport. The large, 
orange arrows indicate endocytosis, recycling and exocytosis. Appropriated cargos are selected and 
internalized by clathrin-coated vesicles. Rab5 mediates transport of vesicles to early endosomes. 
Recruitment of cargos into Rab4-containing microdomains within early endosomes leads to transport 
back to the plasma membrane directly or via recycling endosomes. While sorting into Rab5 
microdomains results in transport either to recycling endosomes or toward late endosomes. Cargos 
sorted to recycling endosomes are subsequently recycled to the plasma membrane, involving Rab11. 
Transport from early endosomes to late endosomes is facilitated by Rab7, whereas recycling of 
mannose 6-phosphate receptors (M6PRs) from late endosome to TGN is mediated by Rab9. Rab7 
also regulates the transport of molecules to lysosomes for degradation, through its effectors RILP and 
ORP1L interaction with motor dynein/dynactin. Exocytosis begins with movement of COPII vesicles 
from ER to the Golgi apparatus, which involves Rab1. Rab6 controls the retrograde Golgi-ER and 
intra-Golgi transport of COPI vesicles, which recycles components involved in anterograde transport. 
Rab33b is localized to the medial Golgi cisternae and may play a role in intra-Golgi transport. 
Successful passage through the Golgi complex brings the products to the TGN, the major distribution 
center along the biosynthetic pathway, where they are packaged and sent to different destinations. 
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Rab3a facilitates the secretion of synaptic vesicles in neurons. Rab8 is involved in TGN-plasma 
membrane transport. In yeast, a Rab homologue, Sec4p is required for delivery of TGN-derived, 
secretory vesicles into the bud. Some Rabs are cell- (for example, Rab3a in neurons) or tissue-
specific (for example, Rab17 in epithelia), or exhibit cell-type-specific localization (for example, Rab13 
in tight junction of epithelial cells). Abbreviations: CCP, clathrin-coated pit; CCV, clathrin-coated 
vesicle; COP, coat protein complex; IC, ER-Golgi intermediated; TGN, trans-Golgi network; EC, 
epithelial cell; SG, secretory granules; SV, synaptic vesicles; PIP2, PIP3, phosphatidylinositol 
bi/trisphosphate (see section 2.2.2). 
 
Post-translational addition of geranylgeranyl moieties at (usually) two cysteine 
residues in the C-termini of Rab proteins enable them to associate with membranes, 
which is essential for Rab function on membranes. This reaction is catalyzed by 
RabGGTase with the aid of REP (Rab prenylation is discussed in section 2.1). In 
addition to support Rab prenylation, REP acts as a molecular chaperone of 
prenylated Rab to make it soluble in cytosol and is responsible for delivery of 
prenylated Rab to the target membrane (Figure 2-14). REP-mediated delivery may 
involve some unknown release factor that facilitates insertion of Rab into membranes 
and disrupts the Rab-REP interaction. The GDI displacement factors (GDF) that are 
capable of displacing GDI (discussed below) from Rab are candidates as release 
factor, if there is an analogous function towards REP. Once prenylated Rab is 
presented to the membrane, REP is released and recycled to the cytosol for 
additional rounds of function (Figure 2-14). Two isoforms of REP (REP-1 and REP-2) 
have been identified in mammalian cells (Cremers et al., 1994; Seabra et al., 1992a).  
Prenylation is known to be crucial for the proper function of Rab proteins. The 
roles of lipid modification can be divided into three parts. First, double hydrophobic 
moieties enable Rabs to stably associate with membranes through hydrophobic 
interaction with the lipid bilayer (Shahinian and Silvius, 1995). Unprenylated Rabs are 
cytosolic proteins and are not able to attach to membranes and exert their function 
on membrane events.  
Second, prenylation serves as one of the determinants of Rab targeting. The 
majority of Rab proteins contain two cysteine residues at the C-termini. Some 
evidence reveals that double prenylation is required for correct localization of 
dicysteine Rab proteins, while mutant Rab proteins that contain only one prenylatable 
cysteine are retained on the ER membrane and are not delivered to their target 
locations (Gomes et al., 2003). However, this seems not to apply to several Rabs 
that natively process only one prenylatable cysteine (see section 2.1). Another similar 
study has revealed that single-cysteine mutants of Ypt1 and Sec4 were mislocalized 
and lost function (Calero et al., 2003). In contrast, Rab1b mutated to GGTaseI 
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substrate CAAX box containing a single prenylation site (Rab1bCLLL) correctly 
targets to Golgi/ER and is functional in ER -> Golgi transport (Overmeyer et al., 
2001). Furthermore, the lipid tail of Rab proteins could be circumvented by replacing 
the prenylation motif with a transmembrane domain, given that the transmembrane 
domain brought them to the correct location (Ossig et al., 1995). 
Third, the prenyl moities are required for interactions of Rabs with effectors and 
regulators. For example, RabGDI does not bind to unprenylated Rab but only with 
prenylated Rab (Musha et al., 1992). Ypt interacting protein1 (Yip1) interacts 
preferentially with digeranylgeranylated Rab proteins but not with mono-
geranylgeranylated Rabs (Calero et al., 2003). Rab3 subfamily-specific GAP and 
GEF show activity on lipid-modified Rab3 but not on the lipid-unmodified Rab3 (Fukui 
et al., 1997; Wada et al., 1997).  
After completion of their designated functions in a round of transport, GTP 
hydrolysis accelerated by GAPs leads to inactivation of Rab proteins. Inactive GDP-
Rab is sequestered by Rab GDP dissociation inhibitor (RabGDI) that inhibits Rab 
reactivation upon binding (Sasaki et al., 1990) and extracts Rab molecules from 
membranes (Sanford JC et al., 1995) (Figure 2-14). Rab recycling factors (RRFs) 
have been postulated to be involved in initiating Rab extraction from membranes 
(Luan et al., 1999). A possible RRF is the heat shock protein 90 (Hsp90)-containing 
chaperone complex, including Hsp90, Hsc70 and cysteine string protein. Interaction 
of αGDI with the complex via GDI mobile effector loop (MEL) is required for efficient 
Rab3A membrane extraction and neurotransmitter release (Sakisaka et al., 2002). 
Later, the Hsp90 chaperone complex was found to function in Rab1-dependent ER to 
Golgi transport as well (Chen and Balch, 2006). RabGDI subsequently delivers 
prenylated Rabs back to donor membrane for another rounds of transport, 
representing Rab recycling. The membrane bound GDI displacement factors (GDFs) 
serve as RabGDI-Rab receptor and dislodge prenylated Rab from GDI (Dirac-
Svejstrup AB et al., 1997). Human Yip3 was shown to catalyze dissociation of 
endosomal Rab-RabGDI complex (Sivars et al., 2003). Very recently, a bifunctional 
protein, SidM from Legionella pneumophila, was found to act as both GEF and GDF 
for Rab1 (Machner and Isberg, 2007). In this bifunctional factor, GDI displacement, 
Rab binding, and nucleotide exchange activity located in the same protein. This 
discovery suggests the possibility of the existence of similar factors in eukaryotic 
cells, despite a lot of evidence showing that nucleotide exchange appears to happen 
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after the release of REP/GDI from the membrane (Soldati et al., 1994; Ullrich et al., 
1994). However, the molecular mechanism of GDI displacement mediated by GDF is 
still unclear. 
REP and GDI are similar in both sequence (30% identity) and structure (Rak et 
al., 2004; Rak et al., 2003) and functionally related. Both proteins can bind prenylated 
Rab, inhibit GDP dissociation, make them soluble in cytosol, and deliver them to 
target membrane. Nevertheless, in contrast to REP, GDI cannot support Rab 
prenylation due to its low affinity to unprenylated Rabs, whereas REP is less efficient 
in retrieving Rab molecules from membranes than GDI (Pylypenko et al., 2006). The 
functional segregation of these two Rab regulators determines their precise role in 
Rab processing and recycling. Therefore, an effort to generate a variant of REP or 
GDI that could perform both functions was only partially successful (Alory and Balch, 
2003). 
Considering the number and importance of intracellular events controlled by Rab 
GTPases, it is not surprising that dysfunction of Rab and regulatory proteins links is 
correlated to human diseases (Seabra et al., 2002). Mutations in Rab27a result in 
Griscelli syndrome due to malfunction of melanosome transport in melanocytes and 
cytotoxic granule secretion by T cells, as described in section 2.2.3. Mutations in 
RabGDIα lead to X-linked non-specific mental retardation. Defects in Rab prenylation 
give rise to abnormalities in mammals. Mutation in RabGGTase gene causes a 
mouse model of Hermansky-Pudlak syndrome (Detter et al., 2000), characterized by 
partial albinism, tendency for bleeding, and lysosomal accumulation of ceroid 
liposuscin. Mutations in REP-1 gene leads to choroideremia (CHM) (Seabra, 1996a; 
Seabra et al., 1993), an X-linked inherited disease characterized by progressive 
retinal degeneration leading to blindness by middle age. 
In the case of CHM, due to the presence of REP-2, loss of REP-1 function does 
not completely abolish the ability of processing Rabs in CHM cells. However, REP-2 
cannot compensate the loss of REP-1 function absolutely, since CHM lymphoblast 
cell lines accumulate unprenylated Rab27A (Seabra et al., 1995). This was proposed 
to be a consequence of a result of low affinity of RabGGTase for the Rab27A:REP-2 
complex (Larijani et al., 2003). Later studies showed that Rab27 binds in lower 
affinity to REP-2 than other Rab proteins, leading to a proposal that the competition 
among Rab proteins for limiting REP-2 molecules results in hierarchical prenylation 
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of Rab proteins (Rak et al., 2004). However, much more work needs to be done to 
prove this model in vivo. 
 
 
Figure 2-14. Rab biogenesis, regulation of vesicular transport and recycling. (1) Newly synthesized 
Rab proteins bind to REP. (2) REP presents Rab proteins to heterodimeric RabGGTase for 
modification of (usually) two geranylgeranyl moieties. (3) REP delivers the prenylated Rab proteins to 
their target membranes. (4) Once REP is released, it recycles into cytosol to support additional rounds 
of Rab prenylation. (5) Prenylated Rab proteins associate with the membrane. (6) Subsequently GEFs 
facilitate exchange of GTP for GDP. (7) GTP bound Rab proteins can bind to effectors that are 
involved in vesicle budding and cargo selection. (8) GTP-Rab proteins directly or via effectors recruit 
motor proteins to drive the movement of vesicles along microtubules and actin filaments. (9) The 
vesicles are transported to the target compartment. GTP-Rab proteins mediate recruitment of effectors, 
tethering factors, SNAREs, facilitating tethering, docking and fusion of vesicles at the target 
membrane. (10, 11) Hydrolysis of GTP is accelerated by GAPs, resulting dissociation of related 
effectors. (12) Extraction of GDP bound Rab proteins from membranes is medicated by GDI. This 
extraction process may involve Rab recycling factors (13) GDI makes prenylated Rab proteins soluble 
in cytosol and delivers them to the donor membrane. GDF facilitates dislodgement of prenylated Rab 
proteins from GDI, enabling them to re-associate with the donor membrane. (14, 15) GDI is released 
and is reused in additional rounds of Rab extraction.  
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2.3 Protein prenyltransferase inhibitors 
2.3.1 Farnesyl transferase inhibitors (FTIs) 
 
As described in section 2.1, Ras proteins play a pivotal role in cellular signal 
transduction controlling cell proliferation, division, and differentiation (Barbacid, 1987). 
Mutation in Ras can lead to loss of its GTPase activity and permanent activation of 
Ras signaling independent of upstream activation (namely oncogenic Ras). A similar 
effect arises from mutation induced increase in the rate of GDP dissociaction. 
Oncogenic Ras genes are among the most common oncogenes found in human 
tumors. They have been found in approximately 20-30% of a wide variety of human 
cancers (Bos, 1988). Particularly, mutations in K-Ras are prevent in >50% of colon 
cancers, >90% of pancreatic cancers, and ~30% of lung cancer. Mutations in N-Ras 
are present in 10-20% melanoma and some hematologic malignancies. Mutations in 
H-Ras are rare in human cancer but have been documented in 15-20% of bladder 
cancers (Basso et al., 2006). The extensive involvement of mutated Ras in the 
development of a number of cancers provides strong indicatives that interfering with 
Ras activity might offer new opportunities for the development of anti-cancer agents. 
One straightforward approach was proposed to be intervention of Ras membrane 
localization (Gibbs, 1991), since Ras proteins require post-translational modification 
with lipids to associate with plasma membrane in order to exert their biological 
function. The discovery that FTase inhibitors (FTIs) can reverse transformed 
phenotype of cancer cells dramatically stimulated interest in the development of FTIs 
(Kohl et al., 1993). Subsequently, one of the FTIs developed by Merck has been  
demonstrated to induce tumor regression in ras transgenic mice without systemic 
toxicity. This finding suggests that FTIs may be safe and effective anti-tumor agents 
(Kohl et al., 1995).  
Over the past ~15 years, a number of FTIs have been developed (Gibbs et al., 
2001; James et al., 1993), showing inhibitory activities in vitro and in vivo up to the 
low nanomolar range with high selectivities. These include natural products, 
tetrapeptide CAAX analogues, nonpeptidic and CAAX-competitive inhibitors, farnesyl 
pyrophosphate analogues and bisubstrate inhibitors. Four of them, R115777 
(tipifarnib) from Janssen, SCH66336 (lonafarnib) from Schering group, BMS214662 
from Bristol-Myers Squibb, and L778,123 from Merck, have advanced into clinical 
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trials. These compounds are highly potent and selective against FTase (>1000-fold 
preference over GGTase-I), except L778,123 which shows moderate selectivity 
between FTase and GGTase-I (Figure 2-15).  
 
 
Figure 2-15. Farnesyl transferase inhibitors (FTIs) in clinical trials; GGTI, a selective, potent and 
cellularly active GGTase-I inhibitor; RabGGTI, a selective and cellularly active RabGGTase inhibitor. 
 
2.3.2 Mechanism of FTIs action 
 
The mechanisms of FTIs action are not fully understood. The lack of toxicity to 
untransformed cells (at pharmacologically relevant drug concentrations) could be 
related to several points (Waldmann and Thutewohl, 2001). First, some 
geranylgeranylated Ras-related proteins (like TC21) that shares indistinguishable 
transforming and differentiating activities with Ras might compensate for the loss of 
Ras function (Graham et al., 1999; Graham et al., 1996). Second, cancer cells may 
be more vulnerable to FTIs than normal cells, probably due to the differential reaction 
to the inhibition of Ras activity. The dose-limiting toxicities of FTIs in clinical trials may 
be evidence for this assumption. Third, prenylation of two Ras isoforms, K-Ras4B 
and N-Ras, are not so efficiently blocked by FTIs as H-Ras (James et al., 1996). 
Thus, normal cells may be less sensitive to FTIs because they express K-Ras4B and 
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N-Ras. Two reasons may account for this consequence. One is that K-Ras4B is a 
better substrate for FTase than H-Ras (James et al., 1995). The other is that N-Ras 
and K-Ras4B are also substrates for GGTase-I, while H-Ras is not (Zhang et al., 
1997). On account of this, in FTI treated cells K-Ras4B and N-Ras are alternatively 
geranylgeranylated by GGTase-I, resulting in persistent membrane association for K-
Ras4B and N-Ras (Whyte et al., 1997; Rowell et al., 1997). Fourth, other signaling 
pathways may be activated when Ras is not active. 
Furthermore, this property of FTIs also makes them useful in the treatment of 
malaria and African sleeping sickness caused by the parasites Plasmodium 
falciparum and Trypanosoma brucei, respectively. FTIs are cytotoxic to these 
parasites while lacking toxicity to humans, perhaps because these protozoa contain 
FTase but lack GGTase-I (Gelb, 2007; Eastman et al., 2006).  
Although geranylgeranylated Ras oncoproteins are also able to transform cells 
(Cox et al., 1994), FTIs inhibit the growth of numerous tumors in preclinical models, 
including K-Ras4B and N-Ras transgenic mouse models (Omer et al., 2000; 
Mangues et al., 1998). In addition, Rat1 fibroblast cells transformed by a myristylated 
Ras construct, which thereby would be expected to associate with membrane 
independent of prenylation, remained susceptible to growth inhibition by FTIs 
(Lebowitz et al., 1995). Moreover, clinical activities of FTIs seem to be largely lack of 
correlation with the inhibition of Ras, since FTIs are also active on the cancer cell 
lines without oncogenic Ras mutations (Gelb et al., 2006; Head and Johnston, 2003). 
It is possible that the anticancer action of FTIs may involve synergetic effects on 
other farnesylated target proteins. These include RhoB, Rheb, CENP-E/F, PRL, HDJ, 
and nuclear lamins (Basso et al., 2006). However, there is no direct evidence linking 
inhibition of the farnesylation of these targets to the mechanism of anticancer activity 
of FTIs (Sebti, 2005). The antiproliferative and proapoptotic activity of FTIs seems to 
be related to their ability to inhibit the PI3K/Akt (Jiang et al., 2000), RheB (Castro et 
al., 2003), and/or mTOR/p70s6k pathways (Law et al., 2000).  
Among these target proteins, RhoB has attracted attention owing to its role in 
mediating the cellular response to FTIs (Prendergast, 2001). Rho family proteins are 
not mutated in cancer cells. They regulate actin stress fiber formation. The evidence 
that prompted the concerning on RhoB as a target of FTIs action comes from the 
work of Prendergast and coworkers (Prendergast et al., 1994). They found that the 
morphological reversion observed in FTI-treated and Ras-transformed Rat1 fibroblast 
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cells is rapid (detectable within 18h) so as to outpace the kinetics of elimination of 
processed Ras from cells (a half-life of ~24h), but correlates with the short-lived 
RhoB (a half-life of ~2h). Moreover, FTIs induced actin stress fiber formation in both 
normal and transformed cells. Additionally, expression of a myristylated RhoB but not 
a myristylated Ras in Ras-transformed Rat1 cells leads to FTI resistance (Lebowitz et 
al., 1995).  
RhoB is a substrate for both FTase and GGTase-I, and therefore exists in both 
farnesylated and geranylgeranylated forms in intact cells, with the geranylgeranylated 
form being more abundant (up to 70%) (Adamson et al., 1992). Some of the 
responses to FTI treatment may result from a loss of farnesylated RhoB (RhoB-F) 
and a gain of function of geranylgeranylated RhoB (Rho-GG). FTIs block formation of 
RhoB-F, leading to accumulation of RhoB-GG. The shifted pattern of RhoB 
prenylation is associated with mislocalization of RhoB-GG away from its target 
endosomal compartment (Lebowitz et al., 1997; Lebowitz et al., 1995). A gain of 
growth-inhibitory function of RhoB-GG has been proposed by the findings that 
overexpression of an engineered RhoB isoform to be only geranylgeranylated 
reverses the phenotype of Ras-transformed Rat1 fibroblast cells (Du et al., 1999), 
and mediates growth inhibition and apoptosis in human tumor cells (Du and 
Prendergast, 1999). Furthermore, knocking out the RhoB gene has no consequence 
in wild type mice (Liu et al., 2001), but in Ras-transformed mice leads to resistance to 
FTI-treatment. In agreement with this, transformed murine fibroblasts that were 
genetically null for RhoB showed defects in their FTI response, although 
farnesylation of mutant Ras was inhibited to the same extent in both Rho-/- and Rho+/- 
cells (Liu et al., 2000). In contrast, FTI-induced alteration of RhoB has strong effects 
in Ras-transformed cells. Therefore, Prendergast et al. postulated that targeting 
RhoB with a transformation-selective property might be one of the reasons for the 
selective effects of FTIs toward transformed cells.  
These studies suggested that RhoB-GG may be crucial to the FTI response. A 
most interesting feature might be RhoB’s ability to mediate the FTI-induced apoptosis 
of transformed cells. FTI or RhoB-GG suppressed the activity of the survival kinase 
Akt-1 in COS cells and MCF-7 breast carcinoma cells (Liu and Prendergast, 2000). A 
study from another group also demonstrated that RhoB-F enhanced and RhoB-GG 
suppressed cell growth and induced apoptosis of Ras-transformed NIH-3T3 cells. 
RhoB-GG, but not RhoB-F, inhibited Ras-induced activation of the tumor survival 
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pathways of Akt and NF-κB (Mazieres et al., 2005). Moreover, suppression of Cyclin 
B1 by FTI is linked to gain of function of RhoB-GG and the fate of cell apoptosis 
(Kamasani et al., 2004). Recently, the downstream adaptor protein mDia was shown 
to be critical for the RhoB-dependent cell death mechanism induced by FTI 
(Kamasani et al., 2007). 
Regardless of these findings on RhoB involvement in the FTI response, some 
other observations suggested that RhoB is not a critical target of FTIs. Sebti and 
coworkers showed that RhoB was as potent as the tumor suppressor p53 at 
inhibiting cell focus formation and growth in soft agar of the human pancreatic tumor 
cell line Panc-1. They demonstrated that RhoB, RhoB-F and RhoB-GG inhibit 
anchorage-dependent and -independent Panc-1 cell growth, induce apoptosis, inhibit 
insulin-like growth factor-1 stimulation of Akt and constitutive activation of Erk, and 
suppress tumor growth in nude mice (Chen et al., 2000). Furthermore, RhoB tumor-
suppressive and proapoptotic activities require palmitoylation at Cys192 and 
prenylation at Cys193 (Wang and Sebti, 2005). Thus, they argued that RhoB-F is not 
a target of FTIs. The role of RhoB in mediating the cellular response to FTIs is still 
controversial. To resolve the contradiction may require further investigation of the 
cellular functions of the two prenylated forms of RhoB. 
2.3.3 GGTase-I and RabGGTase as therapeutic targets 
 
In spite of the extensive studies summarized above, there are still a lot of 
questions remaining unanswered concerning the mechanism of FTI action. Recently, 
the proapoptotic activity of FTIs has been found to be a consequence of RabGGTase 
inhibition (Lackner et al., 2005). Direct inhibition of RabGGTase activity by certain 
FTIs from Bristol-Myers Squibb triggers p53-dependent apoptosis in the nematode 
C.elegans model. Genetic screens implicated Rab proteins (like Rab7 and Rab5 that 
are involved in endosomal trafficking) and RabGGTase in apoptosis. Moreover, 
knockdown of RabGGTase induced apoptosis in several mammalian cancer cell lines. 
Finally, both subunits of RabGGTase were found to be overexpressed in a variety of 
human tumors. These findings suggested that RabGGTase could be a novel target 
for cancer therapy. Moreover, if the character of these FTIs can be extended to other 
FTIs, particularly those in clinical trials, this would contribute to a better 
understanding and interpretation of biological response of FTIs. However, the 
approach of targeting RabGGTase should be further proved by investigation of the 
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toxicity of RabGGTase inhibitors (RabGGTIs), since inhibition of RabGGTase is 
related to blood clotting malignance and retinal degeneration (Seabra et al., 2002). 
Compared to various effective and specific inhibitors discovered for FTase 
(Gibbs et al., 2001) and GGTase-I (El et al., 2006), the development of potent 
inhibitors for RabGGTase has lagged behind. This is despite the relative importance 
of RabGGTase, which is linked with some skeletal diseases, such as excessive 
osteoclast-mediated bone resorption which can cause tumor-induced osteolysis and 
post-menopausal osteoporosis (Coxon et al., 2001). Only one weak (IC50 = 560 μM) 
but specific inhibitor for RabGGTase (Figure 2-15), a phosphonocarboxylate 
analogue of biphosphonate risedronate (RIS), was identified so far and proposed as 
possible lead compound in the development of antitumor (Roelofs et al., 2006) and 
anti-osteoporosis drugs (Coxon et al., 2001).  
GGTase-I has recently emerged as another important target for cancer therapy. 
The interest in GGTase-I inhibitors (GGTIs) was stimulated from the finding that N-
Ras and the most abundant human oncogenic Ras precursor protein K-RasB can be 
geranylgeranylated by GGTase-I when FTase is inhibited (as described before). 
Thus, GGTIs may be used in combination with FTIs to inhibit both FTase and 
GGTase-I. Moreover, the geranylgeranylated proteins RalA (Lim et al., 2005) and 
RhoC (Clark et al., 2000) have been suggested to play a critical role in Ras-induced 
tumorgenesis of several human cancer cells and cancer metastasis, respectively. 
Some recent in vitro studies provided evidence that targeting these two proteins by 
GGTIs is linked to anticancer and anti-metastasis activities of GGTIs. In COS-7 cells 
and human pancreatic MiaPaCa2 cancer cells, suppressing prenylation of RalB and 
RalA by GGTI-2417 correlated with inhibition of anchorage-dependent cell growth 
and induction of apoptosis, and with inhibition of anchorage-independent cell growth, 
respectively (Falsetti et al., 2007). The transendothelial migration of MDA-MB-231 
human breast cancer cells was inhibited potently by GGTI-298, associated with 
inhibition of the membrane localization of RhoA and RhoC (Kusama et al., 2006).  
In addition, GGTI-2154 has been shown to induce breast tumor regression in H-
Ras transgenic mice and suppress constitutively activated phospho-Erk1/2 and 
phospho-Akt and induce apoptosis of breast carcinoma cells (Sun et al., 2003). 
GGTI-298 and GGTI-2166 were found to induce apoptosis of human ovarian 
epithelial cancer cells by inhibition of PI3K/AKT and survivin pathways (Dan et al., 
2004). Interesting results have been obtained in pre-clinical models of tumor 
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progression with dual inhibition of these enzymes (Morgan et al., 2005; Morgan et al., 
2003; Lobell et al., 2001). Notably, the toxicity associated with GGTI treatment in vivo 
may somewhat limit their therapeutic application (Lobell et al., 2001). Recently, the 
first nonpeptidic GGTI, named GGTI-DU40 (Figure 2-15), has been identified with an 
IC50 of 8 nM against GGTase-I and no inhibition to the other two prenyltransferases 
at 2 μM (Peterson et al., 2006). 
Furthermore, GGTIs may be potentially valuable agents for the treatment of 
smooth muscle hyperplasia in relation to restenosis/atherosclerosis (Finder et al., 
1997), multiple sclerosis (Walters et al., 2002), osteoporosis (Woo et al., 2005; 
Coxon et al., 2000), and hepatitis C virus infection (Ye et al., 2003). 
Finally, despite the enigmatic mechanisms of action of prenyltransferases 
inhibitors, a number of efficient compounds provide powerful tools to modulate 
physiological events, which can help to understand molecular mechanisms of cancer 
and other diseases and open up new opportunities for anti-tumor therapy.  
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2.4 Chemical protein ligation 
2.4.1 Native chemical ligation 
 
Chemical synthesis is an attractive alternative to biological methods of protein 
production. Synthetic chemistry provides almost unlimited modulation of the structure 
of a polypeptide chain in order to understand the protein function. However, since 
proteins are large molecules, applying chemical synthesis to them is a considerable 
challenge (Dawson and Kent, 2000).  
In the early 1990s a breakthrough approach using chemoselective reaction to 
couple unprotected peptide segments in chemical protein synthesis was devised in 
the Kent laboratory (Schnolzer and Kent, 1992). In 1994, Kent and coworkers 
introduced the approach of native chemical ligation (NCL), which is now a general 
method in chemical protein synthesis (Dawson et al., 1994). In this method, two 
unprotected synthetic peptide fragments are joined together in neutral aqueous 
conditions with the formation of a native peptide bond at the ligation site. 
 
 
Figure 2-16. Principle of native chemical ligation. Both peptide fragments are fully unprotected and the 
reaction proceeds in aqueous and neutral conditions, given that one contains a C-terminal α-thioester 
and the other contains N-terminal cysteine. 
 
The principle of NCL is depicted in Figure 2-16. The approach is based on the 
chemoselective reaction between a peptide containing a C-terminal thioester and 
another peptide containing an N-terminal cysteine. The initial chemoselective 
transthioesterification in NCL is essentially reversible, whereas the subsequent S→N 
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acyl shift is spontaneous and irreversible. Thus, the reaction is driven to form an 
amide bond specifically at the ligation site, even in the presence of unprotected 
internal cysteine residues.   
NCL has been widely used in the total chemical synthesis of small proteins and 
protein domains, with a number of refinements in ligation methodology and strategy, 
such as auxiliary group-facilitated ligation (Offer et al., 2002; Meutermans et al., 
1999), catalytic thiol cofactors (Johnson and Kent, 2006; Dawson et al., 1997b), 
kinetically controlled ligation (KCL) (Bang et al., 2006), and convergent chemical 
protein synthesis (Durek et al., 2007). However, the scope of NCL was significantly 
widened upon introduction of the approach termed expressed protein ligation (EPL) 
from the Muir laboratory (Severinov and Muir, 1998; Muir et al., 1998). In this method, 
both fragments containing the required C-terminal thioester and N-terminal cysteine 
can be produced recombinantly. 
2.4.2 Expressed protein ligation 
 
 
 
Figure 2-17. Protein splicing mechanism.  
 
EPL emerged as a result of the advances in the use of self-cleavable affinity 
tags for recombinant protein purification using intein chemistry (Chong et al., 1997). 
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Inteins are protein insertion sequences flanked by host protein sequences (N- and C-
exteins) and are eventually removed by a posttranslational process termed protein 
splicing (Kane et al., 1990). Protein splicing does not require specific sequences in 
either of the exteins, whereas inteins are characterized by several conserved motifs 
with over a hundred members of this protein domain in eubacteria, archaea, low 
eukaryotes including fungi and yeast (www.neb.com/neb/inteins.html).  
As shown in Figure 2-17, the first step in typical protein splicing involves an 
N→S(O) acyl rearrangement in which the N-extein is moved to the side chain of a 
conserved cysteine or serine residue at the immediate N-terminus of the intein (Shao 
et al., 1996). This thermodynamicly unfavorable process may be in part catalyzed by 
the intein domain, which twists the scissile amide bond into a conformation with 
higher energy (Romanelli et al., 2004; Klabunde et al., 1998). Next, 
trans(thio)esterification occurs when the (thio)ester is attacked by the side chain of a 
conserved Cys/Ser/Thr residue located at the immediate N-terminus of the C-extein 
(+1 position of intein-C-extein junction) (Xu et al., 1993). The resulting branched 
intermediate is resolved through a cyclization reaction involving a conserved 
asparagine residue at the C-terminus of the intein. The intein is thereby excised as a 
C-terminal succinimide derivative (Xu et al., 1994). The final step of protein splicing 
resembles the second step of NCL, where a spontaneous S(O)→N acyl shift results 
in formation of amide bond linking the N- and C-exteins (Shao and Paulus, 1997). 
Although the biological role of protein splicing is still unclear, it was used to make 
intein-mediated protein purification and engineering tools, including engineered 
inteins and split inteins (see next section). The former make use of knowledge of the 
protein splicing mechanism. Mutated inteins containing a C-terminal Asp→Ala 
substitution have been designed to keep their ability for the initial N→S acyl shift 
without proceeding to later steps of protein splicing (Xu and Perler, 1996). Therefore, 
proteins fused to the N-terminal of these engineered inteins can be cleaved by thiol 
reagents (such as 2-mercapoethanesulfonic acid) via an intermolecular 
transthioesterification reaction, releasing the α-thioester-tagged proteins (Figure 2-18) 
(Chong et al., 1997). Commercially available vectors harbor introduced affinity tags 
(chitin binding domain, CBD), which facilitate purification of target-intein-CBD fusion 
protein by chitin agarose beads and allow inducible self-cleavage of target protein 
from the beads.  
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Figure 2-18. Principle of expressed protein ligation. Thioester tagged protein/peptide can be 
recombinantly produced by C-terminal fusion to and subsequent cleavage of an engineered intein-
CBD fusion. Another protein/peptide fragment bearing an N-terminal cysteine can be either chemically 
synthesized or recombinantly prepared by N-terminal fusion to engineered inteins, or can be prepared 
by proteolytic cleavage to expose a cysteine. 
 
The recombinant polypeptide α-thioesters can then be ligated with a synthetic 
peptide or recombinant protein containing N-terminal cysteine. EPL thereby allows 
site-specific introduction of probes (such as fluorophores and isotopes), 
posttranslational modifications (such as prenylation, glycosylation, phosphorylation 
and ubiquitination), incorporation of unnatural amino acids, and immobilization of 
proteins or peptides onto a chip (reviewed in (Muir et al., 1998)). Moreover, 
sequential EPL strategies make it possible to introduce modification at any position in 
a protein (Cotton and Muir, 2000; Cotton et al., 1999). Therefore, EPL provides a 
platform that makes it possible to apply powerful synthetic chemistry tools to large 
biomolecules. 
2.4.3 Protein trans-splicing 
 
Inteins can also be spliced into two parts that functions only when they bind to 
each other (Southworth et al., 1998; Mills et al., 1998). The precursor fragments can 
be fused to a split intein. When these two pieces meet with each other reconstitution 
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of the intein allows a tans-splicing reaction (Figure 2-19). The discovery of the 
naturally occurring split Synechocytis (Ssp) DnaE intein makes it possible to bypass 
denaturation and renaturation of the isolated precursor fragments (Wu et al., 1998a). 
Protein trans-splicing is a useful approach to selectively ligate two polypeptides, 
thereby providing a valuable tool for protein engineering (Xu and Evans, Jr., 2005). 
This approach has been employed to generate head-to-tail cyclic peptides and 
proteins (Williams et al., 2002; Scott et al., 1999), to selectively incorporate isotopes 
for NMR analysis (Otomo et al., 1999; Xu et al., 1999b), to fluorescently label 
proteins in vivo (Giriat and Muir, 2003),  to assay protein-protein interactions in vivo 
(Kanno et al., 2006b; Paulmurugan et al., 2002; Ozawa et al., 2001; Ozawa et al., 
2000), to detect biological events in vivo (Kanno et al., 2006a; Kim et al., 2005; Kim 
et al., 2004), or to selectively immobilize proteins onto a chip (Kwon et al., 2006). 
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Figure 2-19. Protein tans-splicing and conditional protein splicing. (1) Protein trans-splicing to ligate 
two fragments. The split intein N-terminal part (IN) is fused to the N-extein and the split intein C-
terminal part (IC) is fused to the C-extein. The two pieces of the intein associate to reconstitute splicing 
activity. (2) Intein association and protein splicing induced by the dimerization of two interacting 
proteins fused to split intein fragments. This strategy has been used to reconstitute a reporter that can 
be used for monitoring protein-protein interaction or other biological events in vivo. (3) Conditional 
protein splicing using a temperature-sensitive intein. (4) Split intein association and protein trans-
splicing induced by ligand (e.g. rapamycin) mediated heterodimerization (LBD, ligand-binding domain; 
L, ligand). (5) Conditional protein tans-splicing controlled by a ligand (e.g. 4-hydroxytamoxifen, thyroid 
hormone) that binds to a ligand-binding domain engineered into an intein. The activity of the intein is 
restored by either association of two split intein fragments or activating the engineered intein upon 
binding of a ligand to LBD.  
 
 
Recently, the split intein-mediated protein splicing reaction has been extended in 
a controllable way, leading to conditional protein splicing (Figure 2-19). Several 
approaches have been explored including the use of temperature or pH-sensitive 
splicing, inhibition or activation of intein-mediated splicing by small molecule ligands 
or protein dimerization. Temperature-sensitive splicing based on the vacuolar 
ATPase subunit intein from Saccharomyces cerevisiae has been used to control 
activation transcription regulators, Gal4 and Gal80 (Zeidler et al., 2004). A small cell-
permeable molecule rapamycin was used to trigger splicing mediated by an 
engineered split VMA intein in mammalian cells (Mootz et al., 2004; Mootz et al., 
2003; Mootz and Muir, 2002). The split intein fragments were fused to either the 
rapamycin receptor or the rapamycin binding domain, which undergoes dimerization 
upon binding to rapamycin, thereby facilitating the reconstitution of the split intein. A 
directed evolution approach led to the construction of a chimeric intein with a natural 
ligand-binding domain inserted. The splicing activity of this intein is triggered by a 
small cell-permeable molecule, 4-hydroxytamoxifen (Buskirk et al., 2004). Moreover, 
a chimeric intein containing a thyroid hormone binding domain was rationally 
designed. Protein splicing can then be regulated by the presence of human thyroid 
hormone in E. coli (Skretas and Wood, 2005). Despite the development of screening 
platform, a compound that effectively inhibits splicing of a native intein has not yet 
been found (Gangopadhyay et al., 2003). 
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3. Aims of this work 
This work has used a combination of chemical and biophysical approaches to 
solve specific biological problems.  
The recently developed technology based on intein-chemistry and native 
chemical ligation, the expressed protein ligation (EPL) approach, facilitates 
application of powerful synthetic chemistry to the modifications of proteins. Specific 
features of Rab proteins make them to be suitable targets for a semi-synthetic 
approach. The C-terminal prenylation motif containing typically two cysteines can be 
truncated, and thus a fluorophore can be easily introduced to the unstructured C-
terminus followed by ligation with a short peptide containing intact cysteines. 
Alternatively, truncated Rab can be ligated with a compensating peptide bearing a 
fluorophore.  
In addition to Rab proteins, synthetic chemistry and EPL can also be used to 
make fluorescent analogues of the lipid substrate, GGPP, and prenylated Rab, which 
may function in a similar way to their native counterparts while containing 
spectroscopic probes. If applicable, these approaches would be useful in building 
diversified fluorescent sensors to provide convenient signals for the planned studies. 
Since inhibition of RabGGTase emerged as a very promising approach in cancer 
and osteoporosis therapy, further study of the role of RabGGTase in skeletal 
disorders and cancer would be facilitated by the development of potent and specific 
inhibitors for RabGGTase. In addition, although the reaction pathway of Rab 
prenylation and the structural basis of binary Rab:REP complex and ternary 
REP:RabGGTase:isoprenoid complex were elucidated, the determinants for Rab 
prenylation in prenylation machinery are still unclear. Mechanistic studies and the 
search for inhibitors for Rab prenylation require alternatives to the existing 
radioactivity-based and HPLC assays for RabGGTase activity, which are both 
discontinuous, laborious, and poorly amenable to miniaturization and parallelization. 
Continuous fluorescent assays are much more suitable for high-throughput screening 
of potential inhibitors and more convenient for characterization of prenylation.  
Another purpose of this study is to understand the functional segregation of the 
two related Rab regulators, REP and GDI, in Rab recycling. For this purpose, 
absolute affinities of the interaction of prenylated Rab with REP and GDI need to be 
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determined. However, two technical problems have hampered this kind of study. (a) 
Geranylgeranylated Rabs are not soluble in the absence of either detergents or their 
molecular chaperones. Thus, in cells they are found either in the membranes or in 
complex with REP/GDI. (b) To detect the very tight interaction of prenylated Rab with 
REP/GDI requires a sensitive sensor that behaves analogously to its native 
counterpart, since very low concentrations of material have to be applied in the 
analysis. 
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Figure 3-1. Synthetic chemistry and EPL allow the introduction of fluorophores into unprenylated and 
prenylated Rab proteins and the lipid substrate, phosphoisoprenoid. These sensors were used for the 
identification of RabGGTase inhibitors, mechanistic studies of Rab prenylation and thermodynamic 
analysis of prenylated Rab interaction with REP/GDI.  
 
This study aimed at the development of fluorescent sensors and the application 
of these sensors to identification of RabGGTase inhibitors and mechanistic studies of 
Rab prenylation and Rab recycling (Figure3-1). The former involves extensive 
screening and rational design of fluorescent sensors constructed by the approaches 
described above. These sensors are required to display sensitive fluorescence 
change upon interactions and prenylation. The latter takes use of a variety of 
biochemical and biophysical methods, including protein engineering, protein-
protein/ligand interaction (fluorescence titration, FRET, stopped-flow transient 
kinetics, isothermal titration calorimetry), enzyme kinetics and X-ray crystallography. 
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4. Results and Discussion 
4.1 Development of fluorescent sensors for Rab 
prenylation 
 
Due to their high sensitivity and selectivity, fluorescence techniques stand out 
among the optical techniques used in the detection, quantitation, identification and 
characterization of biological structures and processes. These include conformational 
changes, complex formation, and change of chemical and physical environment 
during enzymatic reactions. Studies of these processes provide information on 
proteins that can be related to their function.  
In the context of this study, the central aim was to use parallel approaches to 
generate fluorescent sensors for analysis of protein prenylation. Efficient continuous 
fluorescence assays for FTase and GGTase-I that utilize the change in fluorescence 
of a fluorophore attached to a pentapeptide containing the CAAX motif have been 
reported (Pham et al., 2006; Pickett et al., 1995; Pompliano et al., 1992a). They take 
advantage of the increase in hydrophobicity of the acceptor peptide following 
incorporation of an isoprenoid moiety in the vicinity of an environmentally sensitive 
dye such as the dansyl group. However, this concept of intramolecular fluorescence 
enhancement cannot be applied directly to RabGGTase which recognizes the 
Rab:REP complex instead of a short peptide (Anant et al., 1998). Expressed protein 
ligation (EPL) (Thoma et al., 2001b; Iakovenko et al., 2000) and fluorescence 
labeling (Alexandrov et al., 2001; Thoma et al., 2001c; Alexandrov et al., 1999) have 
been used to produce fluorescently labeled Rab7 variants, which have been 
demonstrated to be valuable tools for spectroscopic interaction studies. Synthetic 
fluorescent analogues of phosphoisoprenoids have been utilized for monitoring their 
interaction with protein prenyltransferases (Dursina et al., 2002; Thoma et al., 2000). 
Moreover, a fluorescence assay for Rab prenylation using semi-synthetic Rab protein 
substrates with a fluorescent label at the C-terminus was reported (Rak et al., 2004; 
Durek et al., 2004a), but it only gave a fluorescent decrease not exceeding a factor of 
2.  
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This section will describe the development of two types of fluorescent reporters: 
a) semi-synthetic Rab GTPase that can function similarly to the native proteins and 
yet display different spectral properties upon either complex formation with their 
interacting partners or incorporation of geranylgeranyl groups and b) fluorescent 
analogues of phosphoisoprenoids that can function as substrates of RabGGTase and 
display a change in fluorescence upon prenylation. 
4.1.1 Strategy for the construction of fluorescent sensors 
based on Rab proteins 
 
In earlier work, EPL was used to create fluorescent Rab molecules with native 
biochemical properties. This included incorporation of fluorophores and lipids at 
different positions of the Rab C-terminus (Alexandrov et al., 2002; Iakovenko et al., 
2000). This approach was used to generate the semi-synthetic Rab molecules in 
which a fluorescent group is conjugated adjacent to the site of prenylation and 
displays a fluorescence enhancement upon prenylation. This approach was 
employed to detect differences in the action of REP-1 and REP-2, and provides 
insights into the molecular mechanism of choroideremia disease (Rak et al., 2004).  
This successful example of monitoring prenylation using a Rab protein with a C-
terminal fluorescence label prompted us to further persue this concept. Since it is 
impossible to predict which fluorophore will display a substantial change in 
fluorescence upon prenylation, we chose to assemble an array of constructs with 
different fluorophores at different positions. Two strategies can be used to build the 
sensor family. One is to produce peptides with a variety of fluorophores that are 
subsequently ligated to Rab proteins. The other is to generate a pool of fluorescently 
labeled thioester tagged Rab GTPases that can be subsequently ligated with a 
peptide.  
In the first strategy, several aspects about the peptide fragment design should 
be considered. In the context of choosing the site of ligation, Cys205 of Rab7 
appears to be a suitable ligation site for two reasons (Figure 4-1-1): First, the 
downstream tripeptide (205CSC207) contains both prenylatable cysteine residues and 
a compatible N-terminal cysteine that is necessary for ligation. Moreover, residue 206 
can be used for coupling fluorescent groups. Second, the amino acid at the C-
terminus of the Rab7 α-thioester will be serine, which is neither associated with 
extremely slow chemical ligation rates (e.g. Ile, Val or Pro) (Hackeng et al., 1999) nor 
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related to increased levels of premature cleavage of the intein-fusion protein in vivo 
(as for Asp and Gly) (Ayers et al., 1999; Chong et al., 1998). 
The synthetic peptide fragment should be short to ensure simple and high yield 
for synthesis and should resemble the native sequence as closely as possible. 
Fortunately, the highly diversified Rab C-terminal sequences (CXC, CC, CCX, CCXX, 
CCXXX, CXXX) provide sufficient room for C-terminal peptide engineering.  
Positioning of a non-native reporter group requires a compromise between seeking a 
site that is likely to yield large signal change and, on the other hand, trying to 
minimize potentially adverse influence of the introduced modification on the process 
under study. However, the lack of precise information on the molecular basis of Rab 
recognition by the prenylation machinery precludes a rational positioning of the 
reporter group. Thus different sites have to be tested, in order to assess the 
consequences of diverse fluorophores incorporated at each position. In this study the 
fluorophores were coupled to the ε-amino group on the side chain of lysine to provide 
a convenient building block for further assembly of a peptide array. Alternatively, 
fluorophores could also be attached to the C-terminal α-carboxyl group. In this case, 
the synthetic effort could be reduced to construction of Cys-Cys dipeptide in milligram 
amounts (Figure 4-1-1). 
Although the methods of organic chemistry enable incorporation of virtually any 
structure into the synthetic peptide fragment, synthesis of a variety of fluorescent 
peptides is quite laborious and expensive. An alternative would be to produce a 
range of fluorescently labeled Rab thioesters by chemical labeling, which 
subsequently can be ligated with a standard peptide containing two prenylatable 
cysteines or even a single cysteine. If applicable, this strategy would be much more 
convenient and efficient.  
In this approach, site specific fluorescence labeling is the critical issue. Owing to 
the high selectivity, thiol-reactive reagents often provide a means of selectively 
modifying a protein at a defined site (Haugland, 2002). There are five cysteines in the 
Rab7 structure: C83, C84, C143, C207 and C205. C83 and C84 are situated in the 
core of the molecule, while C143 is on the hydrophobic side of a helix facing towards 
the core (PDB code 1VG0) (Rak et al., 2004). Thus, only the C-terminal cysteines are 
able to be labeled by thiol-reactive dyes (Alexandrov et al., 1999). Therefore, a single 
cysteine engineered at the C-terminus of truncated Rab protein would provide a 
precise position for coupling of various thiol-reactive dyes. Furthermore this labeling 
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position can be genetically engineered, potentially allowing rapid production of an 
array of Rab7 variants containing reporter groups at different positions. (Figure 4-1-1).  
 
 
 
Figure 4-1-1. Construction of Rab7 fluorescent conjugates. The ligation sites were indicated by the 
dashed lines. FL: fluorophore, wt: wild type, Sandwich, +1, 0, -1and -2 represent different labeling 
positions according to the modified side chain of amino acid residue away from the first prenylation 
site, while 0 means that the fluorophore is coupled to the C-terminal α-carboxyl group. 
.    
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4.1.2 Semi-synthesis of Rab7 fluorescent conjugates 
4.1.2.1 Expression and purification of Rab7 C-terminal α-thioesters 
 
Figure 4-1-2 shows the cloning and expression strategy for the production of 
Rab7 C-terminal thioesters truncated by 2 or 3 amino acids. The commercially 
available pTWIN1 E. coli expression vector is used together with the IMPACT™ 
(Intein Mediated Purification with an Affinity Chitin-binding Tag) System (Xu and 
Evans, Jr., 2001; Xu et al., 2000). pTWIN vectors are designed for protein purification 
or for the isolation of proteins with an N-terminal cysteine and/or a C-terminal 
thioester. Generation of a C-terminal thioester requires the truncated Rab gene to 
replace the chitin binding domain (CBD)-intein1 (Ssp DnaB interin) gene, resulting in 
a target-intein2 (Mxe GyrA intein)-CBD fusion gene. The presence of the chitin 
binding domain from Bacillus circulans (Ikegami et al., 2000) facilitates purification. 
Expression of the fusion gene is under the control of the T7 promotor/Lac operator 
(Dubendorff and Studier, 1991) and is regulated by IPTG due to the presence of a 
Lac repressor gene.  
 
 
Figure 4-1-2. Production of Rab7 thioesters using IMPACT™ system. MCS: multiple cloning site, 
AmpR: ampicillin resistance gene.  
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Vectors were constructed by PCR amplification of the Rab7 open reading frame 
with primers containing NdeI in the forward primer and synthetic nucleotides 
corresponding to the engineered C-terminal sequences of the truncated Rab7 and 
SapI restriction sites in the reverse primer. The resulting PCR-products were 
subcloned into pTWIN1 vector using NdeI and SapI restriction endonuclease sites. 
The various expression vectors were then transformed into BL21(DE3) competent 
cells. Expression conditions, such as IPTG concentration, induction time and 
temperature were optimized. For soluble Rab fusion protein expression the induction 
temperature had to be lowered to 20°C (Durek et al., 2004a; Iakovenko et al., 2000; 
Georgiou and Valax, 1996; Schein and Noteborn, 1988).  
The resulting Rab-intein-CBD fusion protein was purified from crude cell lysate 
using chitin agarose. The binding of CBD to chitin is mediated mainly by hydrophobic 
interactions, favoring high salt concentration (e.g. 0.5M NaCl) (Hashimoto et al., 
2000). This allows non-specifically bound material to be removed by use of stringent 
wash conditions such as high salt concentration and non-ionic detergents. However, 
extended storage of the immobilized fusion protein under such conditions led to a 
significant reduction of the intein mediated cleavage efficiency, which could be due to 
denaturation of the intein and the fusion protein. Therefore, it is advisable to perform 
the washing step as quickly as possible and to proceed to the thiol induced cleavage 
step without intermediate storage in order to improve yields.  
To produce Rab7 thioesters, the immobilized fusion protein was induced to 
undergo intein-mediated cleavage in the presence of a thiol reagent, sodium 2-
mercaptoethanesulfonate (MESNA). Trials were performed to identify the optimal 
thiolysis conditions, i.e. reaction time, temperature and the concentration of MESNA. 
In addition to MESNA, a variety of molecules have been used to induce the thiolysis 
of the intein fusion proteins, including the commonly used reductants DTT and β-
mercaptoethanol (β-ME) (Chong et al., 1998). Effects of thiol cofactors* like 
ethanethiol, MESNA, 3-mercaptopropanesulfoic acid (MPSNA) and thiophenol on 
thiolysis and EPL have been systematically investigated (Ayers et al., 1999). The 
ethyl α-thioester was found to be quite stable but less reactive in EPL reactions, 
making it ideal for the purification and storage purposes. It is important to note that 
                                                 
* After this part of work was performed, Kent and his co-workers (Johnson and Kent, 2006) published 
a study on the effect of a number of thiol compounds on native chemical ligation (NCL) rate, where 
they found a new effective thiol cofactor, (4-carboxylmethyl)thiophenol (MPAA), a nonmalodorous, 
water-soluble thiol. Use of MPAA gave an order of magnitude faster reaction in model studies.  
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the reactivity of the α-thioester is weaker since the reactivity can be restored by in 
situ transthioesterification during a ligation reaction with a more potent thiol reagent 
(Xu et al., 1999a; Dawson et al., 1997a). Although phenyl thioester and MPSNA are 
much more reactive in EPL reactions, they have the disadvantage of a high 
hydrolysis rate, and are therefore not suitable for storage. Moreover, several practical 
drawbacks of using thiophenol as the cofactor, i.e. the low solubility in aqueous 
buffers at neutral pH, precipitation of the symmetrical disulfide derivative of 
thiophenol during ligation reactions, causing coprecipitation of reactants or products 
and the unpleasant odor, limits its application in EPL reactions (Ayers et al., 1999). In 
contrast, MESNA (Evans et al., 1998) is a relatively good cofactor for EPL since its 
use results in only a 2-fold reduction in the ligation rate as compared to thiophenol. In 
addition, MESNA thioester displays a relatively slow hydrolysis rate, and it is more 
suitable for storage (Ayers et al., 1999). Given its superior solubility and handling 
properties, it is the preferred thiol cofactor in EPL reactions.  
 
 
Figure 4-1-3. Expression and purification of Rab7-MESNA thioester. Lane 1: cell lysate before 
induction, lane 2: cell lysate after induction with IPTG overnight (o/n), lane 3: supernatant of the cell 
lysate after induction, lane 4: pellet of the cell lysate, lane 5: flow through from the chitin column, lane 
6: chitin beads after washing, lane 7 and 8: fractions of the eluted protein after an overnight incubation 
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with 0.5 M MESNA at 20°C, lane 9: chitin beads after the cleavage, lane 10: concentrated Rab7 
thioester. 
 
Thiolysis of Rab-intein-CBD fusion protein with 0.5 M MESNA at room 
temperature overnight led to quantitative cleavage (Figure 4-1-3). These conditions 
also resulted in precipitation of part (ca. 50%) of Rab protein on the beads (Figure 4-
1-3), which could be a result of denaturation or non-specific attachment to the beads. 
Using this single chromatographic step, 5-10 mg Rab thioester tagged proteins were 
typically obtained from a liter of bacterial culture. The soluble Rab protein in the 
supernatant was present in >95% purity with minor contamination of intein-CBD 
(<2%) that was eluted from chitin beads together with the Rab thioester. For the 
purpose of the subsequent fluorescence labeling, the buffer was exchanged using a 
PD-10 gel filtration column to remove MESNA. At this point, the Rab-MESNA α-
thioesters can be stored in a neutral buffer at -80°C for at least one year without any 
obvious decomposition or loss of ligation reactivity. The resulting Rab thioesters were 
characterized by electrospray ionization mass spectroscopy (ESI-MS) and ligation 
reactivity subsequently. 
4.1.2.2 Characterization of Rab7 α-thioesters 
 
Since the Rab7 gene is located at the N-terminus of the fusion protein, the 
expressed Rab7 fusion proteins were processed in vivo by the endogenous 
methionylaminopeptidase (MAP) (Hirel et al., 1989) on account of the nature of the 
second amino acid residue (Thr2) following Met1. As a result, the starting methionine 
residue was cleaved in all Rab7 thioesters. Therefore, when the molecular weight of 
Rab7 thioester was calculated, the Met was left out. Moreover, the presence of 
thioester could be characterized by its susceptibility to hydrolysis under basic 
conditions (pH 9-10, see Figure 4-1-4) and its ligation reactivity with cysteine (Figure 
4-1-4, 4-1-5).  
Figure 4-1-4 shows the LC-ESI-MS analysis of Rab7Δ2CS-MESNA and 
Rab7Δ2SC-MESNA thioesters. Interestingly, instead of the expected single ESI-MS 
peak, both of them displayed multiple peaks at ~23 kDa. In order to establish the 
identities of the conjugates, more experiments had been done to identify these 
moieties. 
In the electrospray ionization mass spectrum of Rab7Δ2CS-MESNA, the 
molecule with molecular mass of 23328 was identified to be the target thioester 
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(Mcalc=23322), which was inferred by the mass reduction of 124 observed upon 
alkaline hydrolysis (Figure 4-1-4 B) and mass reduction of 21 after ligation with 
cysteine (Figure 4-1-4 C).  
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Figure 4-1-4. Reactions scheme of Rab7Δ2CS-MESNA thioester and the ESI mass spectrums of the 
corresponding reaction products. The mass spectrum of the purified Rab7Δ2CS-MESNA protein (A), 
after hydrolysis of the thioester (B), after cysteine ligation (C), after reaction with IAEDANS (D), after 
thiolysis at pH 6.5 (E), and after incubation with 100 mM MESNA (F). The inset of panel A shows the 
original mass spectrum before deconvolution. The identified mass peaks were marked with bold 
numbers corresponding to those reaction products shown in the above scheme. IAEDANS: dansyl 
iodoacetamide, i.e. 5-((((2-iodoacetyl)amino)ethyl)amino) naphthalene-1-sulfonic acid. R: the 
upstream amino acid residues (2-203) of Rab7.  
 
 
 
4.1 Fluorescent sensors for Rab prenylation 
 
67 
Figure 4-1-5. Reactions scheme of Rab7Δ2SC-MESNA thioester and the ESI mass spectrums of the 
corresponding reaction products. The mass spectrum of the purified Rab7Δ2SC-MESNA protein (A), 
after hydrolysis of the thioester (B), after cysteine ligation (C), after reaction with IAEDANS (D), and 
after incubation with 100 mM MESNA (E). The identified mass peaks were marked with bold numbers 
corresponding to those reaction products shown in the above scheme.  
 
The identity of fragment with mass of 23185 was more difficult to establish. It 
was able to be hydrolyzed to Rab7Δ2CS (Figure 4-1-4 B) and remained competent 
for ligation (Figure 4-1-4 C), but was not susceptible to thiol-reactive dyes (Figure 4-
1-4 D). The most likely explanation for these observations could be an intramolecular 
transthioesterification resulting in a cyclization between the Cys204 side chain and 
the carboxyl-terminus, though a seven-member ring (1,4-thiazepane-2,5-dione). This 
would not be normally a favored structure, but, might have increased likelihood of 
generation in the tertiary structure of a protein. This conclusion could be further 
ascertained by the reduction of the cyclization under acidic conditions (pH 6.5) 
(Figure 4-1-4 E) and in the presence of MESNA (Figure 4-1-4 F). Most protein thiols 
have pKa values in the range of 8.5 ± 0.5 (Gitler et al., 1995). It was shown that the 
cysteine thiol of the FTase substrate, GCVLS, ionizes with a pKa of 8 (Hightower et 
al., 2001). Although the pKa of the thiol in Rab C-terminal cysteine is not known, the 
transthioesterification reactivity of the cysteine thiol could be expected to decrease at 
lower pH. This appears to be indeed the case. Under acidic conditions, the formation 
of the 1,4-thiazepane-2,5-dione ring was significantly reduced. Furthermore, the 
presence of excess of MESNA drives the intramolecular transthioesterification 
reaction equilibrium backward, leading to substitution of the α-thioester. Therefore, 
the intramolecular cyclization could be a consequence of the remarkable reactivity of 
the α-thioester or the high reactivity of thiol group of the Rab7 C-terminal cysteine 
due to reduction of pKa, resulting from some tertiary structure features of the C-
terminus leading to deprotonation at neutral pH, or a combination of both.  
The moiety giving a minor peak at 23138 appears to be vulnerable to hydrolysis, 
reactive in cysteine ligation, and impervious to the thiol-reactive dye. These 
observations could be associated with Rab7Δ4-MESNA, i.e. when the cleavage 
occurred at Cys204 instead of at the intein cysteine. To my knowledge, such non-
specific splicing has never been reported before. Protein splicing is a highly 
structured process, where splicing sites are conserved (Klabunde et al., 1998). Most 
intein sequences start with a cysteine or serine residue that is responsible for an acyl 
shift at the N-terminal splice junction (Shao et al., 1996). In this case, the cleavage 
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site has migrated 2 residues upstream to the Rab7 C-terminal cysteines. 
Nevertheless, this splicing site is not as efficient as the native site, due to the 
conserved protein splicing mechanism. 
The fragments observed in the mass spectrum of Rab7Δ2SC-MESNA were 
identified by the same methods as above (see Figure 4-1-5). Interestingly, 
Rab7Δ2SC-MESNA behaves quite differently from Rab7Δ2CS-MESNA. It was 
partially hydrolyzed (mass peak of 23203) accompanied by a minor putative 
intramolecularly cyclized moiety (mass peak of 23186) corresponding to a 1,4-
oxazepane-2,5-dione ring. The hydrolysis was not observed in Rab7Δ2CS-MESNA 
under the same conditions, suggesting that it could be triggered by the primary 
structure or even tertiary structure of the C-terminus of the Rab7Δ2SC-MESNA 
thioester. The hydrolysis might be induced by intramolecular transesterification that 
leads to a dynamic equilibrium between the formation of a 1,4-oxazepane-2,5-dione 
ring and the hydrolyzed product. To confirm this hypothesis, the resulting Rab7Δ2SC-
MESNA thioester was incubated with 100 mM MESNA, under which conditions a 
diminished pool of hydrolyzed molecules and no cyclized molecules were observed 
in the ESI-MS (Figure 4-1-5 E).   
The cyclization effects can be reversed in the presence of MESNA to restore the 
thioester, so that they are not detrimental to ligation (Figure 4-1-4 C, 4-5 C). However, 
the intramolecular cyclization of Rab7Δ2CS-MESNA blocked the cysteine thiol, 
resulting in a low efficiency of thiol labeling (Figure 4-1-4 D). The intramolecular 
cyclization of Rab7Δ2SC-MESNA facilitates an essentially irreversible hydrolysis 
reaction, resulting in a hydrolyzed product that is inaccessible to ligation. In order to 
minimize the adverse effect on fluorescence labeling, the conjugating reaction could 
be performed at pH 6.5, where the cyclization is retarded (Figure 4-1-4 E) while the 
C-terminal cysteine thiol is still susceptible for thiol-reactive dyes (data not shown). 
Alternative solution to this problem was to use ethanethiol in thiolysis of the fusion 
protein, leading to production of Rab7 ethyl α-thioester (Rab7Δ2CS-ET and 
Rab7Δ2SC-ET). Not surprisingly, that the decrease in the reactivity of the thioester 
led to reduction of the cyclization reaction (see Figure 4-1-6). Ethyl α-thioester is 
much more stable (no observed decomposition after 1-day incubation at 4°C) and 
enables efficient fluorescence labeling and ligation in the presence of MESNA as a 
ligation cofactor (data not shown).  
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Figure 4-1-6. ESI mass spectra of the purified Rab7Δ2CS-ET thioester (A) and Rab7Δ2SC-ET 
thioester (B). 
 
4.1.2.3 Fluorophore conjugation and protein ligation 
 
To obtain fluorescently labeled and thioester tagged Rab7 proteins, thiol-reactive 
dyes were used to conjugate a fluorophore to the C-terminal cysteine of Rab7 
thioesters. The thiol-reactive groups used in this study are alkylating reagents, 
including iodoacetamides and maleimides. Reaction of any of these functional groups 
with a C-terminal cysteine of Rab7 thioester usually proceeds quantitatively and 
rapidly (within half an hour) at or below room temperature in pH range from 6.5 to 8.0, 
yielding chemically stable conjugates (Scheme 4-1). However, it should be noted that 
reactions at above pH 8 would increase the risk of non-specific coupling of 
iodoacetamides with other amino acid residues (methionine, histidine, tyrosine, α-
amino group) and hydrolysis of maleimides (Haugland, 2002). Taken together with 
the considerations on the intramolecular reactions of Rab7 thioesters as mentioned 
above, the pH for the labeling reaction was set to 6.5-7.2.  
 
Scheme 4-1 Labeling of protein at cysteine side chain with iodoacetamide and maleimide 
functionalized fluorophores. 
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These labeling reactions typically led to specific conjugation of dyes at the C-
terminal cysteine, as confirmed by tryptic digestion followed by LC-ESI-MS analysis 
of the resulting peptide fragments (Figure 4-1-7). Nevertheless, reactions using 5-10 
equivalents of maleimide dyes (with respect to protein) resulted in labeling at both C-
terminal cysteine and Cys143 (data not shown), which was not observed in 
conjugation of iodoacetamide dyes even with 20 equivalents. This suggested that 
maleimide is much more reactive than iodoacetamide in reaction with thiol groups. 
Thus, 1.5 equivalents of maleimide dyes were applied in labeling reactions. Under 
such conditions, no labeling at Cys143 was observed.  
  
 
Figure 4-1-7. LC-ESI-MS analysis of the peptide fragments resulted from the trypsin digest of 
Rab7Δ2C(dans)SC using reverse-phase C18 column. (A) The elution profile detected by absorbance 
at 214nm (upper panel) and by dansyl fluorescence (lower panel, excitation at 340 nm, emission at 
480 nm). The dashed line shows the percentage of eluent, acetonitrile, in water. (B) The ESI-mass 
spectrum of the collected fluorescent fraction eluted at 4.0 minutes in the HPLC chromatogram. It was 
shown to represent the dansyl labeled C-terminal peptide. Rab7Δ2C(dans)SC was produced by 
conjugation of IAEDANS to Rab7Δ2CS-MESNA thioester followed by ligation to a cysteine. 
 
A set of iodoacetamide or maleimide functionalized fluorophores were used for 
conjugation, which are structurally diversified and excitable by light from UV to far red  
(see Figure 4-1-8). I-BA-s-IA and I-SO-s-IA were contributed by Prof. Dr. Klaus Hahn 
(The Scripps Research Institute, La Jolla, CA, USA) (Toutchkine et al., 2003) while 
the others were obtained from commercial sources.  
Selection of dyes was based on two considerations: First, the dyes should be 
environmentally sensitive in order to monitor the prenylation reaction. 
Environmentally sensitive dyes have been covalently attached to proteins to report a 
diverse array of protein activities in vitro (for review see (Giuliano and Taylor, 1998)), 
including phosphorylation (Wang and Lawrence, 2005; Shults and Imperiali, 2003; 
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Yeh et al., 2002), conformational changes (Hammarstrom et al., 2001), small ligand 
binding (Wada et al., 2003; De Lorimier et al., 2002; Morii et al., 2002; Hamachi et al., 
2000; Marvin and Hellinga, 1998; Gilardi et al., 1994; Brune et al., 1994), and protein-
protein interactions (Nomanbhoy and Cerione, 1999; Daugherty and Gellman, 1999; 
Sloan and Hellinga, 1998; Cerione, 1994). The typically used environmentally 
sensitive dyes such as acrylodan (Prendergast et al., 1983), ANS (Cerione, 1994), 
dansyl, coumarin, NBD, fluorescein, etc., however, have several drawbacks which 
limit their application in in vivo experiments. They fluoresce at short wavelengths 
which fall inside the range of cellular autofluorescence, resulting in high background. 
In contrast to dyes commonly used in live cell imaging (e.g. rhodamine, cyanines, 
Alexa dyes), they show weak absorption, low fluorescence quantum yields, and low 
photostability. Recent advances in the development of new dyes, such as DapoxylTM 
[5-(4’’-dimethylaminophenyl)-2-(4’-phenyl)oxazole] (Wang and Lawrence, 2005; Diwu 
et al., 1997), BODIPY(as shown in Figure 4-1-8) (Korlach et al., 2004; Isaksson et al., 
2003), styryl naphthyl dyes - JPW (De Lorimier et al., 2002), DCDHF 
(dicyanodihydrofuran) (Willets et al., 2003), merocyanine derivatives (I-BA, I-SO, see 
Figure 4-1-8) (Toutchkine et al., 2003) and APM (aminophenoxazone maleimide) 
(Cohen et al., 2005), provide a wider platform for protein activity studies in vitro and 
especially in vivo (Nalbant et al., 2004; Hahn et al., 1992). Selected dyes herein 
(Figure 4-1-8) included the traditional small environmentally sensitive dyes (e.g. 
dansyl, coumarin, NBD, fluorescein) and bright dyes such as rhodamine and its 
derivatives - ATTO 520, 565, coumarin derivative - ATTO 425, acriflavine derivative - 
ATTO 465, and merocyanine derivatives - Dyomics dyes.  
Second, the dyes should be suitable for protein modification. Besides thiol-
reactivity, good aqueous solubility is required for protein labeling, since proteins 
usually cannot tolerate high concentrations of organic solvents. However, only 
relatively hydrophobic dyes tend to be good reporters, presumably because 
interaction with protein hydrophobic regions is necessary to substantially alter the 
dye’s environment (Toutchkine et al., 2003). Moreover, multiply charged dyes can 
perturb local structure and motion as well as inhibit labeling at certain positions. 
Therefore, selection of dyes on the basis of hydrophobicity is a trade-off between the 
compatibility with protein modification and its capability as a reporter. Another 
encountered problem is the self-aggregation of hydrophobic dyes in aqueous 
solvents, which was observed for fluorescein in this study. Aggregation leads to self-
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fluorescence quenching and difficulties during protein labeling and separation of the 
noncovalently attached dyes (Toutchkine et al., 2003). It was shown that the 
inclusion of charged groups (Soper and Mattingly, 1994) and out-of-plane groups 
(Toutchkine et al., 2003) prevents aggregation. The length of linker between probe 
and protein could also be a concern. On the one hand, short linkers would reduce the 
accessibility of dyes to protein due to steric hindrance, as was observed in this study 
(see below). On the other hand, long, flexible linkers may raise the question about 
whether the probe motions faithfully mirror the motions of the residue to which it is 
attached (Cohen et al., 2005). Because of lack of knowledge in this aspect, the 
length of linker between probe and protein ranged from 3 to 10 atoms in this study. 
   
 
 
Figure 4-1-8. Structural formulae of thiol-reactive fluorophores used in this study. Excitation and 
emission wavelength are indicated. For I-BA and I-SO, I = indolenine, BA = barbituric acid, SO = 
benzothiophen-3-one-1,1-dioxide. IAEDANS: 5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-
sulfonic acid, DCIA: 7-diethylamino-3-((4'-(iodoacetyl)amino) phenyl)-4-methylcoumarin, IANBD: N-((2-
(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole, BODIPY: N-(4,4-difluoro-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene-2-yl)iodoacetamide, 5-TMRIA: tetramethylrhodamine-5-
iodoacetamide dihydroiodide. 
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In most cases, conjugation of iodoacetamide functionalized dyes to Rab7 
proceeded without observed influence on the thioester group under neutral 
conditions (examples see Figure 4-1-4 D, 4-5 D). Interestingly, conjugation of 
maleimide dyes to Rab7Δ2SC-MESNA thioester promoted hydrolysis of the thioester. 
The resulting maleimide conjugates lost their reactivity for cysteine ligation (data not 
shown). However, this was not observed in the maleimide conjugates of Rab7Δ2CS-
MESNA thioester, nor was this dependent on the type of dye coupled. Taken 
together, this suggests that attachment of maleimide to the side chain of cysteine 
residue in the vicinity of thioester specifically induced its hydrolysis in the context of 
the Rab7Δ2SC-MESNA protein. To this end, a series of tests were performed to 
study the kinetics of the conjugation of maleimide and the hydrolysis of thioester in 
order to reveal the reason for such a phenomenon. Since both reactions are sensitive 
to pH, the pH and time for conjugation and subsequent incubation were manipulated 
in the tests. 
 
Table 4-1-1-1. Conjugation of ATTO 425-maleimide to Rab7Δ2SC-MESNA thioester. Reactions were 
performed for 30 or 5 minutes at different pH. After reaction, the excess dye was removed and the 
buffer was changed using a spin column.  The resulting conjugates were analyzed by ESI-MS, 
displaying two major mass peaks corresponding to the labeled thioester (expected 23722) and the 
labeled hydrolyzed molecule (expected 23846). 
 
Conjugation ESI-MS relative abundance (%)  
pH Time (min) 
pH after 
conjugation Rab7Δ2SC(425) 
observed 23720 
Rab7Δ2SC(425)-MESNA 
observed 23844 
7.2 30 7.0-7.5 100  10 
6.5 30 7.0-7.5 100  15 
6.5   5 7.0-7.5 100  40 
5.0 30 7.0-7.5 100    0 
6.5 30 5   20 100 
6.5   5 5   10 100 
5.0 30 5   10 100 
 
The data summarized in the Table 4-1-1 indicates that (i) the conjugation of the 
maleimide functionalized dye to Rab7 is rapid (reaction completes within 5 minutes at 
pH 6.5-7.5); (ii) it was the formation of maleimide adduct but not the coupling reaction 
that induced the hydrolysis of the C-terminal thioester; (iii) the hydrolysis was 
relatively slow at pH 7.0-7.5, and was impeded at pH 5.0. Without further 
investigation, it is unclear how the maleimide adduct induces the hydrolysis of α-
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thioester. In a previous report, the conjugation of N-(1-pyrene)maleimide with 
cysteine and protein where primary amino groups were also present led to spectral 
shift of the fluorescence. This spectral change was postulated to be a consequence 
of an intramolecular nucleophilic attack on the succinimido ring of the adduct by the 
primary amino group (Wu et al., 1976). However, no 3-D structure of full length Rab7 
is available due to the highly flexible C-terminus (Rak et al., 2004). The connection 
between maleimide adduct induced possible intramolecular aminolysis and induced 
thioester hydrolysis could not be established. Despite these puzzles, the resulting 
fluorescently labeled α-thioester tagged proteins are able to be ligated with cysteine 
and peptides at pH 5.0 (data not shown).  
Table 4-1-2. Fluorescence labeling efficiency. 
Dyes Rab7Δ2CS-MESNA Rab7Δ2SC-MESNA Rab7wt 
IAEDANS ~90% ~95% Mono-label ~42% 
Di-label       ~29%  
IANBD ~85% ~90%  
DCIA <10% 
  ~50%a 
<10% 
 ~70%a 
<10% 
Fluorescein  ~10%a   ~25%a  
BODIPY <10% ~10% <10% 
5-TMRIA <10% 
 <10%a 
<10%  
 <10%a 
<10%  
 <10%a 
ATTO425 ~70% ~95%  
ATTO465 ~60% ~95%  
ATTO520 ~30% ~95%  
ATTO565 ~65% ~90%  
Dy610 ~40% ~90%  
Dy630 ~50% ~90%  
Dy650 <10% 
 ~30%a 
~50%  
Dy673 <10% 
 ~30%a 
  
 ~90%a 
 
I-BA-s-IA ~60% ~90%  
I-SO-s-IA ~70% ~90%  
 
Labeling efficiency was estimated from the ratio of ESI-MS signals. a in the presence of detergent 
DDMAB. 
 
The summary of conjugation efficiencies of the fluorescent dyes is shown in 
Table 4-1-2. Not surprisingly, as a result of the intramolecular cyclization at the C-
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terminus of Rab7Δ2CS-MESNA, it appears less susceptible for the dyes than 
Rab7Δ2SC-MESNA. Although most of the labeling reactions were rapid and 
quantitative, some hydrophobic dyes, e.g. 5-TMRIA, BODIPY, DCIA and fluorescein, 
with short linkers displayed very poor reactivity for Rab7 (see Table 4-1-2). This 
could be due to a combination of steric clashes, the unfavorable electrostatic 
interactions and poor solubility of bulky fluorescent groups and protein conjugates. In 
order to increase the labeling efficiency, either longer linkers could be introduced or 
an optimization of reaction conditions should be further performed.  
 
 
Figure 4-1-9. Identification of detergents facilitating dye conjugation to Rab7 thioesters by SDS-PAGE 
analysis. (A) Conjugation of DCIA to Rab7Δ2SC-MESNA thioester in the presence of various 
detergents at concentrations above the critical micelle concentration (CMC). The gels were imaged 
using UV illumination (lower panel) and then stained with Coomassie blue (upper panel). (B) 
Conjugation of Dy650-maleimide (lane 1, 2) and Dy673 (lane 3, 4) to Rab7Δ2CS-ET thioester in the 
presence and the absence of 50 mM DDMAB. (C) Structure of DDMAB. SDS: sodium dodecyl sulfate, 
SLS: sodium lauryl sarcosine, DCS: Deoxycholic acid sodium salt, CHAPS: 3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate, DDMAB: N-dodecyl-N,N-
(dimethylammonio)butyrate. 
 
Given the hydrophilic nature of the protein, conditions had to be identified under 
which both molecules (i.e. protein and dye) could be maintained in solution. To make 
dyes soluble, DMSO (up to 30%) was included as a cosolvent that can be tolerated 
by Rab7. The conjugation of dyes to the proteins was assayed by means of ESI-MS 
as well as SDS-PAGE, where the intensity of the fluorescent Rab7 band indicates the 
formation of the conjugate. Although the organic dyes were soluble under these 
conditions, the labeling efficiency was still very low (Figure 4-1-9 A). It should be 
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noted that conjugation of TMRIA and DCIA to Rab7 led to partial precipitation of the 
protein conjugates (data not shown), which could be one of the reasons for the low 
labeling efficiencies with these dyes. Previous work in our lab showed that detergent 
can facilitate the ligation of hydrophobic geranylgeranylated peptide to Rab7 thioester 
(Durek et al., 2004a). This encouraged us to search for detergents supporting the 
conjugation reaction. After screening a small set of detergents, we identified N-
dodecyl-N,N-(dimethylammonio)-butyrate (DDMAB) as a compound efficiently 
supporting the conjugation of DCIA to Rab7 thioesters (Figure 4-1-9 A, Table 4-1-2).   
Although all detergents were able to mediate solubilization of the organic dyes 
and the protein conjugates, only a few of them were able to support efficient protein 
labeling, suggesting that solubilization is not sufficient for conjugation (Figure 4-1-9 
A). Moreover, conjugation of the soluble dyes Dy650 and Dy673 with long linker to 
Rab7Δ2CS-ET can be significantly improved by supplementing the reaction with 50 
mM DDMAB (Figure 4-1-9 B). In addition to supporting fluorophore conjugation, 
DDMAB is able to assist fluorescent peptide ligation toRab7 thioester (Figure 4-1-10 
A). However, DDMAB as well as other detergents tested in this study did not play a 
critical role in the conjugation of some other dyes, like TMRIA and fluorescein, to 
Rab7 protein.  
DDMAB has been found to support the ligation of geranylgeranylated peptide 
with Rab7 thioester (Thomas Durek, PhD thesis, MPI-Dortmund). It is a zwitterionic 
detergent with a critical micelle concentration (CMC) of 4.3 mM (Chevalier et al., 
1991), which was successfully used for solubilization of membrane proteins (Welling-
Wester et al., 1998; Brenner et al., 1995; Tanford and Reynolds, 1976). T. Durek et 
al. proposed that the observed ligation improvement is a result of concentration of 
both reactants into a small micelle, resulting in an increase of the frequency of 
molecular collisions, consequently improving the prenylated peptide ligation. Such a 
proximity effect is often the main factor responsible for the catalysis of reactions in 
micellar solutions (Tascioglu, 1996). Besides concentrating the reactants in a small 
volume, micelles stabilize substrates, intermediates or products, and orient 
substrates so that ionization potentials and oxidation-reduction properties, 
dissociation constants, physical properties and reactivities are changed. Thus, they 
can alter reaction rate, mechanism, and regio- and stereochemistry (Dwars et al., 
2005). 
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Figure 4-1-10. (A) Ligation of C(StBu)C(StBu)-dans to Rab7Δ2SC-MESNA thioester in the presence of 
DDMAB at various concentrations. The gels were imaged using UV illumination (lower panel) and then 
stained with Coomassie blue (upper panel). (B) A model of the DDMAB micelle mediated fluorophore 
conjugation. The C-terminus of Rab7Δ2SC-MESNA thioester is depicted in red ribbon and the side 
chains of amino acid residues (Pro189, I190, K191, L192) colored in blue. While the labeling reagent 
DCIA is shown in green. 
 
In order to understand the function of DDMAB in conjugation and ligation 
reactions, a series of concentrations of DDMAB were used for fluorescent peptide 
ligation. This showed clearly that only at concentrations above the CMC was the 
ligation efficiency significantly enhanced (Figure 4-1-10 A). The frontier of the 
fluorescent gel corresponding to the unreacted peptides shows enhanced fluorescent 
intensity and reduced mobility in the presence of DDMAB of concentration above 
CMC, which could be due to the micelle bound peptides. The formation of micelles 
was also observed in fluorescence labeling reactions (see Figure 4-1-9 A, B). 
Therefore, micelle formation could play an important role in the improvement of the 
labeling and ligation reactions. In the present case, the observed micellar catalysis 
effects could arise from two major factors (Figure 4-1-10 B): (i) an increase in the 
local concentration of both reactants; (ii) denaturation of the Rab7 C-terminus, 
resulting in exposure of the buried thiol group (Gitler et al., 1995). In addition, the 
high charge density at the micelle surface could enhance the polarization of the 
carbonyl thioester, thereby increasing its reactivity for ligation. A cationic detergent 
(cetyltrimethylammonium bromide; CTAB), was proposed to increase the thiol 
ionization and reduce the pKa of dyes bound to the micelles, thereby enhance the 
reactivity of protein to a thiol-reactive dye labeling (Gitler et al., 1995; Montal and 
Gitler, 1973). Nevertheless, the analysis of the exact contribution of these effects on 
the conjugation and ligation efficiencies is quite speculative.  
The lack of response of other dyes to the micelle mediated labeling reactions 
could be due to low affinity to the micelle, determined by the physical properties of 
4.1.2.3 Fluorophore conjugation and protein ligation 
78 
both dyes and detergents. To increase the labeling efficiencies of these dyes would 
require more extensive screening for detergents.  
 
 
Figure 4-1-11. Fluorescent peptides. Fluorophores were linked to the peptides via either ε-amino 
group of lysine or C-terminal α-carboxyl group. 
 
The resulting fluorescently labeled Rab7 thioester protein conjugates were 
ligated with either cysteine or Cys-Cys dipeptide synthesized by standard solid-phase 
peptide synthesis. Ligation of fluorescent conjugates with 40-50 equivalents of 
cysteine or Cys-Cys dipeptide proceeded quantitatively under standard ligation 
conditions, resulting in a fluorescent Rab7 conjugate family applicable for prenylation. 
Those fluorescent groups conjugated to Rab7 that give positive fluorescent signal 
changes upon Rab prenylation were selected for further investigation. Subsequently 
these fluorophores were coupled to a peptide containing two cysteine residues (see 
Figure 4-1-11, obtained from Novabiochem, EMD and Thermo Hybaid GmbH) via 
either ε-amino group of lysine or C-terminal α-carboxyl group. The ligation of a 
cluster of fluorescent peptides with Rab7 thioester further enriched the Rab cojugate 
family (see Table 4-1-3). The extent of ligation was typically 80-95% under standard 
ligation conditions, while the inefficient ligations were improved from 30% to 80% in 
the presence of the detergent micelle (see Figure 4-1-10 A).  
S-tert-butyl protecting groups were cleaved in situ by excess MESNA during 
ligation (Durek et al., 2004a; Alexandrov et al., 2002; Tolbert and Wong, 2000). Upon 
completion of the labeling and ligation reaction, excess dye, peptide, detergents and 
additive (MESNA) were removed by dialysis and gel filtration. However, the 
purification of the labeled and ligated protein from unlabeled and unligated protein 
4.1 Fluorescent sensors for Rab prenylation 
 
79 
turned out to be highly challenging. It was not possible to separate them by gel 
filtration and dialysis due to their close molecular weights. However, we assumed 
that the minor unlabeled and unligated protein would not significantly affect the 
activity of the sensors. This indeed turned out to be the case, as will be shown in the 
following section. Thus, in the initial screening for the sensors these contaminants 
were not removed.  
4.1.2.4 Characterization of Rab7 fluorescent conjugates 
 
Table 4-1-3. List of Rab7 fluorescent conjugates used in screening for prenylation sensors. 
Rab7 conjugate  C-terminus 
for single prenylation 
Rab7 conjugate C-terminus for double prenylation λex/ 
nm 
-2 -1 -2 -1 Sandwich +1 
340 C(dans)SC SC(dans)C C(dans)SCC SC(dans)CC  SCCK(dans) 
SCCC-dans 
379 C(Coum)SC SC(Coum)C     
437 C(425)SC SC(425)C C(425)SCC SC(425)CC SCK(425)C SCCK(425) 
458 C(465)SC SC(465)C     
490 C(NBD)SC SC(NBD)C C(NBD)SCC SC(NBD)CC SCK(NBD)C SCCK(NBD) 
506 C(BO)SC* SC(BO)C*     
524 C(520)SC SC(520)C     
552 C(Rhod)SC* SC(Rhod)C*     
567 C(565)SC SC(565)C     
569 C(I-BA)SC SC(I-BA)C C(I-BA)SCC SC(I-BA)CC   
592 C(I-SO)SC SC(I-SO)C C(I-SO)SCC SC(I-SO)CC   
615 C(610)SC SC(610)C     
633 C(630)SC SC(630)C     
648 C(650)SC SC(650)C     
667 C(673)SC SC(673)C     
dans: dansyl, Coum: coumarin, BO: BODIPY, 425: ATTO 425, 465: ATTO 465, 520: ATTO 520, 565: 
ATTO 565, Fluo: fluorescein, Rhod: rhodamine, 610: Dy610, 633: Dy 633, 648: Dy 648, 667: Dy 667. * 
Yield < 10%. The conjugates that were not reactive in in vitro prenylation are shown in blue. The 
conjugates that displayed florescence changes upon prenylation are shown in red. 
 
The constructed Rab7 conjugate family is listed in Table 4-1-3. Their activities 
for prenylation were measured by a quantitative HPLC assay (Thoma et al., 2001c), 
which took advantage of the different mobilities of un-, mono- and doubly prenylated 
Rab7 on a reverse-phase C4 column. The Rab7 conjugates can be selectively and 
sensitively detected via their fluorescence, even in the case of co-elution with other 
components of the Rab prenylation reaction. Figure 4-1-12 shows an example of this 
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assay quantifying the activity of Rab7Δ3CCK(NBD). The shift of the elution peak to 
longer retention time after prenylation (Figure 4-1-12 A) indicates formation of 
prenylated products that were confirmed by mass spectroscopy (data not shown). As 
a control, the fluorescently labeled Rab7 thioesters that do not contain the 
prenylatable cysteines cannot be prenylated, and thus do not display a shift of 
mobility after the prenylation reaction (Figure 4-1-12 B).  
Most of the Rab7 fluorescent conjugates could serve as substrates of 
RabGGTase, albeit with different efficiencies. However, Dy673 conjugates were not 
able to undergo prenylation (Table 4-1-3). These conjugates contain bulky 
fluorescent groups in the vicinity of the prenylation sites, which might influence the 
accessibility of the C-terminal cysteines to the geranylgeranyl moieties.  
 
 
Figure 4-1-12. (A) The elution profile of a mixture of Rab7wt, REP-1 and RabGGTase resolved on the 
C-4 reversed phase column detected by absorption at 280 nm (top panel), the elution profile of a 
mixture of Rab7Δ3CCK(NBD) (17.3 min), RabGGTase and GGPP resolved on the same column using 
a fluorescence detector (Ex: 490 nm, Em: 535 nm) (middle panel), and the elution profile of an 
identical sample supplemented with REP-1 and incubated for 30 min at room temperature. The peak 
of Rab7Δ3CCK(NBD) shifted to 20.2 min was assigned as the doubly prenylated  Rab7Δ3CCK(NBD) 
(bottom panel). (B) The elution profile of Rab7Δ2C(dans)S-M before and after prenylation detected by 
dansyl fluorescence  (Ex: 340 nm, Em: 480 nm) (C) In vitro prenylation isotopic assay using (3H) 
labeled GGPP. Incorporation of (3H)-geranylgeranyl into wild-type Rab7 protein (lane 2) and 
Rab7Δ3CCK(NBD) (lane 3) catalyzed by RabGGTase. The reactions contained 100 pmol (3H)-labeled 
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GGPP (2652 cpm/pmol), 10 pmol of Rab7:REP-1 complex and 10 pmol of mammalian RabGGTase. 
REP-1 was omitted in the control reaction (lane 1) containing wt Rab7.  
 
 
Figure 4-1-13. Time course of change in fluorescence seen upon mixing 100nM Rab7 fluorescent 
conjugates, REP-1 and RabGGTase with 10μM GGpp (the time point indicated by the arrow). 
Reactions were run at 20°C in prenylation buffer: 50 mM Hepes, pH7.2, 50 mM NaCl, 5 mMDTE,  
2mM MgCl2, 100μM GDP. 
 
Only a small subset of the fluorescent conjugates that are capable of reporting 
prenylation was identified. These conjugates bear fluorescent groups such as dansyl, 
NBD and coumarin derivatives that are known to be environmentally sensitive, while 
some conjugates constructed from other fluorophores such as coumarin, BODIPY, I-
BA and I-SO which have been used as sensitive reporters in protein studies did not 
display significant change in fluorescence upon prenylation. Interestingly, for a given 
fluorescent group some attachment sites are more effective in sensing prenylation 
than others. Among NBD conjugates, placing NBD at the +1 (with respect to the 
prenylation site) lysine side chain resulted in the highest sensitivity to prenylation, 
yielding a 2-fold fluorescence increase. Within the dansyl modified proteins, the 
conjugate compromising a dansyl group linked to the C-terminal α-carboxyl exhibits 
the best fluorescence enhancement (1.5-fold) upon prenylation. Other conjugates 
show only moderate changes in fluorescence upon prenylation (Figure 4-1-13). 
Rab7Δ3CCK(NBD) 
Rab7Δ2SCC-dans 
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Figure 4-1-14. Emission spectra of Rab7 fluorescent conjugates (solid lines), the binary complexes 
with REP-1(open circles), and the ternary complexes with RabGGTase (dotted lines), and emission 
scan after prenylation (dashed lines, shown only in G-L). (A) Rab7Δ2C(I-BA)SCC, λex=570nm. (B) 
Rab7Δ2SC(I-BA)CC, λex=570nm. (C) Rab7Δ2C(I-SO)SCC, λex=595nm. (D) Rab7Δ2SC(I-SO)CC, 
λex=595nm. (E) Rab7Δ2SC(NBD)CC, λex=495nm. (F) Rab7Δ3CCK(NBD), λex=490nm. (G) 
Rab7Δ2SCCC-dans, λex=333nm. (H) Rab7Δ3CCK(dans), λex=340nm. (I) Rab7Δ2SCCC-dans, 
λex=280nm. (J) Rab7Δ3CCK(dans), λex=280nm. (K) Rab7Δ2C(dans)SCC, λex=340nm. (L) 
Rab7Δ2SC(dans)CC, λex=340nm.The concentration of each fluorescent protein conjugate was ca. 100 
nM. 
 
Despite the relatively low sensitivity to prenylation, some of the fluorescent 
conjugates were capable of sensitively reporting interactions between Rab, REP and 
RabGGTase. I-BA and I-SO Rab7 conjugates displayed 200% and 350% increase in 
fluorescence intensity, respectively, upon binding to REP-1, but only a limited change 
in fluorescence intensity upon assembly of the ternary Rab7:REP-1:RabGGTase 
complex (Figure 4-1-14 A-D). All NBD conjugates constructed here were able to 
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report on both binary Rab7:REP-1 and ternary Rab7:REP-1:RabGGTase complex 
formation, which typically resulted in 2-3 fold increase and 2-fold quenching in the 
NBD fluorescence, respectively (two examples are shown in Figure 4-1-14 E, F). The 
dansyl conjugates could respond to both interactions when either directly excited at 
340 nm or via fluorescence resonance energy transfer (FRET) from tryptophan at 
280 nm (Figure 4-1-14 G-L). Whereas several dansyl conjugates showed only a 
minor change in the emission spectra (Figure 4-1-14 K, L), the two with dansyl linked 
to the side chain of +1 lysine [Rab7Δ3CCK(dans)] and to α-carboxyl group 
(Rab7Δ2SCCC-dans) displayed dramatic enhancements in fluorescence intensity 
accompanied by a spectral shift upon interactions (Figure 4-1-14 G, H). Upon 
interaction with REP-1, Rab7Δ3CCK(dans) exhibited a 6-fold increase in the dansyl 
fluorescence at 504 nm as well as a blue shift of emission maximum from 540 nm to 
506 nm. Binding of Rab7Δ2SCCC-dans to REP-1 resulted in a 5-fold fluorescence 
enhancement at 504 nm accompanied by a blue shift of λmax from 540 nm to 504 nm. 
In contrast, only 130% increase in fluorescence intensity as well as minor emission 
shift was observed on binding of RabGGTase to REP-1 complexed with 
Rab7Δ3CCK(dans) or Rab7Δ2SCCC-dans, however, 10-fold fluorescence 
enhancement was observed in both cases using the FRET signal (Figure 4-1-14 I, J; 
4-16 F). After prenylation, both Rab7Δ3CCK(dans) and Rab7Δ2SCCC-dans exhibited 
an 8-nm blue shift of the emission maximum as compared with those of ternary 
complexes (Figure 4-1-14 G, H).  
The labeling position of I-SO, I-BA and NBD in the Rab7 conjugates did not 
significantly influence the character of their emission spectra as well as their 
sensitivity for the interactions (Figure 4-1-14 A-F). Nevertheless, when dansyl group 
was attached to Rab7 via the N-(2-sulfonylamino)alkyl group [ligation with DNS 
labeled peptides, CCK(dans) and CC-dans] instead of N-(2-aminoethyl)acetamido 
group (coupling with IAEDANS) (Figure 4-1-15), the emission maxima of the resulting 
conjugates shift from 490  nm (Figure 4-1-14 K, L) to 540 nm (Figure 4-1-14 G, H) 
with a concomitant decrease in fluorescence intensity. As a result, the former can 
report interactions and prenylation much more efficiently via either direct 
fluorescence or FRET. 
The utility of the merocyanine dyes has been demonstrated by using them to 
build a biosensor that reported activation of camodulin in living cells (Hahn et al., 
1992; Hahn et al., 1990) and an endogenous GTPase, Cdc42, in vitro (Toutchkine et 
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al., 2003) and in vivo (Nalbant et al., 2004). The S-SO (benzothiazole - 
benzothiophen-3-one-1,1-dioxide) labeled Wiskott Aldrich Syndrome Protein (WASP) 
molecule showed a 300% increase in fluorescence intensity without a change of 
emission maximum upon binding to GTP bound Cdc42. I-SO and I-BA biosensors 
that respond to the interactions with REP showed a similar character of fluorescent 
response to those of Cdc42 activation. The minimal change in the fluorescence 
maxima was supposed to be a result of the cyanine limit structure of the dyes by 
experimental and theoretical studies (Toutchkine et al., 2003; Han et al., 2003). The 
change in fluorescence intensity could be interpreted as the variation in hydrogen 
bonding of the dyes, which has been shown in cyanine (Soper and Mattingly, 1994), 
merocyanine (Liu et al., 2004; Onganer et al., 1993) and Nile Red (Cser et al., 2002). 
The properties of I-SO and I-BA biosensors, i.e. excitation at long wavelength, high 
quantum yield, high photostability and 2-3 fold increase in fluorescence intensity 
upon binding to REP make them suitable for in vivo applications. 
The NBD and dansyl moieties are characterized by a high sensitivity of the 
emission to the polarity of the surrounding solvent, enabling their use as reporters in 
biophysical studies on proteins (Lakowicz, 1999). The increase in the fluorescent 
intensity as well as the blue shift of emission maximum observed upon interactions 
shown in Figure 4-1-14 E-H could be interpreted in terms of decrease in polarity of 
the microenvironment around the NBD (Gether et al., 1995) and dansyl (Hudson and 
Weber, 1973) group caused by a reduction in solvent accessibility. In NBD-
conjugated maltose binding protein (Gilardi et al., 1997), ligand binding induced 
differences in spectral properties have been explained by a twisted intramolecular 
charge transfer (TICT) mechanism (Grabowski et al., 2003), wherein the NBD group 
is constrained into a conformation that prevents efficient relaxation of the excited 
state.  
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Figure 4-1-15. Two types of dansyl conjugates. R: other part of protein 
 
As mentioned above, the linking format between dansyl and protein determined 
the sensitivity of the dansyl conjugates. Figure 4-1-15 shows two types of dansyl 
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conjugates dependent on the linkage through either tertiary amino group (AEANS) or 
sulfonyl group (DNS). The AEANS conjugate is a result of IAEDANS attachment to a 
cysteine thiol, while the DNS conjugate is typically generated by coupling dansyl 
chloride to a primary amino group on the side chain of a peptide. The observed much 
higher sensitivity of the DNS conjugates as compared with that of the AENS 
conjugates could be rationalized in terms of a TICT mechanism. DNS has been 
suggested to relax from the excited state via TICT, where a pair of charge transfer 
groups, donor and acceptor, are present (Ren et al., 1999) (Grabowski et al., 2003). 
In this case the donor is the tertiary amino group and the acceptor is the sulfonyl 
group (Figure 4-1-15). In Rab7-DNS, the dimethylamino group is relatively free to 
rotate and hence the relaxation of the excited state of DNS through TICT is efficient, 
representing emission at low energy (λem=540nm, A* state). While in Rab7-AEANS, 
the conjugated protein molecule increases the viscous drag and is sufficient to inhibit 
the rotation of the amino group of AEANS during its excited state lifetime, thus 
AEANS conjugates exhibit fluorescence at high energy (λem=490nm, B* state) as 
compared with that of free IAEDANS in the same solution (λem=520nm). The 
subsequent interaction of Rab7-DNS with REP and RabGGTase could result in a 
restriction of the rotational mobility of DNS so as to bring about an increase in the 
emission energy characterized by a blue shift of emission maximum.  
In the light of this idea, DNS would be more useful as a reporter that AEANS, 
leaving aside the concern of the facility in chemical modification. Besides the 
observation in this study, DNS has been widely used in the construction of highly 
sensitive biosensors for Zn2+ binding (Walkup and Imperiali, 1996), farnesylation 
(Pompliano et al., 1992a), DNA interaction (Barawkar and Ganesh, 1995), etc. In 
contrast, AEANS conjugates display relatively low sensitivity in their applications 
(Hammarstrom et al., 2001; Post et al., 1994). 
On account of the photophysical properties of NBD and dansyl, their usefulness 
for in vivo studies is limited. However, NBD and dansyl conjugates respond to REP 
and RabGGTase binding by undergoing highly sensitive spectral shifts and changes 
in fluorescence intensity, making them useful in the characterization of the 
interactions of the prenylation machinery in vitro (see Chapter 4.3).  
The sensitive change in fluorescence upon the formation of complexes can be 
used to quantitatively analyze the interactions of the binary and the ternary 
complexes. As shown in Figure 4-1-16, titration of REP-1 to a fixed concentration of 
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the Rab7 fluorescent conjugates or titration of RabGGTase to the Rab7:REP-1 
complexes resulted in a dose-dependent change in fluorescent intensity or FRET 
signal, which could be utilized to determine the equilibrium constants of the 
interactions.  
 
 
Figure 4-1-16. (A) Titration of REP-1 to Rab7∆2SC(I-BA)CC (λex=570 nm, λem=590 nm). (B) Titration 
of REP-1 to Rab7∆2C(I-SO)SCC (λex=595 nm, λem=615 nm). (C) Titration of REP-1 to 
Rab7∆3CCK(NBD) (λex=490 nm, λem=535 nm). (D) Titration of RabGGTase to the 
Rab7∆3CCK(NBD):REP-1 complex (λex=490 nm, λem=535 nm). (E) Titration of REP-1 to 
Rab7∆2SCCC-dans (λex=333 nm, λem=504 nm). (F) Titration of RabGGTase to the Rab7∆2SCCC-
dans:REP-1 complex using the FRET signal (λex=280 nm, λem=508 nm). (G) Titration of REP-1 to 
Rab7∆3CCK(dans) (λex=340 nm, λem=504 nm). The solid lines show the fits to a quadratic equation as 
described in Chapter 8.1.1 to give Kd values. To each fluorescence titration, corrections were made for 
background signal from Rayleigh scattering of the buffer and the non-specific background 
fluorescence of titrating components. All reactions were performed at 20°C in titration buffer (50 mM 
Hepes, pH7.2, 50 mM NaCl, 5 mM DTE).  
 
The dissociation constants, Kd, extracted from the binding curves are 
summarized in Table 4-1-4. Because there is a thermodynamic linkage between the 
protein binding and the interaction of the coupled fluorophore with the protein, the 
fluorophore is expected to change the intrinsic dissociation constant. The change in 
affinity imparted by the fluorophore is dependent on its nature and its location in the 
protein. The two DNS conjugates Rab7∆2SCCC-dans and Rab7∆3CCK(dans) 
display higher affinity to REP-1 than wild type Rab7. The others exhibit lower affinity 
to REP-1 than the wild type, with the ATTO425 conjugates showing the lowest affinity. 
However, the conjugation of fluorophores to Rab7 increases the affinities of the 
ternary complexes, which might result from the interaction of the conjugated 
fluorophore with RabGGTase. Interestingly, among these conjugates the most 
sensitive sensors (i.e. showing the highest fluorescence change, Figure 4-1-13) for 
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prenylation, Rab7∆3CCK(NBD) (2-fold) and Rab7∆3CCK(dans) (1.5 fold), show the 
highest affinity to REP and RabGGTase, presumably coincidently. 
 
Table 4-1-4 Kd values of binary and ternary complexes of Rab7 fluorescent conjugates determined by 
fluorescence titration as shown in Figure 4-1-16. 
Construct Kd (Rab:REP-1) /nM Kd (Rab:REP-1:RabGGTase) /nM 
Rab7wt* 1 121 
Rab7∆2C(dans)SC 14 44 
Rab7∆2SC(dans)C 2.4 14 
Rab7∆2SCCC-dans 0.94 3.9 
Rab7∆3CCK(dans) 0.85 ND 
Rab7∆2C(NBD)SC 2.2 63 
Rab7∆2SC(NBD)C 9.5 33 
Rab7∆3CCK(NBD) 9.0      6.8 
Rab7∆2C(425)SC 16 ND 
Rab7∆2SC(425)C 83 ND 
Rab7∆2SC(I-BA)CC 2.0 ND 
Rab7∆2C(I-SO)SCC 2.1 ND 
* see ref (Alexandrov et al., 1999; Alexandrov et al., 1998), ND: not determined 
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4.1.3 NBD-FPP as a sensitive fluorescent sensor for Rab 
prenylation 
 
In spite of the limited success in the prenylation sensors based on Rab proteins, 
several useful lessons could be extracted: first, the modified set-up for the concept of 
intramolecular fluorescence enhancement, i.e. introduction of a fluorophore in the 
vicinity of the Rab prenylation sites, yielded only moderately efficient sensors for Rab 
prenylation, which only gave fluorescence intensity changes not exceeding a factor of 
2. This can be rationalized in terms of the probability that the hydrophobic 
geranylgeranyl groups are already buried deeply in REP in order to increase the 
solubility of the prenylated Rab proteins (Rak et al., 2004). Second, among 
constructed fluorescent sensors, semi-synthetic Rab with a small environmentally 
sensitive fluorescent group like NBD or DNS conjugated in the proximity of the C-
terminal cysteine showed the best fluorescence enhancement upon prenylation. This 
indicates that NBD or DNS could be good candidates for the construction of other 
types of fluorescent sensor in the context of the prenylation machinery. In addition, 
construction of Rab protein conjugates required labor-intensive screening for 
fluorophores and labeling positions, and moreover, this kind of sensor is based on 
such a specific Rab construct that it cannot be a versatile reporter for prenylation of 
other Rab GTPases. Hence, we devised an alternative strategy in which a 
fluorophore is incorporated into the soluble isoprenoid donor which is expected to 
undergo marked changes of hydrophobicity during the prenylation reaction. Towards 
this goal we prepared a fluorescent analogue of geranylgeranyl pyrophosphate, 
{3,7,11-trimethyl-12-(7-nitro-benzo[1,2,5]oxadiazo-4-ylamino)-dodeca-2,6,10-trien-1} 
pyrophosphate (NBD-FPP) in collaboration with Prof. Dr. Waldmann in MPI 
Dortmund and demonstrated that it serves as a sensitive sensor for Rab prenylation.  
4.1.3.1 A sensitive, real-time fluorometric assay for RabGGTase 
activity 
 
NBD-FPP with an NBD group coupled to a C-15 farnesyl moiety approximately 
mimics the length of a C-20 native lipid substrate, GGPP (see Figure 4-1-17 A). As 
shown in Figure 4-17 B, addition of RabGGTase to a solution of NBD-FPP resulted in 
fluorescence quenching by 70% with a concurrent 8-nm blue shift of emission 
maximum (from 547 to 539nm). Addition of an excess of GGPP to the mixture 
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resulted in a reversal of the signal change and return of the fluorescence to the 
original level, indicating that the fluorescence change indeed reflected specific 
interaction of the developed compound with the active site of the enzyme (data not 
shown). The sensitive changes in fluorescence allowed us to determine the affinity of 
the GGPP analogue for RabGGTase. Titration of NBD-FPP with RabGGTase is 
shown in Figure 4-1-17 C to give Kd = 73 ± 2 nM.  
The titration was subsequently carried out under competitive conditions to 
determine the Kd for the interaction of RabGGTase with its natural substrate GGPP. 
In this experiment, 200 nM NBD-FPP was mixed with 100 nM GGPP and the 
resulting mixture was titrated with increasing concentrations of RabGGTase. As 
shown in Figure 4-1-17 D, there is an initial lag in the fluorescence decrease. This is 
explained by GGPP binding more strongly than NBD-FPP to the enzyme, initially 
resulting in the formation of a fluorescently silent complex. However, at higher 
RabGGTase concentrations, the enzyme forms a complex with NBD-FPP, causing a 
decrease in fluorescence intensity. The data were fitted numerically using the 
program SCIENTISTTM and led to a Kd value of 0.85 nM (for competitive titration 
model see Appendix 6.2). The Kd value of 0.83 nM for GGPP interaction with 
RabGGTase was also determined using another fluorescent isoprenoid mant-FPP, 
which displays fluorescene enhancement upon binding to RabGGTase. This shows 
that RabGGTase bound its lipid substrate 10 times more tightly than was previously 
determined using mant-FPP as a reporter [Kd(GGPP:RabGGTase) = 8 nM] (Thoma 
et al., 2000). The discrepancy could arise from the systematic errors. 
The fluorescence titrations show that RabGGTase binds NBD-FPP ca. 70-fold 
more weakly than it binds GGPP. This is not surprising, since the fluorescent reporter 
group often impairs binding of the modified substrate molecule, as also observed in 
fluorescently labeled Rab proteins (see section 4.1.2.4). NBD-FPP binds 
RabGGTase (Kd=73nM) with a affinity similar to that FPP does (Kd=60nM) (Thoma et 
al., 2000), suggesting that NBD does not significantly compensate for the affinity of 
phosphoisoprenoid, in other words, the phosphoisoprenoid plays a dominant role in 
the contact with the RabGGTase site. It has been suggested that the length of the 
isoprenoid correlates with the affinity to RabGGTase (Thoma et al., 2000). Therefore, 
it is the shortening of the isoprenoid chain in NBD-FPP that probably leads to the 
decrease of affinity. 
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Following the observation that NBD-FPP can bind to prenyltransferases in a 
mode similar to that of native phosphoisoprenoids, we set out to determine whether 
these compounds could also serve as lipid donors for these enzymes. To this end, 
we performed an in vitro prenylation reaction in which enzyme was mixed with its 
corresponding fluorescent isoprenoid substrate and Rab7 GTPase. Control samples 
were supplemented with an excess of GGPP that would compete with the fluorescent 
analogues and thus yield nonfluorescent prenylated GTPases. The reaction was 
allowed to proceed for 1 h at room temperature and was quenched by addition of 
SDS-PAGE sample buffer, after which the samples were resolved on a 15% SDS-
PAGE gel and scanned for fluorescence using a laser fluorescent image reader 
followed by Coomassie blue staining. As can be seen in Figure 4-1-17 E, under these 
conditions incubation of RabGGTase with its protein substrate led to emergence of a 
fluorescent band corresponding to the prenylated Rab7. No fluorescent product was 
generated when REP-1 was omitted. As expected, the reaction was strongly inhibited 
by excess GGPP (Figure 4-1-17 E). The resulting product was further confirmed by 
HPLC and mass spectroscopy (not shown). Therefore, we conclude that the 
observed fluorescent Rab7 GTPase does indeed represent the specific product of 
the prenylation reaction. NBD-FPP and NBD-GPP, the fluorescent analogue of FPP 
(farnesyl pyrophosphate), were also found earlier to be efficient lipid donors for 
GGTase-I and FTase, respectively (Dursina et al., 2006). 
  
 
Figure 4-1-17. (A) Fluorescent analogue of GGPP, NBD-FPP. (B) Emission spectra of 400nM NBD-
FPP in the absence (black line) and the presence of increasing concentrations of RabGGTase as 
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indicated by arrow. λex= 479 nm. (C) Titration of 200nM of NBD-FPP with increasing concentrations of 
RabGGTase (exciation at 479 nm, emission at 547 nm). The data were fitted to a quadratic equation 
as described in Chapter 8.1.1, during the simulation the concentration of NBD-FPP was kept constant 
at 0.2 µM to give Kd value.  (D) Co-titration of a mixture of 200nM NBD-FPP and 100 nM GGPP with 
RabGGTase. The Kd value for GGPP was obtained by simulation with a competitive titration model 
where the Kd for NBD-FPP determined in C was fixed. (E) Incorporation of NBD-FPP to Rab7 upon in 
vitro prenylation resolved by SDS-PAGE (left panel: Coomassie blue staining, right panel: 
fluorescence scan). Lane 2, prenylation in the presence of 5 µM Rab7, REP-1 and RabGGTase 
initiated with 15µM NBD-FPP for 1h; lane1, control reaction where REP-1 was omitted; lane3, control 
reaction where 25 µM GGPP was added to compete with the fluorescent lipid substrate. 
 
To assess the sensitivity of this method, decreasing amounts of the prenylation 
mixture were loaded onto the SDS-PAGE gel and analyzed by fluorescent scanning. 
The highly sensitive fluorescent signal excited by the laser makes it possible to 
detect as little as 6 fmol of fluorescent protein, indicating that the developed methods 
could be significantly scaled down (data not shown). Fluorescent scanning and 
quantification of the SDS-PAGE gels loaded with increasing amounts of NBD-FPP 
showed that the fluorescence intensity of the NBD-FPP bands is a linear function of 
the concentration up to 400 pmol (Figure 4-1-22 A), indicating no “inner filter effect” 
(for details, see section 4.1.3.3) over the range of fluorescent conjugate 
concentrations used in the reactions. This suggests that NBD-FPP can be used in an 
SDS-PAGE assay for RabGGTase activity, which will be discussed in section 4.1.3.3. 
Although very sensitive, the SDS-PAGE assay using NBD-FPP as a fluorescent 
substrate is discontinuous, laborious, and poorly amenable to parallelization. 
Continuous fluorescence assays are much better suited for high-throughput 
screening and characterization of potential inhibitors. Therefore, we sought to 
develop a continuous fluorometric assay for Rab prenylation based on NBD-FPP.  
 
 
Figure 4-1-18 (A) Time-course of fluorescence change upon prenylation catalyzed by RabGGTase 
(0.02μM) on Rab7:REP-1 complex (6 μM) in the presence of NBD-FPP (4 μM) at 37°C. Fluorecence 
was recorded at 520 nm. Assay buffer: 50 mM Hepes, pH7.2, 50 mM NaCl, 5mM DTE, 2mM MgCl2, 
10μM GDP. Inset: Emission spectra (λex= 479 nm) of 1 μM substrate NBD-FPP (dashed line) and 1 
μM product mono-NBD-farnesylated Rab7:REP-1 complex (solid line). (B) HPLC assayed time-
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dependent generation of mono-NBD-farnesylated Rab7 (open circles), doubly NBD-farnesylated Rab7 
(open square) and total NBD-farnesylated Rab7 (open triangles) in the prenylation reaction catalyzed 
by RabGGTase (0.02μM) using the Rab7:REP-1 complex (1 μM) in the presence of NBD-FPP (4 μM) 
at 37°C.  
 
To this end, we analyzed the fluorescence changes of the in vitro prenylation 
reaction supplemented with NBD-FPP. As can be seen in Figure 4-1-18 A, upon 
incorporation of the NBD-farnesyl group into Rab proteins, an increase in 
fluorescence intensity over time with excitation at 479 nm and emission at 520 nm 
was observed. The correlation of the reaction progress with the fluorescence 
increase was confirmed by HPLC analysis (Figure 4-1-18 B). Fluorescence emission 
spectra taken before and after the reaction showed a shift of the emission maximum 
from 547 to 525 nm. To determine the extent of fluorescence enhancement, mono-
NBD-farnesylated Rab7 (Rab7_NF):REP-1 was prepared by in vitro prenylation 
essentially as described before but using the Rab7C207S single cysteine mutant and 
NBD-FPP as an isoprenoid donor (Kalinin et al., 2001). The product was 
characterized by MALDI-TOF and fluorescence scanning (Chapter 6.4.3). 
Rab7_NF:REP displays an emission maximum at 525 nm, i.e. the same as that of 
the products after multi-turnover NBD-farnesylation reactions. A 23-fold 
enhancement of fluorescence intensity at 525 nm was observed when the same 
concentration of Rab7_NF:REP and NBD-FPP were used (Figure 4-1-18 A inset).  
This dramatic increase in fluorescence can be interpreted as a consequence of 
the Rab-conjugated NBD-farnesyl group’s binding into the lipid binding pocket of 
REP. This interpretation was ascertained by the finding that Rab7-NBD-farnesyl 
displays a 10-fold enhancement in fluorescence upon binding to REP-1 accompanied 
by a blue shift of emission maximum from 545 nm to 525 nm (see Chapter 4.4, 
Figure 4-1-40 A). In this case, REP would play a dual role as both Rab chaperone 
and conjugated fluorescent isoprenoid trapper, in the process enhancing its 
fluorescence (Rak et al., 2004; Pylypenko et al., 2003; Thoma et al., 2001b). This 
idea is indirectly supported by the observation that GGTase-I mediated prenylation of 
RhoA with NBD-FPP resulted in only a moderate fluorescence increase (data not 
shown).  
 
4.1.3.2 Characterization of NBD-farnesyltation  
 
4.1 Fluorescent sensors for Rab prenylation 
 
93 
In order to gain insight into the details of the NBD-farnesylation reaction, a 
previously established HPLC based method was used to simultaneously measure the 
absolute amounts of unprenylated, mono- and di-NBD-farnesylated Rab7 (Thoma et 
al., 2001c), which was also used in characterization of prenylation of fluorescent 
Rab7 conjugates (see section 4.1.2.4).  
For investigation of single turn-over reaction kinetics, at different time intervals, a 
constant amount (40 μl) of the reaction mixture was withdrawn and mixed with an 
equal volume of quenching buffer containing 0.4% TFA and 10% glycerol. Addition of 
TFA reduced the pH to 2-3, which is sufficient to stop enzyme activity and quench the 
reaction. The presence of glycerol is to prevent the protein from aggregation and 
precipitation under acidic conditions. The quenched reaction samples were subjected 
to reverse-phase chromatography. Identification of the elution peaks corresponding 
to Rab7 and its NBD-farnesylated products was carried out using purified standards 
and ESI-mass spectroscopy. Rab7, REP and RabGGTase were detected by 
absorbance at 280 nm. As can be seen in Figure 4-1-19 A, B, mono-NBD-
farnesylated Rab7 (Rab7_NF) at 17.7 min co-eluted with REP-1 and di-NBD-
farnesylated Rab7 (Rab7_NFNF) at 18.4 min co-eluted with the RabGGTase alpha 
subunit, but they can be specifically detected by fluorescence. 
The primary HPLC data (Figure 4-1-19 A, B) analysis was performed by 
integrating the peak areas of absorbance at 280 nm for Rab7 and the fluorescence 
intensity for mono- and di-NBD-farnesylated Rab7. The data at each individual time 
point were subsequently processed by normalizing against an internal standard. In 
this case, the beta subunit of RabGGTase (retention time: 20.1 min) that gave a 
strong enough signal and did not co-elute with any other molecule in the system was 
used as an internal standard. 
To obtain individual prenylation rate constants, the experiments were carried out 
using concentrations of Rab7, REP, RabGGTase, NBD-FPP far above their 
respective Kd values (Alexandrov et al., 1999; Alexandrov et al., 1998). Thus, even if 
dissociation of substrate and intermediate is mandatory, re-association should be fast 
enough not to be rate limiting, ensuring that the observed rate constants represent 
the prenylation reaction steps. Essentially identical observed rate constant for the 
decay of Rab7 during prenylation were observed when 4 μM Rab7:REP, 
RabGGTase and 20 μM NBD-FPP were used (kobs = 0.12 min-1 or 0.0021 s-1) instead 
of 1 μM Rab7:REP, RabGGTase and 2 μM NBD-FPP (kobs = 0.11 min-1 or 0.0018 s-1), 
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indicating that prenyl transfer is slower than binding of substrate to RabGGTase. In a 
typical pseudo first order consecutive reaction S→I→P (S: substrate, I: intermediate, 
P: product), the substrate decays with a transient increase and then decay of the 
intermediate and the emergence of the product (see model in Scheme 4-2). 
  
Scheme 4-2.  
Rab7:REP:RabGGTase + NBD-FPP Rab7_NF:REP:RabGGTase
k1
Rab7_NF:REP:RabGGTase + NBD-FPP Rab7_NFNF:REP:RabGGTase
k2
 
 
However, in the reaction system containing 1 μM protein substrate - Rab7:REP-
1 complex, 2 μM lipid substrate - NBD-FPP and 1 μM enzyme - RabGGTase, 
substrate Rab7 decayed accompanied by a saturable increase of both mono- and di-
NBD-farnesylated Rab7 (Figure 4-1-19 C). This indicated that NBD-FPP was so 
limited as to be consumed before Rab7 and Rab7_NF were fully transformed to 
Rab7_NF and Rab7_NFNF respectively. Therefore, the pseudo first order treatment 
cannot be applied in the model, and the reversible equilibrium between substrates 
and enzyme should be taken into account between the prenylation reaction steps, as 
described in Scheme 4-3. 
 
Scheme 4-3.  
Rab7_NF:REP + RabGGTase
k2
k-2
k3
k4
k-4
k6
Rab7:REP:RabGGTase + NBD-FPP Rab7:REP:RabGGTase:NBD-FPP
Rab7:REP:RabGGTase:NBD-FPP Rab7_NF:REP:RabGGTase
Rab7_NF:REP:RabGGTase
Rab7_NF:REP:RabGGTase + NBD-FPP Rab7_NF:REP:RabGGTase:NBD-FPP
k5
k-5
Rab7_NF:REP:RabGGTase:NBD-FPP Rab7_NFNF:REP:RabGGTase
k1
k-1
Rab7:REP + RabGGTase Rab7:REP:RabGGTase
Rab7_NFNF:REP + RabGGTase
k-7
k7
Rab7_NFNF:REP:RabGGTase
 
 
Based on this model, rate constants were extracted from the time traces of Rab7, 
Rab7_NF and Rab7_NFNF using a global-fitting approach through numerical 
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integration according to a set of differential equations (see Appendix 6.4). Since the 
equilibrium constants between Rab7:REP and RabGGTase (Alexandrov et al., 1999), 
NBD-FPP and RabGGTase (Figure 4-1-17 C), Rab7_NF:REP and RabGGTase 
(Figure 4-1-21) have been determined independently, during simulation these 
parameters were kept constant to allow the rate constants of prenylation to be fitted. 
This model resulted in an excellent fit using the program ScientistTM (MicroMath 
Software) giving k3 = 0.11±0.0089 min-1 (0.0019 s-1) for the first prenyltransfer step, 
k6 = 0.12±0.012 min-1 (0.0021 s-1) for the conversion of mono-NBD-farnesylated 
Rab7 into doubly NBD-farnesylated Rab7, and an effective (i.e. fitted) NBD-FPP 
concentration of 0.93 μM (Figure 4-1-19 C). It is not surprising that the effective NBD-
FPP concentration is 2-fold lower than the nominal concentration. TLC (silica gel Thin 
Layer Chromatography) analysis of NBD-FPP showed that storage of NBD-FPP in 
ammonium carbonate buffer for long periods led to partial hydrolysis (data not 
shown). Moreover, REP expressed in the baculovirus system has been found to have 
some phosphatase contamination resulting in degradation of pyrophosphate 
(Pylypenko et al., 2003). Thus, it is possible that NBD-FPP was partially degraded 
during the course of the reaction. 
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Figure 4-1-19. HPLC elution profile of the in vitro NBD-farnesylation reaction at defined time intervals 
detected by absorbance at 280 nm (A) and fluorescence with λex=490nm, λem=535nm (B). Reaction 
was performed using 1 μM Rab7, REP-1 and RabGGTase, and 2 μM NBD-FPP at 25°C. As indicated, 
the peak for Rab7 at 17.4 min decreases, while the peaks for Rab7_NF at 17.7 min and Rab7_NFNF 
at 18.4 min increase and eventually saturate. (C) Kinetics and global fitting of unprenylated Rab7 
(open circle), mono-prenylated Rab7 (open square), and doubly prenylated Rab7 (open triangle) in the 
in vitro NBD-farnesylation reaction. Data were processed based on peak intensity shown in A and B. 
The fits (solid, doted, and dashed line respectively) shown are based on numerical simulation using 
the model shown in Scheme 4-3, giving k3 = 0.11±0.0089 min-1 for the first prenyltransfer step, k6 = 
0.12±0.012 min-1 for the conversion of Rab7_NF into Rab7_NFNF. (D) SDS-PAGE based assay for in 
vitro NBD-farnesylation (2 μM Rab7:REP-1, 3 μM RabGGTase, 40 μM NBD-FPP) at 25°C gives an 
observed rate constant. The solid line showed the fit to a single exponential function. 
 
To determine the NBD-farnesylation reaction rate using an independent method, 
a quantitative SDS-PAGE based assay as shown in 4.1.3.1 was utilized, where at 
different time intervals an aliquot of reaction mixture was withdrawn, quenched by 
SDS-sample buffer and resolved by SDS-PAGE. Quantitative scanning of the gel by 
laser fluorescence reader led to the profile of time-dependent incorporation of NBD-
farnesyl into Rab7, giving the observed rate constant (kobs = 0.14±0.016 min-1, or 
0.0024±0.0003 s-1) (Figure 4-1-19 D). This result is consistent with those determined 
by HPLC assay.  
The kinetic data revealed that NBD-farnesylation of Rab7 is ca. 84-fold slower 
for the prenylation of the first cysteine and 19-fold slower for the prenylation of the 
second cysteine than in the case of native substrate (Thoma et al., 2001c). Since 
these rate constants represent the prenyl transfer step of the reaction, the reduced 
affinities of lipid substrate and intermediate do not contribute to the lower rate 
constants for prenyl transfer. However, the method used here does not distingusih 
the sub-steps in prenyl transfer, such as conformational changes before and/or after 
prenylation chemistry (condensation of the cysteine thiol with the prenyl group). So 
the critical step responsible for the reduced rate of prenyl transfer is still unclear. As 
proposed by a molecular ruler mechanism for prenyltransferases (Liang et al., 2002), 
FTase transfers only FPP efficiently but not GGPP, because the C1 of 20-carbon 
GGPP is out of reach of the catalytic center Zn2+, while FPP still serves as a 
moderately effective substrate of GGTase-I because its diphosphate moiety can be 
located in the vicinity of Zn2+. Conjugation of FPP to peptide substrates catalyzed by 
GGTase-I occurs 37-fold slower (0.015 s-1) than the analogous geranylgeranylation 
reaction (0.56 s-1) (Yokoyama et al., 1997). In contrast, FPP is transferred by 
RabGGTase with a similar observed rate constant to that of GGPP (Thoma et al., 
2000). The identical rate for the first and the second NBD-farnesyl transfer indicates 
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that the impaired rates could be due to the change of geometry of NBD-FPP, which 
also alters the prenylation preference of two C-terminal cysteines. 
The observed NBD-farnesylation reaction rate of the single cysteine mutant 
Rab7C207S (Rab7CSS, kobs=8.4±0.1×10-4 s-1) is ca. 3-fold faster than that of 
Rab7C205S (Rab7SSC, kobs=2.8±0.1×10-4 s-1) (Figure 4-1-20). Essentially the same 
rate constants were obtained when saturating concentrations of protein substrate and 
NBD-FPP were used in the SDS-PAGE assay (Figure 4-1-20 B), which indicates that 
NBD-farnesyl transfer is rate limiting, and thus the rate of NBD-farnesyl transfer from 
the ternary complex being measured is not limited by both substrates binding, 
consistent with the double NBD-farnesylation reaction assayed by HPLC (Scheme 4-
3 and Figure 4-1-19). In other words, the observed rate constants for NBD-
farnesylation reactions of Rab7CSS and Rab7SSC represent rates of prenyl transfer. 
This suggests that the N-terminally located cysteine is somewhat preferred for the 
first NBD-farnesylation. This contrasts with the previous observations made with 
native lipid substrates, which indicate no strict order of first isoprenoid addition, 
where a preference for one of the residues can be influenced by the sequence of the 
Rab C-terminus or the geometry of the lipid substrate.  
 
 
Figure 4-1-20. Single turnover NBD-farnesylation reactions of Rab7C207S (Rab7CSS) and 
Rab7C205S (Rab7SSC) monitored by continuous fluorometric and SDS-PAGE assays. (A) In the 
fluorometric assay, the reaction contained 200nM of REP-1, RabGGTase and 4 μM NBD-FPP and 
was initiated by adding 200 nM Rab7 in assay buffer (50 mM Hepes, pH7.2, 50 mM NaCl, 5 mMDTE,  
2mM MgCl2, 10μM GDP) at 25°C. (λex=479nm, λem=521nm) The solid lines represent fits to single-
exponential functions for Rab7C207S in red (kobs= 8.4X10-4 s-1) and for Rab7C205S in blue (kobs= 
2.7X10-4 s-1). The fluorescence intensity was quantified as described in Materials and Methods 
(Chapter 6.4.3). (B) In the SDS-PAGE assay, 4 μM Rab7 and 4 μM REP-1 were incubated with 4 μM 
of RabGGTase and 50 μM NBD-FPP in the same prenylation buffer at 25°C. The solid lines represent 
fits to single-exponential functions for Rab7C207S in red (kobs= 8.3X10-4 s-1) and for Rab7C205S in 
blue (kobs= 2.8X10-4 s-1). The fluorescence incorporation was quantified as described in Materials and 
Methods (Chapter 6.4.3) 
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Figure 4-1-21. (A and B) Titration of RabGGTase to 100 nM Rab7CSS_NF:REP-1 complex (excitation 
wavelength 479 nm, emission 525 nm) in the presence (A) and the absence (B) of 30 μM FCPCP. 
Conditions: 25°C, 50 mM Hepes, pH7.2, 50 mM NaCl, 5 mM DTE. The solid line shows the fit to a 
quadratic equation giving values of 447±10 nM and 611±23 nM for Kd,  respetively. (C and D) Stopped-
flow measurement of the dissociation rate of Rab7_NF:REP1 from RabGGTase. (C) 385nM of 
Rab7CSS_NF:REP-1 complex were premixed with 3.3μM RabGGTase and then dissociated by 
addition of 9.5μM Rab7:REP-1. (D) 35nM of Rab7_NF:REP-1 complex were mixed with 35nM 
RabGGTase complex and was dissociated by addition of 400 nM Rab7:REP-1 in the presence of 2 
μM NBD-FPP; The interaction was monitored from the increase in fluorescence of the NBD group with 
excitation at 479nm and the fluorescence recorded through a 530nm cut-off filter. Mixing and 
measuring chambers were thermostated at 25◦C. The transients were fitted to a single exponential 
function, resulting in the observed rate constants. 
 
It has been previously demonstrated that during the prenylation reaction the 
mono-geranylgeranylated Rab7:REP complex remained bound to RabGGTase very 
tightly and the second prenylation step occurs without dissociation of the catalytic 
ternary complex (Thoma et al., 2001b; Thoma et al., 2001c). Prompted by the 
apparent accumulation of Rab7_NF during the multi-turnover reaction (Figure 4-1-18 
B), we decided to analyze the interaction of Rab7_NF:REP-1 complex with 
RabGGTase. Titration and dissociation experiments were preformed in the presence 
and the absence of a non-hydrolysable analogue of FPP, (hydroxy((3E,7E)-4,8,12-
trimethyltrideca-3,7,11-trienyl)phosphoryl)methylphosphonic acid (i.e. farnesyl-C-P-
C-P, FCPCP), showing that the isoprenoid has no influence on the interaction of 
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Rab7_NF:REP with RabGGTase. The data shown in the Figure 4-1-21 indicate that 
the interaction of the reaction intermediate, Rab7_NF:REP-1 complex, with 
RabGGTase (Kd= 447±10 nM) is weakened by a factor of ca. 500 when the 
conjugated prenyl moiety is NBD-farnesyl instead of geranylgeranyl. This is a 
surprising finding, which suggests that the intermediate Rab7_NF:REP-1 complex is 
bound even more loosely to the RabGGTase than the Rab7:REP-1 substrate making 
the release of the mono-NBD-farnesylated intermediate  mandatory (Scheme 4-4). 
The reduced affinity arises from the increase of dissociation rate (koff = 18±0.4 s-
1)(Figure. C,D) that is much faster than the second prenylation step. As a 
consequence, more than 99% of the mono-NBD-farnesylated Rab7 molecules would 
dissociate and must reassociate before they become prenylated with the second lipid. 
This explains the accumulation of the mono-prenylated intermediate in the multi-
turnover NBD-farnesylation reaction (Figure 4-1-18 B).  Since the fluorescent trace 
(Figure 4-1-18 A) is correlated with the accumulation of mono-prenylated Rab7 
(Figure 4-1-18 B), we conclude that the first prenylation step is predominantly 
responsible for the observed fluorescence enhancement.  
 
Scheme 4-4. The kinetic and equilibrium constants of the Rab7 prenylation reaction using 
geranylgeranyl pyrophosphate (black) or NBD-farnesyl pyrophospahte (red in brackets) as a substrate. 
 
 
 
From the mechanistic point of view this observation can be rationalized in the 
following way. The affinity of REP:RabGGTase interactions vary over a broad range. 
Unliganded REP binds to RabGGTase with an affinity of several micromolar via a 
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compact protein:protein interface formed by α helices in the vicinity of the lipid 
binding site on the domain II of REP and α-subunit of RabGGTase  (Pylypenko et al., 
2003). The affinity is dramatically increased by either binding of GGPP to 
RabGGTase (Kd=6 nM) or by binding of a Rab molecule to REP-1 (Kd=120nM) 
(Thoma et al., 2001a; Alexandrov et al., 1999). The affinity of the Rab7:REP-1 
complex towards RabGGTase increases from ca. 120 nM to ca. 2 nM in the 
presence of GGPP. The mono-geranylgeranylated Rab7:REP complex binds to 
RabGGTase with an affinity of ca. 1 nM indicating that binding of a conjugated 
geranylgeranyl moiety to the lipid binding site does not destroy the interaction of 
Rab7:REP complex with RabGGTase (Thoma et al., 2001c). Doubly prenylated 
Rab:REP complex remains  tightly associated with RabGGTase (Kd= 2 nM) until the 
latter binds another molecule of GGPP which leads to a reduction in affinity (Kd= 18 
nM) and product release (Thoma et al., 2001b). In contrast, the presence of excess 
non-hydrolysable FPP analogue, FCPCP, as well as GGPP (data not shown) had no 
significant influence on the affinity of Rab7_NF:REP to RabGGTase, and the 
presence of NBD-FPP had essentially no effect on the dissociation rate either, 
possibly indicating that the observed affinity represents the upper limit of affinities for 
the interaction between Rab7_NF:REP complex and RabGGTase (Figure 4-1-21). 
The kinetic and equilibrium constants of the Rab7 prenylation reaction pathway, the 
substrate binding and product release are shown in Scheme 4-4. We propose that 
binding of the bulky isoprenoid NBD-farnesyl moiety into the lipid binding pocket of 
REP leads to allosteric distortion of the REP:RabGGTase binding interface and 
simulates the release of mono-NBD-farnesylated intermediate.  
Based on the above observations, we propose a mechanistic model of the 
developed prenylation assay (Scheme 4-5). 
Scheme 4-5. Schematic illustration of the proposed function model of the prenylation sensor. 
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4.1.3.3 Steady-state kinetics of the NBD-farnesylation reaction 
 
With both the SDS-PAGE assay and the continuous fluorometric assay for in 
vitro Rab prenylation, we were able to collect statistically relevant data on initial 
reaction rates. To make a comparison, the steady-state kinetic studies of Rab NBD-
farnesylation reaction were performed by both assays. 
Recombinant RabGGTase and Rab7 used here were expressed in E. coli., while 
recombinant REP-1 was produced from infected SF9 cells. However, it was shown 
before that recombinant REP-1 has some phosphatase activity most likely from 
contaminants (Pylypenko et al., 2003). Anant J.S. et. al. (Anant et al., 1998) found 
that an excess of REP inhibits the prenylation reaction. This effect was assigned to 
the free REP’s competition for Rab:REP prenylation by forming nonproductive 
complexes with RabGGTase. It is a possible explanation, since REP-1 with the 
affinity of ca. 6 nM to RabGGTase in the presence of GGPP is sufficient to compete 
with the Rab:REP complex for binding to RabGGTase (Kd =ca. 2 nM). However, it 
cannot be ruled out that the inhibition comes from phosphatase activity present in the 
recombinant REP-1.  
Since Rab is recognized by RabGGTase through REP, the Rab:REP complex is 
the true substrate for RabGGTase, and REP should be regarded as a component of 
the substrate but not as a component of the enzyme (Pylypenko et al., 2003; Anant 
et al., 1998). To reduce REP inhibition, a limited amount of REP (1 eq. to Rab) was 
applied in the reaction. It is known that Rab7 binds to REP-1 with a very high affinity 
of Kd =1 nM (Alexandrov et al., 1998). Thus, the Rab7:REP-1 complex could be 
treated as one substrate component, since the concentrations of Rab7 and REP-1 
applied in the reaction are far above the Kd value.  
For routine measurements of RabGGTase activity, various concentrations (0.5 - 
10 μM) of the protein substrate, Rab7:REP-1 complex, and 1 - 18 μM of the lipid 
substrate, NBD-FPP, provide an adequate signal to noise ration for both 
measurements on the fluorometer and the laser scanner. Velocities were derived 
from the initial 10 minutes of the reaction, typically corresponding to less than 2% 
prenyl transfer of the total substrate, which would in principle provide a good 
estimation of the initial velocity. Here we assumed that REP-1 associated 
phosphatase activity does not significantly influence the prenylation rates at the initial 
short time.  
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For quantification of the fluorometric assay and the SDS-PAGE assay, samples 
were tested for an “inner filter effect”, i.e. the absorption of the exciting light and/or 
the absorption of the emitted radiation, which cause non-linearity between 
fluorescence intensity and fluorophore concentration. Inner filter effects are observed 
in samples where the optical density (OD = log I0/I) of a solution at the excitation 
wavelength is sufficiently high that the intensity of exciting light in the cuvette is 
significantly less than at the front face of the cuvette. Because fluorescence intensity 
is proportional to the intensity of exciting light, the inner filter effect causes a 
deviation from linearity in the relationship between concentration and fluorescence 
intensity. If there is an inner filter effect, fluorescence intensities must be corrected at 
every lipid concentration used (Lutz and Luisi, 1983). 
To determine whether a significant inner filter effect is present, the observed 
fluorescence intensities of NBD-FPP measured under the same conditions 
(bandpass, emission and excitation wavelengths) as those under which reaction 
velocity measurements are made was plotted against concentration (Figure 4-1-22 
D). No inner filter effect was observed for the fluorescent lipid concentrations up to 10 
μM used in this study.  
 
 
Figure 4-1-22. (A) Plot of the fluorescence versus the amount of NBD-FPP samples resolved on SDS-
PAGE. The fluorescence of the fluorescent isoprenoid was determined by scanning of the gels as 
described in Chapter 6.4.3. (B and C) In the SDS-PAGE assay, determination of initial velocities 
versus increasing concentrations of NBD-FPP (B) and Rab7:REP-1 complex (C) catalyzed by 0.2 
pmol RabGGTase at 30°C. Reaction mixture contained 6 μM Rab7:REP-1 and 20 μM NBD-FPP, 
respectively. (D) Plot of the fluorescence intensity versus the concentration of NBD-FPP in the cuvette. 
Fluorescence was recorded in a Fluomax-3 fluorometer with λex= 479 nm (slit width = 1nm) and λem= 
520 nm (slit width = 5nm).  (E and F) In the fluorometric assay, determination of initial velocities of 
prenylation reaction catalyzed by 0.02 μM RabGGTase at 37°C as a function of NBD-FPP (D) and the 
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protein substrate concentrations (F). Reaction mixture contained 2 μM Rab7:REP-1 complex and 4 μM 
NBD-FPP respectively. Hyperbolic lines show the fits to the Michaelis-Menten equation. (Inset) Initial 
phase of the prenylation at different concentrations of substrates used for prenylation rate 
determinations. 
 
According to the model proposed for the NBD-farnesylation reaction, for the kcat 
calculation the transfer of one NBD-farnesyl group to Rab should be assumed rather 
than two NBD-farnesyl groups. Under the standard assay conditions, Michaelis-
Menten kinetic parameters were determined by the fluorometric assay at 37°C and 
SDS-PAGE assay at 30°C. Typical reaction velocity versus substrate concentration 
profiles for the transformation of Rab7 and NBD-FPP by RabGGTase are presented 
in Figure 4-1-22. 
 
Table 4-1-5. Steady-state kinetic parameters for protein and lipid substrates of RabGGTase 
determined by two assays.  
Assay Substrate Km (µM) kcat (s-1) 
NBD-FPP 4.7±1.1 
SDS-PAGE assay Rab7:REP-1 0.54±0.11 
0.043ab 
 
NBD-FPP 0.8±0.34 
Continuous assay Rab7:REP-1 1.1±0.23 
0.013b 
a Quantitation with NBD-FPP. 
b kcat values are calculated assuming transfer of one NBD-farnesyl group to Rab7. 
 
From Table 4-1-5, it can be seen that both assays give comparable steady-state 
parameters. The significant difference between the Km values for NBD-FPP could be 
due to the use of different batches of reagents, and the partially hydrolyzed 
phosphoisoprenoids would lead to substrate inhibition that can be observed at high 
concentrations of NBD-FPP (data not shown). The difference in the of kcat values 
could result from distinct activities of different batches of the recombinant enzyme 
and/or systematic error from two quantitation methods. 
The availability of a continuous fluorometric assay with a large dynamic range 
prompted us to test whether it can be used for identification and characterization of 
RabGGTase inhibitors. As a test example we used NE10790 - the first reported 
specific but weak biphosphonate analogue inhibitor of RabGGTase (Coxon et al., 
2001). Using the fluorometric assay, we determined an IC50 value of 502±113 μM 
which is identical to that determined by a radioactive assay, and it was shown to be 
essentially non-competitive to NBD-FPP with a Ki of 176±18 μM according to the 
Lineweaver-Burk plot (Figure 4-1-23). 
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Figure 4-1-23. Inhibition of RabGGTase by NE10790. (A) Lineweaver-Burk plot. The reaction mixture 
contained 2 μM Rab7:REP-1 complex, 0.02 μM RabGGTase and varying concentrations of NBD-FPP 
in the absence and the presence of the indicated concentrations of inhibitor. (B) Concentration 
dependent inhibition of RabGGTase by NE10790. 
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4.2 Identification of RabGGTase inhibitors  
4.2.1 High-throughput screening for RabGGTase inhibitors  
 
Having developed a continuous fluorometric assay for RabGGTase activity, we 
sought to miniaturize and parallelize the assay to make it suitable for high-throughout 
screening and characterization of potential inhibitors. We adapted the assay for 96-
well and 384-well plate formats, with improved efficiency with respect to both time 
and reagents. 
Fluorescence intensities of the substrate NBD-FPP and the product Rab7-NBD-
farnesyl:REP-1 complex were measured using a Fluoroskan plate reader (Thermo 
BioAnalysis) (Figure 4-2-1 B). A 21-fold enhancement of fluorescence was observed, 
which is quite similar to what was observed in the cuvette assay described in section 
4.1.3 (Wu et al., 2006).  
A typical 96-well assay to identify RabGGTase inhibitors is shown in Figure 4-2-
1. The fluorescence intensity increased upon reaction in the positive control, whereas 
there was a decrease in the negative control where the protein substrate Rab7:REP 
was omitted. We assumed that the decrease of fluorescence intensity could be the 
result of photo-bleaching of the NBD. As shown in Figure 4-2-1 A, the reaction in the 
presence of various concentrations of inhibitor showed a time-dependent 
fluorescence change between the positive control and the negative control, from 
which an inhibition profile could be extracted as shown in Figure 4-2-1 C. In order to 
obtain an estimate of a genuine IC50, a set of corrections were performed, where the 
velocity of the inhibited reaction was corrected by the velocity of the negative control 
(no substrate) in the presence of the corresponding concentration of inhibitor, while 
the velocity of the positive control was corrected by subtraction of the velocity of the 
negative control in the absence of inhibitor. The IC50s were calculated using a 2 
parameter equation using GraFit 5.0 (Erithacus Software Limited)(Figure 4-2-1 D).  
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where vi is the inhibited velocity minus the background, i.e. the negative control in the 
presence of the corresponding concentration of inhibitor, v0 is the uninhibited velocity 
(positive control) minus the background (the negative control in the absence of 
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inhibitor), [I] is the concentration of inhibitor, s is a slope factor and IC50 is the 
concentration of the inhibitor that produces 50% inhibition.  
 
Figure 4-2-1. (A) Time-course of fluorescence change upon prenylation of 2 μM Rab7:REP-1 complex 
and 2 μM NBD-FPP catalyzed by RabGGTase (0.02 μM) in the absence (PC) and the presence of 
various concentrations of inhibitor at 37°C and time-dependent decrease of 2 μM NBD-FPP 
fluorescence in the presence of 0.02 μM RabGGTase (NC). Solid lines show the linear fits. 
Fluorecence was recorded on Fluoroskan with exitation cut-off filter 485 nm and emission cut-off filter 
538nm. Buffer: 50mM Hepes, pH 7.2, 50mM NaCl, 2mM MgCl2, 5mM DTE, 0.01% Triton-X100. (B) 
The fluorescence intensity of 100 μl of 1 μM fluorescent substrate NBD-FPP and the fluorescent 
product Rab7-NBD-farnesyl:REP-1 in a 96-well plate recorded in the same conditions. The 
fluorescence intensities shown in the graph are subtracted the background of buffer, and a 21-fold 
fluorescence enhancement was observed. Buffer: 50mM Hepes, pH 7.2, 50mM NaCl, 2mM MgCl2, 
5mM DTE. (C) Inhibition profile of the inhibitor. Observed rates were obtained by linear regressions of 
the traces shown in panel A. (D) Determination of IC50 of the inhibitor using the equation as described 
in the text. 
 
High-throughput screening (HTS) is a major technique used in early-stage drug 
discovery. A key problem in HTS is the prevalence of nonspecific or promiscuous 
inhibitors (Rishton, 1997). A major cause of this is aggregation, especially when 
compounds are screened at high concentrations (>10 μM). Some organic molecules 
tend to form large colloid-like aggregates that sequester and thereby inhibit enzymes 
(McGovern et al., 2003; McGovern et al., 2002). Screening at high concentration of 
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compounds would also lead to false-negatives, since at high concentration 
compounds with low solubility would precipitate, resulting in a decrease of actual 
concentration and possibly an influence on fluorescence read-out. False-positive and 
false-negative hits from HTS may make the SAR analysis flat and mislead the 
discovery optimization of lead compounds. Addition of detergent in the high-
throughput assays largely or completely attenuated the nonspecific inhibition in a 
library composed of random drug-like molecules (Feng et al., 2005). In order to 
reduce promiscuous inhibitors in the high-throughput screening, 0.01% Triton X-100 
was included in our assay buffer. The presence of detergent on the one hand 
increases the solubility of compounds on the other hand reduces aggregation of 
compounds that could lead to promiscuous inhibition 
4.2.2 In silico screening of RabGGTase inhibitors 
 
In recent years, the need for acceleration of the drug development process has 
inspired the advance of a large number of new methods aimed at a more efficient 
and rapid lead structure discovery process. Recent advances in combinatorial 
chemistry enable rapid synthesis of large compound libraries with diversified 
structures. High-throughput screening (HTS) allows considerable reduction of the 
time required for the discovery of new active molecules which modulate a particular 
biomolecular pathway. However, the experimental screening of millions of 
compounds is prohibitively expensive. Therefore, in silico screening of compound 
databases for potential new lead compounds, referred to as virtual screening (VS), 
has emerged as a promising tool for decreasing both the time and cost of drug 
discovery (Jalaie and Shanmugasundaram, 2006). 
Virtual ligand screening (VLS) can be used for screening as many compounds 
as desired depending on the amount of computer power available. Internal 
coordinate mechanics (ICM) is the software product from Molsoft LLC (La Jolla, CA, 
USA). ICM-Pro contains an all atom internal coordinate force field and efficient 
algorithm to perform local and global energy optimization of small or large molecules 
with respect to an arbitrary subset of variables. In addition, ICM contains MMFF94 
force field for energy optimization in Cartesian space for any organic molecule. ICM-
VLS is an add-on product to ICM-Pro. It has been successfully used by the 
pharmaceutical industry and academia for identifying drugs and inhibitors for a wide 
variety of diseases (Cavasotto et al., 2006; Cavasotto and Abagyan, 2004). Virtual 
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ligand screening using Molsoft-ICM is performed by docking a database of ligands to 
a receptor structure followed by an evaluation of the docked conformation with a 
binding-score function.  
The crystal structure of a truncated version of RabGGTase in complex with an 
inhibitor, MT650 (Dursina et al., 2006; Thutewohl et al., 2002), which has recently 
been solved by Zhong Guo in our group, enables us to perform a VLS using ICM 
platform (this work was done during a visit to the Scripps Research Institute, La Jolla, 
CA). ICM pocket finder function in the ICM-Pro was used to predict the binding 
pockets that drugs could potentially target. Three of them are located in the active 
site of RabGGTase (pocket 1, 2 and 3, Figure 4-2-2 A). Pocket 1 is mainly in the beta 
subunit, overlapping with the GGPP binding site (Figure 4-2-2 A, C) and the MT650 
binding site (Figure 4-2-2 B). Thus, pocket 1 is a well-defined pocket for the VLS, 
since its volume and area fall into the range of drug targets. Pocket 2 is situated 
between the alpha and beta subunit. Pocket 3 (displayed in dark gray in Figure 4-2-2 
A) is located at the beta subunit, resembling a balcony projecting from the GGPP 
binding cavity. 
 
 
Figure 4-2-2. Binding pockets and virtual ligand screening of RabGGTase. (A) Ribbon representations 
of RabGGTase α subunit (yellow) and RabGGTase β subunit (green) in complex with MT650 (not 
shown in the panel), while the Zn2+ is shown as a turquoise ball. The binding pockets are shown in 
gray and blue meshes. One of the docked compounds to the pocket is in stick representation colored 
by atom type. The crystal structure of the RabGGTase:GGPP complex was superimposed with that of 
RabGGTase:MT650 to show the GGPP in stick representation colored by atom type. (B) Surface 
representations of the active site of RabGGTase. RabGGTase β subunit is in green surface 
representations, and the α subunit is in yellow ribbon representations. MT650 is in stick representation 
colored by atom type. The docked compound is shown in blue stick representation. Zn2+ is shown as a 
turquoise ball. (C) The same as B, but the superimposed GGPP is shown instead of MT650.  
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However, the location of the putative binding site for the isoprenoid of mono-
prenylated Rab is still unclear, which would be expected to exist in RabGGTase 
since the mono-prenylated Rab intermediate has to associate with RabGGTase for 
the second prenyl transfer (Thoma et al., 2001b; Thoma et al., 2001c). Many 
processive enzymes feature two product-binding sites as those observed for CaaX 
prenyltraseferases, FTase (Long et al., 2002) and GGTase-I (Taylor et al., 2003). In 
the last step of reaction pathway of FTase and GGTase-I, binding of a fresh 
FPP/GGPP substrate molecule leads to translocation of the prenyl group of 
prenylated CaaX to a new binding site, termed the “exit groove”. The exit groove 
observed in CaaX prenyltransferases is a conserved structural feature of 
RabGGTase. In apo-RabGGTase (1DCE), a 7.5 Å diameter hydrophobic tunnel that 
originates from a shallow groove analogous to the exit groove in FTase (1KZO) and 
GGTase-I (1N4S) extends through the beta subunit (residues βTyr30, βTyr39, βArg46, 
βGly49, and βPro288 line the tunnel). This tunnel was proposed to be the binding site 
for the geranylgeranyl moiety of the mono-prenylated Rab intermediate (Long et al., 
2002). Pocket 3 extends along the putative binding site for the isoprenoid of mono-
prenylated Rab (Figure 4-2-2 A), and could be an important pocket for drug targeting.  
 
 
Figure 4-2-3. The docked compound in the REP binding interface of RabGGTase. The compound is in 
surface representation, RabGGTase in stick representation. 
 
Another small pocket (pocket 4, Figure 4-2-2 A) located at the REP binding 
interface (Pylypenko et al., 2003), though too small to qualify as a classical drug 
target site, could be promising for the purpose of design of a specific inhibitor for 
RabGGTase. A compound binding to pocket 3 would be able to disrupt the 
REP:RabGGTase interaction, so that Rab cannot be processed by RabGGTase. 
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Since this mechanism is only present in RabGGTase, an inhibitor targeting the 
interface of REP:RabGGTase would be expected to inhibit RabGGTase with high 
specificity. Based on the crystal structure of REP:RabGGTase (PDB code 1LTX), an 
in silico screening of ligands targeted to the REP binding interface of RabGGTase 
was performed by Mahesh Kulharia in our group (Figure 4-2-3) (see Ph.D. Thesis,  
Dortmund University, 2008). One of nine virtual hits was identified to be a real 
inhibitor for RabGGTase (Table 4-2-6, MK21986).  
A virtual library of 3263807 compounds was docked into pocket 1 and 2 of 
RabGGTase using the Molsoft ICM-VLS platform, and ca. 500 hits were identified. 
These hits were further reduced by the Lipinski rule of five (Lipinski et al., 2001) to 
give 62 potential hits. These commercially available compounds were further 
evaluated by the 96-well plate assay for RabGGTase. Two of them 
(AG205/33152020 and AH487/41653773) were identified as actual hits, as shown in 
Table 4-2-6. 
4.2.3 Structure and activity relationship (SAR) analysis of 
peptide inhibitors for RabGGTase 
 
The high-throughput screening assay allows for the rapid identification and 
characterization of RabGGTase inhibitors. To this end, a large compound library (ca. 
7000 species) composed of commercially available compounds and the compounds 
synthesized in Prof. Dr. Waldmann’s department was screened on a TECAN™ 
Freedom EVO® automation platform using this assay. A diverse library of around 400 
Pepticinnamin E derivatives prepared using a hydrazine linker and 2-chlorotrityl 
chloride resin (synthesized by Kui-Thong Tan and Dr. Ester Guiu-Rozas) together 
with 50 previously identified FTase inhibitors (Dursina et al., 2006; Thutewohl et al., 
2002) was screened for inhibition of RabGGTase both manually in the 96-well plate 
assay and in the robot-assisted 384-well plate assay.  
The synthesis of the peptide inhibitors is decribed and discussed in detail in the 
thesis of Kui-Thong Tan (Ph.D. Thesis, Dortmund University, 2007). Figure 4-2-4 
shows the building blocks used in the combinatorial Fmoc-solid phase peptide 
synthesis (Fmoc-SPPS). 
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Figure 4-2-4. Representative building blocks used in the Fmoc-SPPS. 
 
The 450 peptides can be divided into two categories based on the modification 
of the N-terminus (R5 position). Type-I consists of around 200 peptides with lipid 
chains at their N-terminus (R5 position), whereas 250 peptides in Type-II carries an 
aromatic functionality at the N-terminus. Table 4-2-1 and 4-2-2 list the IC50 values for 
selected Type-I and Type-II inhibitors.   
Table 4-2-1. IC50 values of the Type-1 inhibitors with a lipid chain at the R5 position  
R5
H
N
N
H
H
N
R1
O
R2O
R3O
R4  
Entry Peptide R5 R4 R3 R2 R1 IC50 (μM)a 
1 5 L-His L-Phe L-Tyr NN
 
4.7 ± 0.1 
2 6 L-Tyr L-His L-Tyr OMe 3.9 ± 0.2 
3 7 L-Tyr L-His L-Tyr NN
 
6.3 ± 0.6 
4 8 L-Tyr L-His L-Tyr 
HN NH2
 7.1 ± 0.3 
5 9 L-His L-His L-Tyr 
HN NH2
 5.2 ± 0.7 
6 10 
O
9  
L-His L-His L-Tyr NN
 
11.0 ± 1.2 
7 11 
O
6  
L-His L-Phe L-Tyr NN
 
2.8 ± 0.4 
8 12 
O
13  
L-His L-Phe L-Tyr NN
 
26 ± 0.3 
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9 13 
O
2  
L-His L-Phe L-Tyr NN
 
> 100 
10 14 L-Tyr L-Tyr L-Tyr 
HN NH2
 11.6 ± 1.2 
11 15 L-His L-His L-His NN
 
12.1 ± 0.8 
12 16 L-His L-His L-His 
HN NH2
 24.0 ± 1.4 
13 17 
 
O
O
9  
L-His L-Tyr L-Phe N
N
HN  12.3 ± 0.6 
a the IC50 values were calculated from 3 independent measurement 
 
 
Table 4-2-2. IC50 values of the Type-II inhibitors with an aromatic functionality at R5 position 
R5
H
N
N
H
H
N
R1
O
R2O
R3O
R4  
Entry Peptide R5 R4 R3 R2 R1 IC50 (μM) 
1 31 D-Tyr L-Phe L-Tyr OH 4.1 ± 0.2 
2 32 L-His L-(Me)Phe L-Trp NH-OH 5.2 ± 0.6 
3 33 L-His L-(Me)Phe L-Tyr NH-OH 9.0 ± 1.0 
4 34 L-His L-(Me)Phe D-Tyr NH-OH 13.6 ± 1.1 
5 35 
O
O
 
L-His L-(Me)Phe L-Tyr OH 22.7 ± 1.7 
6 36 D-Tyr L-Tyr L-Phe OH 11.0 ± 1.4 
7 37 D-Tyr L-Tyr Si
 
OH 19.1 ± 2.4 
8 38 
O
 
 
 
D-His L-(Me)Phe L-Phe OH 19.0 ± 3.8 
9 39 D-His L-Tyr L-Phe OH 15.6 ± 1.3 
10 40 
 
OBn
O
O
 L-His L-Tyr L-Phe OH 19.3 ± 3.6 
11 41 
O
 
D-His L-Tyr D-Phe OH 15.2 ± 2.2 
12 42 
O
Ph  
D-His L-Tyr L-Tyr OH 22.7 ± 2.9 
13 43 N
O
O
 
L-His Gly L-His(Trt) OH 8.1 ± 1.0 
 
SAR analysis of the sequence and nature of amino acid residues in the peptide 
central core of both types of inhibitors reveals that aromatic amino acids, namely 
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histidine, phenylalanine and tyrosine are essential for give good inhibitory activity 
towards RabGGTase (Table 4-2-1 and 4-2-2). For example, in Type-I inhibitors, 
changing the L-tyrosine at the R2 position (Table 4-2-1, entries 5 and 6) to L-serine 
increases the IC50 values of peptides 9 and 10 from 5 μM and 11 μM to over 100 μM. 
Type-II peptides with alanine, leucine, proline, serine, threonine, glutamine, glutamic 
acid and lysine in the peptide central core did not give pronounced inhibitory activity 
for RabGGTase. For example, by substituting phenylalanine with glycine and β-
alanine at the R3 position, the inhibitory activity of peptide 35 decreases dramatically 
from an IC50 value of 22 μM to no detectable inhibitory activity at 100 μM. The non-
tolerance of aliphatic amino acid residues in the two types of RabGGTase peptide 
inhibitors may be due to the large and deep active site of RabGGTase, which 
requires rigid and bulky amino acids to fill the binding pocket. SAR analysis reveals 
that a central core consisting of histidine at the R4 position, tyrosine and 
phenylalanine residues at the R2 and R3 positions is important for the inhibitory 
activity of Type-II peptide inhibitors against RabGGTase. 
The length of the lipid chain of Type-I compounds is critical for the inhibitory 
activity. It appears that the optimal length of lipid chain is between 7 and 10-carbon 
(Table 4-2-1, entry 1-7). Peptide 11 with a heptyl chain (IC50 = 2.8 μM) is the most 
potent inhibitor for RabGGTase in this compound collection (Table 4-2-1, entry 7). 
Extending the chain length to 14 carbons (Table 4-2-1, entry 8) or reducing the lipid 
chain to 3 carbons (Table 4-2-1, entry 9) significantly decrease the inhibitory activity.  
All the peptides except compounds 6 and 17 listed in Table 4-2-1 contain a 
pyridine ring or an amine group at the R1 position. In order to understand the effect of 
C-terminal groups on the inhibitory activity, different moieties were used to substitute 
the R1 group of peptide 5, which is one of the most potent inhibitors in this peptide 
collection. As can be seen in Table 4-2-3, chemical moieties at R1 position play a 
decisive role in influencing the potency of inhibitors. In general, only those containing 
potential Zn2+ coordinating group such as N-methyl 2-ethyl pyridine (Table 4-2-3, 
entry 1) gave better inhibitory activity. Although the hydroxylamine group of peptide 
26 (Table 4-2-3, entry 10) is a better zinc ion binding group, 26 does not show 
inhibition to RabGGTase at 100 μM, which might be attributed to the short chain 
length of the hydroxylamine group. Reducing the 2-carbon chain connecting amine 
and pyridine of N-methyl 2-ethyl pyridine group resulted the peptide 28 and 29 (Table 
4-2-3, entry 12 and 13) that show no inhibitory activity towards RabGGTase at 100 
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μM. In addition, the N-methyl moiety of N-methyl 2-ethyl pyridine group is very 
important for keeping the inhibitory activity towards RabGGTase (Table 4-2-3, entry 
14).  
 
Table 4-2-3. Inhibitory activity of various substituents at R1 position of peptides 5. 
H
N
N
H
H
N
R1
O
O
O
O
N
NH OH 
Entry Peptide R1 IC50 (μM)c 
1 5 NN
 
4.7±0.1 
2   18b HN OH
OH
 n.a. 
3 19 N OMe  n.a. 
4   20b HN OH
OH
 > 50 
5 21 NH2 > 50 
6 22 OMe n.a. 
7 23 O NH2  n.a. 
8 24 
NH2
HN
 
> 50 
9 25 OH n.a. 
10 26 NH-OH n.a. 
11 27 OHN  n.a. 
12 28 
NHN
 n.a. 
13 29 
NHN
 n.a. 
14 30 
NHN
n.a. 
n.a.: not active at 100 μM (<50% inhibition). b Inhibitors 18 and 20 are diastereoisomers with the 
variable stereochemistry at the C-terminal secondary alcohol. c The screening was performed at 100 
μM. 
 
 
Table 4-2-4. IC50s of the Type-II peptides with or without trityl protecting group (Trt) 
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R5
H
N
N
H
H
N
R1
O
R2O
R3O
R4  
Entry Peptide R5 R4 R3 R2 R1 IC50 (μM)a 
1 43 L-His Gly L-His(Trt) OH 8.1 ± 1.0 
2 44 L-His Gly L-His OH > 50 
3 45 
N
O
O
 
L-His(Trt) Gly L-His OH 38 ± 8.7 
4 46 His Gly L-Phe OH > 50 
5 47 
N
O
O
 L-His(Trt) Gly L-Phe OH 30 ± 1.8 
6 48 Gly L-Phe L-His OH 45 ± 21 
7 49 Gly L-Phe L-His(Trt) OH 25 ± 8.0 
8 50 Gly L-Phe L-His(Bn) OH > 50 
9 51 
N
O
O
 
Gly L-Phe L-His(Boc) OH > 50 
10 52 Gly L-Phe L-His OH > 50 
11 53 O
N
O
 Gly L-Phe L-His(Trt) OH 46 ± 5.4 
12 54 Gly L-Phe L-His OH 41 ± 6.2 
13 55 
S
S
N
O
 Gly L-Phe L-His(Trt) OH 36 ± 5.7 
14 56 Gly L-Phe L-His OH > 50 
15 57 
N
S
N
O
 Gly L-Phe L-His(Trt) OH 37 ± 2.0 
a The IC50 was determined manually using 96 well-plate assay. 
 
Interestingly, Type-II compounds with a trityl protecting group (Trt) showed 
higher activity than the corresponding unprotected compounds (Table 4-2-4), 
suggesting that the binding is enhanced by hydrophobic interactions. This is 
consistent with the crystal structure of RabGGTase in complex with one of the Type-
II compounds (Figure 4-2-2 A), where the interaction between RabGGTase and 
compound 35 is mainly hydrophobic. This also correlates with the finding from the 
interaction analysis that compound 43 associates with the prenyl binding site (Figure 
4-2-2 B). Therefore, introduction of hydrophobic groups to the peptides may improve 
the activity of the peptide inhibitors. 
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R5 N
H
H
N
O
R4
O
N
H
O
R2
O
R3
R1Long lipid chain 
and aryl ring
Aromatic amino acids
Phe, His, Tyr
N N
HN NH2
OH
NH-OH
Aromatic ring at 
N-terminus
Long aliphatic chain
at N-terminus
 
Figure 4-2-5. Features of the active compounds in the peptide library.   
 
4.2.4 Quantitative analysis of the interaction of identified 
inhibitors with prenyltransferases 
 
The obtained IC50 values provide an indication of the inhibitory activity of the 
identified compounds under the chosen conditions but do not provide direct 
information on either their mode of action or their affinity for prenyltransferases. To 
gain insights into the mechanisms of action of the compounds, a series of 
fluorescence titrations and enzyme kinetic studies were performed with two Type-I 
inhibitors, 5 and 10, and a Type-II inhibitor, 43.  
 
 
Figure 4-2-6. Lineweaver-Burk plot against NBD-FPP in the presence and the absence of 5 (A) and 43 
(B). The concentration of Rab7:REP-1 (1.2 μM) and RabGGTase (0.03 μM) were kept constant, while 
the concentration of NBD-FPP varied. The concentrations of inhibitor 5 and 43 were indicated in the 
plot.  
 
Classic enzyme catalyzed reactions follow the Michaelis-Menten equation 
{v=Vmax/(1+Km/[S])}. Transformations of the equation to other mathematical forms 
provide useful methods of analysis. A double-reciprocal plot constructed from 1/v and 
1/[S], both measurable variables, referred to as a Lineweaver-Burk plot, has most 
commonly been used for presenting inhibition patterns (Engel, 1996). Figure 4-2-6 
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shows the double-reciprocal plots of the initial velocity against the NBD-FPP 
concentration in the absence and presence of inhibitor. The plots intersect at the x-
axis in Figure 4-2-6 A, indicating that 5 is non-competitive with respect to NBD-FPP. 
In contrast, the plots do not exactly intersect at the y-axis in Figure 4-2-6 B, 
suggesting mixed inhibition with a competitive component. 
To further assess the compounds’ interactions with RabGGTase, we took 
advantage of the fluorescence change of NBD-FPP upon its binding to RabGGTase. 
Using this signal change, a Kd value for the NBD-FPP:RabGGTase interaction of 
around 160 nM was obtained (Figure 4-2-5 C, F). To test the effects of 5 and 10 on 
this interaction, two titration strategies were adopted. In one, the inhibitor was titrated 
to a mixture of RabGGTase and NBD-FPP. As shown in Figure 4-2-7 A and C, the 
fluorescence intensity decreased significantly after addition of RabGGTase to NBD-
FPP, indicating binding of NBD-FPP to RabGGTase. On titration of 5 to the solution, 
there was a modest but dose-dependent and saturable increase in fluorescence 
intensity (Figure 4-2-7 A). In contrast, titration of 10 into RabGGTase:NBD-FPP 
resulted in a dose-dependent increase in fluorescence intensity that saturated until 
the recovery of NBD-FPP fluorescence (Figure 4-2-7 D). This indicates that 10 
competes with NBD-FPP resulting in full displacement of NBD-FPP. In a control 
experiment where the enzyme was omitted no fluorescence change was observed, 
suggesting that the fluorescence change upon titration of 5 and 10 was specific for 
binding of the compounds to the enzyme. The observed fluorescence increase data 
could be fitted as described above to give an apparent Kd value of 645±137 nM for 5. 
As shown in Figure 4-2-7 A, the fluorescence recovery was not complete at the 
concentrations where addition of 5 did not lead to further fluorescence change. At 
this point an excess of GGPP was added to the reaction mixture, resulting in 
fluorescence increase to the level of unbound NBD-FPP, indicating the full 
displacement of NBD-FPP from RabGGTase. This can be interpreted as either 5 
induced partial displacement of NBD-FPP from RabGGTase or that simultaneous 
binding of 5 to the enzyme allosterically induces fluorescence change of the 
associated NBD-FPP.  
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Figure 4-2-7. Analysis of the interaction of compound 5 (A-C) and 10 (D-F) with RabGGTase. (A) Raw 
data for a titration of 5 into the solution of RabGGTase complexed with NBD-FPP followed by addition 
of GGPP. The initial level of the fluorescence signal represents the fluorescence of free NBD-FPP 
(400 nM). In the first titration step RabGGTase were added to a final concentration of 550 nM. 
Subsequently, 5 was titrated into the cuvette in 1 μM steps. Finally, GGPP was added to a final 
concentration of 4 μM. (B) The same process as in (A), the data was fitted by numerical simulation to 
a non-competitive model to give a genuine Kd of 645±153 nM for the interaction of 5 with RabGGTase. 
(C) Titration of a 200 nM solution of NBD-FPP with RabGGTase in the absence of 5 (open circles) and 
in the presence of 2 μM (filled triangles) and 5 μM (filled squares) of 5. The data were fitted with a 
quadratic equation to obtain the apparent Kd values as shown in the inset table. (D) Raw data for a 
titration of NBD-FPP:RabGGTase with 10 followed by addition of  GGPP. The initial level of the 
fluorescence signal represents the fluorescence of free NBD-FPP (400 nM). In the first titration step 
RabGGTase was added to a final concentration of 650 nM. Subsequently, 10 was titrated into the 
cuvette in 1 µM and 5 µM steps. Finally, GGPP was added to a final concentration of 4 µM. (E) The 
same process as in (D), the data were fitted by numerical simulation to a competitive model leading to 
the dissociation constant of 10 from RabGGTase (Kd=1.0±0.078 µM). (F) Titration of a 400 nM solution 
of NBD-FPP with RabGGTase in the absence of 10 (open circles) and in the presence of 1 µM (filled 
triangles) and 2 µM (filled squares) of 10. The data were fitted with a quadratic equation to obtain the 
apparent Kd values as shown in the inset table. The fluorescence of NBD was excited at 479 nm, and 
the data were collected at 547 nm. 
  
To distinguish between these two scenarios for the binding of 5 to RabGGTase 
and to confirm the binding mode of 10, an independent co-titration experiment was 
performed, in which RabGGTase was titrated to NBD-FPP in the presence of 2 and 5 
µM of 5 (Figure 4-2-7 C), 1 and 2 µM 10 (Figure 4-2-7 F). No significant change was 
observed in the apparent Kd values in the presence of 5 (Figure 4-2-7 C inset table), 
suggesting that binding of 5 has no, or very little influence on the affinity of NBD-FPP 
to RabGGTase. This is consistent with the observation from the Lineweaver-Burk plot 
(Figure 4-2-6 A), which shows that 5 is non-competitive with respect to NBD-FPP. 
Taken together, the titrations shown in Figure 4-2-7 C suggest that 5 and NBD-FPP 
concurrently bind at two independent but weakly communicating sites of the enzyme. 
In contrast, the presence of 10 reduced the affinity between NBD-FPP and 
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RabGGTase in a dose-dependent manner (Figure 4-2-7 F inset table), indicating that 
10 is competitive to NBD-FPP. From these data, the KI value was calculated to be 
0.94±0.025 µM from the relationship, Kapp=Kd(1+[I]/KI).  
Fitting the competitive titration data shown in Figure 4-2-7 B by numerical 
simulation to a non-competitive model led to a Kd value of 645±153 nM for the 
interaction of 5 with RabGGTase. This represents the genuine Kd value for 5 with 
RabGGTase. Since 5 binds in a non-competitive site with respect to the NBD-FPP 
binding site, the apparent Kd value is the same as the genuine one. In this situation, 
NBD-FPP acts essentially as a tracer that monitors the interaction between 5 and 
RabGGTase. Simulation of the competitive titration and co-titration data shown in 
Figure 4-2-7 E and F through a competitive model gave Kd values of 1.0±0.078 µM 
(Figure 4-2-7 E) and 1.1±0.042 µM, respectively, for the binding of 10 to 
RabGGTase. These results are in good agreement with the obtained KI value 
estimated by the competitive inhibition equation as described above. Hence 10 
competes with NBD-FPP for the prenyl binding site of RabGGTase. 
Compounds 5 and 10 differ in only one amino acid residue (R3). Replacing  
phenylalanine to a histidine residue at R3 leads to a significant change of the binding 
mode of the compound. The crystal structure of the RabGGTase:10 complex (Figure 
4-2-8) shows that the R3 histidyl side chain coordinates to Zn2+ and the N-terminal 
decyl chain extends into the GGPP binding cavity. This suggests that 10 competes 
with NBD-FPP mainly via the decyl chain. Coordination of the peptide side chain of 
10 with Zn2+ could bring the molecule to the entrance of the cavity, facilitating 
insertion of the N-terminal decyl chain into the lipid binding cavity. However, based 
on the interaction analysis of 5 interaction with RabGGTase, it is possible to 
postulate that changing the R3 amino acid residue of the peptide core may change 
the orientation of the decyl chain of 5 that could now possibly bind to the putative 
binding site for the isoprenoid of mono-prenylated Rab (Figure 4-2-2 A), which is 
expected to be located between the reactive center (Zn2+) and the rim of the β 
subunit. The crystal structure of RabGGTase complexed with 10 as well as the 
interaction analysis of 5 and 10 with RabGGTase suggest that the peptide core 
determines the geometry of the molecule bound with RabGGTase, while the lipid 
chain further enhances the interaction. 
 
4.2.4 Quantitative analysis of the interaction of inhibitors with prenyltransferases 
120 
 
Figure 4-2-8. Crystal structure of the RabGGTase:10 complex. RabGGTase is in ribbon representation 
(cyan), Zn2+ is shown as a gray ball, while 10 is in stick representation. The histidyl side chain of 
peptide backbone coordinates to Zn2+ and the N-terminal decyl chain overlaps with the GGPP binding 
site. (Crystal structure determinated by Zhong Guo) 
 
The same analysis was applied to Type-II inhibitor 43 to reveal the mechanism 
of inhibition of RabGGTase. The Lineweaver-Burk plot for compound 43 suggests 
that it is essentially a competitive inhibitor for RabGGTase with respect to NBD-FPP. 
The competitive titration of 43 into the RabGGTase:NBD-FPP complex revealed that 
compound 43 has a Kd value of 9.2 μM for the interaction with RabGGTase. Fitting of 
the co-titration data by numerical simulation to a competitive model led to a genuine 
Kd value of 5.3 μM for the interaction of compound 43 with RabGGTase. The action 
of 43 towards RabGGTase appears to be quite similar to that of another Type-II 
inhibitor, 35 (Dursina et al., 2006). The crystal structure of RabGGTase:35 complex 
reveals that 35 competes with the lipid substrate mainly through hydrophobic 
association with the prenyl binding site (Figure 4-2-2 B). It would be expected that 43 
also associates with the prenyl binding site via the hydrophobic moieties.  
The interaction and SAR analysis of the two types of inhibitors for RabGGTase 
suggest that the hydrophobic residues play a predominant role in the association of 
inhibitor with RabGGTase. This is determined by the nature of the active site of 
RabGGTase, which consists of the prenyl binding site and the putative binding site 
for the isoprenoid of mono-prenylated Rab. Both sites are promising target pockets 
for inhibitors. In addition to the hydrophobic interactions, the presence of hydrogen-
bonding and Zn2+ coordination groups would provide additional interaction free 
energy of the inhibitor with RabGGTase.  
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The interactions of some inhibitors with RabGGTase were also investigated by 
isothermal titration calorimetry (ITC), and the results are summarized in Table 4-2-5. 
Interaction analyses of PA with RabGGTase and other inhibitors from VLS with 
FTase (Table 4-2-5) have been discussed in detail in the Diploma thesis of Weiyun 
Zhou (Diplom Thesis, Dortmund University, 2007). 
 
Table 4-2-5. Kd values of inhibitor interaction with RabGGTase and FTase. 
 
Kd (μM) for RabGGTase Compound Inhibition type with 
respect to NBD-FPP 
Co-titration Competitive titration ITC 
5 non-competitive  0.645  
10 competitive 1.1 1.0  
43 competitive 5.3 9.2  
PA competitive 0.122 0.053 0.543 
MK21986 non-competitive  13.8  
AG205/33152020 mixed inhibition    
 
Kd (μM) for FTase Compound Inhibition type with 
respect to peptide 
Inhibition type 
with respect to 
FPP Co-
titration 
Competitive 
titration 
ITC 
MK21986 competitive non-competitive 1.4 1.3 2.4 
AG205/33152020 mixed inhibition mixed inhibition    
 
4.2.5 Selectivity of inhibitors towards RabGGTase, FTase 
and GGTase-I 
 
In order to identify selective inhibitors for prenyltransferases, some of the 
identified active compounds were evaluated for their inhibitory activity towards 
RabGGTase, FTase and GGTase-I by an SDS-PAGE end-point assay. A typical 
SDS-PAGE end-point assay for characterization of prenyltransferase inhibitors is 
shown in Figure 4-2-9. In FTase and GGTase-I reactions, protein substrates GST-
KiRas and GST-RhoA, and fluorescent lipid substrate NBD-GPP and NBD-FPP were 
used, respectively. Reactions were carried out in the presence and the absence of 
various concentrations of inhibitor for the same period of time and quenched by 
adding SDS sample buffer. The reaction mixtures were resolved by 15% SDS-PAGE, 
and the fluorescence bands corresponding to the formation of the prenylated product 
were quantified. The data were processed in the same way as the plate assay 
(section 4.2.1). 
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Figure 4-2-9. Determination of IC50 of PA for RabGGTase (A), FTase (B) and GGTase-I (C) by SDS-
PAGE end-point assay. The top panels show the fluorescence scan of the gel, the middle panels show 
the Coomassie blue stained gel as a loading control, the bottom panels show the inhibition profile by 
quantification of the prenylation reaction shown in the top panels. In PC (positive control) no inhibitor 
was added. In NC (negative control) both inhibitor and enzyme were omitted.  
 
The SDS-PAGE end-point assay (further referred to as a gel assay) enables us 
to evaluate of the inhibitory activity of the inhibitor towards the three 
prenyltransferases systematically. Table 4-2-6 shows the IC50 values of inhibitors for 
FTase, GGTase-I and RabGGTase determined by the gel assay. The IC50 values 
determined using the gel assay were comparable to those obtained using the plate 
assay as decribed in section 4.2.1, suggesting that both assays were able to provide 
comparable and consistent estimation of the inhibitory activity of the compounds. 
 
   
 
Figure 4-2-10. Inhibition profiles of compounds 5 (A) and 7 (B) against FTase. vi/v0 represents the 
remaining activity in the presence of inhibitor. 
A B
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The IC50 values of 5 and 7 (Table 4-2-6, entry 1 and 2) for FTase were not 
extractable. Although the compounds showed dose-dependent inhibition of FTase, 
the inhibition saturated at less than 50% (Figure 4-2-10), which was not observed in 
the cases of the other two prenyltransferases. This suggests that both compounds 
partially inhibit FTase with a complex inhibition mode, i.e. neither classicially non-
competitive nor competitive to both substrates. Compounds 5 and 7 exhibit more 
than 50- and 20-fold selectivity for RabGGTase over FTase and GGTase-I. Peptide 
11 (Table 4-2-6, entry 4) with a three-carbon shorter N-terminal lipid chain than 
peptide 5, displays an 11-fold selectivity for RabGGTase over FTase and GGTase-I. 
Peptide 10 (Table 4-2-6, entry 3) is only 3 and 6 times more specific towards 
RabGGTase over FTase and GGTase-I, respectively. The inhibition profile of these 4 
inhibitors for FTase exhibits a similar trend as observed for GGTase-I. Thus, Type-I 
compounds, 10, 11 ,7 and 5, show moderate to very good selectivity for RabGGTase 
and can be regarded as the first low micromolar RabGGTase inhibitors that do not 
show significant cross-activity for FTase and GGTase-I.  
Certain Type-II compounds shown in Table 4-2-4, which do not show very high 
inhibitory activity for RabGGTase, were chosen for selectivity studies with the other 
two prenyltransferases. As shown in Table 4-2-6, in contrast to 43 (Table 4-2-6, entry 
5) that extensively inhibits three prenyltransferases, the compounds, 45, 49 and 58 
(Table 4-2-6, entry 6, 7 and 8), exhibit 5-20 fold inhibitory selectivity for FTase and 
GGTase-I over RabGGTase.  
 
Figure 4-2-11. Initial velocity of prenyltransferases-mediated reactions in the presence of 50 μM of the 
indicated compounds as a percentage of that in the absence of the compounds. 
 
A potent RabGGTase inhibitor, PA, was identified, which shows 70- and 50-fold 
selectivity for RabGGTase over FTase and GGTase-I, respectively. To compare the 
selectivity of the compounds in another manner, the same concentration of 5, 7, 10 
and 43 were analyzed for their ability to inhibit prenylation mediated by the three 
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prenyltransferases. From Figure 4-2-11, we can see that the selectivity of 
compounds 5, 7 and 10 for inhibition of RabGGTase is indeed much better than that 
of 43. 
Since the prenyl binding sites in RabGGTase, FTase and GGTase-I are 
conserved, compounds with a lipid chain would be expected to universally inhibit the 
three prenyltransferases. However, these compounds showed significantly higher 
inhibitory activity towards RabGGTase than towards FTase and GGTase-I, 
suggesting that the lipid chain does not determine the binding mode of the 
compound. Together with the findings from the interaction analysis, we concluded 
that the peptide core of the inhibitors is the key determinant of the geometry of the 
bound molecule, whereas the lipid chain is directed by binding of the peptide core 
and further strengthens the protein-inhibitor interaction. It should be noted that the 
not-competitive* inhibitor 5 with respect to NBD-FPP showed better selectivity for 
RabGGTase than the competitive inhibitor 10. This is not surprising, since a 
compound with a lipid chain that associates with the conserved prenyl binding site of 
prenyltransferases would be more likely to display cross-activity for the three 
prenyltransferases. As mentioned above, the not-competitive inhibitor may bind to 
the putative binding site for the isoprenoid of mono-prenylated Rab, which is 
structurally different from the analogous exit grooves in FTase and GGTase-I. This 
suggests that the putative binding site for the isoprenoid of mono-prenylated Rab 
represents an important binding pocket for rational design of selective RabGGTase 
inhibitors. Compound 5 would be a good starting point for the design of not-
competitive and selective inhibitors. 
The variation in the structures of the peptides with very good inhibitory selectivity 
for one of the three prenyltransferases suggests that selectivity of the inhibitors in this 
compound class can be attenuated to yield specific prenyltransferase inhibitors. In 
this peptide library, the R5 position appears to be critical for selectivity among the 
three prenyltransferases. A long lipid chain at R5 position was found to improve 
selectivity of the compounds, with the preference towards RabGGTase. These 
observations provide guidance for design of new selective prenyltransferase 
inhibitors. 
                                                 
* Since non-competitive and uncompetitive have distinct definitions, we use the term ‘not competitive’ here. 
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4.2.6 Inhibition of RabGGTase in vivo by peptide inhibitors 
 
To evaluate the cellular activity of the identified peptide inhibitors of RabGGTase, 
a cellular assay for RabGGTase activity was performed (Figure 4-2-12). Briefly, COS-
7 cells were transfected with a construct mediating overexpression of a EYFP-Rab7 
fusion protein. Transfected cells were treated with the compounds, incubated for 24h, 
then harvested and lysed. The resulting cell lysate was assayed for presence of 
unprenylated Rabs by incubation with excess RabGGTase, REP1 and BiotinGPP. 
Subsequently cell lysates were then resolved by SDS-PAGE, Western blotted and 
probed with steptavidin-horse radish peroxidase to detect Rab-geranyl-biotin 
conjugates (Figure 4-2-13). The emergence of blot bands of Rab GTPases indicates 
the presence of unprenylated Rabs and therefore inhibition of Rab prenylation in cells. 
(In vivo evaluation was performed by Dr. Christine Delon) 
 
 
Figure 4-2-12. Schematic illustration of the principle of the in vitro prenylation assay. Black lines 
represent GGPP and red lines represent biotin-GPP. (A) No drug is added to the cell assay. The Rab 
proteins are prenylated by endogenous GGPP, therefore subsequent in vitro prenylation by 
RabGGTase, REP1 and biotin-GPP gives no signal. (B) Compactin is added as a positive control for 
the inhibition of the biosynthesis of isoprenoids. Rab proteins are not prenylated in the cell and 
therefore subsequent in vitro prenylation by RabGGTase, REP1 and biotin-GPP gives signal. (C) A 
known RabGGTase inhibitor, NE10790, is added to the cell assay. Rab proteins are not prenylated in 
the cell and therefore subsequent in vitro prenylation by RabGGTase, REP1 and biotin-GPP gives a 
signal.   
 
The test compounds 5, 7, 10, 32, 33 and 43, were observed to be non-cytotoxic 
to the cells at 100 μM. Although the inhibitors did not significantly affect the 
endogenous pool of Rab proteins, they all caused increased incorporation of biotin-
GPP to YFP-Rab7 (Figure 4-2-13 A), indicating that these compounds were able to 
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inhibit the prenylation of over-expressed EYFP-Rab7 in vivo to an extent comparable 
to inhibition by compactin (which prevents formation of GGPP by inhibiting the 
mevalonate pathway) (Woo et al., 2000; Brown et al., 1978) or NE10790, a selective 
inhibitor of RabGGTase (Coxon et al., 2001).  
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Figure 4-2-13. In vivo inhibition of RabGGTase by peptide inhibitors. COS-7 cells transiently over-
expressing EYFP-Rab7 were treated with 20 μM compactin as a positive control, with 1% (v/v) DMSO 
as a negative control, with the inhibitors of three different concentrations, 100 μM, 50 μM and 10 μM, 
and with 5mM, 1mM and 0.5 mM NE10790. The cells were lysed and the resulting cell lysates were 
collected and prenylated in vitro with 0.5µM RabGGTase and REP1 and 5µM BiotinGPP for 1h at 
25°C. The in vitro prenylated cell lysate was resolved by SDS-PAGE followed by Western blotting with 
Streptavidin-HRP. Western blot (A) and the in vivo inhibition profile of inhibitors (B) are shown here. 
The in vivo inhibition profile was obtained by quantification of the band intensity and subsequent 
normalization of the intensity against the positive control (compactin) and negative control (DMSO). 
 
The six inhibitors show concentration-dependent inhibition of RabGGTase in the 
cellular assay (Figure 4-2-13 B). The intensity of the blot bands were quantified and 
data were processed in the same way as described in section 4.2.1, assuming 100% 
inhibition by 20 μM compactin and 0% inhibition by 1% DMSO. All inhibitors show 
more than 50% inhibition of RabGGTase at 100 μM. The peptide inhibitors identified 
in this assay are 10 times more potent than the previously validated RabGGTase 
inhibitor, NE10790. In general, the peptide inhibitors show higher inhibitory activity at 
50 μM than NE10790 at 500 μM. Moreover, peptide 32 exhibits an in vivo inhibition at 
100 μM comparable to that induced by NE10790 at 1 mM. 
A 
B 
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In conclusion, a building block strategy equipped with the hydrazine linker and 
the 2-chlorotrityl chloride resin led to generation of a peptide library derived from 
Pepticinnamin E with different chemical functionalities at the N- and C-terminus and 
incorporation of various amino acids at the peptides central core. Several potent 
RabGGTase inhibitors with low micromolar IC50s have been identified from a 
screening of 450 peptides. The SAR analysis of the peptide library has revealed 
several functional groups which are essential for the inhibitory activity of the peptides 
for RabGGTase. Figure 4-2-5 outlines the important features of the active 
RabGGTase inhibitors from the peptide library. Aromatic amino acid residues at the 
peptide central core (R2-R4), phenylalanine, histidine and tyrosine, are essential for 
the inhitory activity of the peptide inhibitors towards RabGGTase. The Type-I 
inhibitors with a combination of a long lipid chain at the N-terminus (R5) and a 
potential zinc binding group, such as N-methyl 2-ethyl pyridine, at the C-terminus (R1) 
have shown good inhibitory activity for RabGGTase, whereas the active Type-II 
inhibitors contain an aryl ring at the N-terminus (R5) and a carboxylic acid at the C-
termunus (R1).  
The quantitative analyses and selectivity studies of the peptide inhibitors with 
RabGGTase, FTase and GGTase-I suggest that changes of the chemical structures 
of the peptides lead to different modes of inhibition, binding sites and selectivity 
profiles. The peptide central core (R2-R4) determines the binding configuration of the 
compound and the R1 residue strongly influences the activity of the peptide. However, 
the chemical moiety at R5 position appears to be critical for the selectivity among the 
three prenyltransferases. The large volume of the active site of RabGGTase makes 
the rational design of potent and selective inhibitors challenging. However, targeting 
the putative binding site for the isoprenoid of mono-prenylated Rab in RabGGTase 
would be a very promising approach for future identification of specific RabGGTase 
inhibitors. Compound 5 can be a suitable starting point for this purpose. Furthermore, 
the interesting selectivity of the inhibitors for the three prenyltransferases found here 
may lead to a better understanding and interpretation of the extensive inhibition of 
three prenyltraseferses by FTIs (farnesyltransferase inhibitors). The identification of 
cellularly active peptides, in particular highly specific inhibitors, would open up the 
opportunity for Pepticinnamin E derivatives as small and selective molecular probes 
for the in vivo investigation of prenyltransferases via a chemical genetic approach 
(Lackner et al., 2005).  
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4.3 The mechanistic basis of Rab prenylation  
4.3.1 Simulation of the Rab C-terminus in the ternary 
protein complex 
 
The mechanism of the Rab prenylation pathway including the lipid substrate 
binding and specificity (Thoma et al., 2000), binary (Rak et al., 2004; Pylypenko et al., 
2003) and catalytic ternary complex assembly (Thoma et al., 2001a; Alexandrov et 
al., 1999), the process of double prenylation (Thoma et al., 2001c), and product 
release (Thoma et al., 2001b), have been systematically investigated in our group by 
kinetic and structural methods (see the summary of kinetic and thermodynamic 
studies in Scheme 4-4, and for a review see (Goody et al., 2005)). In brief, there are 
two pathways for assembly of the prenylation machinery. One of them, referred to as 
the ‘classical’ pathway, involves initial binding of Rab and REP molecules with 
variable affinity. Subsequently REP presents Rab to the RabGGTase:GGPP complex 
in a high-affinity interaction (Kd = ca. 2 nM). The contact between the protein 
substrate Rab and enzyme RabGGTase is believed to occur via REP, since Rab and 
RabGGTase have no detectable affinity, but the crystal structure of the 
Rab:REP:RabGGTase ternary complex is not available yet. REP has low affinity for 
RabGGTase in the absence of Rab and of GGPP, but both entities have a positive 
effect on this affinity. Binding of GGPP to the active site of RabGGTase appears to 
induce long-range (36 Å) structural changes that are transduced from the core of β 
subunit to the outer helices of the α subunit of RabGGTase in order to accommodate 
the side chain of repF279 of REP-1, resulting in a Kd of 6 nM for the REP interaction 
with RabGGTase. Since Rab can now bind with high affinity to form the quaternary 
complex (Kd = 28 nM), this order of binding represents an ‘alternative’ pathway of the 
catalytic complex formation. After assembly of the prenylation machinery, double 
prenylation proceeds without dissociation of the mono-prenylated intermediate, with a 
preference of the C-terminal cysteine in Rab7 for the first prenyl transfer. After 
prenylation, the prenylated Rab:REP remains tightly associated with RabGGTase (Kd 
= ca. 2 nM). This high affinity would result in product inhibition as well as a problem 
for Rab membrane delivery. However, this situation appears to be relieved by binding 
of an additional phosphoisoprenoid substrate (i.e. GGPP) molecule, since this 
binding leads to a decrease in the affinity of RabGGTase to the prenylated Rab:REP 
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complex by an order of magnitude (Kd = 18 nM). The crystal structures of the 
prenylated Rab:REP complex and REP:RabGGTase complex led to a proposal for 
the a mechanism for product release. After prenylation, binding of a further 
isoprenoid molecule expels the conjugated geranylgeranyl moieties from the active 
site on RabGGTase. After release, they must migrate towards their binding site on 
domain II of the REP molecule. Creation of a lipid-harboring cavity to generate the 
binding pocket for the conjugated isoprenoids leads to displacement of repF279 and 
repR290 from their binding interface on RabGGTase, resulting in dissociation of the 
RabGGTase. 
The ternary protein complex has so far not proven amenable to structural 
analysis, although it has been generated and crystallized (Rak et al., 2002). The 
availability of the prenylated Rab7:REP complex and REP:RabGGTase complex 
structures allows modeling of the Rab:REP:RabGGTase ternary complex (Rak et al., 
2004). However, electron density in the prenylated Rab7:REP complex can only be 
traced until D193 of Rab7, with the remaining 14 residues being invisible in the 
electron density map, probably due to high flexibility in the structure. Based on the 
structures of the prenylated Rab7:REP complex (PDB access code, 1VG0) and 
REP:RabGGTase complex (PDB access code, 1LTX), internal coordinate mechanics 
(ICM) methodology (Molsoft) was used to simulate of the disordered C-terminus of 
Rab7 in the ternary complex, leading to a lowest energy conformation shown in 
Figure 4-3-1 (this work was done together with Prof. Dr. Ruben Abagyan during a 
visit to the Scripps Institute, La Jolla, CA). In the resulting model, the Rab molecule is 
located above the α subunit of RabGGTase and the last visible residue of Rab7 C-
terminus is positioned ca. 35 Å above its active site (Figure 4-3-1 A). The flexible 
Rab7 C-terminus is long enough to reach the active site on the β subunit (Figure 4-3-
1 A and B).  
As shown in Figure 4-3-1 C, the simulated C-terminus of Rab7 extends on the 
surface of REP and RabGGTase and protrudes into the active center, where the 
cysteine thiol coordinates the Zn2+ ion. However, no interaction could be detected 
between a Rab7 C-terminal 10-mer peptide and RabGGTase by isothermal titration 
calorimetry (ITC) (data not shown). This suggests that the contact of the disordered 
C-terminus with the protein surface is weak and probably non-specific, in keeping 
with the idea that the Rab C-terminus needs to be flexible for movement in later 
events, including prenylation of the second cysteines and translocation of the 
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conjugated geranylgeranyl moieties from RabGGTase to REP, and also in keeping 
with the fact that both the sequence and length of this reagion vary highly. The low 
specificity of the contact also ensures that RabGGTase and REP can process all Rab 
proteins with their highly variable C-termini. Nevertheless, it is still unclear what the 
critical determinants for Rab prenylation are.  
       
Figure 4-3-1. Simulation of the Rab7 C-terminus in the ternary complex base on structures of 
prenylated Rab7:REP complex (1VG0) and REP-1:RabGGTase (1LTX). (A) Ribbon representations of 
Rab7 (orange) with CIM highlighted in black, REP-1 (blue), RabGGTase α subunit (gray), 
RabGGTase β subunit (green), and simulated Rab7 C-terminus (gold). The farnesyl group is show in 
stick representation in red, and Zn2+ as a turquoise ball. (B) Surface representations of RabGGTase 
with the C-terminus of Rab7 protruding into the active site. The colors of all species are the same as in 
A. The residues of the two cysteines at Rab7 C-terminus are show in stick representation. (C) Ribbon 
representation of simulated C-terminus of Rab7 on the surface of REP and RabGGTase. All species 
are colored the same as in A. RabGGTase is sliced to show the active site. 
 
4.3.2 Rab C-terminus plays multiple roles in Rab 
prenylation 
4.3.2.1 Engineering of the Rab C-terminus based on simulation and 
binary complex structures  
 
The structures of mono-prenlyated Rab7:REP-1 as well as mono- and di-
prenylated Ypt1:GDI complexes (Pylypenko et al., 2006; Rak et al., 2003) provided 
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detailed information on the interaction mechanism of RabGTPases with REP and 
GDI. Both REP and GDI interact with Rab proteins through two binding sites 
designated the Rab Binding Platform (RBP) and the C-terminal binding region (CBR). 
The Rab Binding Platform interacts via a complex network of primarily polar 
interactions with the switch regions I and II of RabGTPases forming both a specific 
and conformation sensitive protein:protein interface. In contrast to the RBP, the CBR 
of both REP and GDI molecules interacts with the C-terminus of Rab molecules via 
primarily hydrophobic interactions formed by a patch of two or three hydrophobic 
amino acid residues (I, L and P) located within the last 10-20 residues of Rab 
molecules (Figure 4-3-2). As shown in Figure 4-3-3, sequence analysis of Rab 
proteins revealed that this cryptic motif is identifiable in most RabGTPases and 
binding this motif to the hydrophobic CBR on the surface of REP/GDI molecules 
appears to be required for proper fixation of the long unstructured C-terminus of 
RabGTPase (Rak et al., 2004). This coordination was assumed to be required for the 
proper positioning of the C-terminal cysteine residues in the active center of the 
RabGGTase and the positioning of the conjugated geranylgeranyl moieties in the 
lipid binding site of REP/GDI, as shown in the simulation (Figure 4-3-2). Moreover, 
the hydrophobic C-terminal motif, termed the CBR Interacting Motif (CIM), is in the 
hypervariable part of Rab’s C-terminus that is believed to be largely or at least 
partially responsible for their targeting to specific membranes. This idea is indirectly 
supported by the fact that, being bound to the CBR via the CIM motif, the 
hypervariable part of the C-terminus is located in the immediate proximity of the so-
called mobile effector loop of REP/GDI molecules, which is believed to be a second 
component required for the membrane delivery of prenylated Rab proteins (Sakisaka 
et al., 2002). However, it remains unclear whether the CIM is strictly required for Rab 
prenylation since it cannot be identified with certainty in all RabGTPases. Moreover, 
its contribution to overall affinity and specificity of the REP/GDI interaction is unclear 
since Rab7 lacking 22 C-terminal residues retains the ability to stably associate with 
REP (Rak et al., 2004).  
In addition, the simulation of the Rab C-terminus in the ternary protein complex 
reveals that the length of the C-terminus downstream of the CIM could be important 
for Rab prenylation. If we assume that the geometry of the overall 
Rab:REP:RabGGTase ternary complex is rigid as we have in our simulation, the 
appropriate length of the chain after CIM would determine the proper targeting of the 
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C-terminal cysteine to the active site for its prenylation, i.e. the downstream C-
terminal chain must be long enough to bridge the CBR of REP and the active site of 
RabGGTase. The length of the C-terminus after the CIM should also be enough to 
ensure the positioning of conjugated geranylgeranyl moieties in the lipid binding site 
of REP. Furthermore, the exact nature of the C-terminal residues after the CIM may 
or may not play a role in Rab prenylation. As already mentioned, this region is 
hypervariable in Rab proteins.  
 
            
Figure 4-3-2. Interaction of the Rab7 CIM with the CBR of REP-1. (A) The hydrophobic patch of REP-
1 is displayed in surface representation and hydrophobic residues are colored in yellow, polar and 
charged residues are colored in pink, blue (+) and red (-). The main chain atoms involved in hydrogen 
bonding are displayed in atomic colors. The C-terminus of Rab7 is displayed as an orange worm and 
the residues RabP189-RabL192 are displayed in stick format. The hydrogen bonds are displayed as 
strings of tiny cyan balls. The water molecule involved in H-bonding is displayed as a red ball. (B) 
Calculation of the contact area of these residues with REP displayed and colored as in (A). The atoms 
involved in hydrophobic interactions are colored green. The more they are involved in the interaction 
with REP, the bolder is the residue stick. The order of contact area for these residues is: 
L192>I190>P189>K191. 
 
In the light of this idea, we designed a series of Rab7 mutants with engineered 
C-termini (Figure 4-3-4). To identify cryptic CIMs in other Rab proteins, mutations at 
the putative CIM motif of different Rab proteins were generated. The established and 
versatile reporter NBD-FPP (Chapter 4.1.3) enables us to study the prenylation of a 
large number of Rab proteins and Rab mutants. The fluorescent Rab conjugates 
described in Chapter 4.1 were used as sensors for the interaction of Rab proteins 
and mutants with REP and RabGGTase. These analyses will be described in a later 
section. 
A B 
RabP189 
RabI190 
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hRAB6A          --------------D-RSREDMID-----IKLEKPQEQPVS-EGGCS---C---- 27 
hRAB6B          --------------E-KSKEGMID-----IKLDKPQEPPAS-EGGCS---C---- 27 
hRAB7           --------------Q-ETEVELYNEFPEPIKLDKNDRAKAS-AESCS---C---- 32 
hRAB39          -----GEICIQDGWE-GVKSGFVP-----NTVHPSEEAVKP-RKECS---C---- 36 
hRAB39B         -----GEITIQEGWE-GVKSGFVP-----NVVHSSEEVVKS-ERRCL---C---- 36 
hRAB11A         -----KQMSDRRENDMSPSNNVVP-----IHVPPTTE-NKP-KVQC----CQNI- 38 
hRAB11B         -----KQIADRAAHDESPGNNVVD-----ISVPPTTDGQKPNKLQC----CQNL- 40 
hRAB9           --------------TEDRSDHLIQ-----TDTVNLH-RKPKPSSSC----C---- 27 
rRAB29          ------------NSREDIMSSSTQ-----GNYINLQ-TKPSPGWTC----C---- 29 
rRAB12          ---------VLRSELSNSILSLQP-----EPEIPPELPPPRPHVRC----C---- 33 
mRAB33B         -------------SHKPLMLSQLP-----DNRISLK-PETKPAVTCW---C---- 29 
hRAB27A         -----MERCVDKSWIPEGVVRSN------GHASTDQLSEEKEKGACG---C---- 37 
hRAB27B         -----MEQCVEKTQIPDTVNGGNS-----GNLDGEKPPEKK----CI---C---- 34 
HRAB35          ----KKDNLAKQQQQQQNDVVKLT-----KN--------SKRKKRC----C---- 30 
bRAB34          -------ELEKSGSRRIGDVVRIN-----SDDSNLYLTASKKKPTC----CP--- 36 
hRAB1A          ----------MGPGA---TAGGAEK----SNVK-IQSTP-VKQSGGG---CC--- 30 
rRAB1B          ----------MGPGA---ASGG-ER----PNLK-IDSTP-VKSASGG---CC--- 29 
cRAB21          ---AQVDERAKGNGS---SQPGAAR----RGVQIIDDEPQAQSSGGG---CCSSG 42 
rRAB26          ------------STK---APSEPRF----RLHDYVKREG--RGVSC----CRL-- 28 
mRab37          ------------AGR---QPDEPSF----QIRDYVESQK--KRSSC----CSFV- 29 
rRAB3C          -----MS-ESLETDP---AITAAK-----QSTRLKETPP-PPQPNCG---C---- 33 
hRAB3B          -----MS-DSLDTDP---SMLGSS-----KNTRLSDTPP-LLQQNCS---C---- 33 
rRAB16          IICDKMN-ESLEPSS---SPGSNG-----KGPSLGDTPP-PQPSSCG---C---- 38 
hRAB3D          -----MN-ESLEPSS---SSGSNG-----KGPAVGDAPA-PQPSSCS---C---- 33 
hRAB4A          ---GELDPERMGSGI---QYGDAAL----RQLRSPRRTQAPNAQECG---C---- 38 
rRAB4B          ---GELDPERMGSGI---QYGDISL----RQLRQPRSAQAVAPQPCG---C---- 38 
rRAB14          ---GSLDLNAAESGV---QHKPSAP----QGGRLTSEPQ-PQREGCG---C---- 37 
hRAB5B          --------EPQNLGG---AAGRSR------GVDLHEQSQ-QNKSQC----CSN-- 31 
hRAB5C          --------EPQNATG---APGRNR------GVDLQENNP-ASRSQC----CSN-- 31 
hRAB5A          --------EPQNPGA---NSARGG------GVDLTEPTQ-PTRNQC----CSN-- 31 
hRAB8           -------DKKLEGNS----PQGSN-----QGVKITPD-Q-QKRSSFFR--CVLL- 34 
rRAB8B          -------NRKMNDSN----SSGAG-----GPVKITE-SR-SKKTSFFR--CSLL- 34 
hRAB40A         ARMMHGGSYSLTTSS---THKRSSL----RKVKLVRPPQ-SPPKNCTRNSCKIS- 46 
hRAB40B         ARMMRGLSYSLTTSS---THKRSSL----CKVKIVCPPQ-SPPKNCTRNSCKIS- 46 
hRAB40C         --------YSLASGAGGGGSKGNSL----KRSKSIRPPQ-SPPQNCSRSNCKIS- 41 
cRAB22          -----------DANP----PSGGK------GFKLRRQPS-EPQRSC----C---- 25 
hRAB3A          -----MSESLDTADP---AVTGAK-----QGPQLSDQQV-PPHQDCA---C---- 34 
rRAB10          ------------PVK---EPNSEN-----VDISSGGGVT-GWKSKC----C---- 26 
mRAB20          --------MIMRQRA---EESDQT-----VDIASCKTPK-QTRSGC----CA--- 31 
mRAB24          -----------AAFQ---VMTEDK------GVDLSQKAN-PYFYSC----CHH-- 28 
mRAB17          ---------AGDTGS---SRPQEG-----EAVALNQEPP-IRQRQC----CAR-- 31 
mRAB23          ---VFNASVGSHLGQNSSSLNGGD----VINLRPNKQRTKRTRNPFSS--CSVP- 45 
hRAB22B         -----------DPHE-----NGNN------GTIKVEKPTMQSSRRC----C---- 25 
hRAB32          -------NHQSFPNE---ENDVDK-----IKLDQETLRA-ENKSQC----C---- 31 
rbRAB25         --------KQIQNSP---RSNAIAL----GSAQAGQEPGPGQKRAC----CINL- 35 
rRAB15          -------GLRTCASN---ELALAEL----EEDEGKTEGPANSSKTCW---C---- 34 
hRAB33A         ----AQKSLLYRDAE---RQQGKV-----QKLEFPQEAN--SKTSCP---C---- 34 
hRAB41          ---YNVKKLFRRVASALLSTRTSPPPK--EGTVEIELESFEESGNRS--YC---- 44 
mRAB19          ----ARNSLHLYGES---AQQGLSQ----DSSPVLVAQVPNESTRCT---C---- 37 
mRAB18          ----------LWESE-----NQNK------GVKLSHREESRGGGACGG-YCSVL- 32 
hRAB2           ---GVFDINNEANGIKIGPQHAAT-----NATHAGNQGGQQAGGGC----C---- 39 
hRAB36          ------DLERQSSAR--LQVGDGDLIQMEGSPPETQESKRPSSLGC----C---- 39 
hRAB30          ----------ARQNT---LVNNVS-------SPLPGEGKSISYLTC----CNFN- 30 
hRAB13          -----------GGRR---SGNGNK-----PPSTDLKTCDKKNTNKCS---LG--- 30 
rRAB38          -----------NECD---FIESIE-----PDIVKPHLTS-PKVVSCSG--CAKS- 32 
hRAB28          --------IKLNKAEIEQSQRIVR-----AEIVKYPEEENQHTTSTQSRICSVQ- 41 
 
Figure 4-3-3. Sequences of the Rab C-terminus. The non-polar residues (I, L, V, P) shown in bold 
typeface and highlighted are the putative CBR interacting motif (CIM). In some Rab proteins, it is 
difficult to assign this motif.  
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                      190  195  200  205 
Rab7wt             EFPEPIKLDKNDRAKTSAESCSC 
Rab7Δ204           EFPEPIKLDKNDRAKTSAECSC 
Rab7Δ203-204       EFPEPIKLDKNDRAKTSACSC 
Rab7Δ202-204       EFPEPIKLDKNDRAKTSCSC 
Rab7Δ201-204       EFPEPIKLDKNDRAKTCSC 
Rab7Δ200-204       EFPEPIKLDKNDRAKCSC 
Rab7Δ199-204       EFPEPIKLDKNDRACSC 
Rab7Δ198-204       EFPEPIKLDKNDRCSC 
Rab7Δ197-204       EFPEPIKLDKNDCSC 
Rab7Δ3             EFPEPIKLDKNDRAKTSAES 
Rab7Δ14            EFPEPIKLD 
Rab7Δ22            E 
Rab7-7A            EFPEPIKLAAAAAAASAESCSC 
Rab7-5A            EFPEPIKLDKNDRAAAAAACSC 
Rab7-11A           EFPEPIKLAAAAAAAAAAACSC 
Rab7_ASA           EFPEPIKLDKNDRAKTSAESCSCASA 
Rab7_NLYFQ         EFPEPIKLDKNDRAKTSAESCSCNLYFQ 
Rab7_WFY           EFPEPIKLDKNDRAKTSAESCSCWFY 
Rab7I190H          EFPEPHKLDKNDRAKTSAESCSC 
Rab7L192S          EFPEPIKSDKNDRAKTSAESCSC 
Rab7I190HL192S     EFPEPHKSDKNDRAKTSAESCSC 
 
                        200       210       220  
Rab27            KSWIPEGVVRSNGHTSTDQLSEEKEKGLCGC 
Rab27_Rab7_Cter  KSWIPEPIKLDKNDRAKTSAESCSC 
 
Figure 4-3-4. The upper panel shows sequences of the C-terminus of a series of Rab7 mutants. The 
lower panel shows the C-terminal sequences of Rab27 and a Rab27_Rab7 chimera, where part of the 
C-terminus of Rab27 was replaced by Rab7 CIM and downstream sequence (shown in red). Note: 
expression of Rab7-7A and Rab7-11A in E. coli was not successful, resulting in a protein with 13 C-
terminal residues truncated (reason unknown). 
 
4.3.2.2 CBR interacting motif is essential for Rab prenylation in vitro 
 
As described above, the Rab7 C-terminus is mounted to REP-1 via the 
interaction of I190 and L192 with the CBR of the latter (Figure 4-3-2). In order to 
understand the effect of this interaction on Rab prenylation, we prepared mutants of 
Rab7 where either or both of the residues were mutated to polar amino acids. The 
resulting mutants were purified and subjected to in vitro prenylation analysis using a 
fluorescent analogue of geranylgeranyl pyrophosphate, NBD-FPP (see Chapter 
4.1.3). As can be seen in Figure 4-3-5 A and Table 4-3-1, individual mutations led to 
a reduction in the rate and total yield of the prenylation reaction. The Rab7 L192S 
mutant displayed more significant inhibition of prenylation than Rab7 I190H, 
suggesting that L192 is the more critical residue in the CBR:CIM interaction. This 
finding is consistent with the structure of the CBR:CIM interface, where L192 
protrudes deeply into the hydrophobic cavity on the REP-1 surface while I190 
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contacts the outer edge of the CBR. Calculation of the contact area of these residues 
also shows that L192 has a higher contact area with REP than I190 (Figure 4-3-2 B). 
The mutations appear to have more than an additive effect since the double 
mutant Rab7 I190HL192S showed no detectable prenylation. While single mutatants 
showed reduction in prenylation efficiency. This indicats that the CIM motif is strictly 
required for Rab prenylation (Figure 4-3-5 A, Table 4-3-1). 
Analysis of Rab:REP and Rab:GDI structures shows that the CIM motif functions 
as a hydrophobic anchor which in principle can be composed of different amino acid 
residues. Moreover, the C-terminus of Rab GTPases can differ significantly in length. 
These situations complicate the unambiguous identification of the CIM motif in Rab 
proteins. While some Rab proteins contain a clearly identifiable CIM motif resembling 
that of Rab7, others do not (Figure 4-3-3). To test experimentally whether CIM 
sequences are present in other RabGTPase, we chose Rab2, Rab13 and Rab16 
proteins for detailed analysis. As shown in Figure 4-3-6, Rab13 and Rab16 have an 
obvious CIM motif in their C-terminus. But Rab2 has two putative CIM motifs in the C-
terminal region, if we assumed that the CIM motif would highly likely be located in the 
unstructured domain of apo-Rab GTPase. In Rab2, I185 and I187 appear to more 
resemble a CIM motif.  
 
Figure 4-3-5. In vitro prenylation of wild type and CIM mutants of Rab7, Rab2, Rab13 and Rab16 with 
NBD-FPP. The reaction was started by addition of NBD-FPP to a mixture of RabGTPase, 
RabGGTase and REP and aliquots were withdrawn at indicated time points quenched and resolved 
on 15% SDS-PAGE gel. Fluorescent scanning of the gels and data analysis was performed as 
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described under the Chapter 6.4.3. (A) { Rab7 wt,  Rab7 I190H, U Rab7 L192S and  Rab7 
I190HL192S. (B) { Rab2 wt, U Rab2 I185S and  Rab2 I185SI187S. (C) Wild type ({) and L189S 
mutant (U) of Rab13. (D) Wild type ({) and L185S mutant (U) of Rab16. The solid lines show the fits 
to single exponential functions. 
 
Table 4-3-1. Observed in vitro prenylation rate of wild type and CIM mutants of Rab proteins. 
Protein Rate X10-3 (s-1) Protein Rate X10-3 (s-1) 
Rab7wt 2.39±0.28 Rab2wt 5.80±0.46 
Rab7I190H 2.36±0.15 Rab2I185S 3.91±0.33 
Rab7L192S 1.09±0.10 Rab2I185SI187S 3.20±0.21 
Rab7I190HL192S -   
Rab13wt 4.11±0.32 Rab16wt 1.57±0.14 
Rab13L189S 1.30±0.06 Rab16L185S 0.22±0.07 
 
  
hRAB2      AFINTAKEIYEKIQEGVFDINNEANGIKIGPQHAATNATHAGNQGGQQAGGGCC 212 
hRAB7      AFQTIARNALKQETE--------VELYNEFPEPIKLDKNDRAKASAESCSC--- 207 
rRAB13     AFSSLARDILLKTGG-------RRSGNSSKPSS--TDLKVSDKKNSNKCSLG-- 203 
rRAB16     VFERLV-DIICDKMN-------ESLEPSSSPGSNGKGPSLGDTPPPQPSSCGC- 198 
             .*   . :   .               .  *     .     .   : ..   
 
                  170       180       190       200       210 
hRAB2      INTAKEIYEKIQEGVFDINNEANGIKIGPQHAATNATHAGNQGGQQAGGGCC  
hRAB7      NVEQAFQTIARNALKQETEVELYNEFPEPIKLDKNDRAKASAESCSC 
rRAB13     AFSSLARDILLKTGGRRSGNSSKPSSTDLKVSDKKNSNKCSLG 
rRAB16     IICDKMNESLEPSSSPGSNGKGPSLGDTPPPQPSSCGC 
 
Figure 4-3-6. C-terminal sequence alignment and residue number in each pr 
otein. The putative CIM motifs (I, L, V, P) are shown in bold typeface and highlighted in yellow, the 
regions highlighted in pink are α-helixes observed in the crystal structures. 
 
First we produced recombinant wild type and I187S and I185SI187S mutants of 
Rab2 and assessed their ability to undergo prenylation in vitro. The results shown in 
Figure 4-3-5 B and Table 4-3-1 demonstrate that I185S mutation slightly reduced the 
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prenylation of Rab2 protein. Unlike in the case of Rab7, the activity of the Rab2 
I185SI187S double mutant for prenylation only decreased by a factor of 2. This 
indicates that I185 and I187 may not be the correct CIM motif for Rab2 protein. 
Another putative CIM motif of Rab2, V175 and I178, should be tested further.  
To analyse the CIM motifs of Rab13 and Rab16 we introduced a single point L to 
S mutation in each of these proteins at the position that would correspond to I190 or 
L192 in Rab7. As shown in the Figure 4-3-5 C, D and Table 4-3-1, in both cases the 
mutations led to a substantial reduction in the rate and the total amount of GTPase 
prenylation. This indicates that the CIM is functionally important for Rab prenylation 
across the Rab family.   
4.3.2.3 Effects of sequence downstream CIM on Rab prenylation  
 
As shown in the simulation (Figure 4-3-1), the length of the chain after CIM has 
to be long enough to deliver the C-terminal cysteine residues to the active center of 
the RabGGTase. Nevertheless, it is the most divergent part of Rab proteins and no 
specific sequence could be identified in this domain across the Rab family. In order to 
understand the effect of the sequence downstream CIM on Rab prenylation, we 
truncated sequentially 1 to 8 amino acid residues located before the first prenylatable 
cysteine. This resulted in shortening of the length of the linker between CIM and the 
active site. In other constructs, the length of the linker was kept but either 
(193)DKNDRAKT(198), (199)KTSAES(204) or the whole linker, 
(193)DKNDRAKTSAES(204), was replaced by a poly-alanine chain to verify whether 
specific residues in this domain are required for Rab prenylation (Figure 4-3-4). 
The continuous fluorometric assay as described in section 4.1.3 was used to 
evaluate the prenylation rate of these Rab constructs. The chosen concentrations of 
the individual components were far above the respective Kd values. Under such 
conditions the dissociation and association would not be rate limiting so as to ensure 
a single turnover reaction. The obtained time traces (Figure 4-3-7 A) upon reaction 
could be fitted to the double exponential functions, giving two rate constants (Table 
4-3-2). This indicated that at least two steps give rise to fluorescence changes. 
Because the fluorescence time trace exactly correlates with reaction progress 
assayed by HPLC and SDS-PAGE (section 4.1.3, Figure 4-1-18, Figure 4-1-20),  this 
type of experiment can still be used to derive prenylation rate constant, although 
such fits do not have a direct physical meaning.  
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Figure 4-3-7. (A) Time-course of in vitro prenylation of Rab7wt and its mutants at 25°C. Reaction 
mixture contains 1 μM Rab, REP-1 and RabGGTase, and 4 μM NBD-FPP. (B) Quantification of 
prenylated products after saturation of the reaction by SDS-PAGE analysis. The reaction mixture 
contains 6 μM Rab protein (totally 61 pmol), 10 μM REP-1 and 6 μM RabGGTase, and 40 μM NBD-
FPP. The fluorescence of the bands corresponding to the prenylated Rab was quantified using AIDA 
densitometry software and the values were corrected using Coomassie blue staining of the same 
bands 
 
Table 4-3-2. Observed in vitro prenylation rates of Rab7wt and its mutants 
Species C-terminus of Rab7wt and mutants Amp1 Rate1 (s-1) Amp2 Rate2 (s-1)
Rab7wt IKLDKNDRAKTSAESCSC 0.61 0.0068 0.31 0.0010 
Rab7Δ204           IKLDKNDRAKTSAECSC 0.82 0.0018 0.41 0.00018 
Rab7Δ203-204    IKLDKNDRAKTSACSC  1.3 0.0062 0.34 0.00083 
Rab7Δ202-204    IKLDKNDRAKTSCSC 1.3 0.0050 0.40 0.00070 
Rab7Δ201-204    IKLDKNDRAKTCSC 0.5 0.0015 0.18 0.00012 
Rab7Δ200-204    IKLDKNDRAKCSC 0.32 0.0013 0.19 0.00011 
Rab7Δ199-204    IKLDKNDRACSC 0.015 0.0014 0.04 0.00048 
Rab7Δ198-204    IKLDKNDRCSC 0 0 0 0 
Rab7Δ197-204    IKLDKNDCSC 0 0 0 0 
Rab7-5A IKLDKNDRAAAAAACSC 0.79 0.0096 0.19 0.00057 
Rab7_ASA IKLDKNDRAKTSAESCSCASA 0.14 0.0079 0.17 0.00018 
Rab7_NLYFQ IKLDKNDRAKTSAESCSCNLYFQ 0.38 0.0039 0.21 0.00030 
Rab7_WFY IKLDKNDRAKTSAESCSCWFY 0.019 0.0082 0.082 0.0003 
A 
B 
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As shown in Figure 4-3-7 and Table 4-3-2, the length of the linker between CIM 
and first prenylatable cysteine is critical. Truncation of the linker from 12 residues to 9 
residues did not lead to significant influence on both prenylation rate and total 
amount of prenylated Rab (Rab7Δ204 to Rab7Δ202-204). However, truncation of the 
linker peptide to less than 8 amino acid residues resulted in significant reduction of 
prenylation efficiency (Rab7Δ201-204 to Rab7Δ197-204). The replacement of 
(199)KTSAES(204) with a poly alanine sequence even slightly improved Rab 
prenylation. These observations indicate that there is a strict criterion for the bridge 
between the CBR on REP and the active site on RabGGTase. This criterion is based 
on the length, but not the sequence of the bridging. It appears that the length 
between CIM and first prenylatable cysteine should not be too short (no less than 9 
amino acids), and the length varies among different Rab proteins. Indeed a 
truncation of 10 amino acids in the C terminus (adjacent sequences in the upstream 
of cysteine motif) of Rab5 renders the protein cytosolic despite the presence of intact 
cysteine motif (Chavrier et al., 1991). It also suggests that another anchor within the 
linker is not required for proper Rab prenylation, correlating with the simulation 
results, which shows the downstream C-terminal chain non-specifically extends on 
the surface of REP and RabGGTase. This is further supported by the fact that Rab 
family possesses a diverse array of C-terminus. An additional anchor might actually 
be disadvantageous, since it might adversely influence translocation of the 
conjugated geranylgeranyl moieties from RabGGTase to REP, which would require a 
large movement of C-terminus.  
An additional random sequence with 3-5 residues following prenylatable cysteine 
did not reduce Rab prenylation, consistent with the fact that 1-3 residues occur after 
C-terminal cysteine in some Rab proteins. However, addition of a group of aromatic 
amino acid residues (WFY) after the prenylatable cysteine considerably inhibits Rab 
prenylation. These aromatic residues may contact with the active site so as to 
influence prenylation, as will be discussed in a later section. 
4.3.2.4 Rab C-terminus modulates affinity of Rab:REP binary 
complex and Rab:REP:RabGGTase ternary complex  
 
There are two most obvious explanations for the effect of CIM motif mutations on 
Rab prenylation. Since the CIM motif provides an additional contact between REP 
and Rab proteins it may contribute to the overall affinity of the complex and thereby 
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modulate the ability of RabGGTase to recruit and process the Rab protein. It is also 
possible that it is required for the coordination of Rab C-terminus and the observed 
reduction in prenylation of CIM mutants reflects the failure of the C-terminus to 
associate with the active site of RabGGTase efficiently. To discriminate between 
these possibilities, we quantitatively analysed the role of the Rab C-terminus in the 
interaction of Rab:REP binary complex and Rab:REP:RabGGTase ternary complex.  
 
 
Figure 4-3-8. (A) Titration of REP-1 into 100 nM Rab7C(NBD)SCC in the absence (open circle) and 
the presence of 106 nM (filled square) and 424 nM (filled triangle) Rab7wt. Free titration data were 
fitted to a quadratic equation giving Kd of 3 nM. The co-titration data were fitted by numerical 
simulation with a competitive model to obtain Kd of 5.6 nM and 9.4 nM for Rab7wt:REP-1, during 
which the Kd of 3 nM for the reporter was fixed. (B) Titration of RabGGTase into 65 nM 
Rab7C(NBD)SC:REP-1 in the absence (open circle) and the presence of 500 nM (filled square) and 
1000 nM (filled triangle) Rab7wt:REP-1. Data fitting was performed as in A to give Kd of 66 nM for 
Rab7C(NBD)SC:REP-1:RabGGTase, Kd of 137 nM and 124 nM for Rab7wt:REP-1:RabGGTase. 
 
Since the affinity of the Rab7:REP interaction is very high (Kd~1nM) it can be 
accurately measured only when the titration experiment is performed at low 
concentrations of the reactants (Thomä and Goody, 2003). This in turn requires an 
assay with a sensitive fluorescence change and good quantum yield that enables 
reliable monitoring of the interactions at low concentrations. The Rab biosensor 
construction efforts performed before provided us with such a platform. As described 
in Chapter 4.1, we used the expressed protein ligation (EPL) approach to generate a 
Rab7 protein C-terminally modified with NBD group (Figure 4-1-1). Addition of REP-1 
protein to a solution of Rab7C(NBD)SC or Rab7C(NBD)SCC (termed Rab7-NBD) 
resulted in 4-fold increase in NBD fluorescence, while association of RabGGTase 
with Rab7-NBD:REP-1 binary complex led to 2-fold fluorescence quenching (Figure 
4-1-14 E).  We used this sensitive signal change to monitor the interaction of a 50 nM 
solution of Rab7–NBD and Rab7-NBD:REP-1 with increasing concentrations of REP-
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1 and RabGGTase respectively (Figure 4-3-8). The fit of the data to the quadratic 
equation led to a Kd value of 2.8±0.8 nM for Rab7-NBD:REP-1 and 61±7 for Rab7-
NBD:REP-1:RabGGTase.  
In order to obtain the values for interaction of Rab7 wild type and mutants with 
REP and RabGGTase, we performed co-titration experiments in which a mixture of 
Rab7-NBD and Rab7wt/mutant, or Rab7-NBD:REP-1 and Rab7wt/mutant:REP-1 
were titrated with increasing concentrations of REP or RabGGTase. Typical co-
titration experiments were shown in Figure 4-3-8. In the presence of non-fluorescent 
Rab7 protein, a “lag” of fluorescence increase or decrease during the titration was 
observed, indicating that the non-fluorescent molecule competes with the fluorescent 
molecule in binding to REP or RabGGTase. The resulting data was processed with a 
set of differentiation equations for a competitive model using program SCIENTISTTM 
(Thoma et al., 2000), resulting in the dissociation constants for binary and ternary 
complex summarized in Table 4-3-3. 
 
Table 4-3-3. Summery of dissociation constants for interaction between Rab7wt/mutants and REP and 
RabGGTase. 
Rab wt/mutants C-terminal sequence 
Kd of the 
binary 
complex 
(REP-1) 
[nM] 
Kd of the 
ternary 
complex 
(RabGGTase) 
[nM] 
Rab7C(NBD)SC EFPEPIKLDKNDRAKTSAEC(NBD)SC     2.8±0.8   61±6.9 
Rab7C(NBD)SCC EFPEPIKLDKNDRAKTSAEC(NBD)SCC     3.2±0.9 nd 
Rab7wt EFPEPIKLDKNDRAKTSAESCSC 7.5±2.7 130±9.3 
Rab7Δ3 EFPEPIKLDKNDRAKTSAES 16.1±1.0 191±22 
Rab7Δ14 EFPEPIKLD 15.8±2.1 321±11 
Rab7Δ22 E 381±37 491±31 
Rab7-5A EFPEPIKLDKNDRAAAAAACSC 21.5±1.1 188±45 
Rab7_WFY EFPEPIKLDKNDRAKTSAESCSCWFY nd 107±16 
Rab7I190H EFPEPHKLDKNDRAKTSAESCSC 228±59 nd 
Rab7L192S EFPEPIKSDKNDRAKTSAESCSC 341±74 nd 
Rab7I190HL192S EFPEPHKSDKNDRAKTSAESCSC 547±46 nd 
nd: not determined. 
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As shown in Table 4-3-3, the determined Kd values for Rab7wt binary and 
ternary complex are very close to the affinity values extracted previously from the 
kinetic experiments (Alexandrov et al., 1999; Alexandrov et al., 1998), indicating that 
this assay is suitable for monitoring Rab7:REP and Rab7:REP:RabGGTase 
interactions. Mutation of residues of the CIM motif results in ca. 30-70 fold reduction 
in Rab7:REP affinity, suggesting that interactions of the CIM with the CBR makes a 
significant contribution to the overall affinity of the binary complex. The order of the 
affinity of the CIM mutants with REP correlates with the calculation results of the 
contact area between the CIM residues and the CBR shown in Figure 4-3-2 and the 
observed effects of CIM mutations on the efficiency of the prenylation shown in 
Figure 4-3-5 A. To further verify our findings we prepared three mutants of Rab7 
truncated by 3, 14 and 22 amino acids (Figure 4-3-4). Rab7Δ3 lacks the C-terminal 
cysteines, Rab7Δ14 keeps the CIM motif intact while Rab7Δ22 removes C-terminus 
including the CIM motif. Analysis of Rab7Δ3, Rab7Δ14 interaction with REP reveals 
that the deletion of the prenylation motif and (Rab7Δ3) even the whole downstream 
residues after CIM (Rab7Δ14) motif does not dramatically influence the affinity of the 
interaction. However, deletion of the 22 residues including the CIM motif resulted in 
50-fold decrease in the affinity for binary complex. This observation indicates that in 
accord with the structural data, the CIM motif is the only site in the Rab7 C-terminus 
that contributes significantly to Rab7:REP interaction. Kd for Rab7Δ22 is quite close 
to that of the double mutant Rab7I190HL192S, suggesting that I190 and L192S play 
a central role in coordination of the Rab C-terminus on the surface of REP molecule. 
This is also consistent with the calculation results of contact area for the CIM motif 
(Figure 4-3-2). 
Next we wanted to confirm our observations using an independent and 
preferably direct method. We chose the isothermal titration calorimetry (ITC) to 
measure the influence of CIM mutation on the Rab:REP interactions. The results of 
the titration experiments, in which a  fixed amount of wild type or mutant Rab7 were 
titrated with increasing concentrations of REP are shown in the Figure 4-3-9. The fit 
of the ITC data to the binding constant equation via an iteration method resulted in a 
Kd value of 476 ± 8nM and 21 ± 185nM for Rab7L192S and Rab7wt, respectively. 
The high error for the Kd value determined for wild type Rab7 is due to the limitation 
of the ITC method for monitoring of the interaction with low nanomolar affinities. 
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Nevertheless this experiment clearly confirms the results obtained using fluorescence 
co-titration approach.  
 
Figure 4-3-9. Isothermal titration calorimetry titration of the wild type Rab7 (A) and Rab7L192S (B) 
with REP-1. The best values for stoichiometry, binding constant, and enthalpy are shown in the box. 
 
As can be seen in Table 4-3-3, interaction of Rab:REP:RabGGTase ternary 
complex of Rab7wt, Rab7Δ3, Rab7Δ14 and Rab7Δ22 displays a trend of slight 
decrease in affinity with truncation of C-terminal residues. Replacement of 
(199)KTSAES(204) of Rab7 by poly alanine (Rab7-5A) and additional aromatic 
amino acid residues at the Rab7 C-terminus (Rab7_WFY) result in minor reduction 
and enhancement in ternary complex affinity, respectively. These observations 
demonstrate that the amino acids of the C-terminus make only a limited contribution 
of the overall affinity of the Rab:REP complex interaction with RabGGTase, which is 
consistent with previous finding (Alexandrov et al., 1999). However, the C-terminus is 
obviously involved in the association of ternary complex, from the evidence of 
quantitative analyses shown here. The disordered Rab C-terminus must weakly 
associate with REP:RabGGTase for prenylation instead of freely hanging outside, as 
can also be seen in the simulation (section 4.3.1). Interestingly, Rab7_WFY leads to 
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increased affinity of the ternary complex, whereas its prenylation was inhibited. This 
suggests that aromatic WFY residues may bind to the active site of RabGGTase. 
There could be two possible explanations for the inhibition effect. First, the interaction 
of WFY with the active site changes the orientation of C-terminal cysteines so that it 
is not able to coordinate Zn2+. Second, WFY disrupts the proximity effect between 
prenyl and cysteines thiol groups, resulting in inhibition of reaction between these two 
moieties.  
Analysis of the Kd values for binary and ternary complexes shown in Table 4-3-3 
enables us to conclude that the CIM motif, though is shown to be an important 
contributor to Rab:REP binding, is not so significant for ternary complex assembly as 
GTPase domain functions. This excludes the first possibility for the effect of CIM 
mutations on Rab prenylation, as mentioned at the beginning of this section, i.e. the 
CIM motif does not significantly influence the recruitment of the Rab:REP complex by 
RabGGTase. As shown in section 4.3.2.2, the in vitro prenylation experiments 
(Figure 4-3-5) were performed under conditions where all components were present 
at concentrations far above the respective Kd values, incomplete complex formation 
should not be rate limiting. Moreover, further increase of the concentration of each 
component does not lead to a change in the observed rate constant, thus the 
observed rate reflects the single turnover reaction rate. Although CIM mutations lead 
to considerable reduction in the stability of the binary complex, Rab7 CIM mutants 
still associate with REP in affinity high enough, and it would not be expected the 
significant decrease in affinity of ternary complex. In principle, at the sufficiently high 
concentration of prenylation components, the observed rate would not change upon 
CIM mutations. However, it turned out not to be the case. Therefore, we conclude 
that the CIM mutation changes the micro-environment within the ternary protein 
complex rather than the assembly of the whole complex. It appears that loss of 
coordination of the C-terminus reduces the likelihood of its proper association with 
the catalytic site of RabGGTase. To an extent one can view CIM fairy like an AAX 
motif of CAAX box in the case of FTase and GGTase-I working from a remote 
location.  From this perspective the primary purpose of the CIM motif is to provide an 
anchor facilitating extension of downstream C-terminal residues on the surface of 
REP and RabGGTase so as to position cysteines in the vicinity of the active site of 
RabGGTase for conjugation with prenyl groups. Taking into account the diversity of 
the Rab C-terminal sequence and the variation in length of the C-terminal fragments 
4.3.2.4 Rab C-terminus modulates affinity of binary and ternary complexes 
146 
among Rab proteins, the fact that the C-terminus of Rab proteins is dispensable for 
assembly of high affinity Rab:REP:RabGGTase ternary complex supports this model.  
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In conclusion, the interaction of the CIM motif of RabGTPases with the CBR on 
REP-1 makes a significant contribution to the overall affinity of the binary complex. 
But the trigger for the assembly of Rab:REP:RabGGTase is mostly contributed from 
the GTPase domain of Rab, while the Rab C-terminus donates only a minor fraction 
of the binding energy of Rab:REP interaction with RabGGTase. However, mutation of 
the CIM motif considerably reduces both single turnover prenylation rate and the final 
amount of prenylated Rab. This effect arises from the change of micro-environment 
inside the ternary complex rather than disrupted assembly of the complex. Based on 
the simulation of the disordered Rab C-terminus in the ternary protein complex, we 
propose a model (Scheme 4-6) for Rab prenylation. In this model, the CIM:CBR 
interaction functions as a anchor to support weak and non-specific association of 
Rab C-terminus on the REP and RabGGTase surface in order to position C-terminal 
cysteines in the active site of RabGGTase. During reaction, there must be large 
motions of the Rab C-terminus for the purpose of double prenylation and 
translocation of conjugated prenyl moieties. In addition to these objectives, specific 
coordination of the Rab C-terminal fragment downstream the CIM does not exist, 
which might be an explanation for the fact that RabGGTase can process Rab 
proteins containing C-terminal peptides with diverse sequences and varied lengths. It 
appears that the proper length of this fragment rather than the sequence is critical for 
Rab prenylation. This in turn suggests that the overall configuration of the ternary 
protein complex is more of less rigid, but some degree of internal flexibility is required 
during prenylation. Hence, we could divide the interactions within the ternary complex 
into three parts, one of which is the interaction between the GTPase domain of Rab 
and the RBP on REP, the second is binding of the CIM with the CBR, and the last is 
the formation of the interface between RabGGTase and REP. The first and the third 
determine the assembly of the ternary protein complex, while the second serves as a 
coordinator within the micro-environment of the machinery for communication 
between the Rab C-terminus and the active site of RabGGTase. Once the 
communication is established, prenylation occurs in a dynamic way where flipping of 
the first conjugated prenyl group and translocation of the doubly conjugated prenyl 
moieties might be triggered by binding of phosphoisoprenoids (Thoma et al., 2001b; 
Thoma et al., 2001c).  
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Scheme 4-6. A model for assembly of Rab prenylation machinery and subsequent Rab prenylation. 
RBP: Rab binding platform, CBR: C-terminal binding region. CIM: CBR interacting motif.  
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4.4 The thermodynamic basis of Rab recycling  
4.4.1 The functional segregation of REP and GDI  
 
As described in Chapter 4.3, REP is a multifunctional protein that recruits a 
newly synthesized RabGTPase and presents it to the RabGGTase by binding to its α 
subunit (Pylypenko et al., 2003). After addition of, in most cases, two geranylgeranyl 
moieties onto C-terminal cysteines of Rab, the catalytic ternary complex dissociates 
and the prenylated Rab:REP complex travels to the destined membrane organelle 
(Alexandrov et al., 1994). Insertion of geranylgeranyl moieties into lipid bilayers 
ensures stable association of RabGTPases with membranes (Ghomashchi et al., 
1995; Shahinian and Silvius, 1995). Membrane-bound Rabs are activated by 
nucleotide exchange and mediate processes of vesicular transport, docking and 
fusion. Eventually Rab proteins are converted into the GDP bound form and become 
available for extraction by GDP dissociation inhibitor (GDI) (Araki et al., 1990). 
Similar to REP, GDI is a tightly packed molecule composed of two domains (Figure 
4-4-1), the larger of which forms an extended protein:protein interface with the  
catalytic domain of the GTPase, while the smaller one harbors conjugated 
isoprenoids (Rak et al., 2004; Rak et al., 2003; Schalk et al., 1996). GDI is able to 
extract prenylated Rab proteins from membranes and mediate their reinsertion into 
donor membranes. The process of extraction is believed to be thermodynamically 
favored and can occur spontaneously, but additional factors were proposed to be 
involved in its regulation (Chen and Balch, 2006; Goody et al., 2005). Remarkably, 
the structurally and functionally related REP is inefficient in extracting Rab proteins 
from membranes despite its high affinity for these molecules (Pylypenko et al., 2006; 
Rak et al., 2004).  
As mentioned above, the overall structure of REP-1 shows high similarity with 
that of RabGDI (Figure 4-4-1). Comparative structural and functional analysis of REP 
and GDI revealed that the Rab binding site of REP is more extensive than that of GDI 
and allows it to bind unprenylated RabGTPases with nanomolar affinity. In contrast, 
GDI binds unprenylated Rab proteins with micromolar or worse affinity and 
prenylation of Rabs is strictly required for stable complex formation as discussed in 
Chapter 4.3. Moreover, residues correspondingly to F279 and R290 in REP, whereas 
the key residues in REP:RabGGTase interaction that are essential for prenylation of 
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Rab proteins revealed by crystal structure of REP-1:RabGGTase and mutational 
analysis, are not present in GDI (Pylypenko et al., 2003; Alory and Balch, 2000). 
These observations explain why it is REP but not GDI can support Rab prenylation.   
 
Figure 4-4-1. Structural comparison of REP-1 (left) and αRabGDI (right). Domain I of REP-1 and 
RabGDI is shown as a blue ribbon, domain II is displayed in light blue, the Rab-binding platform in red, 
the C-terminal binding region (CBR) in pale orange and the mobile effector loop (MEL) in green. The 
lime dashed arrow ribbon shown in REP-1 represents the unstructured part. 
 
In order to understand the functional segregation of these two molecules in Rab 
recycling, recently, we proposed a model that postulated that the affinity difference in 
the REP/GDI interaction with prenylated and unprenylated forms of Rab proteins 
determines and distinguishes their role in the Rab cycle (Goody et al., 2005). 
Although formally consistent, this model was based on very approximate estimates of 
the prenylated Rab affinities for GDI and REP, due to technical difficulties associated 
with handling prenylated proteins. Geranylgeranylated proteins aggregate in aqueous 
solutions and require the presence of detergents to compensate for the 
hydrophobicity of the lipid moieties. Classical experiments used low concentrations of 
detergent to keep prenylated Rab9 in solution and estimate its affinity to GDI by 
measuring the influence of the GDI concentration on the rate of nucleotide release 
from the former (Shapiro and Pfeffer, 1995). This study concluded that prenylated 
Rab9 has a nanomolar affinity for GDI while also demonstrating that concentration of 
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detergent strongly influences Rab:GDI interactions. The affinity of REP for prenyated 
Rab is still unknown, making it impossible to develop a quantitative comparative 
model of REP/GDI mediated Rab cycling. This is a shared problem in the analysis of 
geranylgeranylated proteins and is exemplified, for instance, by Rho and RhoGDI 
interactions, where no reliable affinity estimates are available. In this work, to 
address that perplexing question we used novel techniques that enable us to get the 
absolute affinities and study the kinetics of interaction of GDI and REP with 
prenylated RabGTPase.  
4.4.2 Development of a fluorescent sensor for the 
interaction of prenylated Rab with REP and GDI  
 
In order to gain insight into the interaction of prenylated Rab GTPase with its 
regulatory proteins or membranes, two interconnected technical issues need to be 
addressed. First, an efficient and if possible time-resolved method for monitoring the 
interaction of prenylated Rab with REP and GDI needs to be devised. Secondly, a 
way needs to be found to apply this assay to monitor the interaction of prenylated 
Rab with REP and GDI in the absence of detergent, which is known to strongly 
influence the properties of the prenylated proteins (Shapiro and Pfeffer, 1995). 
As already shown in Chapter 4.1.3, we have developed an in vitro Rab 
prenylation assay that takes advantage of a 20-fold increase in the fluorescence 
intensity of a geranylgeranyl pyrophosphate (GGPP) analogue, NBD-FPP (Scheme 
4-7), upon its utilization as lipid substrate by RabGGTase (Wu et al., 2006). In the 
case of NBD-FPP, a monoprenylated reaction intermediate could dissociate from 
RabGGTase and needed to rebind to acquire the second prenyl moiety, in stark 
contrast to the native reaction (Wu et al., 2006; Thoma et al., 2001c). This increased 
tendency to dissociate is a consequence of reduced hydrophobicity of the fluorescent 
analogue compared with the native isoprenoid. We conjectured that the NBD-
farnesylated Rab molecule would on the one hand have the features of 
geranylgeranylated Rab proteins and on the other hand be more soluble than 
natively prenylated protein. However, to produce NBD-farnesylated Rab by 
enzymatic approach turned out to be impractical, since it binds to REP too tightly to 
be efficiently separated. Since we have established a platform for production of 
fluorescent Rab conjugates as described in Chapter 4.1, we chose an expressed 
protein ligation approach for construction of NBD-farnesylated Rab (Durek et al., 
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2004a; Muir, 2003; Muir et al., 1998). To this end, we synthesized a tripeptide Cys-
Ser-Cys(NBD-farnesyl) and ligated it in vitro to sodium 2-mercaptoethanesulfonate 
(MESNA) thioester-tagged Rab7 lacking three C-terminal amino acids (Scheme 4-7). 
The Rab7Δ3-MESNA thioester is produced using the same approach as described in 
section 4.1.2.1. 
Scheme 4-7. Construction of prenylated fluorescent Rab7. (A) The fluorescent analogue of 
geranylgeranyl, NBD-farnesyl. (B) Synthesis of the fluorescent analogue of mono-geranylgeranylated 
Rab, Rab7-NBD-farnesyl. 
 
 
 
Ligation of soluble Rab thioester with aqueously non-soluble prenylated peptide 
meets a problem of inhomogeneous reaction, which makes the typical ligation 
condition not applicable. Our group has identified detergents that are able to mediate 
the ligation of Rab with prenylated peptide. Only few of them are functional, like 
DDMAB (N-dodecyl-N,N-(dimethylammonio)butyrate) and CTAB 
(Cetyltrimethylammonium bromide), which are also observed facilitating the 
conjugation of fluorescent dye with Rab (section 4.1.2.3, Figure 4-9).   
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Figure 4-4-2. Optimization of the reaction conditions for the ligation of Rab7Δ3-MESNA with 
Cys(StBu)SerCys(NBD-farnesyl). (A) Screening of detergent for ligation. Reaction was run overnight 
at 30°C in the presence of 50mM detergent in buffer: 25mM Na-Pi, pH 7.5, 25mM NaCl, 2mM MgCl2, 
100μM GDP, 100mM MESNA. The concentrations of protein and peptide are 0.21 mM and 2 mM, 
respectively. (B) Ligation in the presence of various concentrations of CTAB at 30°C. Other conditions 
are the same as in A. (C) Ligation in the presence of 40 mM CTAB at different temperatures. Other 
conditions are the same as in A. As a control Rab7wt was present in the reaction instead of Rab7Δ3-
MESNA thioester. The lower columns in each panel show the quantification of the corresponding 
fluorescent bands. (D) The structure of CTAB. 
 
In the effort to create Rab7-NBD-farnesyl conjugate, we encounter the same 
problem as the synthesis of geranylgeranylated Rab. Based on previous experience, 
we sought to identify an additive that would facilitate synthesis of NBD-farnesylated 
Rab. The fluorescently labeled peptide allows convenient assay of the ligation 
efficiency by means of SDS-PAGE where the ligated product can be quantified by a 
fluorescence reader as described in section 4.1.3. A small set of detergents including 
CTAB and DDMAB were screened for their abilities to support ligation reaction. 
Although all of detergents can facilitate solubilization of the prenylated peptide, only 
CTAB is able to efficiently support the ligation (Figure 4-4-2 A). We then sought to 
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find out at what concentration CTAB can catalyze the ligation reaction. As can be 
seen in Figure 4-4-2 B, reducing the concentration of CTAB lower than 10mM led to 
significant decrease of ligation efficiency, suggesting that the concentration of CTAB 
above CMC is essential for the ligation (CMC of CTAB is 0.9mM in aqueous solution). 
As discussed in section 4.1.2.3, this effect might be a result of micelle catalyzed 
reaction (Figure 4-1-10).  
Figure 4-4-2 C shows that the level of ligation after 12 h was essentially 
independent of reaction temperature above 20°C. In a control experiment, Rab7wt 
lacking the thioester, thereby would be expected not to undergo ligation, showed only 
residual fluorescence incorporation, which might be resulted from non-specific 
binding and coupling with peptide through disulfide bonds. This result confirms the 
specificity of the chemical ligation reaction (Dawson et al., 1994) and reliability of the 
SDS-PAGE assay. 
 
 
Figure 4-4-3. Purification of NBD-farnesylated Rab7. (A) After reaction, supernatant (S) and pellet (P) 
were separated. In the control experiments, Rab7wt was used instead of Rab7Δ3-MESNA thioester in 
the presence of peptide and the absence of peptide. (B) Quantification of the fluorescence of the 
protein bands shown in A. (C) Separation of protein and unligated peptide by washing with organic 
solvents. T: mixture after reaction, S: supernatant after reaction, W: MeOH solution after washing the 
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pellet, P: pellet after washing. (D)   Quantification of the fluorescence of the corresponding protein and 
peptide bands shown in C. 
 
As expected under such harsh reaction conditions both ligated and unligated 
protein were denatured and formed precipitate. As can be seen in Figure 4-4-3 A and 
B, protein was found mostly in the pellet, while the majority of unligated peptide 
remained in the supernatant. A crude purification of the ligated protein from unligated 
peptide and detergent can be achieved simply by separation of the supernatant and 
the pellet. Subsequent washing of the ligation mixture with organic solvent, such as 
methanol and dichloromethane, led to extraction of the peptide and detergent to the 
organic phase but left protein in the pellet (Figure 4-4-3 C and D). Some residual 
contaminating peptide and detergent could be removed in a later refolding, dialysis 
and gel filtration step.  
 
 
Figure 4-4-4. Gel filtration chromatography of semi-synthetic Rab7-NF and confirmation of its correct 
folding. (A) Elution profile of Rab7-NF resolved on a Superdex-200 column and analysis of the 
resulting fractions by SDS-PAGE followed by Coomassie blue staining (inset). The black lines 
represent absorbance at 280 nm while the blue line represents fluorescence detection. The arrows on 
the top panel indicate elution position of molecular weight standards in kDa. Fractions 19-21 
containing Rab7-NF were collected with >80% purity and used for further analysis. (B) HPLC elution 
profile of Rab7-NF alone (17.8 min, black line) or in vitro prenylated with GGPP (19.1 min, red line). 
The control reaction where REP was omitted is shown as a blue line (17.8 min.). The HPLC 
fluorescence detector was set to λex/em values of 490 and 535 nm. (C) MALDI-MS analysis of Rab7-NF 
(black, Mcalc = 23,770 Da) and its in vitro geranylgeranylated form (blue, Mcalc = 24,043 Da), i.e., 
Rab7C(geranylgeranyl)SC(NBD-farnesyl). (D) Gel filtration chromatography of Rab7-NF (black solid 
line) and Rab7-NF in the presence of GDI. The samples were resolved by a Superdex-200 gel 
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filtration column and eluted proteins were detected both by absorbance at 280 nm (black dashed line) 
and by fluorescence (blue solid line) of NBD. 
 
Subsequent resolubilization and renaturation steps follow the protocol developed 
for geranylgeranylated Rab (Durek et al., 2004b). The denatured ligated product was 
resolubilized in 6 M GdmHCl buffer containing reductant DTE and detergent CHAPS. 
Renaturation of the denatured protein was achieved by pulse-refolding approach in 
which the denatured protein was titrated into refolding buffer of typical 30-fold dilution 
in pulses (Clark et al., 1999). Addition of CHAPS, arginine, trehalose and cofactors 
(e.g. GDP or GTP) in the refolding buffer has been shown to improve yields of 
renaturation. 
The resulting Ra7-NF protein remained in solution after removal of detergent 
present during protein ligation and purification - an atypical behavior for 
geranylgeranylated protein that tends to form aggregates under these conditions. 
The ligated protein eluted from a size exclusion column at a position corresponding 
to a molecular mass <10 kDa whereas unligated protein eluted at the expected 
position corresponding to 28 kDa (Figure 4-4-4 A), suggesting that the protein does 
not form multimers and that its migration is retarded on the column probably by 
hydrophobic interaction with the matrix. Distinct character of ligated and unligated 
protein allows convenient separation of both species by gel filtration.  
The solubility of Rab7-NF is not surprising, since the reduction in the length of 
the isoprenoid chain is known to decrease the hydrophobicity of the prenylated 
protein, for example, farnesylated RasGTPases per se is soluble (Jügen Kulmann, 
personal communication), and the introduction of polar NBD group to farnesyl moiety 
could also reduce its hydrophobicity (Nguyen et al., 2007; Dursina et al., 2005; 
Chehade et al., 2002).  
Semisynthetic Rab7-NBD-farnesyl (Rab7-NF) displayed the expected molecular 
mass (Figure 4-4-4 C) and was correctly folded as judged by its ability to form a 
stoichiometric complex with GDI (Figure 4-4-4 D). The formation of the complex gives 
a first indication that the NBD-farnesyl group contributes to assembly of the Rab:GDI 
complex. To further assess the extent to which the semisynthetic Rab7-NF emulates 
the monoprenylated Rab protein we subjected it to in vitro prenylation by 
RabGGTase by using geranylgeranyl pyrophosphate (GGPP) as a substrate. In this 
case, the isoprenoid should be incorporated onto the C-terminal cysteine that was 
used as a ligation site (Scheme 4-7). The in vitro prenylation reaction was analyzed 
both by reversed phase HPLC (Figure 4-4-4 B) and MALDI-TOF (Figure 4-4-4 C), 
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confirming that the geranylgeranyl group was conjugated to the previously free C-
terminal cysteine. Therefore, the constructed semisynthetic protein closely mimics 
monoprenylated Rab7 in this respect. 
 
 
Figure 4-4-5. Analysis of interaction of Rab7-NF with RPE and GDI. (A, C) Emission spectra of Rab7-
NF in the absence and in the presence of REP-1 (A) and αRabGDI (C). (B, D) Titration of REP-1 (B) 
and RabGDI (D) to a 10 nM solution of Rab7-NF. (D) Titration of GDI to a 10 nM solution of Rab7-NF. 
The fluorescence of NBD was excited at 479 nm, and the emission was collected at 525 nm. Kd values 
were obtained by fitting the data to a quadratic equation (see section 8.1.1). 
 
Since semi-synthetic Rab7-NF is both soluble and active, we attempted to use 
the fluorescence of the conjugated NBD-farnesyl group to monitor its interaction with 
REP and GDI. As shown in Figure 4-4-5 A, addition of REP-1 to a solution of Rab7-
NF resulted in a 10-fold increase of fluorescence and a blue shift from 545 to 525 nm. 
Similar behavior was observed on addition of GDI, albeit with a 5-fold fluorescence 
increase (Figure 4-4-5 C). The large fluorescence change enabled us to perform 
titration experiments to determine the affinity of the Rab7-NF:REP interaction, which 
is expected to be in the low nanomolar range and hence must be assayed at very low 
concentrations of the reactant. The dramatic enhancement in fluorescence is 
presumably a consequence of the Rab-conjugated NBD-farnesyl group binding in the 
hydrophobic lipid binding site on REP and GDI, as proposed in the model of 
fluorescence enhancement in the NBD-farnesylation (Wu et al., 2006; Pylypenko et 
al., 2006; Rak et al., 2004). Titration of 10 nM Rab7-NF with REP-1 yielded a Kd 
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value of 0.28 nM (Figure 4-4-5 B). A similar experiment using GDI yielded a Kd value 
of 21nM (Figure 4-4-5 D). These data indicate that the Rab7-conjugated NBD-
farnesyl group increases the affinity of Rab7:REP complex by a factor of ca. 5 
compared with unprenylated Rab (Kd= ca. 1 nM, ref (Alexandrov et al., 1998)), while 
its effect on the Rab7:GDI interaction is much more pronounced. Unprenylated 
RabGTPases interact with GDI with micromolar affinities implying that the presence 
of NBD-farnesyl increases the affinity of the complex by >100 fold (Pylypenko et al., 
2006). 
4.4.3 Construction and solubilization of semi-synthetic 
geranylgeranylted Rab7  
 
The data described above reflects the different effects prenylation has on 
Rab:REP and Rab:GDI interactions. However, this is an artificial system and thus the 
data may be only an approximation of the native situation. Thus, we sought a way to 
repeat some of these experiments with natively geranylgeranylated Rab7.  
Geranylgeranyl modified Rab proteins are soluble in the presence of detergents, 
however their presence significantly affects the interaction between prenylated Rab 
and GDI (Shapiro and Pfeffer, 1995).  Ideally, a chaperone would be needed that on 
the one hand would prevent aggregation of prenylated Rab but on the other hand not 
interfere with its protein:protein interactions.  
To make geranylgeranylated Rab soluble but exclude detergent, we searched 
for a chaperone that can stabilize the prenylated Rab and can deliver it to REP and 
GDI. Yeast GDI (yGDI) and yeast homologue of REP, MRS6, which can be 
expressed in E coli., bind with Rab7-NF in a high affinity (Kd=4.3±0.49nM and 
0.94±0.46nM, respectively). This prompted us to choose the relative low affinity 
chaperone, yGDI, for protein engineering, in order to idenfity yGDI mutants that could 
solubilize prenylated Rab but display much lower affinity for it. Analysis of crystal 
structure of prenylated Ypt1:yGDI complex (PDB code 1URV) (Rak et al., 2003) 
reveals that Y44, E241 and R248 are important residues in Rab binding platform of 
yGDI. Mutation of these residues would be expected to reduce the affinity between 
yGDI and GTPase domain of Rab. Quantitative analyses of the interactions between 
Rab7-NF and yGDI mutants show that the mutations indeed lead to significant 
decrease in affinity, and this effect correlates with the contribution of these residues 
to the interaction of the complex (Table 4-4-1).  
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Table 4-4-1. Affinity of Rab7-NF to MRS6 and yGDI. 
Protein Kd (nM) 
Fluorescence 
enhancement  (fold) Contact area
a 
MRS6       0.91±0.46 6  
yGDI       4.0±0.49 7  
yGDI Y44A   670±72 6 47 
yGDI E241A   114±7.5    6.5    29.6 
yGDI R248A 2505±220 8 60 
a Contact area involved for the corresponding residue in Ypt1-G:yGDI complex (PDB code 1URV) 
 
 
Figure 4-4-6. Analysis of interaction of Rab7-NF:REP-1 in the absence and the presence of indicated 
concentrations of yGDI E241A. The graph shows the titration profiles and fittings. Results are 
summarized in the table. Effective concentration of Rab7-NF is the concentration fitted. 
 
Gel filtration analysis shows that yGDI E241A is able to form a complex with 
Ypt1Δ3CC(geranylgeranyl)C(geranylgeranyl), so that it can be used as a chaperone 
to solubilize the doubly geranylgeranylated Ypt1 protein (data not shown). The 
relative low affinity between prenylated Rab and yGDI mutant enables delivery of 
prenylated Rab to REP as can be seen in Figure 4-4-6. The starting fluorescence of 
Rab7-NF before titration of REP increased with the increase of concentration of yGDI 
E241A, indicating the formation of complex between Rab7-NF and yGDI E241A.  
Titration of REP led to further increase of the fluorescence, suggesting competition 
between REP and yGDI in binding to Rab7-NF, since REP binds Rab-NF much 
tighter and gives higher enhancement (10-fold) in fluorescent intensity. The presence 
of increasing concentration of yGDI E241A resulted in enlargement of apparent Kd 
values but constant effective concentration of Rab7-NF. This further confirmed that 
yGDI E241A is competitive with REP in binding to Rab7-NF and was fully displaced 
by REP at the end.  
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Although we achieved our objective of creating a chaperone capable of 
solubilization and release of prenylated Rab, it displayed several drawbacks that 
rendered its usefulness for our purpose. First, binding of Rab7-NF to yGDI and 
mutants saturates the fluorescence enhancement (Table 4-4-1), resulting in reduction 
of the fluorescence sensitivity upon binding of Rab7-NF to REP and GDI. Moreover, 
and most importantly, yGDI mutant also functions as a good competitor for the 
interaction of prenylated Rab with REP/GDI. To make geranylgeranylated Rab 
(especially doubly geranylgeranylated Rab) stable in solution, a high concentration of 
the chaperone has to be applied. This would cause significant inhibition of the 
interaction of prenylated Rab with REP/GDI (Figure 4-4-6).  
The limited success of engineered specific chaperone drove our attention to 
unspecific chaperone that would not influence the fluorescent signal and interaction 
of the system. Since the hydrophobic geranylgeranyl moiety is the primary cause for 
the insolubility of prenylated Rab, we speculated that the β-subunit of RabGGTase, 
which contains a geranylgeranyl lipid binding site, might function as an unspecific 
isoprenoid chaperone. To prevent interactions of RabGGTase with REP we chose to 
work with the β-subunit only (Pylypenko et al., 2003).  
In the light of this idea, semi-synthetic mono-geranylgeranylated Rab7 (Rab7-G) 
was prepared as described before and was renatured in the presence of an 
equimolar amount of recombinant β-subunit of RabGGTase (βGGT). The mixture 
was subjected to size exclusion chromatography. Both proteins coeluted at a position 
corresponding to a molecular weight of ca. 45kDa, which is deviated from the elution 
position of the mixture of unprenylated Rab7 and βGGT from gel filtration (Figure 4-4-
7 A). This and the fact that no Rab7-G was recovered in the void volume indicate that 
prenylated Rab7 was stabilized in solution in the absence of detergent by forming a 
stoichiometric complex with βGGT. This finding is not surprising considering the fact 
that prenyltransferases typically remain in complex with their products and that these 
are eventually released by the binding of new lipid substrate molecules (Thoma et al., 
2001b; Tschantz et al., 1997). We believe that the presented method will be 
applicable to all prenylated polypeptides and should enable quantitative analysis of 
their interactions with proteins and membranes. 
The native folding and functionality of stabilized monoprenylated Rab7 was 
assessed by in vitro prenylation and analyzed by SDS-PAGE in which the 
incorporation of NBD-farnesyl to Rab7-G was quantified (Figure 4-4-7 C). The βGGT 
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stabilized Rab7-G complex could be efficiently prenylated by RabGGTase, 
confirming that the protein was fully functional and that the presence of βGGT did not 
significantly influence its ability to interact with REP. Its functionality was assayed by 
the conjugation of the second geranylgeranyl group resolved on MALDI-TOF as well 
(data not shown). Prenylated Rab proteins could also be stabilized in solution using 
delipidated BSA (Dirac-Svejstrup et al., 1994), but required higher molar excess of 
the later.  
 
Figure 4-4-7. The construction of soluble mono-geranylgeranylated Rab7 stabilized with the β subunit 
of RabGGTase. (A) Gel filtration chromatography of Rab7-G:βGGT on a Superdex 200 column and 
SDS-PAGE analysis of resulting fractions (upper). As a control, the same process applied to a mixture 
of Rab7wt and βGGT gave SDS-PAGE analysis of the same fractions as above (lower). (B) MALDI-
MS analysis of Rab7-G:βGGT complex (Mcalc=23660Da for Rab7-G). (C) The activity of Rab7-G in 
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complex with RabGGTase (Rab7-G:GGT) and βGGT (Rab7-G:βGGT) was confirmed by in vitro 
prenylation assay resolved by SDS-PAGE. The same amount of single C-terminal Cys mutant 
Rab7C207S was run as a positive control. The middle panel represents the fluorescent scan of the gel, 
while the top panel shows the same gel stained with Coomassie blue. The bottom panel shows the 
quantification of incorporation of NBD-farnesyl to Rab7 in the corresponding reactions. 
 
Our group previously reported synthesis of a semi-synthetic doubly prenylated 
fluorescent variant, Rab7-A202C-E203K(dans)SC(GG)SC(GG) termed Rab7d-GG. 
This protein was produced using ligation of Rab7Δ6-MESNA thioester with a peptide 
CK(dans)SC(GG)SC(GG). The molecule displayed near native properties and was 
used earlier as a fluorescent sensor for analysis of the interaction of the prenylated 
Rab7:REP complex with RabGGTase (Durek et al., 2004a).  
 
 
Figure 4-4-8. Analysis of stability of Rab7d-GG:βGGT and Rab7d-GG:BSA by SDS-PAGE. 28 μM 
Rab7d-GG were present in 10.3 mg/ml βGGT and 15.6 mg/ml delipidated BSA, respectively. The 
protein mixture was diluted 5, 10, 20, 40, 80 and 160 times, and incubated in room temperature for 1h. 
Mixture was ultracentrifuged for 10 min to separate the supernatant and pellet, and subsequently 
resolved by SDS-PAGE followed by fluorescent scanning. The fluorescence of dansyl was quantified 
by Quantity One software. 
 
 However, not like in case of mono-geranygeranylated Rab7, the stoichiometric 
complex of Rab7d-GG with βGGT could not be detected by gel filtration 
chromatography. After dialysis of detergent at the presence of low concentration 
(nanomolar) of βGGT, most of digeranylgeranylated protein precipitated, which can 
be judged by the fluorescence of the protein in the supernatant and the pellet (data 
not shown). We interpreted this as a consequence of the relative low affinity of 
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digeranylgeranylated Rab7 from βGGT and the higher hydrophobicity of 
digeranylgeranylated molecules that tend to aggregate. Nevertheless, this molecule 
could be stabilized in solution in the absence of detergent with higher concentration 
(micromolar) of βGGT or dellipidated BSA (Figure 4-4-8). Most of the 
digeranylgeranylated protein remained soluble even after the hundred times dilution 
with buffer. 
 
 
Figure 4-4-9. (A) Elution profile of a Superdex 200 gel filtration chromatography loaded with Rab7d-
GG refolded in the presence of BSA (black line), Rab7d-GG:BSA in the presence of REP (red line), 
Rab7d-GG refolded by REP (blue line) and Rab7d-GG:REP low molecular mass fractions from gel 
filtration (lime line), detected by fluorescence with excitation at 340 nm and emission at 480 nm. (B) 
The same as A, elution profile was recorded by absorbance at 280 nm. 
 
Both approaches yielded native, correctly folded Rab7 GTPase that could form a 
binary complex with REP and GDI as confirmed by gel filtration analysis (Figure 4-4-
9) and fluorescence resonance energy transfer (FRET) detection (Figure 4-4-10). As 
can be seen in Figure 4-4-9, Rab7d-GG refolded in the presence of REP displayed 
two fractions, one eluted at 670 kDa and the other at 220 kDa, which correspond to 
oligomer and dimer of the complex, respectively. Figure 4-4-9 B blue line shows that 
dimer is the major component, while the fluorescence of dansyl was enhanced in the 
oligomeric protein so that a larger peak appeared at 670 kDa in the fluorescence GF-
profile (Figure 4-4-9 A, blue line). The black profile in Figure 4-4-9 shows that Rab7d-
GG:BSA is a heterogeneous mixture, addition of REP into it resulted in the formation 
of Rab7d-GG:REP complex characterized by appearance of a peak at 220 kDa (red 
line). The functionality of Rab7d-GG was also ascertained by FRET analysis. As 
shown in Figure 4-4-10 A and B, addition of REP or GDI to Rab7d-GG:BSA led to 
A B 
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reduction of FRET from tryptophan to dansyl. Assuming BSA bound Rab7d-GG has 
higher FRET efficiency than REP bound state, which could be a result of more 
tryptophans in BSA, shorter distance between tryptophan and dansyl in BSA bound 
state, or more oligomization of Rab7d-GG:BSA, decrease in FRET indicates 
transformation of Rab7d-GG:BSA to Rab7d-GG:REP. As a control, dansyl labeled 
unprenylated Rab7, Rab7Δ2C(dansyl)SCC (see Chapter 4.1.2), exhibited increase of 
FRET upon addition of REP, but no FRET on addition of GDI (Figure 4-4-10 E, F), 
consistent with the fact that REP can bind to unprenylated Rab but GDI cannot. In a 
positive control, a homogeneous complex of dansylated monoprenylated Rab7 
(Rab7-A202C-E203K(dans)SC(GG)SC (Durek et al., 2004a), Rab7d-G) with βGGT 
that was shown to be functional by the same assays as those used for Rab7-G:βGGT 
(data not shown) displayed analogous decrease of FRET upon addition of REP or 
GDI (Figure 4-4-10 C, D). This suggests that translocation of Rab7d-G from βGGT to 
REP/GDI is characterized by decrease in FRET between trypophan and dansyl. 
These observations demonstrate that Rab7d-GG in the presence of BSA or βGGT, 
albeit heterogeneous, is functional and capable to a complex with REP and GDI. 
 
 
Figure 4-4-10. Emission spectra of Rab7d-GG:BSA (A-B), Rab7d-G:βGGT (C-D), 
Rab7Δ2C(dans)SCC (E-F) in the absence (solid line) the presence of REP/GDI (dashed line). 
Excitation was at 280nm to record the FRET from tryptophan to dansyl. 25 nM Rab7d-GG with 250 nM 
BSA, 100 nM Rab7d-G:βGGT, 150 nM Rab7Δ2C(dansyl) in E and 75 nM in F. 80 nM REP in A, 109 
nM GDI in B, 120 nM REP in C, 218 nM GDI in D, 520 nM βGGT and 300 nM REP in E, 250 nM 
βGGT and 218 nM REP in F, 
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4.4.4 Quantitative analysis of the interaction of mono- and 
digeranylgeranylated Rab7 with REP and GDI  
 
The availability of solubilized Rab7-G allowed us to devise an approach for 
monitoring its interaction with REP and GDI. Since Rab7-G by itself cannot be used 
as a reporter of the interaction, we decided to use the fluorescent Rab7-NF as a 
reporter. To this end 10nM Rab7-NF was mixed with 10nM Rab7-G:βGGT complex 
and the resulting solution was titrated with increasing concentrations of REP.  As 
shown in Figure 4-4-11 A, there was an initial “lag” in the fluorescence increase, 
indicating that Rab7-G bound more strongly to the REP than Rab7-NF, initially 
resulting in the formation of a fluorescently silent complex. However, at higher REP 
concentrations, complex formation with Rab7-NF then occurs, leading to an increase 
in fluorescence intensity. Since the Kd value for the Rab7-NF:REP interaction had 
been determined independently, the data could be fitted numerically using a 
competitive binding model leading to a Kd value of 58 pM for the Rab7-G:REP. The 
same approach was applied to the analysis of the interaction of GDI with Rab7-G and 
determined a Kd value of 1.2 nM for this interaction (Figure 4-4-11 B). 
 
 
Figure 4-4-11. Analysis of interaction of mono- and digeranylgeranylated Rab7 with REP and GDI 
using Rab7-NF as a reporter. (A and B) Titration of REP (A) or GDI (B) to a mixture of 10 nM Rab7-
G:βGGT and 10 nM Rab7-NF. (C) Titration of REP to 25 nM Rab7-NF (open cycle) and a mixture of 
25nM Rab7-NF and 50 nM Rab7d-GG with 500 nM BSA (filled square). (D) Titration of GDI to 25 nM 
Rab7-NF (open cycle) and a mixture of 25nM Rab7-NF and 25 nM Rab7d-GG with 250 nM BSA (filled 
square) (λex/em:479/525nm). The data were fitted to a competitive binding model to give Kd values of 
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Rab7-G and Rab7d-GG for REP and GDI, where Kd values of 0.22nM and 21nM of Rab7-NF for REP 
and GDI respectively were fixed. 
 
A potential pitfall of this experiment relates to the influence of βGGT. This 
uncertainty comes from the unavailability of the affinity between Rab7-G and βGGT. 
Although this could in principle be included during fitting procedure, introduction of 
more parameters complicates the fitting and reduces the accuracy of simulation. 
However, the presence of low concentration of βGGT has negligible influence on 
Rab7-G:REP/GDI interaction. As shown in Figure 4-4-12, a series of titrations in the 
presence of different concentrations (<20 nM) of Rab7-G:βGGT complex resulted in 
identical Kd values for Rab7-G and REP/GDI interaction. Remarkably, Rab7-NF binds 
βGGT with relatively low affinity (Kd=114±0.1nM), and assuming a not dramatically 
higher affinity of Rab7-G, the presence of βGGT with a concentration far below Kd 
would not give rise to significant association with Rab7-NF and Rab7-G, so that the 
influence of these interactions on the calculation of Kd values for Rab7-G:REP/GDI 
can be ignored. Hence, the approximation is sound and sufficient for the 
mathematical simulation.  
This argument, however, provokes another question: since Rab7-G is mostly 
dissociated from βGGT under such a low concentration, how could the prenylated 
Rab still be in the solution but not precipitate? We proposed that the dynamic 
equilibrium of interaction between Rab7-G and βGGT would transiently stabilize 
Rab7-G. This effect as well as the low concentration of protein may lead to a slow 
aggregation of Rab7-G so that it is available for titration that was typically completed 
within several minutes. Because the concentration of Rab7-G applied in titration is 
much higher than Kd values, its effective concentration could be accurately 
determined from the titration, which is quite close to the nominal concentration. This 
implies that most of Rab7-G is soluble and functional during the course of experiment. 
  
 
Figure 4-4-12. (A) Titration of REP to 5 nM Rab7-NF in the presence of the indicated concentrations of 
Rab7-G:βGGT. (B) Titration of GDI to 19 nM Rab7-NF in the presence of indicated concentrations of 
Concentration  
of Rab7-
G:βGGT (nM) 
Kd(Rab7-
G:REP) 
(nM) 
Kd(Rab7-
G:GDI) 
(nM) 
 5  1.1 
    7.5 0.058  
10     0.88 
15 0.081  
19 0.079  
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Rab7-G:βGGT. The data were processed as in Figure 4-4-11. The resulting Kd values were 
summarized in the table. 
Natively monoprenylated Rab proteins comprise only a small subgroup of 
mammalian Rab GTPases and are absent in yeast. We therefore wished to explore 
the possible differences in the interaction of REP and GDI with the doubly and singly 
prenylated forms of Rab7. To measure the affinities for these interactions we used 
the above described competitive titration with Rab7-NF as a fluorescent reporter. A 
mixture of equimolar amount of Rab7-NF and Rab7d-GG was titrated with REP and 
GDI using only the NBD fluorescence as a signal (Figure 4-4-11 C,D). Remarkably, 
in this case the initial lag in fluorescence increase was not observed, suggesting that 
diprenylated Rab7 binds to its regulators more weakly than its monoprenylated form.  
 
Figure 4-4-13. Interaction analysis of Rab7d-GG with REP and GDI. (A and B) The emission spectra 
of Rab7d-GG:BSA in the absence and the presence of REP(A) or GDI (B), λex=340nm. (C and D) 
Titration of REP (C) or GDI (D) to 25 nM Rab7d-GG with 250 nM BSA (λex/em: 340/479nm). Kd values 
were obtained by fitting the data to a quadratic equation. (E and F) Titration of REP (E) or GDI (F) to a 
mixture of 25nM Rab7d-GG with 250 nM BSA and 25nM Rab7-G:βGGT. (λex/em: 340/479nm). Kd 
values were obtained by fitting the data by numerical simulation where the Kd values of 0.06nM and 
1.5nM of Rab7-G for REP and GDI respectively were fixed. 
 
To confirm these data using an independent approach we took advantage of the 
dansyl group at position 203 of Rab7 that provides a sensitive fluorescence change 
upon interaction of Rab7d-GG with REP or GDI (Figure 4-4-13 A, B) and was used 
as a reporter in the titrations. Competitive titration of an equimolar mixture of Rab7d-
GG and Rab7-G with REP using the fluorescence of dansyl group, which displayed a 
lag in the fluorescence change (decrease in this case) arising from preferential 
binding to the non-fluorescent monoprenylated form (Figure 4-4-13 E, F). Numerical 
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fit of the data from the competitive titrations of the Rab7-NF/Rab7d-GG and the 
Rab7d-GG/Rab7-G mixture with REP and GDI gave Kd values consistent with those 
obtained from direct titrations [Kd(Rab7d-GG:REP)=1.3 nM, Kd(Rab7d-GG:GDI)=5.0 
nM] (see Figure 4-4-13 C, D). The dissociation constants indicate that mono-
prenylated Rab GTPase has a 20-fold higher affinity for REP than the doubly 
prenylated form, while in case of GDI the affinity difference is only 3-fold. 
 
 
Figure 4-4-14. (A and B) The emission spectra of Rab7Δ2C(dans)SCC in the absence and in the 
presence of GDI (A) and REP (B), λex=340nm. (C) Titration of REP to 75nM Rab7Δ2C(dans)SCC. 
(ex/em:340/486nm). The Kd value was obtained by fitting the data to a quadratic equation. 
The REP/GDI-induced decrease in dansyl fluorescence is specific for prenylated 
Rab7. As shown in Figure 4-4-14 A, no fluorescence change was observed when 
GDI was added to unprenylated and dansylated Rab, Rab7Δ2C(dansyl)SCC, in 
agreement with previous observations and ITC result (Table 4-4-3). Addition of REP 
to Rab7Δ2C(dansyl)SCC resulted in  ca. 10% fluorescence increase. These 
observations indicate that the observed quenching of dansyl fluorescence in the case 
of Rab7d-GG:REP/GDI interactions was indeed due to the presence of the 
isoprenoid moieties (Figure 4-4-14 B,C). The Kd value of Rab7Δ2C(dansyl)SCC:REP 
interaction was determined to be 1.1±0.3nM, in agreement with the previous report 
(Alexandrov et al., 1998). 
It should be noted that the titration system for Rab7d-GG contains an excess of 
solubilizer, delipidated BSA (250 nM). However, the presence low micromolar BSA 
did not have obvious influence on the interactions of Rab7d-GG with REP and GDI 
(Figure 4-4-15). This could be interpreted to be a result of low affinity of Rab7d-GG 
for BSA, associated with that digeranylgeranylated Rab has to be solubilized with 
high concentration of delipidated BSA (section 4.4.3). Still, low concentration of 
delipidated BSA present in titration are sufficient to stabilize Rab7d-GG within the 
time frame of a titration (<10 min). Since the concentration of Rab7d-GG applied in 
REP titration is much higher than Kd value, its effective concentration could be 
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extracted reliably. The effective concentrations of Rab7d-GG obtained from titrations 
in the presence of different concentrations of BSA was close to the nominal one, 
indicating that Rab7d-GG is soluble and functional during the titration. 
 
Figure 4-4-15. Titration of REP (A) and GDI (B) to nominal concentration of 30 nM of Rab7d-GG in the 
presence of indicated concentrations of delipidated BSA. Tables show the values of apparent Kd and 
effective concentration of Rab7d-GG obtained from titrations. 
Table 4-4-2. Summery of dissociation constants and rate constants for interaction between prenylated 
Rab and REP/GDI. 
Complex Kd (nM) koff (s-1) 
Rab7wt:REP-1 1a 0.012a 
Rab7wt:GDI > 5 ×104 b  
Rab7Δ3CSC(NBD-farnesyl):REP-1 0.22±0.06 6.1±0.02 ×10-4 
Rab7Δ3CSC(NBD-farnesyl):GDI-1 14±5.5 0.031±0.001 
Rab7Δ3CSC(NBD-farnesyl): β-GGT 114±0.1 0.13±0.01 
Rab7Δ2SSCC(GG):REP-1 0.061±0.03  
Rab7Δ2SSCC(GG):GDI-1 1.5±0.3  
Rab7Δ6CK(Dans)SC(GG)SC-OMe:REP-1 0.41±0.06  
Rab7Δ6CK(Dans)SC(GG)SC-OMe:GDI-1 4.0±1.4  
Rab7Δ6CK(Dans)SC(GG)SC-OMe:β-GGT  0.1±0.01 
Rab7Δ6CK(NBD)SCSC(GG)-OMe:REP-1 0.19±0.05  
Rab7Δ6CK(NBD)SCSC(GG)-OMe:GDI-1   2.5±0.4  
Rab7Δ6CK(NBD)SCSC(GG)-OMe: β-GGT  0.25±0.05 
Rab7Δ6CK(Dans)SC(GG)SC(GG)-OMe:REP-1   1.3±0.2 0.002 
Rab7Δ6CK(Dans)SC(GG)SC(GG)-OMe:GDI-1   5.2±2.2 0.0013±0.0005 
a(Alexandrov et al., 1998).  b measurement by isothermal titration calorimetery (data not shown) 
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4.4.5 A model for Rab recycling  
 
Table 4-4-3. Kd values of complexes of unprenylated wild type Rab7 and differently prenylated Rab7 
with REP and GDI. 
 Kd  for REP (nM) Kd for GDI (nM) 
Rab7wt 1a > 5x104 b 
Rab7-NBD-farnesyl 0.22±0.06    14±5.5 
mono-geranylgeranylated Rab7 0.061±0.03      1.5±0.3 
di-geranylgeranylated Rab7 1.3±0.2      5.2±2.2 
a(Alexandrov et al., 1998).  b measured by isothermal titration calorimetery (data not shown) 
 
 
Figure 4-4-16. Comparison of lipid binding sites of GDI and REP molecules in complex with prenylated 
Rab GTPases. (A) monoprenylated Ypt1:GDI complex (1UKV), (B) di-prenylated Ypt1:GDI complex 
(2BCG), (C) monoprenylated Rab7:REP complex (1VG0) (D) unprenylated Rab7Δ22:REP complex 
(1VG9). The complexes were optimally superimposed and the domains II were sliced to expose the 
lipid binding site. All molecular manipulations including generation of images were performed with ICM 
browser Pro (Molsoft LLC). 
 
The quantitative analysis results are summarized in Table 4-4-3, analysis of the 
interactions of prenylated Rab7 with REP and GDI revealed that they display 
comparable affinities to the di-prenylated form of this GTPase. In constrast, its 
monoprenylated form bound 3 times more tightly than the di-prenylated form to GDI 
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and nearly 20 times more tightly to REP. The latter observation finds support in 
earlier findings that unlike the diprenylated protein, the mono-prenylated Rab1 is not 
easily dissociated from REP by detergent and phospholipid, an observation that was 
interpreted as  reflecting a higher affinity of the monoprenylated Rab form for  REP 
compared to  di-prenylated  (Shen and Seabra, 1996). A small difference in the 
affinities of mono- and di-prenylated Rab7 for GDI can be rationalized on the basis of 
the recently solved structures of Ypt1:GDI complexes (Pylypenko et al., 2006; Rak et 
al., 2003). In the structure of the mono-prenylated Ypt1:GDI complex the conjugated 
lipid is inserted into the lipid binding pocket in a bent conformation with both ends 
being solvent exposed, partially occupying the  binding sites of both lipids (Figure 4-
4-16 A).  In the doubly prenylated Ypt1:GDI complex, one isoprenoid is buried at the 
bottom of the hydrophobic binding site while the second stacks on top of it, forming 
relatively few contacts with GDI (Figure 4-4-16 B). Because of this, the overall 
contact area of the protein:lipid interface is increased only modestly upon conjugation 
of the second isoprenoid. The situation with the Rab:REP interaction appears to be 
more complex. Monoprenylation increases the affinity of the Rab:REP complex to an 
affinity of 60pM which is then reduced to ca. 1 nM after the attachment of the second 
lipid. This implies that the prenyl groups bound only very weakly to REP in the di-
prenylated complex.  
At the mechanistic level these observations can be rationalized in the following 
way: The binding site of REP is narrower than that of GDI and the lipid is inserted in 
an extended conformation (Figure 4-4-16 C). The structure of the doubly prenylated 
REP:Rab complex is not available, but should its lipid binding site be already fully 
dilated in the complex with the monoprenyated GTPase, then the second lipid could 
bind outside of it.  This may also lead to partial displacement of the isoprenoid moiety 
from the lipid binding site, leading to the observed affinity decease.  The “purpose” of 
this mechanism may be the retention of the monoprenylated reaction intermediate in 
the complex to assure its complete processing. However, this model raises the 
question about the way natively monoprenylated RabGTPases are processed, since 
they may form a complex too tight to be dissociated for membrane insertion. Indirect 
support of this idea comes form the observation that mono-cysteine Rab5a and 
Rab27a mutants are retained on the ER membrane and are not delivered to their 
native locations (Gomes et al., 2003).  The answer probably lies in a large variation 
of affinities for the interaction of the Rab protein core with REP, with Rab7 being one 
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of the tightest binders (Rak et al., 2004). With many Rab:REP interactions displaying 
Kd values of several hundred nM, the overall affinity of monoprenylated complexes 
can be expected to remain in the nanomolar range.  
Finally, and probably most importantly, our study provides evidence for a 
proposed model of RabGTPase membrane delivery and extraction (Figure 4-4-17). It 
was shown that REP appears to be much less efficient than GDI in Rab extraction. 
This difference in efficiency is in keeping with their biological roles, since REP is 
probably only involved in delivery of Rabs to membranes, whereas GDI, in addition to 
having this property, must also be able to extract them. These different properties 
can be explained by considering the affinities of REP/GDI for unmodified and 
prenylated forms of Rab, respectively. As shown in Table 4-4-2, whereas REP binds 
with the same high affinity to both unprenylated and di-prenylated Rab, enabling it to 
present the unprenylated form to RabGGTase, GDI binds to prenylated Rab with at 
least 1000-fold higher affinity than to unprenylated Rab. The large increase in affinity 
of GDI to Rab on docking of the C-terminus and the conjugated isopreniod groups is 
the driving force for the extraction process. Expressed in another manner, GDI is 
efficient in extraction of Rabs from membrane since there is a large difference in 
binding energy between the situations in which only the GTPase domain interacts 
with GDI and the situation in which the C-terminus and conjugated isopreniod moiety 
are also docked. Therefore, the difference in binding energies provides the 
thermodynamic driving force for the extraction from the membrane. In contrast, most 
of the binding energy in the case of REP comes from the interaction with the GTPase 
domain, with only very little or no driving force for the extraction provided by the 
interaction of the isoprenoid conjugated C-terminus. As a consequence, REP has 
very low potential to extract Rab from membranes, but can readily release the prenyl 
groups for insertion into the membrane. Therefore, the thermodynamic driving force 
in the process from B to C shown in Figure 4-4-17 determines the functional 
segregation of REP and GDI in extraction of Rab from membranes. A remaining 
problem concerns the dissociation of REP from a Rab molecule which has inserted 
its lipid into a membrane. Based on what is known about the kinetics of dissociation 
of REP from unprenylated Rab, this should occur at a rate of ca. 0.01 s-1, 
corresponding to a half-life in the range of 1 minute (Alexandrov et al., 1998).  It is 
possible that this is rapid enough for the physiological role of REP, especially when it 
is considered that after GTP/GDP exchange, a process which happens on the 
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membrane, the affinity of REP for Rab is reduced by at least a factor of 10 through 
acceleration of the dissociation rate (Alexandrov et al., 1998). However, it is also 
possible that additional proteinaceous factors are involved, as already implied for 
GDI in several studies (Sivars et al., 2003; Dirac-Svejstrup AB et al., 1997). 
 
 
Figure 4-4-17. Model for the extraction of Rab from membranes by GDI or REP. (A) Membrane 
associated Rab proteins undergo hydrolysis of GTP to GDP after a round of vesicular transport. (B) 
Initial recognition of the GDP-bound Rab. (C) Formation of the membrane bound Rab:REP/GDI 
complex. (D) Translocation of the conjugated isoprenoid moieties to the GDI/REP and release form 
the membrane. 
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5. Materials and Methods 
5.1 Materials 
5.1.1 Chemicals 
Chemicals Supplier 
Acetic acid,  Merck (Darmstadt, DE) 
Acetonitrile JT Baker (Deventer, NL) 
Acetone JT Baker (Deventer, NL) 
Acrylamid/Bisacrylamide (37.5:1, 30 % w/v) Applichem (Darmstadt, DE) 
Ammonium carbonate Riedel-de Haën (Seelze,DE) 
Ammonium sulfate Applichem (Darmstadt, DE) 
Ammonium persulfate (APS) Merck (Darmstadt, DE) 
Ampicillin (Amp) Serva (Heidelberg, DE) 
Bradford reagent Bio-Rad (München, DE) 
Bromphenol blue Serva (Heidelberg, DE) 
Bovine serum albumine (BSA) Sigma  
Cetyltrimethylammoniumbromide (CTAB) Roth (Karlsruhe, DE) 
Chloroform JT Baker (Deventer, NL) 
3-[(3-Cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS) Roth (Karlsruhe, DE) 
Chloramphenicol (Cam) Merck (Darmstadt, DE) 
Coomassie Brilliant Blue G250+R250 Serva (Heidelberg, DE) 
N-dodecyl-N,N-(dimethylammonio)butyrate 
(DDMAB) Calbiochem 
Deoxycholic acid sodium salt (DCS) Serva (Heidelberg, DE) 
Dichloromethane JT Baker (Deventer, NL) 
Dimethylsulfoxide(DMSO) Fluka 
Disodium hydrogenphosphate JT Baker (Deventer, NL) 
Dithioerythitol (DTE) Gerbu (Gaiberg, DE) 
Dithiothreitol (DTT) Gerbu (Gaiberg, DE) 
Ethylenediaminetetraacetic adic (EDTA) Gerbu (Gaiberg, DE) 
Ethanethiol Fluka 
Ethanol JT Baker (Deventer, NL) 
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Ethidium bromide Sigma 
Farnesyl pyrophosphate  (FPP) Sigma  
Farnesyl triphosphate (FTP) Sigma  
GdmHCl Applichem (Darmstadt, DE) 
Gernylgernyl monophosphate (GGMP) Sigma  
Gernylgernyl pyrophosphate (GGPP) Sigma  
Gernylgernyl trihosphate (GGTP) Sigma  
Glycerol Gerbu Gaiberg, DE 
Glycine Roth (Karlsruhe, DE) 
Guanosine diphophate (GDP) Pharma Waldhof (Düsseldorf, DE) 
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
(HEPES) Gerbu (Gaiberg, DE) 
Hydrochloric acid JT Baker (Deventer, NL) 
Imidazol Gerbu (Gaiberg, DE) 
Isopropyl-β-D-thiogalactopyranoside (IPTG) Gerbu (Gaiberg, DE) 
Kanamycin Boehringer (Mannheim,DE) 
Magnesium chloride JT Baker (Deventer, NL) 
Methanol Applichem (Darmstadt, DE) 
β-Mercaptoethanol Serva (Heidelberg, DE) 
Organic dyes 
Molecular Probes (Eugene, 
OR, USA), ATTO-TEC 
GmbH (Siegen, DE), 
Dyomics GmbH (Jena, DE) 
Phenylmethylsulfonylfluoride (PMSF) Sigma  
Potassium dihydrogenphosphate JT Baker (Deventer, NL) 
Potassium hydroxide JT Baker (Deventer, NL) 
2-Propanol JT Baker (Deventer, NL) 
Sinapinic acid Sigma  
Sodium chloride Fluka 
Sodium dihydrogenphosphate,  JT Baker (Deventer, NL) 
Sodium dodecylsulphate (SDS) Gerbu (Gaiberg, DE) 
Sodium hydroxide JT Baker (Deventer, NL) 
Sodium lauryl sarcosine (SLS) Sigma 
Sodium 2-mercaptoehanesulfonate (MESNA) Sigma 
N,N,N’,N’-tetramethylethylendiamin (TEMED) Roth (Karlsruhe, DE) 
D(+)-trehalose Roth (Karlsruhe, DE) 
5. Materials and Methods 
 
177 
Trichloroacetic acid (TCA) Fluka 
Trifluoroacetic acid (TFA) Fluka 
Trihydroxymethylaminomethane (TRIS) Roth (Karlsruhe, DE) 
Triton X-100 Serva (Heidelberg, DE) 
Urea JT Baker (Deventer, NL) 
 
5.1.2 Other chemicals from collaborators 
The novel dyes I-SO-s-IA and I-BA-s-IA (Figure 4-1-8) were gifts from Prof. Dr. 
Klaus Hahn (The Scripps Research Institute, San Diego, USA). The fluorescent 
peptides shown in Figure 4-1-11, chapter 4.1.2.3 were obtained from Thermo Hybaid 
GmbH, Novabiochem and EMD Biosciences. The NBD-farnesylated peptide, 
C(StBu)SC(NBD-farensyl) (Scheme 4-7) was synthesized by Dr. Kui-Thong Tan in 
Prof. Waldmann´s group at the Max-Planck-Institute of Molecular Physiology, 
Dortmund and the Dortmund University. These peptides were stored as powder at -
20°C under an atmosphere of argon, and were dissolved in DMSO to prepare 
solutions of 40mM before use. They were ligated to truncated Rab7 proteins by 
means of EPL.  
NBD-FPP (Figure 4-1-17) was synthesized by Dr. Reinhard Reents and Dr. Kui-
Thong Tan in Prof. Waldmann´s group. It was stored as power or 40 mM stock 
solution in 20 mM (NH4)2CO3 at -20°C. 
Table 5-1. Peptides used in this study. 
Entry Compounds Mw (g/mol) Supplier 
1 CK(NBD)C 515.6 Thermo 
2 CCK(NBD) 515.6 Thermo 
3 CCK(dans) 585.8 Novabiochem 
4 C(StBu)C(StBu)-dans 676.0 EMD 
5 CK(ATTO425)C 735.9 Novabiochem 
6 CCK(ATTO425) 735.9 Novabiochem 
7 C(StBu)SC(NBD-farensyl) 782.0 Dr. Kui-Thong Tan 
8 NBD-FPP 560.4 Dr. Reinhard Reents and 
Dr. Kui-Thong Tan 
 
 The peptide compounds for the screening of RabGGTase inhibitors (Figure 4-2-
4 in chapter 4.2.3) were synthesized with purity >95% by Dr. Kui-Thong Tan and Dr. 
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Ester Guiu-Rozas in Prof. Waldmann´s group. Synthetic procedures and analytical 
data can be found in Kui-Thong Tan’s PhD thesis (Dortmund University). 
5.1.3 Other materials 
Materials Supplier 
Amicon Ultra-4,15 (10K, 30K) Concentrator Milipore (Ireland) 
BioSep-SEC-2000 gel filtration Phenomenex (Aschaffenburg, DE) 
Chitin beads New England Biolabs (Beverly, USA) 
Dialysis membrane tubing (MWCO: 12-
14 kDa, 5-8 kDa) 
Spectrum Lab Inc. (Racho 
ٛ Dominguez, CA, USA) 
DyeEx 2.0 Spin Kit Qiagen GmbH (Hilden, DE) 
Electroporation cuvettes Bio-Rad (München,DE) 
Eppendorf tube (0.5 mL, 1.5 mL, 2.0 mL)  Eppendorf (Hamburg,DE) 
Falcon Tube (50 mL, 15 mL) Falcon GmbH (Gräfeling-Locham, DE) 
Glutathione Sepharose GE Healthcare (Uppsala, SE) 
HiTrap Ni-NTA column Pharmacia Biotech (Uppsala, SE) 
Jupiter 5μm C4 300A reverse phase column Phenomenex (Aschaffenburg, DE) 
Low molecular weight marker Amersham Biosciences (Uppsala, SE) 
NAP-5 desalting column Amersham Biosciences (Uppsala, SE) 
Nitrocellulose paper Schleicher&Schuell (Dassel, DE) 
PD-10 desalting column Amersham Biosciences (Uppsala, SE) 
PRCNTOSIL 120-5-C18-AQ 5 μm reverse 
phase column Bischoff-Chrom (Leor, DE) 
Quartz cuvette (1cm) Hellma Optik GmbH (Jena, DE) 
Superdex 75/200 Gel filtration Pharmacia Biotech (Uppsala, SE) 
Whatman FP 30/0.2, 0.4 μm cellulose filter Schleicher&Schuell (Dassel, DE) 
ZapCap filter Nalgene (Rochaster, NY, USA) 
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5.1.4 Instruments 
Instruments Supplier 
Äkta prime system with REC112 recorder Pharmacia Biotech (Uppsala, SE) 
Biorad PE 9700 thermocycler Applied Biosystems (Weiterstadt, DE) 
Centrifuge Allegra X-22R  Beckman Coulter (Palo Alto,  USA) 
Centrifuge Avanti J20-XP Beckman Coulter (Palo Alto,  USA) 
Centrifuge Optima L-70K Ultracentrifuge Beckman Coulter (Palo Alto,  USA) 
Centrifuge Eppendorf 5415C/D benchtop Eppendorf (Hamburg, DE) 
Electroporation  device E. coli Pulser Bio-Rad (München,DE) 
Deionized water apparatus Millipore (Eschborn, DE) 
FLA-5000 (Fluorescence image reader) Fujifilm (Japan) 
Fluoroskan Ascent Fl type 374  Thermo BioAnalysis (Santa Fe, New Mexico, USA) 
Gel-electrophoresis system  Bio-Rad (München, DE) 
High pressure liquid chromatography 
(HPLC) Waters (Eschborn, DE) 
HPLC-ESI-MS Agilent, Finnigan 
Isothermal titration calorimeter MicroCal (Northampton, USA) 
MALDI-TOF-MS Applied Biosystem (Darmstadt, DE) 
Microfluidizer Microfluidics (Newton, MA, USA) 
PH-meter 761 Calimatic Knick (Berlin, DE) 
SDS-PAGE Mini-Protean II system Bio-Rad (München, DE) 
Shaker Infors (Bottmingen, CH) 
Spex Fluoromax-3 Spectrofluorometer  Jobin Yvon Horiba Group (NJ, USA)
Stopped-flow spectrometer SX20 Applied Photophysics (Leatherhead, UK) 
Thermomixer 5436 (1.5 mL) Eppendorf (Hamburg, DE) 
Ultrasonic cell disruptor (SONIFIER) Branson (Danbury, CT, USA) 
UV/Visible  Spectrometer DU 640 Beckman Coulter (Palo Alto, USA) 
 
Representations of crystal structures were created with the program Molsoft-ICM 
(Molsoft LLC, La Jolla, USA). Simulation of ternary Rab:REP:RabGGTase complex 
was carried out by Prof. Dr. Ruben Abagyan, The Scripps Research Institute (La 
Jolla, USA) using the ICM 3.4-8cj software package (Molsoft).  
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5.1.5 Buffers and growth media 
LB medium      LB agar plates 
5 g/L yeast extract    15 g/L  Bacto agar 
10 g/L Tryptone 50 mg/L Ampicillin 
10 g/L  NaCl      
 
Antibiotics      SDS-PAGE running buffer (10x) 
125 mg/L Ampicillin    0.25 M  Tris-HCl   
34 mg/L  Chloramphenicol   2 M   Glycine 
50 mg/L  Kanamycin    1% (w/v) SDS 
 
SDS-PAGE stacking gel buffer (4X)  SDS-PAGE resolving gel buffer(4X) 
0.5 M  Tris-HCl, pH 6.8   1.5 M   Tris-HCl, pH 8.8 
0.4 % (w/v) SDS      0.4 % (w/v) SDS 
 
SDS-PAGE loading buffer (2x)   Coomassie staining solution 
62.3 mM  Tris-HCl, pH 6.8   10 % (v/v)  acetic acid 
2 % (w/v) SDS     40 % (v/v)  ethanol 
10 % (v/v) glycerol    0.1 % (w/v) Coomassie Brilliant  
5 % (v/v) β-Mercaptoethanol     Blue R250 
0.001 % (w/v)bromophenol blue 
 
Destaining solution    TAE buffer (1x)   
10 % (v/v) acetic acid    40 mM  Tris acetate, pH 8.5  
       2 mM   EDTA 
       20 mM Glacial acetic acid 
        
PBS (10x)      DNA loading buffer (5x)   
80 g/L  NaCl     30 %(w/v) Sucrose 
2 g/L    KCl     20 % (v/v)  glycerol 
14.4 g/L  Na2HPO4⋅2 H2O   0.2 % (w/v)  orange G 
2.4 g/L KH2PO4  
 
Bug Buffer       Buffer A 
50 mM NaH2PO4, pH 8.0   50 mM NaH2PO4, pH 8.0 
0.3 M   NaCl     0.3 M   NaCl 
       2 mM  β-mercaptoethanol 
 
Buffer B      Breaking Buffer 
50 mM NaH2PO4, pH 8.0   25 mM  NaH2PO4, pH 7.5 
0.3 M   NaCl     0.5 M   NaCl 
2 mM  β-mercaptoethanol   2 mM  MgCl2 
0.5 M  Imidazole    10 μM  GDP 
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5.2 Molecular cloning methods 
5.2.1 Plasmids and bacterial strains 
Plasmids  
Plasmid Name Insert 
Resistance/ 
Selection 
marker 
Application and 
References 
pTWIN2_Rab7Δ3 canine Rab7Δ3 Amp 
pTYB1_Rab7Δ6 canine Rab7Δ6 Amp 
pTWIN1_Rab7Δ2SS canine Rab7Δ2 Amp 
pTWIN1_Rab7Δ2SC canine Rab7Δ2 Amp 
pTWIN1_Rab7Δ2CS canine Rab7Δ2 Amp 
Expression of Rab-
intein-CBD fusion 
proteins and production 
of C-terminal 
α-thioesters. (Durek et 
al., 2004a; Alexandrov 
et al., 2002; Iakovenko 
et al., 2000) 
pGATEVmod_RabGGTase α rat 
RabGGTase α Amp 
pET30_RabGGTase β rat 
RabGGTase β Kan 
Coexpression of the 
RabGGTase subunits 
with a 6XHis-GST tag 
on the N-terminus of 
the α-subunit. The tag 
can be cleaved off by 
TEV protease. (Kalinin 
et al., 2001) 
pET19mod_yGDI yeast GDI Amp 
* pFastBac_GDI-1 bovine GDI-1  Amp 
Expression of the 
corresponding protein 
N-terminally containing 
a 6XHis tag, which can 
be cleaved off by TEV 
protease.  
* pVL_REP-1 rat REP-1 Amp 
pET30a_MRS6 yeast MRS6p Kan 
Expression of REP-1 or 
MRS6p with a 6XHis 
tag.(Armstrong et al., 
1995a) 
pIF-Rab7SSSC Rab7C205S Amp 
pIF-Rab7SCSS Rab7C207S Amp 
Expression of Rab7 
single cysteine mutants 
with a 6XHis-IF tag at 
the N-terminus, which 
can be cleaved off by 
TEV protease. 
pMAL_Rab7 canine Rab7wt Amp 
pMAL_Rab7delata14 Rab7Δ14 Amp 
pMAL_Rab7_ASA Rab7_ASA Amp 
pMAL_Rab7_TEV_ASA Rab7_TEV_ASA Amp 
pMAL_Rab7_WFY Rab7_WFY Amp 
pMAL_Rab7AAAAACSC Rab7-5A Amp 
pMAL_Rab7Δ204 Rab7Δ204 Amp 
pMAL_Rab7Δ203-204 Rab7Δ203-204 Amp 
Expression of Rab7wt 
and truncation mutants 
with 6XHis-MBP tag on 
the N-terminus, which 
can be cleaved off by 
TEV protease.  
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pMAL_Rab7Δ202-204 Rab7Δ202-204 Amp 
pMAL_Rab7Δ201-204 Rab7Δ202-204 Amp 
pMAL_Rab7Δ199-204 Rab7Δ202-204 Amp 
pMAL_Rab7Δ198-204 Rab7Δ202-204 Amp 
pMAL_Rab7Δ197-204 Rab7Δ202-204 Amp 
pET19modRab7_L192S Rab7 L192S Amp 
pET19modRab7_I190H Rab7 L192S Amp 
pET19modRab7_I190H 
L192S 
Rab7 I190H 
L192S 
Amp 
Expression of the 
corresponding protein 
N-terminally containing 
with a 6XHis tag, which 
can be removed by 
TEV protease. 
Empty pTWIN and pTYB vectors were obtained from New England Biolabs (Beverly, MA, USA). 
Typically expression was performed using one of the E. coli strains listed below. * Expression in SF9 
or SF21 cells upon infection with recombinant baculovirus. Amp = ampicillin, CBD = chitin-binding 
domain, Kan = kanamycin. 
 
 
Bacterial strains   Genotypes 
 
XL1 Blue     recA1, endA1, gyrA96, thi-1, hsdR17, supE44,  
(Stratagene)    relA1, lac [F´, proAB, lacIqZΔM15, Tn10 (Tetr)] 
 
BL21(DE3)     F-, ompT, lon, hsdS (rB-, mB-), dcm, gal, λ(DE3)  
(Novagen)    
 
BL21(DE3) Codon Plus RIL  F-, ompT, lon, hsdS (rB-, mB-), dcm, gal, λ(DE3), 
(Stratagene)    endA, Hte [argU ileY leuW CamR] 
 
BL21(DE3) Codon Plus RP  F-, ompT, lon, hsdS (rB-, mB-), dcm, gal, λ(DE3), 
(Stratagene)    endA, Hte [argU proL CamR]  
 
BL21(DE3) Rosetta    F-, ompT, lon, hsdS (rB-, mB-), dcm, gal, λ(DE3), 
(Novagen)    pRARE2 (CamR) 
 
5.2.2 Preparation of competent cells 
1 L of LB medium was inoculated with 1 mL of an overnight-grown culture of the 
desired E.coli strain. Cells possessing antibiotic resistance genes were grown in the 
presence of the corresponding antibiotics. The culture was incubated at 37° C on a 
shaker, until the OD600 reached 0.5 (ca. 3 - 4 h). The culture was cooled on ice for 20 
min, transferred to sterile centrifugation vessels and centrifuged for 10 min at 4°C at 
2000 g. The supernatant was discarded. 
Electro-competent cells 
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The bacterial cell pellet was gently resuspended in 5 mL of ice-cold sterile GYT 
(0.125 % (w/v) yeast extract, 0.25 % (w/v) tryptone, 10 % (v/v) glycerol) and 
recentrifuged as described above. Cell pellet were resuspended in 1 mL GYT, 
dispensed in 50 µl aliquots, shock frozen in liquid nitrogen and stored at -80° C.  
Chemical-competent cells 
The pellet was gently resuspended in 20 mL of ice-cold sterile 100 mM CaCl2 
solution and incubated on ice for 30 min. The cells were centrifuged at 2000 g for 
5 min at 4° C and were resuspended in 1 - 5 mL of TFBII buffer (10 mM MOPS, pH 
7.0, 75 mM CaCl2, 10 mM NaCl, 15 % glycerol). Aliquots of 50 - 100 µl were shock 
frozen in liquid nitrogen and stored frozen at -80° C. 
5.2.3 Preparative PCR 
The appropriate 5’- and 3’-primers were designed. The PCR reaction mixture 
was prepared in steps shown in Table 5-2 in a PCR tube. The mixture was incubated 
in Biorad PE 9700 thermocycler (Applied Biosystems) using PCR program as 
described in table 5-3. 
 
Table 5-2. Preparation of PCR reaction mixture. 
Step Material Volume (μL) 
1 Sterile water 37 
2 Buffer (Expend High Fidelity 10X) 5 
3 DMSO 3 
4 Template DNA (10-100 ng) 1 
5 Primers (final conc. 1 μM) 1.5 
6 dNTPs (10 mM, final conc. 200 μM) 1 
7 
Enzyme: 2-3 units of Expand High 
Fidelity Polymerase mix (Roche 
Diagnostics, Mannheim, DE) 
1 
Total 50 
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Table 5-3. PCR program 
Temp (°C) Time  Step function 
94 2-3 min Hold 
94 cycle40 s Denaturation: the first cycling event causes melting of DNA template and primers. 
50-62 cycle 30 s Annealing: the temperature is dependent on melting temp (Tm) of primer, typically 3-5°C below Tm. 
72 
cycle         
1 min/kb 
Extension: the time is dependent on the length of 
amplifying fragment. 
72 7-10 min Final elongation: after the last PCR cycle to ensure that any remaining single-stranded DNA is fully extended. 
4 indefinite Final Hold: short-term storage of the reaction. 
cycle PCR for 20-30 cycles. 
5.2.4 Purification of PCR products by agarose gel 
electrophoresis 
Depending on the size of the DNA fragment, the agarose concentration was 
between 0.8 and 2 % (w/v).  
1| Dissolve the required amount of agarose by heating in TAE buffer.  
2| Add ethidium bromide to a final concentration of 0.5 μg/mL 
3| Pour the solution into the gel casting equipment and allowed to polymerize.  
4| Mix the samples with 5X DNA loading buffer and load into the wells. A 1 kb 
DNA ladder (GibcoBRL) was used as a molecular weight standard. 
5| Run the gels horizontally at 10 V/cm immersed in TAE-buffer until fragment 
separation was complete.  
6| Excise the bands of interest and extract the DNA from the gel using a gel 
extraction kit from Qiagen according to the instructions of the manufacturer. 
5.2.5 Subcloning 
Restriction enzyme digestion 
Both vector and purified PCR product were digested by the appropriate 
restriction enzymes. Digestions of DNA fragments were performed as recommended 
by the manufacturer at 37°C for 2 h. An example is shown in Table 5-4. The reaction 
was stopped by addition of DNA loading buffer. Fragments produced by restriction 
enzyme digestion were purified using agarose gel electrophoresis. 
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Table 5-4. Restriction enzyme digestions. 
Step Material Volume (μL) Volume (μL) 
1 Sterile water 29 27 
2 Buffer (NEB4 10X) 5 10 
3 Vector (0.2 μg/μL) or PCR product (1 μg/μL) Vector 10 PCR product 53 
4 Enzyme: NdeI (20 U/μL)* 3 5 
5 Enzyme: SapI (20 U/μL) 3 5 
Total 50 100 
*1 unit of enzyme can digest 1 μg DNA. 
Ligation 
For ligation 1-10 ƒmol of linear plasmid DNA was mixed with a 10 fold molar 
excess of insert fragment. Ligation was performed in ligation buffer in a volume of 
20 µl, using 5 units of T4 DNA ligase (Roche Diagnostics, Mannheim, Germany) for 
1 h at 20°C. Subsequent deactivation was performed at 65°C for 10 min. An example 
is shown in Table 5-5. 
 
Table 5-5. Preparation of ligation reaction mixture. 
Step Material Volume (μL) 
1 Vector (0.06 μg/μL) 3 
2 Insert (0.3 μg/μL) 12 
3 Ligation buffer (5X) 4 
4 T4 DNA ligase (5 U/μL) 1 
Total 20 
 
5.2.6 Chemical transformation 
1| Add the ligation mixture containing approximately 1 ng of the desired plasmid 
DNA to 50 μL chemical competent cells. The mixture was incubated on ice for 
30 min without shaking.  
2| Heat the cells at 42° C for 1 min and immediately cooled on ice for 2 min.  
3| Add 1 mL of LB medium was added to the cells. 
4| Incubate at 37°C for 1 h on a shaker. 
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5| Spread 100 μL cells on agar plates supplemented with the corresponding 
antibiotics. 
6| Invert plates and incubate overnight (12-16 h) at 37°C. 
5.2.7 Colony PCR screen 
1| Pick a single bacterial colony growing on LB agar plate with the corresponding 
antibiotics using a sterile inoculating loop.  
2| Inoculate the colony into 2 mL of LB medium with the corresponding antibiotics.  
3| After overnight growth, withdraw 10 μL culture and mix it with 10 μL 0.05% 
Triton-X 100 in a PCR test tube using sterile tips.  
4| Heat the mixture at 95°C for 10 min. 
5| Centrifuge the mixture at 4°C (16,000 g, 2min).  
6| Perform PCR using 3 µL of the supernatant. The preparation of the PCR 
reaction mixture is depicted in Table 5-6. 
 
Table 5-6. Preparation of colony PCR reaction mixture. 
Step Material Volume (μL) 
1 Sterile water 15.7 
2 Buffer (Bio Therm 10X) 2.5 
3 DMSO 1.5 
4 Template DNA (mixture of cell lysate) 3 
5 Primers (final conc. 1 μM) 1 
6 dNTPs (10 mM, final conc. 200 μM) 0.5 
7 Enzyme: 1 unit Bio Therm DNA polymerase 0.3 
Total 25 
 
7| Analyze the PCR products by agarose gel electrophoresis. The one showing a 
band of PCR product at the expected molecular weight suggests a successful 
subcloning. 
5.2.8 Preparation of plasmid DNA 
Plasmid DNA was prepared using the plasmid mini-prep kit (Qiagen) as follows: 
1| Pick a single bacterial colony to seed 2 mL of LB medium containing the 
appropriate antibiotics.  
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2| Grow the culture overnight (10 - 12 h) at 37°C.  
3| Harvest cells by centrifugation (16,000 g, 1 min). Discard the supernatant. 
4| Resuspend the cell pellet in 250 μL Buffer I with RNase A by vortex. 
5| Add 250 μL Buffer II and mix extensively until the solution becomes clear. 
6| Add 350 μL Buffer III into clear lysate to precipitate chromosomal DNA, lipids, 
and proteins.  
7| Remove the precipitates by centrifugation (16,000 g, 15 min).  
8| Load the supernatant on a silica spin column. Centrifuge the column for 0.5 min 
at 10,000 rpm. 
9| Wash the column with 500 μL HB buffer, 700 μL wash buffer (with ethanol) for 2 
times by centrifugation (10,000 rpm, 0.5 min). 
10| Centrifuge the column for 1.5 min at 10,000 rpm to get rid of ethanol. 
11| Elute the plasmid DNA with 30-50 μL EB buffer by centrifugation (10,000 rpm, 
1 min). 
5.2.9 DNA sequencing  
For DNA sequencing, the cloned plasmid was subjected to PCR using the 
BigDyeDesoxy terminator cycle sequencing kit. The sequencing reactions were 
prepared as described in Table 5-7. And PCR program was set as shown in Table 5-
8.  
 
Table 5-7. Preparation of sequencing reaction mixture. 
Step Material Volume (μL)
1 Sterile water 3 
2 Plasmid (0.1 – 0.5 μg) 2 
3 Primers (3 pmol) 1 
4 BigDye mix 4 
Total 10 
Table 5-8. PCR program 
Temp 
(°C) Time  Step 
98 2 min Hold 
94 cycle20 s Denaturation 
50 cycle 30 s Annealing 
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60 cycle4 min Extension 
4 indefinite Final Hold 
cycle PCR for 25 cycles. 
Ethanol precipitation 
1| Dilute the PCR product with 10 μL H2O. 
2| Add sodium acetate (pH 5.5) to a final concentration 250 - 300 mM to the 
sample. 
3| Precipitate DNA by adding ethanol (96 %) to a final concentration of ca. 70 %  
4| Incubate the sample for 15 min at room temperature.  
5| Centrifuge the sample at 16,000 g for 10 min at 4°C. Remove the supernatant. 
6| Wash the precipitate once with 50 μL 70 % ethanol. Centrifuge the sample at 
16,000 g for 10 min at 4°C.  
7| Dry the sample under vacuum. 
 
The sample was analyzed by the in house sequencing facility.  
5.2.10 Transformation by electroporation 
1| Add ca. 1 ng of plasmid DNA in a volume of 0.5 μL to 50 μL electro-competent 
cell suspension in a chilled electroporation cuvette (0.2 μm path length).  
2| Tap the cuvette to exclude air bubbles. 
3| Apply a high voltage pulse using a E.coli Pulser from Biorad (conditions: 25 µF, 
200 Ω, 2.5 kV).  
4| Immediately add 1 mL of LB medium to the cuvette after pulsing.  
5| Grow the culture at 37°C for 1 h on a shaker.  
6| Spread 100 μL cell suspensions on agar plates containing the appropriate 
antibiotics. 
7| Invert plates and incubate overnight (12-16 h) at 37°C. 
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5.3 Protein expression and purification methods 
5.3.1. Expression and purification of RabGGTase, REP-1, 
RabGDI, Rab7wt and Rab7 mutants 
Expression of Rab7 in E. coli 
1| Transform BL21(DE3) cells with plasmid pMAL_Rab7 and select on a LB agar 
plate containing 50 mg/L ampicillin (Amp). 
2| Pick a single colony from the agar plate using a sterile inoculating loop and 
inoculate it into 100 mL of LB-medium containing 125 mg/L ampicillin.  
3| Incubate at 37°C at 160 rpm on a rotatory shaker overnight.  
4| Inoculate this pre-culture into 5 L of LB-medium containing 125 mg/L Amp.  
5| Grow cells in five 5 L flasks at 37°C on a shaker (160 rpm) until the absorbance 
at 600 nm (OD600) reached 0.5-0.7 (ca. 4-6 h).  
6| Put the flasks in the cold room to reduce the temperature of the culture to 20°C. 
7| For induction of the protein expression, add IPTG to the culture to a final 
concentration of 0.1 mM.  
8| Incubate at 20°C on a shaker (160 rpm) overnight (5-12 h). 
9| Before harvesting cells, take a sample of 30 μL from the cell suspension, mix it 
with 30 μL 2×SDS sample buffer, boile at 95°C for 10 min and run a denaturing 
SDS-PAGE (see section 5.4.1) to estimate the protein expression level.  
10| Harvest cells by centrifugation in the centrifuge Avanti J20-XP (Beckman 
Coulter) at 6000 rpm, 4°C for 20 min.  
11| Discard the supernatant carefully and wash the cells with PBS by centrifugation 
in the centrifuge Allegra X-22R (Beckman Coulter) at 4000 rpm, 4°C for 15 min. 
■ PAUSE POINT The cells can be frozen in liquid nitrogen and stored in -80°C. 
Lysis of E. coli cells 
12| Resuspend the cell pellet in 50 mL ice-cold Bug Buffer (50 mM NaH2PO4, pH 
8.0, 0.3 M NaCl) freshly supplemented with 1 mM PMSF and 2 mM (140 μL/L) 
β-mercaptoenthanol. ▲CRITICAL The PMSF and β-mercaptoenthanol should 
be added freshly. 
13| Pass the cell suspensions through the chilled pressure chamber of 
Microfluidizer twice at 40,000 psi. 
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14| Centrifuge the cell lysate in the ultracentrifuge Optima L-70K (Beckman Coulter) 
at 35,000 rpm, 4°C for 30 min. 
15| Filter the supernatant through a 0.2 μm ZapCap filter (Nalgene). 
Purification of Rab7 
16| Load the filtrate with a flow rate of 2 mL/min on a 5 mL Hi-Trap Ni-NTA column 
that has been equilibrated with the Buffer A (50 mM NaH2PO4, pH 8.0, 0.3 M 
NaCl, 2 mM β-mercaptoethanol). 
17| Wash the column with Buffer A with a flow rate of 3 mL/min until the absorbance 
reached the baseline. 
18| Wash the column with 2% Buffer B (50 mM NaH2PO4, pH 8.0, 0.3 M NaCl, 2 
mM β-mercaptoethanol, 0.5 M imidazole) with a flow rate of 3 mL/min until the 
absorbance reached the baseline. 
19| Elute the column with a gradient of 2-100% Buffer B with a flow rate of 3 mL/min 
for 250 mL. Collect 5 mL/fraction. 
20| Run SDS-PAGE and identify the fractions of interest. 
21| Wash the column with 2 mM NaN3. 
22| Collect the fractions of interest and dialyze the sample against buffer for TEV-
protease (25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 4 mM sodium citrate, 2 mM 
β-mercaptoethanol). 
23| Add TEV protease at 1:20 molar ratio to the protein in the dialysis membrane 
tubing. 
24| After dialysis overnight, spin down the precipitates at 8000 rpm for 10 min. 
25| Discard the pellet and collect the supernatant. 
26| Add MgCl2 and imidazole to the supernatant to a final concentration of 5 mM 
and 10 mM, respectively. 
27| Load the cleavage mixture with a flow rate of 2 mL/min on a 5 mL Hi-Trap Ni-
NTA column to remove the cleaved-off 6XHis-MBP tag and uncleaved 6XHis-
MBP-Rab7.  
28| Collect the flow-through and reload on the column. 
29| Wash the column with 2% Buffer B with a flow rate of 3 mL/min until the 
absorbance reached the baseline and collect the flow-through. 
30| Elute the column with 5% Buffer B and a gradient of 5-100% Buffer B with a 
flow rate of 3 mL/min for 150 mL. Collect 5 mL/fraction. 
31| Concentrate the flow-through to 3-4 mL using a Centricon concentrator. 
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32| Centrifuge the sample in a benchtop centrifuge Eppendorf 5415C/D at 16,000 
rpm, 4°C for 20 min. 
33| Load the supernatant with a flow rate of 2 mL/min on the gel-filtration column 
Superdex-75 26/60 that has been equilibrated with the gel filtration buffer (25 
mM HEPES, pH 7.2, 50 mM NaCl, 5 mM DTE, 2 mM MgCl2, 20 μM GDP). 
Collect 5 mL/fraction. ▲CRITICAL Prepare fresh solution, filter the buffer 
through a 0.2 μm membrane filter (Whatman) and degas on a vacuum-
membrane pump (ILM/VAC GmbH) by stirring for 0.5 h at room temperature 
(20°C). 
34| Run SDS-PAGE and collect those fractions containing pure Rab7. 
35| Concentrate the sample to 10 mg/mL, separate them in aliquots and froze them 
flashily in liquid nitrogen. Store the protein in -80°C. 
 
The other proteins were purified in a similar protocol as Rab7. Mammalian 
RabGGTase was expressed in E. coli BL21(DE3) codon plus RIL cells, with a 
hexahistidine-GST tagged  α-subunit and an untagged β-subunit (Kalinin et al., 
2001). REP-1 and α-RabGDI were expressed in SF21 and SF9 insect cells, 
respectively, infected with recombinant baculovirus (Armstrong et al., 1995a) or from 
recombinant yeast S. cerevisiae (Sidorovitch et al., 2002). Rab7 wild-type and mutant 
proteins were expressed and purified in a similar manner.  
5.3.2 Expression and purification of Rab-thioester proteins 
The expression of the Rab-Intein-CBD fusion proteins was performed in a similar 
way as described in 5.3.1 (steps 1 to step 11).  
Lysis of E. coli cells 
1| Resuspend the cell pellet in 25 mL ice-cold Breaking Buffer (25 mM NaH2PO4, 
pH 7.5, 0.5 M NaCl, 1 mM MgCl2) freshly supplemented with 1 mM PMSF, 10 
μM GDP. ▲CRITICAL The PMSF and GDP should be added freshly. Don’t add 
any reducing substances. 
2| Pass the cell suspensions through the chilled pressure chamber of 
Microfluidizer twice at 40,000 psi. 
3| Add new portion of PMSF to 0.5 mM and TritonX-100 to 1% (v/v). ▲CRITICAL 
The TritonX-100 should be added after breaking the cells. 
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4| Centrifuge the cell lysate in the ultracentrifuge Optima L-70K (Beckman Coulter) 
at 35,000 rpm, 4°C for 30 min. 
Purification of Rab7 α-thioester 
5| Transfer the supernatant to Falcon tubes. 
6| Add an appropriate amount of chitin beads that have been washed with 
Breaking Buffer containing 1 % TritonX-100. ▲CRITICAL 1 mL beads can bind 
ca. 2-5 mg protein. 
7| Incubate for 1 h on a rotating wheel at 4°C. 
8| Centrifuge the suspension at 2500 g, 4°C for 5 min to remove the supernatant. 
9| Wash the beads 5 times with 3X bed volume of Breaking Buffer containing 1 % 
TritonX-100  
10| Wash the beads 5 times with 3X bed volume of Breaking Buffer. 
11| Add sodium 2-mercaptoehanesulfonate (MESNA) powder to the beads 
suspension to a concentration of 0.5 M and incubate overnight on a rotating 
wheel at 20°C. 
12| Collect the supernatant by centrifugation (2500 g, 4°C for 5 min) and 
concentrate it to 3-4 mL using a Centricon concentrator. 
13| Run gel filtration on the Superdex-75 column using buffer (25mM NaH2PO4, pH 
7.2, 30 mM NaCl, 1 mM MgCl2, 20 μM GDP). ▲CRITICAL Prepare fresh 
solution, filter the buffer through a 0.2 μm membrane filter (Whatman) and 
degas on a vacuum-membrane pump (ILM/VAC GmbH) by stirring for 0.5 h at 
room temperature (20°C). 
14| Run SDS-PAGE and collect those fractions containing pure Rab7 α-thioester. 
15| Concentrate the sample to at least 10 mg/mL, separate them in aliquots and 
froze them flashily in liquid nitrogen. Store the protein in -80°C. 
 
The proteins stored at -80°C for 2 years did not significantly reduce the ligation 
efficiency. Yields typically ranged from 5 - 10 mg of Rab thioester per liter of bacterial 
culture.  
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5.4 Analytical methods 
5.4.1 Denaturing SDS-PAGE 
Preparation of SDS-Polyacrylamide Gel Electrophoresis (PAGE) gels 
1| Prepare the resolving gel by mixing the individual components as indicated in 
Table 5-9 following the adding sequence. ▲CRITICAL Finally add APS and 
TEMED to start polymerization. 
2| Pour the solution into a Biorad Multi-casting apparatus (9 gels). Add 50% 
isopropanol on the top of the resolving gel. Incubate at room temperature until 
the resolving gel was polymerized (ca. 30 min). 
3| Remove the isopropanol and add the stacking gel solution (prepared as shown 
in Table 5-9) atop the resolving gel. Insert combs immediately. 
4| Incubate at room temperature until the stacking gel was polymerized (ca. 20 
min). ■ PAUSE POINT The gels can be stored in 4°C in a wet paper packet. 
Table 5-9: Receipts for making SDS-PAGE gels. 
Adding 
sequence 1 2 3 4 5 6 
Type of gel 
(%) 
Acrylamide/ 
bisacrylamide 
(29:1, 30 %) 
Mili-Q H2O 
Resolving 
gel buffer 
(4X) 
Stacking 
gel buffer 
(4X) 
10 % 
APS TEMED 
Resolving gel (60 mL) 
10 % 20 mL 25 mL 15 mL – 300 µl 30 µl 
15 % 30 mL 15 mL 15 mL – 300 µl 30 µl 
Stacking gel (30 mL) 
5 % 5 mL 17.5 mL – 7.5 mL 240 µl 30 µl 
TEMED: N,N,N´,N´-tetramethylethylendiamine, APS: ammoniumpersulfate.  
Gel electrophoresis 
5| Prepare protein samples by adding an equal amount of SDS-PAGE sample 
buffer (2x) and heat them for 5 min at 95°C.  
6| Run gels electrophoresis at 50 A until the bromphenol blue front entered the 
buffer solution.  
7| Visualize fluorescent proteins by exposing the unstained SDS-PAGE gel to UV 
light or fluorescent image reader.  
8| Stain the proteins by heating the gels in the Coomassie staining solution 
(section 5.1.5) in a microwave. Incubate on a shaker at room temperature for 10 
min. 
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9| Destain the gels by heating the gels in the destaining solution (section 5.1.5) in 
a microwave. Incubate on a shaker at room temperature. 
 
15 % SDS-PAGE gels were used for the analysis of REP (73 kDa), RabGGTase 
α (63 kDa) and β subunit (37 kDa) and Rab proteins (24 kDa).  
5.4.2 MALDI-TOF-mass spectrometry 
Matrix Assisted Laser Desorbtion Ionization - Time Of Flight (MALDI-TOF) 
spectra were recorded on a Voyager-DE Pro Biospectrometry workstation from 
Applied Biosystems (Weiterstadt, Germany). Protein samples were desalted using 
small GF spin columns (DyeEx 2.0 Spin Kit, Qiagen, Hilden, Germany) and mixed 
with an equal volume of matrice (saturated sinapinic acid solution in 0.3 % 
TFA/acetonitrile (2:1 v/v)). The mixture was quickly spotted on a MALDI sample 
plate, air-dried. Spectra were measured with the following instrument settings: 
acceleration voltage = 25 kV, grid voltage = 93 %, extraction delay time = 750 ns and 
guide wire = 0.3 %. The laser intensity was manually adjusted during the 
measurements in order to obtain optimal signal to noise ratios. Calibrations were 
carried out using a protein mixture of defined molecular mass (Sigma). Spectra 
recording and data evaluation was performed using the supplied Voyager software 
package. The accuracy of the method for proteins within the molecular weight range 
of 20-30 kDa is ca. ± 20 Da. 
5.4.3 LC-ESI-mass spectrometry 
Liquid Chromatography-Electrospray Ionization-Mass Spectrometry (LC-ESI-
MS) analysis was performed on an Agilent 1100 series chromatography system 
(Hewlett Packard) equipped with an LCQ ESI mass spectrometer (Finnigan, San 
Jose, USA) using Jupiter C4 columns (5 µm, 15 x 0.46 cm, 300 Å pore-size) from 
Phenomenex (Aschaffenburg, Germany) for proteins and 125/21 NUCLEODUR 5 µm 
C18 columns for peptides. For LC separation a gradient of buffer B (0.1 % formic 
acid in acetonitrile) in buffer A (0.1 % formic acid in water) with a constant flow-rate of 
1 mL/min was applied, with a gradient program as shown in Table 5-10 and 5-11. 
Under these conditions, Rab proteins typically were eluted at 12-13 min. Mass 
spectra data evaluation and deconvolution was performed using the Xcalibur 
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software package. The accuracy of the method for proteins within the molecular 
weight range of 20 kDa is ca. ± 1-2 Da. 
Table 5-10: Gradient program for LC-ESI-MS measurements of protein using a C4 column. 
Time (min) buffer A (0.1% FA,  H2O) % buffer B (0.1% FA, ACN) % 
5 20 80 
15 70 30 
17 90 10 
19 90 10 
20 20 80 
22 20 80 
Table 5-11: Gradient program for LC-ESI-MS measurements of peptide using a C18 column. 
Time (min) buffer A (0.1% FA,  H2O) % buffer B (0.1% FA, ACN) % 
1 90 10 
17 60 40 
22 20 80 
25 20 80 
26 90 10 
30 90 10 
5.4.4 Analytical reversed-phase (RP)- and gel filtration (GF)-
HPLC 
Analytical reversed-phase (RP) and gel filtration (GF) chromatography were 
performed on a Waters 600 chromatography instrument equipped with a Waters 
2487 absorbance detector and a Waters 2475 fluorescence detector (Waters, 
Milford, MA, USA). Jupiter C4 column (5 µm, 15 x 0.46 cm, 300 Å pore-size) from 
Phenomenex (Aschaffenburg, Germany) was used for RP-HPLC, while Biosep-SEC-
2000 column (60 x 0.78 cm, separation range 1-300 kDa, Phenomenex), Superdex 
75 HR 10/30 column (separation range 3-70 kDa) or Superdex 200 HR 10/30 column 
(separation range 10-600 kDa) from Pharmacia Biotech (Uppsala, SE) was used for 
GF-HPLC. GF chromatography were carried out using a running buffer (50 mM 
HEPES, pH 7.2, 50 mM NaCl, 2 mM MgCl2, 5 mM DTE, 10 µM GDP) at a flow rate of 
0.5 mL/min.  
For RP-HPLC the gradient of buffer B (0.1 % TFA in acetonitrile) in buffer A 
(0.1 % TFA in water) at a flow rate of 1 mL/min was applied using a gradient program 
described in Table 5-12. Under these conditions, unprenylated Rab proteins typically 
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were eluted at ca. 17 min. Data analysis was carried out using the software package 
provided by Waters. 
Table 5-12: Gradient program for HPLC measurements of protein using a C4 column. 
Time (min) buffer A (0.1% TFA,  H2O) % buffer B (0.1% TFA, ACN) % 
2 95 5 
17 30 70 
22 30 70 
24 0 100 
26 0 100 
28 95 5 
30 95 5 
5.4.5 Ion exchange chromatography 
Poros HQ (PerSeptive Biosystem) and HiTrap Q Sepharose (Amersham 
Biosciences) anion-exchange columns were used for ion exchange chromatography. 
The columns were washed with buffer A (10 mM NaH2PO4, pH 7.5, 2 M NaCl, 1 mM 
MgCl2) and subsequently equilibrated with buffer B (10 mM NaH2PO4, pH 7.5, 10 mM 
NaCl, 1 mM MgCl2, 5 mM MESNA). The proteins were loaded onto the column and 
eluted with a linear gradient from 10 mM (buffer B) to 500 mM NaCl (buffer C: 10 mM 
NaH2PO4, pH 7.5, 500 mM NaCl, 1 mM MgCl2, 5 mM MESNA). 
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5.5 Biochemical methods 
5.5.1 Conjugation of organic dyes to Rab7 α-thioester  
50-100 μM protein in buffer (25 mM NaH2PO4, pH 7.2, 30 mM NaCl, 1 mM 
MgCl2, 20 μM GDP) was added with 2-10 eq. (versus cysteine) thio-reactive organic 
dyes from a stock solution in DMSO. The final concentration of DMSO as a cosolvent 
is typical 5% (v/v). The reaction mixture was incubated at room temperature (20°C) 
for 0.5-1 h under an atmosphere of argon. The reaction was quenched by adding 
MESNA to a final concentration of 10 mM. After reaction, dyes were removed by a 
NAP-5 desalting column (Amersham) equilibrated with buffer (25 mM NaH2PO4, pH 
7.2, 30 mM NaCl, 1 mM MgCl2, 20 μM GDP, 10 mM MESNA). The protein 
conjugates were further purified by ion exchange chromatography on a 1 mL Poros 
HQ anion-exchange column. The fractions of interest were collected and carried out 
buffer exchange using a NAP-5 desalting column equilibrated with ligation buffer (25 
mM NaH2PO4, pH 7.5, 30 mM NaCl, 1 mM MgCl2, 100 μM GDP, 10 mM MESNA). 
The flow-through was concentrated to 5-10 mg/mL with VIVASPIN 500 (MWCO: 
10kDa) (Vivascience AG, Hannover, Germany). 
5.5.2 Ligation of unprenylated peptide to Rab α-thioester  
5-10 mg/mL Rab α-thioester in ligation buffer (25 mM NaH2PO4, pH 7.5, 30 mM 
NaCl, 1 mM MgCl2, 100 μM GDP, 10 mM MESNA) was supplemented with 100 mM 
MESNA (final concentration). The reaction was initiated by adding fluorescently 
labeled or unlabeled peptide in a final concentration of 2-4 mM (20 eq.) from a stock 
solution in DMSO. The final concentration of DMSO as a cosolvent is typical 5% 
(v/v). The reaction mixture was incubated at room temperature (20°C) overnight (10-
12h). After reaction, unreacted peptides were removed by a NAP-5 desalting column 
or dialysis against buffer (25 mM NaH2PO4, pH 7.2, 30 mM NaCl, 1 mM MgCl2, 20 
μM GDP, 2 mM DTE). 
5.5.3 Ligation of prenylated peptide to Rab α-thioester 
Ligation of the mono- and di-geranylgeranylated peptide to Rab7Δ6 and 
Rab7Δ2SS α-thioester to prepare Rab7-C205S-CC(GG) and Rab7-A202C-
5.5 Biochemical methods  
198 
E203K(dans)SC(GG)SC(GG) was previously performed by Dr. Thomas Durek in 
MPI-Dortmund (Durek et al., 2004a; Rak et al., 2003). 
To prepare Rab7CSC(NBD-farnesyl) (Rab7-NF), Rab7Δ3-MESNA thioester 
protein (>10 mg/mL) in ligation buffer was supplemented with 40 mM CTAB and 100 
mM MESNA. Ligation was initiated by adding >2mM peptide C(StBu)SC(NBD-
farnesyl) from a ca. 40 mM stock solution in DMSO. The reaction mixture was 
incubated overnight at 40°C with vigorous agitation. The reaction mixture was 
centrifuged, and the supernatant was removed. The pellet was washed 4 times with 
methanol, 4 times with of dichloromethane, 4 times with methanol, and 4 times with 
Milli-Q water at room temperature in order to remove contaminating peptide and 
unligated protein. The precipitate was dissolved in denaturation buffer (100 mM Tris-
HCl, pH 8.0, 6 M guanidinium-HCl, 100 mM DTE, 1% CHAPS, 1 mM EDTA) to a final 
protein concentration of 0.5-1.0 mg/mL and incubated overnight at 4°C with slight 
agitation. The solution was cleared by centrifugation. The solution can be stored at 
this point at -80°C. 
5.5.4 Refolding of the prenylated Rab  
Mono-, di-geranylgeranylated or NBD-farnesylated Rab7 in denaturation buffer 
was renatured by diluting it at least 30-fold dropwise into refolding buffer (50 mM 
HEPES, pH 7.5, 2.5 mM DTE, 2 mM MgCl2, 100 μM GDP, 1% CHAPS, 400 mM 
arginine-HCl, 400 mM trehalose, 1 mM PMSF) in the presence or the absence of an 
equimolar amount of RabGGTase beta subunit (βGGT) with gentle stirring at room 
temperature. Alternatively 10 molar excess of delipidated BSA was used. The 
mixture was incubated for 30min at room temperature and 60 min on ice, and 
concentrated to 2-5 mg/mL using Amicon Ultra-5 concentrator (MWCO: 10 kDa) from 
Milipore. The concentrated mixture was dialyzed overnight against two 2 L changes 
of dialysis buffer (25 mM HEPES, pH 7.5, 50 mM (NH4)2SO4, 50mM NaCl, 2 mM 
MgCl2, 2.5 mM DTE, 10 μM GDP, 10% glycerol, 1 mM PMSF). The dialyzed material 
was centrifuged at 16,000 g for 10 min to remove aggregates and subsequently 
loaded on a Superdex-200 HR 10/30 gel filtration column (Pharmacia Biotech) 
equilibrated with gel filtration buffer (50 mM HEPES, pH 7.2, 50mM NaCl, 5 mM DTE, 
2 mM MgCl2, 10 μM GDP). The fractions containing the Rab7:βGGT complex or 
Rab7(NBD-farnesyl) were collected, concentrated to 2mg/mL, flash-frozen in liquid 
nitrogen in multiple aliquots and stored at -80°C.     
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5.5.5 In vitro prenylation to prepare Rab7-NF:REP-1 
complex 
Single cysteine mutant Rab7C207S (0.4 mg, 16.7 nmol) was mixed with 1.22 mg 
REP-1 (16.7 nmol) and 2.6 mg GST-RabGGTase (20 nmol) in prenylation buffer (25 
mM HEPES, pH 7.2, 50 mM NaCl, 3 mM MgCl2, 5 mM DTE,10 µM GDP). 167 nmol 
(10 eq.) of NBD-farnesyl pyrophosphate (NBD-FPP) from a 10 mM stock solution in 
25 mM (NH4)2CO3 was added to initiate the reaction. The reaction mixture was 
incubated at 20°C for 1h followed by dilution to 4 mL with prenylation buffer 
containing 5% CHAPS. The solution was passed three times over a glutathione 
Sepharose column (Pharmacia, 0.5 mL bed volume) equilibrated with the same 
buffer. The flow-through was collected and dialyzed against gel filtration buffer (50 
mM NaH2PO4, pH 7.2, 50 mM NaCl, 1 mM MgCl2, 10 μM GDP, 2 mM β-
mercaptoethanol). After dialysis, the sample was concentrated to 300 μL and loaded 
on a Superdex 200 HR 10/30 GF column (Pharmacia) equilibrated with gel filtration 
buffer. Fractions containing binary Rab7-NF:REP-1 complex were pooled, 
concentrated to approximately 20 mg/mL and stored at -80°C in multiple aliquots. 
5.5.6 Screening of RabGGTase inhibitors by 96-well plate 
assay 
1|  Prepare fresh prenylation buffer (50 mM HEPES, pH7.2, 50 mM NaCl, 2 mM 
MgCl2, 5 mM DTE, 20 μM GDP, 0.01% TritonX-100), filter the buffer through a 
0.2 μm membrane filter (Whatman) and degas on a vacuum-membrane 
(ILM/VAC GmbH) pump by stirring for 0.5 h at room temperature. 
2|  Switch on the Fluoroskan Acsent Fl machine (Thermo BioAnalysis, Santa Fe, 
New Mexico, USA), set the system temperature to 37°C, and let it equilibrate 
while preparing test samples. 
3|  Dispense 50 μl 4 μM NBD-FPP (560.4 Da) and 40 nM RabGGTase (100 kDa) 
cocktail from a groove to each well of a 95-well plate using a 8-channel 
multipipette. The number of wells should correspond to the number of test 
samples, positive and negative controls in triplicate. In the case of the positive 
control no inhibitor is added to the solution.  
4|  If performing inhibitor screening, add the desired compounds at the selected 
concentrations to the plate. Typically 0.5 μl of 10 mM compound in DMSO is 
added to reach a final concentration of 50 μM in each reaction. 
5.5 Biochemical methods  
200 
5|  Mix the plate on an orbital shaker integrated in the Fluoroskan machine. 
6|  Incubate the plate with cover at 37°C for 5 min. 
7|  Incubate the 4 μM Rab7 (24 kDa) and 4 μM REP-1 (76 kDa) protein substrate 
cocktail and prenylation buffer at 37°C for 5 min. 
8|  Dispense 50 μl of the Rab7:REP-1 protein substrate cocktail from a groove to 
the wells for the corresponding samples and positive controls using a 
multipipette. For the negative controls, add 50 μl of prenylation buffer instead. 
9|  Immediately start measuring the fluorescence intensity of each well over a time 
period of 10-20 min (with approximately 30-50 individual measurements per 
well). Use an excitation cut-off filter of 485 nm and an emission cut-off filter of 
538 nm.  
10|  After measurement, reactions were quenched by addition of 1 μl 10% 
trifluoroacetic acid (TFA) quenching buffer, final concentration of TFA is 0.1% 
(v/v).  
11|  Process the time-dependent fluorescence change of each well to obtain the 
average rate with the Acsent Fl software provided by the manufacturer. 
 
Before start a screening of compounds, a series of test experiments where the 
different combinations of the concentrations of Rab7:REP-1, NBD-FPP and 
RabGGTase should be performed to find out those conditions providing enough 
signal to noise ratio. Then the screening follows the step 1 to 11. The IC50 was 
calculated as described in section 4.2.1. 
5.5.7 SDS-PAGE end-point assay to investigate selectivity 
of inhibitors 
In the SDS-polyacrylamide gel electrophoresis end-point assay for inhibitors of 
FTase, GGTase-I and RabGGTase, recombinant protein substrate GST-KiRas , 
GST-RhoA and Rab7, and fluorescent lipid substrate NBD-GPP and NBD-FPP were 
used, respectively. In the prenylation buffer (50 mM HEPES, pH 7.2, 50 mM NaCl, 2 
mM MgCl2, 2 mM DTE, 0.01% Triton X-100), a 10 µl mixture of FTase with NBD-GPP, 
GGTase-I with NBD-FPP, RabGGTase with NBD-FPP in the presence and the 
absence of various concentrations of inhibitor were incubated for 5 minutes at 37°C, 
the same volume of protein substrate GST-KiRas , GST-RhoA and Rab7 with REP-1 
were added to initiate the reaction. For the FTase assay, 3 µM GST-KiRas, 2 µM 
5. Materials and Methods 
 
201 
NBD-FPP, and 20 nM FTase, for the GGTase-I assay, 6 µM GST-RhoA, 6 µM NBD-
FPP, and 1 µM GGTase-I; for the RabGGTase assay 3 µM Rab, 3 µM REP, 2 µM 
NBD-FPP, and 40 nM RabGGTase, respectively, were used. In the negative controls, 
the enzymes were omitted. Reactions were run for the same period of time (10 min) 
and quenched by adding cold 2X SDS sample buffer. The reaction mixtures were 
resolved by 15% SDS-PAGE and the gel was scanned using a Fluorescent Image 
Reader FLA-5000 (Fujifilm) (excitation laser at 473 nm and emission cutoff filter at 
510 nm). The fluorescent bands corresponding to the formation of the prenylated 
product were quantified using the AIDA densitometry software. The data were 
processed in the same way as in the plate assay. 
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5.6 Biophysical methods 
Fluorescence measurements were performed on a Spex Fluoromax-3 
spectrofluorometer (Jobin Yvon, Edison, NJ, USA). Measurements were carried out 
in 1 mL quartz cuvettes (Hellma) with continuous stirring and thermostated at 25° C 
unless otherwise indicated. Transient kinetics was recorded on a stopped-flow 
spectrometer SX20 (Applied Photophysics, Leatherhead, UK). Isothermal titration 
calorimetry (ITC) measurements were carried out on a VP-isothermal titration 
calorimeter (MicroCal, Northampton, USA). All buffers used in these experiments 
were filtered through a 0.2 μm membrane filter (Whatman) and degassed on a 
vacuum-membrane (ILM/VAC GmbH) pump by stirring for 0.5 h at room temperature. 
5.6.1 Continuous fluorometric assay for Rab prenylation 
To perform the assay using fluorescent Rab7 proteins, 100-200 nM of 
fluorescently labeled Rab7 was mixed with an equal amount of REP-1 and 
RabGGTase in a quartz cuvette, containing 1 mL of prenylation buffer (50 mM 
HEPES, pH 7.2, 50 mM NaCl, 5 mM DTE, 2 mM MgCl2, 10 µM GDP). After a 5 min-
incubation at 25°C, the reaction was initiated by adding geranylgeranyl 
pyrophosphate (GGPP) to a final concentration of ca. 10 µM. Excitation and emission 
monochromators settings were dependent on the feature of dyes. The fluorescence 
(count/sec) was related to the amount of prenylated product formation (μM) using the 
following equation: 
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where P is the amount of product, F is the fluorescent intensity, e is the fluorescence 
enhancement factor, i.e. the ratio of the fluorescence of the prenylated product to the 
fluorescence of the starting material, m is the conversion factor, i.e. the slope of the 
line generated in a plot of concentration of prenylated protein substrate versus 
fluorescence intensity. e and m should be measured at the same conditions. 
To perform the assay using NBD-FPP, 1 μM of REP-1 and RabGGTase in a 
quartz cuvette were mixed with 4 μM NBD-FPP in the same buffer. Rab7 wild-type or 
mutants were added to a final concentration of 1 μM to start the reaction. Excitation 
and emission monochromators were set to 479 nm and 520 nm, respectively. The 
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traces were fitted to a single or double exponential equation using GraFit 5.0 
(Erithacus software, Surrey, UK): 
tkeAFF −+= 0  
tktk eAeAFF 21 210
−− ++=  
 
where F is the observed fluorescence intensity, F0 is the fluorescence intensity at 
t = ∞, A, A1 and A2 are the amplitudes, t is the time, k, k1 and k2 are the rate 
constants. 
5.6.2 Fluorescence titrations – determination of Kd 
Fluorescence titrations were performed in titration buffer (50 mM HEPES, 
pH 7.2, 50 mM NaCl and 5 mM DTE). Fluorescently labelled reactant A was added to 
a quartz cuvette containing 1 mL buffer with continuous stirring. Small aliquots of 
titrant E were then added to the cuvette, until the fluorescence signal change 
reached situation. The change in fluorescence was corrected for light scattering as 
well as dilution and plotted as a function of the reactant concentration. The data was 
fitted to the following equation using GraFit 5.0 (Erithacus software, Surrey, UK): 
 
( )
0
minmax
00
2
0000min 2
4
A
FFEAEAKEAKFF dd
−⎟⎠
⎞⎜⎝
⎛ −++−+++=  
 
where F is the observed fluorescence intensity after each step of titrant E addition, E0 
is the total (cumulative) concentration of titrant E, A0 is the concentration of 
fluorescent reactant A, Fmin is the initial fluorescence intensity at E0 = 0, Fmax is the 
final fluorescence intensity at E0 = ∞, and Kd is the equilibrium constant, which is to 
be determined (see Appendix 6.1 for a derivation of this equation).  
Competitive titration was performed by titrating of competitor B to a preformed 
A:E complex. Co-titration was carried out by titrating of reactant E to a mixture of A 
and competitor B. Data analysis was performed with the program SCIENTIST 
(MicroMath Scientific Software, Saint Louis, Missouri USA). A description of 
equations is in Appendix 6.2. 
5.6.3 Transient kinetics 
Stopped-flow measurements 
5.6 Biophysical methods  
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Fluorescent reactant A in buffer (50 mM HEPES, pH 7.2, 50 mM NaCl, 5 mM 
DTE) was rapidly mixed in the stopped-flow apparatus with an equal volume of 
reactant B in the same buffer. Excitation was at 479 nm for NBD, while fluorescene 
was recorded through a 530 nm cut-off filter. Mixing and measuring chamber were 
thermostated at 25° C using a water bath. Typically, traces of 3 independent 
experiments were averaged using the software package provided by Applied 
Photophysics.   
Determination of koff 
Fluorescent A complexed with E was displaced from E by addition of excess 
amount of competitor B. The dissociation was monitored either in Fluoromax-3 for 
slow dissociation process or stopped-flow machine for fast dissociation process. The 
measurements were performed at 25°C in buffer (50 mM HEPES, pH 7.2, 50 mM 
NaCl and 5 mM DTE). The obtained dissociation traces could be fitted to a single 
exponential equation: 
tkoffAeFF −+= 0  
where F is the observed fluorescence, F0 is the offset, A is the signal amplitude, t is 
the time, and koff is the dissociation rate constant. Data analysis was carried out 
using GraFit 5.0 (Erithacus software). 
5.6.4 Isothermal titration calorimetry (ITC) 
ITC measurements were carried out in the ITC buffer (50 mM HEPES, pH7.2, 50 
mM NaCl, 0.2 mM β-mercaptoethanol) at 25°C. 
1|  Dialyze both protein reactants against the same ITC buffer. In the case of 
titration with a compound, the protein was dialyzed against ITC buffer, while the 
ligand was dissolved in the same buffer.  
2|  Centrifuge the protein and the ligand solution to remove any unsoluble material. 
Degas the samples in a ThermoVac degassing apparatus (MicroCal) 
thermostated at 25°C to remove residual air bubbles.  
3|  Slowly withdraw 2 ml of 50 μM protein into the filling syringe with a long needle. 
4|  Remove all air from the filling syringe by tapping the syringe. ▲CRITICAL Do 
not allow air bubbles to be introduced into the cell. 
5|  Inject the solution with an abrupt spurt of ca. 0.25 mL into the cell until you see 
it spill out the top of the cell stem. ▲CRITICAL This bursting of solution will help 
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remove bubbles that may rest on the edges of the coin shaped area where the 
junction of the stem is.  
6|  Drain off the solution overflow. ▲CRITICAL Place the syringe on the ledge at 
the top of the metal cell stem and remove the excess solution. 
7|  Fill the reference cell with water as above. 
8|  Attach the tube of the plastic filling syringe to the filling port of the injection 
syringe. Click on the Open Fill Port button in the ITC Controls window. 
9|  Slowly withdraw the plunger of the plastic filling syringe to draw up the 0.5 mM 
ligand from a 500 μL reservoir until you see the solution exit through the top 
filling port. Then click on the Close Fill Port button. ▲CRITICAL Keep 
submersing the pipette tip in eppendorf tube containing ligand solution. 
10|  Click on the Purge->ReFill button to apply two purge/refill procedures in order 
to dislodge any air bubbles from inside walls of the injection syringe. 
▲CRITICAL The long needle and stir paddle on the pipette injection syringe 
must not be bent even slightly. 
11|  Carefully insert the pipette into the sample cell access tube. Watch the end 
paddle of the long needle to insure it is inserted directly into the access hole, 
hold the pipette vertical and slowly lower the pipette. When the pipette is 
completely inserted, push down slightly to compensate for the resistance of the 
rubber o-ring to seat the pipette. 
12|  Set the run parameters. Total number of injections: 26, Injection volume: 8 μL, 
Duration: 16 sec (injection time, this value yields an injection rate of 0.5 μL/sec), 
Spacing: 240 sec (the interval between injections), Cell temperature: 25°C, 
Reference Power: 18 μCal/sec (large exothermic reactions require 30 μCal/sec, 
large endothermic reactions require 2 μCal/sec), Stirring Speed: 310 rpm.  
13|  Start to run an ITC experiment. ▲CRITICAL Make a small first injection (2 μL) 
to avoid a smaller heat effect that may be resulted from leakage or bending the 
syringe needle. Then delete the first data point before doing curve-fitting. 
14|  Perform control experiments to determine the heat of dilution of the ligand by 
titrating the ligand into the buffer in the same way as the experiment with protein 
present. ▲CRITICAL These heats of dilution should be subtracted from the 
corresponding injection into the protein solution. 
15|  Perform least-squares fit to a single-site binding model using the program Origin 
that includes routines designed to analyze ITC data (MicroCal). 
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6. Appendices 
6.1 Equilibrium titration 
In a reversible second-order reaction: 
kon
koff
A + E AE
 
the dissociation constant is defined as:                                                           
on
off
d k
k
AE
EAK =⋅=  
where A, E and AE are the equilibrium concentrations of labeled ligand A,  titrant E 
and complex AE, respectively. Kd is the dissociation constant. 
The mass conservation relations AEAA −= 0  AEEE −= 0  
 
result in ( ) ( )
AE
AEEAEAKd
−⋅−= 00  
 
where A0 and E0 are the total concentrations (free and bound) of labeled ligand A and 
titrant E, respectively. 
This can be rearranged to  ( ) ( ) 000002 =+++− EAEAKAEAE d  
The solutions of this quadratic equation are : 
( ) ( ) ⎥⎦⎤⎢⎣⎡ −++±++= 0020000 42
1 EAEAKEAKAE dd  
 
The relation AE ≤ E0 gives 
 ( ) ( ) ⎥⎦⎤⎢⎣⎡ −++−++= 0020000 42
1 EAEAKEAKAE dd  (eq. 1) 
 
The fractional completion of the binding reaction (r) can be observed using 
spectroscopic techniques and corresponds to : 
minmax
min
0 FF
FF
A
AEr −
−==  
 
where F is the experimentally observed signal, such as fluorescence intensity, 
anisotropy or absorbance, Fmin is the initial signal at E0 = 0, Fmax is the final signal at 
E0 = ∞. This equation is only valid if the quantity of F is a linear function of the 
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fractional completion of the reaction and does not depend on other reactions. This 
equation can be rearranged to: 
 
 
0
minmax
min A
FFAEFF −+=  (eq. 2) 
Replacing AE in eq. 2 with eq. 1 results in: 
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Figure 6-1. Simulation of titration curves. In all cases 100 nM labeled ligand A (A0=100 nM) is titrated 
with increasing concentrations of binder E. Fmax and Fmin are set to 10 and 1, respectively. Kd=1 nM 
(black), Kd=10nM (red), Kd=100nM (blue), Kd=200 nM (green). 
6.2 Competitive titration 
A and B competitively bind to E: 
k+1
k-1
A + E AE
k+2
k-2
B + E BE
KdA Labeled
KdB Unlabeled
 
the dissociation constant is defined as:                                                           
AE
EAKdA
⋅=  
BE
EBKdB
⋅=  
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where A, B, E, AE and BE are the equilibrium concentrations of labeled ligand A, 
unlabeled competitor B, binder E, complex AE and complex BE, respectively. KdA is 
the dissociation constant of AE, KdB is the dissociation constant of BE. 
There are mass conservation relations: 
AEAA −= 0  
BEBB −= 0  
BEAEEE −−= 0  
where A0, B0 and E0 are the total concentrations (free and bound) of labeled ligand A, 
competitor B and binder E, respectively. 
The signal observed has the relation: 
AEYAYF aea ⋅+⋅=  
where F is the experimentally observed signal, Ya and Yae are the quantum yields or 
extinction coefficients of ligand A and complex AE, respectively. These two values 
can be estimated by the initial signal at E0 = 0, Fmin = Ya*A0, and the final signal at 
E0 = ∞, Fmax = Yae*A0. 
The KdA of the reporter is first determined by titrating binder E to a fixed 
concentration of ligand A as described in 6.1. Competition titrations can be done in 
two ways: (a) competitive titration: a complex of E and A at concentrations above its 
determined KdA is pre-formed followed by titrating with competitor B (Figure 6-3); (b) 
co-titration: A is premixed with B, and E is titrated into the mixture (Figure 6-2). This 
value KdA is fixed during the simulation of competitive titration data, allowing 
calculation of KdB using the equations described above.  
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Figure 6-2. Simulation of co-titration curves. In all cases 100 nM labeled ligand A mixed with 100 nM 
competitor B is titrated with increasing concentrations of binder E. Ya and Yae are set to 0.01 and 0.1, 
respectively. KdB=0.1 nM (black), KdB=1 nM (red), KdB=10 nM (blue), KdB=100 nM (green). 
 
    
Figure 6-3. Simulation of competitive titration curves. In all cases 100 nM labeled ligand A pre-mixed 
with 100 nM binder E is titrated with increasing concentrations of competitor B. Ya and Yae are set to 
0.01 and 0.1, respectively. KdB=100 nM (A), KdB=10 nM (B), KdB=1 nM (C), KdB=0.1 nM (D). 
 
6.3 Dissociation kinetics  
The two competitive reaction models shown in 6.2 can be transformed as: 
k+1
k-1
A + E + BAE
k+2
k-2
BE
 
where k+1 and k-1 are association and dissociation rate constant of a labeled ligand A 
from its complex AE, respectively, and k+2 and k-2 are association and dissociation 
rate constant of a unlabeled ligand B (competitor) from its complex BE, respectively.  
The decay of AE can be described by  
 
 AEkEAk
dt
dAE ⋅−⋅⋅= −+ 11 . (eq. 3) 
A B 
C D 
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In the present case it is assumed that both the labeled and the unlabeled ligand 
interact with the protein in a similar manner. If a large excess of unlabeled ligand B is 
applied (B>>A, E), the association rate of the competitor B with the free protein E is 
significantly faster than the association of the labeled ligand A (i.e. k2*B >> k1*A*E), 
which would drive the reaction towards the formation of BE complex and make the 
dissociation of AE pseudo-irreversible. Under such conditions the concentration of 
free (unbound) protein E is very low (E Æ 0) and thereby k1*A*E is negligible. This 
will give 
 AEk
dt
dAE ⋅−= −1  (eq. 4) 
integration gives a single exponential equation: 
tkeAEAE 10 −
−=  
where AE0 is the concentration of the complex AE when B0 = 0. 
6.4 Consecutive reaction kinetics  
A simple model of a first order consecutive reaction is: 
S
k1 I
k2 P 
The substrate (S) decays with a transient increase and then decay of the 
intermediate (I) and the emergence of the product (P). 
 Sk
dt
dS ⋅−= 1  (eq. 5) 
 IkSk
dt
dI ⋅−⋅= 21  (eq. 6) 
 Ik
dt
dS ⋅= 2  (eq. 7) 
Integrations give equations: 
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where S0 is the concentration of substrate at the beginning of the reaction. A 
simulation of the reaction is shown in Figure 6-4. 
 
 
Figure 6-4. Simulation of the process of a first order consecutive reaction. S: concentration of 
substrate (red), I: concentration of intermediate (blue), P: concentration of product (green). 
 
The prenylation reaction described in Scheme 4-3 (section 4.1.3.2) is shown in a 
simple way (Scheme 6-1) and give a set of differential equations (eq. 8-17). 
 
Scheme 6-1. 
B + E
k2
k-2
k3
k-4
k4
k6
AE + N AEN
AEN BE
BE
BE + N BEN
k5
k-5
BEN CE
k1
k-1
A + E AE
C+E
k-7
k7
CE
 
where A is Rab7:REP, E is RabGGTase, N is NBD-FPP, B is Rab7_NF:REP, C is 
Rab7_NFNF:REP.  
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EAkAEk
dt
dA ⋅⋅−⋅= − 11  (eq. 8) 
ECkCEkEBkBEkEAkAEk
dt
dE ⋅⋅−⋅+⋅⋅−⋅+⋅⋅−⋅= −−− 774411  (eq. 9) 
NAEkAENkAEkEAk
dt
dAE ⋅⋅−⋅+⋅−⋅⋅= −− 2211  (eq. 10) 
NBEkBENkNAEkAENk
dt
dN ⋅⋅−⋅+⋅⋅−⋅= −− 5522  (eq. 11) 
AENkAENkNAEk
dt
dAEN ⋅−⋅−⋅⋅= − 322  (eq. 12) 
BENkNBEkEBkBEkAENk
dt
dBE ⋅+⋅⋅−⋅⋅+⋅−⋅= −− 55443  (eq. 13) 
EBkBEk
dt
dB ⋅⋅−⋅= − 44  (eq. 14) 
BENkBENkNBEk
dt
dBEN ⋅−⋅−⋅⋅= − 655  (eq. 15) 
ECkCEkBENk
dt
dCE ⋅⋅−⋅−⋅= − 776  (eq. 16) 
ECkCEk
dt
dC ⋅⋅−⋅= − 77  (eq. 17) 
6.5 Isothermal titration calorimetry (ITC)  
ITC (Lewis and Murphy, 2005) is a quantitative approach for measuring protein-
protein/ligand interactions. It does not rely on the presence of chromophores or 
fluorophores, nor does it require an enzymatic assay. ITC detects a heat effect upon 
binding. An ITC experiment can be used to determine the binding the binding 
constant (Ka), the enthalpy of binding (∆H), and the stoichiometry (n) or number of 
binding sites. The entropy change (∆S) of binding is calculated from ∆H and Ka:  
STHKRTG a Δ−Δ=−=Δ ln  
where ∆G is Gibbs free energy, R is gas constant, T is absolute temperature. 
At the beginning of an experiment, the cell of calorimeter is filled with 
macromolecule solution (working volume V0) and the injection of ligand solution 
drives an equivalent volume (Vinj) of solution out of the cell. The concentration of 
macromolecule decreases at injection number i as: 
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i
inj
totitot V
V
nMM ⎟⎟⎠
⎞
⎜⎜⎝
⎛ −=
0
0,, 1  (eq. 18) 
where Mtot,i is the total concentration of protein in the cell after injection step i, Mtot,0 is 
the total concentration of protein in the cell before injection, which is known quantity. 
V0 is the volume of the cell, Vinj is the injection volume, and n is the number of binding 
sites. 
The total concentration of the titrant ligand increases with each injection step as: 
 
i
inj
totitot V
V
LL ⎟⎟⎠
⎞
⎜⎜⎝
⎛=
0
0,,  (eq. 19) 
where Ltot,i is the total concentration of ligand in the cell after injection step I and Ltot,0 
is the total concentration of ligand in the injection syringe. 
The total concentration of macromolecule and ligand is equal to the sum of the 
bound and the free (unbound) forms at injection number i, and is given as: 
 )1(, iaiiiitot LKMMLMM +=+=  (eq. 20) 
 )1(, iaiiiitot MKLMLLL +=+=  (eq. 21) 
where Mi, Li and MLi are the concentrations of free macromolecule, free ligand and 
ML complex at injection number i, Ka is the binding constant. 
Eq. 20 can be rearranged to give the concentration of free M as: 
 
ia
itot
i LK
M
M += 1
,  (eq. 22) 
Eq. 22 can be substituted into eq. 21 and rearranged to give the following quadratic 
expression: 
 ( )[ ] 01 ,,,2 =−−++ itotiitotitotaia LLLMKLK  (eq. 23) 
The meaningful solution of this quadratic equation gives the concentration of free 
ligand after any injection step: 
 
( )[ ] ( )[ ]
a
itotaitotitotaitotitota
i K
LKLMKLMK
L
2
411 ,
2
,,,, +−++−+−=  (eq. 24) 
The heat that is absorbed or produced for each injection in an ITC experiment is 
the difference in heat content before and after the injection. The heat for injection 
number i is defined as: 
 ( )injitotiitotii VVMHVMHQ −Δ−Δ= −− 01,10,  (eq. 25) 
where <ΔH> is the cumulative enthalpy change per mole of macromolecule. 
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In case of one to one binding, the cumulative enthalpy change is given as: 
 
ia
ia
i
i
itot
i
i LK
LKH
MLM
MLH
M
MLHH +Δ=+Δ=Δ=Δ 1,
 (eq. 26) 
where ΔH is the enthalpy change for binding one mole of ligand to one mole of 
macromolecule, Mtot,i and MLi are the concentrations of total and bound 
macromolecule at injection number i. 
Replacing <ΔH> in eq. 26 with eq. 25 results in: 
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1
01,10,
11 −
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ia
injitotia
ia
itotia
i LK
VVMLHK
LK
VMLHK
Q  (eq. 27) 
where the Mtot,i and Ltot,i can be calculated from eq. 18 and 19, respectively, while Li 
can be substituted using eq. 24. Therefore, eq. 27 is a quadratic equation of Ka. 
Fitting the ITC data to this equation allows for direct determination of ∆H, Ka and n.  
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